abemaciclib profile

ID Source	ID
PubMed CID	46220502
CHEMBL ID	3301610
SCHEMBL ID	2487229
MeSH ID	M000596583

Synonym
ly2835219
UZWDCWONPYILKI-UHFFFAOYSA-N
[5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3h-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine
abemaciclib ,
HY-16297A ,
CS-1230 ,
S5716
gtpl7382
verzenios
n-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine
ly-2835219
verzenio
ly 2835219
abemaciclib [usan]
abemaciclib [inn]
abemaciclib [mi]
abemaciclib [jan]
2-pyrimidinamine, n-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1h-benzimidazol-6-yl)
60UAB198HK ,
abemaciclib [who-dd]
abemaciclib [orange book]
CHEMBL3301610
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3h-benzimidazol-5-yl)pyrimidin-2-yl)amine
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3h-benzoimidazol-5-yl)pyrimidin-2-yl)amine
ly 2835210
unii-60uab198hk
abemaciclib [usan:inn]
ly2835210
1231929-97-7
ly2835219 (free base)
SCHEMBL2487229
c27h32f2n8
n-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1h-benzo[d]imidazol-6-yl)pyrimidin-2-amine
verzenio (tn)
abemaciclib (jan/usan)
D10688
ly 2835219 (free base)
ly2835219 free base
AC-30666
6zv ,
AKOS025404907
J-690083
DTXSID20673119
n-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1h-benzimidazol-6-yl]pyrimidin-2-amine
EX-A521
cdk4/6 dual inhibitor
mfcd22665744
bdbm50110183
NCGC00351599-06
n-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-1,3-benzodiazol-5-yl)pyrimidin-2-amine
ly2835219 free base (abemaciclib)
DB12001
rimidin-2-amine
n-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1h-benzimidazol-6-yl]py
1231929-97-7, verzenio,
FT-0700134
ly2835219 ms salt, abemaciclib ms salt
EX-A1588
Q23901483
AS-10230
BCP13079
SB16476
HMS3673I05
2-pyrimidinamine, n-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1h-benzimidazol-6-yl]-
CCG-269750
NCGC00351599-02
nsc783671
nsc-783671
nsc768073
nsc-768073
n-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1h-benzimidazol-6-yl]py rimidin-2-amine
abemaciclibum
n-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1h-benzimidazol-6-yl)pyrimidin-2-amine
l01xe50
n-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1h-1,3-benzodiazol-6-yl]pyrimidin-2-amine
EN300-7406007

Excerpt	Reference	Relevance
"Abemaciclib is a selective cyclin-dependent kinase(CDK)4 & 6 inhibitor, which induces G1 cell cycle arrest and tumour growth inhibition. "	( [Development of CDK4 & 6 Inhibitor Abemaciclib in Breast Cancer]. Chen, Y; Kawaguchi, T; Masuda, N; Ohno, S; Saji, S, 2021)	2.34
"Abemaciclib is an oral, selective cyclin-dependent kinase 4 & 6 inhibitor (CDK4 & 6i), approved for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) as monotherapy for endocrine refractory disease, and with endocrine therapy (ET) for initial treatment and after progression on ET. "	( Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation. Baquero, C; Bian, H; de Dios, A; Du, J; Ganado, MP; Lallena, MJ; Marugan, C; Mur, C; Puig, O; Torres-Guzmán, R; Yang, Y; Zeng, Y, 2022)	2.46
"Abemaciclib is an effective selective cyclin-dependent kinases 4 and 6 inhibitors for cancer therapy. "	( Development and validation of a reversed-phase high-performance liquid chromatography-ultraviolet method for abemaciclib-related substance detection in bulk drugs. Cai, L; Du, X; Huang, R; Ma, X; Ni, R; Wu, W; Xu, J, 2022)	2.38
"Abemaciclib (ABE) is a cyclin-dependent kinase inhibitor used in combination with an antiestrogen in the treatment of breast cancer. "	( The protective effect of curcumin on cardiac markers and fibrosis in abemaciclib-induced cardiac damage in rats. Altındağ, F; Huyut, Z; Uçar, B; Yıldızhan, K, 2023)	2.59
"Abemaciclib (ABEM) is an important antitumor agent for breast cancer treatment. "	( Effect of curcumin on lipid profile, fibrosis, and apoptosis in liver tissue in abemaciclib-administered rats. Altındağ, F; Huyut, MT; Huyut, Z; Uçar, B; Yıldızhan, K, 2023)	2.58
"Abemaciclib is a cyclin-dependent kinase 4/6 inhibitor approved in combination with endocrine therapy for treating hormone receptor-positive and human epidermal growth factor receptor 2-negative early and advanced breast cancer patients. "	( Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data. Caruso, M; Gebbia, V; Giotta, F; Martorana, F; Piazza, D; Sanò, MV; Spada, M; Valerio, MR; Vigneri, P, 2023)	3.8
"Abemaciclib is an orally administered, potent, and selective small molecule inhibitor of cyclin-dependent kinases 4 and 6, approved for advanced or metastatic breast cancer. "	( Abemaciclib does not increase the corrected QT interval in healthy participants. Chappell, JC; Chiang, AY; Coleman, H; Kulanthaivel, P; Royalty, J; Turner, PK, 2023)	3.8
"Abemaciclib is an oral anticancer drug that inhibits cyclin dependent kinases 4 and 6 and is metabolized by cytochrome P450 3A in the intestines and liver to active metabolites. "	( Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics. Chigutsa, E; Kambhampati, SRP; Karen Sykes, A; Posada, MM; Turner, PK; van der Walt, JS, 2020)	2.22
"Abemaciclib is an oral, continuously dosed, CDK4/6 inhibitor approved for HR+, HER2- advanced breast cancer (ABC)."	( Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). Boyle, F; Campone, M; Cicin, I; Cortés, J; Cox, J; Frenzel, M; Guarneri, V; Hamilton, E; Harbeck, N; Headley, D; Hegg, R; Hulstijn, M; Huober, J; Johnston, SRD; Martin, M; Martinez Rodriguez, JL; Neven, P; O'Shaughnessy, J; Okada, M; Rastogi, P; San Antonio, B; Shao, ZM; Smith, IC; Sohn, J; Toi, M; Tolaney, SM; Wardley, A; Wei, R; Zhang, QY, 2020)	2.72
"Abemaciclib is a selective cyclin-dependent kinase 4 and 6 inhibitor administered continuously for hormone receptor-positive (HR"	( nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer. Bear, MM; Chapman, SC; Chen, SC; Cortes, J; Hamilton, E; Hardebeck, MC; Hegg, R; Huober, J; Jerusalem, G; Johnston, EL; Lu, Y; Manikhas, A; Martin, M; Ozyilkan, O; Petrakova, K, 2021)	2.43
"Abemaciclib is a specific CDK4/6 inhibitor that has been shown to improve treatment efficacy in hormone receptor-positive advanced breast cancer; however, its potential therapeutic value and predictive markers have not yet been revealed in GC."	( p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer. Bae, HJ; Chung, HC; Jeong, HC; Jeong, I; Kang, SK; Kim, H; Kim, KH; Kim, TS; Kwon, WS; Park, S; Rha, SY, 2021)	1.59
"Abemaciclib is a cyclin-dependent kinase 4 and 6 inhibitor that has recently demonstrated efficacy and safety in advanced breast cancer."	( Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect? Alfonso, F; Alvarado-Casas, T; Rivero, F; Salamanca, J; Vera, A, 2021)	1.63
"Abemaciclib is a CDK4/6 inhibitor used to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. "	( Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib. Badaoui, S; Hopkins, AM; Kichenadasse, G; Rowland, A; Sorich, MJ, 2021)	2.27
"Abemaciclib (Verzenio™) is an orally administered inhibitor of cyclin-dependent kinases 4 and 6 that is being developed by Eli Lilly and Company. "	( Abemaciclib: First Global Approval. Kim, ES, 2017)	3.34
"Abemaciclib is a molecular-targeted agent that targets basic cell cycle regulatory mechanisms."	( Abemaciclib for the treatment of breast cancer. Kotake, T; Toi, M, 2018)	2.64
"Abemaciclib is an oral, potent, small molecule inhibitor of CDK4 and CDK6 activity, which blocks retinoblastoma tumor suppressor protein phosphorylation and thereby prevents progression through the cell cycle. "	( Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer. Lau, G; Palumbo, A; Saraceni, M, 2019)	3.4
"Abemaciclib is an effective and well-tolerated treatment for HR-positive, HER2-negative advanced or metastatic breast cancer."	( Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer. Lau, G; Palumbo, A; Saraceni, M, 2019)	3.4
"Abemaciclib (LY2835219) is an orally bioavailable CDK4/6 inhibitor under phase III clinical trials."	( Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Chen, Z; Cheng, B; Fang, X; Fu, L; To, KKW; Wang, F; Wu, T, 2017)	1.58

Excerpt	Reference	Relevance
"Abemaciclib has a lower incidence of neutropenia and a much greater incidence of all grades of diarrhea compared with other CDK4/6i, making diarrhea the key toxicity for abemaciclib."	( CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib. Degenhardt, T; Eggersmann, TK; Gluz, O; Harbeck, N; Wuerstlein, R, 2019)	1.45
"Abemaciclib has been developed for use in hormone receptor positive(HR+)breast cancer, dosed daily in combination with endocrine therapy."	( [Development of CDK4 & 6 Inhibitor Abemaciclib in Breast Cancer]. Chen, Y; Kawaguchi, T; Masuda, N; Ohno, S; Saji, S, 2021)	1.62
"Abemaciclib has been approved in the USA for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, in combination with fulvestrant in women with disease progression following endocrine therapy, and as monotherapy in adult patients with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting."	( Abemaciclib: First Global Approval. Kim, ES, 2017)	2.62

Excerpt	Reference	Relevance
"Abemaciclib can also increase the expression of PD-L1 in SCLC."	( [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression]. Guo, J; Han, Y; Mu, D; Ren, X; Sun, L; Yu, W; Zhang, J, 2023)	1.63
"Abemaciclib has a lower incidence of neutropenia and a much greater incidence of all grades of diarrhea compared with other CDK4/6i, making diarrhea the key toxicity for abemaciclib."	( CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib. Degenhardt, T; Eggersmann, TK; Gluz, O; Harbeck, N; Wuerstlein, R, 2019)	1.45

Excerpt	Reference	Relevance
"Abemaciclib-treated patients experienced more serious AEs (15.2% versus 8.8%)."	( Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study. Blancas, I; Boyle, F; Broom, R; Brown, J; Campone, M; Gumus, M; Hulstijn, M; Im, YH; Johnston, SRD; O'Shaughnessy, J; Rastogi, P; Reinisch, M; Rugo, HS; San Antonio, B; Shahir, A; Song, C; Toi, M; Tolaney, SM; Wei, R; Yamashita, T; Zagouri, F; Zimmermann, A, 2022)	1.86
"Treatment with abemaciclib or palbociclib at 100 nM significantly decreased cell proliferation in all cell models evaluated."	( Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma. Alay, A; Aliagas, E; Aso, S; Busacca, S; Cordero, D; Dawson, A; Dorca, E; Escobar, I; Fennell, D; Gausachs, M; Hernández-Madrigal, M; Llatjós, R; Martínez-Iniesta, M; Muñoz-Pinedo, C; Nadal, E; Padrones, S; Palmero, R; Pros, E; Ramos, R; Ruffinelli, JC; Saigí, M; Sánchez-Céspedes, M; Sharkley, AJ; Solé, X; Varela, M; Vidal, A; Villanueva, A, 2021)	0.96
"Treatment with abemaciclib plus fulvestrant resulted in a statistically significant and clinically meaningful median OS improvement of 9.4 months for patients with HR-positive, ERBB2-negative ABC who progressed after prior ET regardless of menopausal status. "	( The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial. Barriga, S; Burdaeva, O; Conte, P; Frenzel, M; Grischke, EM; Hurt, K; Inoue, K; Johnston, S; Kaufman, PA; Koh, H; Llombart-Cussac, A; Lu, Y; Masuda, N; Neven, P; Okera, M; Pivot, X; Sledge, GW; Sohn, J; Toi, M, 2020)	1.27
"Treatment with abemaciclib plus fulvestrant or nonsteroidal aromatase inhibitors is generally well tolerated in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. "	( Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3. Andre, VAM; Barriga, S; Cox, J; García-Sáenz, JA; Goetz, M; Huober, J; Masuda, N; Rugo, HS; Sohn, JH, 2021)	1.33
"Treatment with abemaciclib and palbociclib is associated with a potential complication of interstitial lung disease, regardless of age."	( Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments. Goda, M; Ishizawa, K; Nawa, H; Niimura, T; Yagi, K; Zamami, Y, 2022)	1.31

Excerpt	Reference	Relevance
" The most common possibly related treatment-emergent adverse events involved fatigue and the gastrointestinal, renal, or hematopoietic systems."	( Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors. Beckmann, RP; Beeram, M; Chan, EM; Cronier, DM; Flaherty, KT; Frenzel, M; Fulford, AD; Gandhi, L; Goldman, JW; Hilton, JF; Kulanthaivel, P; Li, LQ; Martinez, R; Nasir, A; Nguyen, TS; Papadopoulos, KP; Patnaik, A; Rasco, DW; Rosen, LS; Schade, AE; Shapiro, GI; Tolaney, SM; Tolcher, AW; Wen, PY, 2016)	0.74
" Discuss the key side effects associated with CDK4/6 inhibitors along with considerations for adverse event management and patient monitoring."	( HR+, HER2- Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles. Blackwell, KL; Sammons, SL; Topping, DL, 2017)	0.46
" The side-effect profile of each agent is described, along with implications for patient monitoring, and considerations for patient care providers and pharmacists."	( HR+, HER2- Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles. Blackwell, KL; Sammons, SL; Topping, DL, 2017)	0.46
" Insight into the unique side-effect profiles of this class of agents and effective patient monitoring will facilitate the successful use of CDK4/6 inhibitor-based therapies in the clinic."	( HR+, HER2- Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles. Blackwell, KL; Sammons, SL; Topping, DL, 2017)	0.46
" For example, neutropenia is observed at varying incidences in patients treated with these drugs; however, it is the most common adverse event for palbociclib and ribociclib, whereas diarrhea is the most common adverse event observed in patients treated with abemaciclib."	( Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary Pharmacology. Finkelstein, M; Franks, T; Hirakawa, B; Hu, W; Jessen, B; Kalabat, D; Khoh-Reiter, S; Lu, S; Sacaan, A; Sung, T; Thibault, S, 2019)	0.69
"Purpose The CKD4/6 inhibitor abemaciclib is related to adverse events such as hematological toxicity and increase in serum creatinine levels associated with abemaciclib pharmacokinetics."	( Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report. Ando, H; Ebi, H; Fukushima, S; Hashimoto, N; Irie, K; Iwata, H; Kajita, M; Maeda, A; Okada, A; Sawaki, M, 2021)	1.17
" Data on common and serious adverse events (AE) were extracted for each approved drug."	( Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis. Amir, E; Desnoyers, A; Kumar, V; Nadler, MB; Saleh, R, 2020)	0.56
" Here we provide a comprehensive summary of the most common adverse events (AEs), their management, and whether AEs or dose reductions influenced progression-free survival (PFS), in the MONARCH 2 and 3 trials."	( Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3. Andre, VAM; Barriga, S; Cox, J; García-Sáenz, JA; Goetz, M; Huober, J; Masuda, N; Rugo, HS; Sohn, JH, 2021)	0.98
" Clinicians should be aware of and implement management strategies, including dose adjustments according to local labels, for commonly occurring and serious adverse events to ensure continued treatment and optimize clinical benefit/risk ratio."	( Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3. Andre, VAM; Barriga, S; Cox, J; García-Sáenz, JA; Goetz, M; Huober, J; Masuda, N; Rugo, HS; Sohn, JH, 2021)	0.98
"Treatment-related adverse events included fatigue and nausea in the monotherapy arm (13% for each), hypothyroidism (30%) in the ramucirumab arm, diarrhea (54%) in the abemaciclib arm, and nausea (25%) in the merestinib arm."	( Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial. Bang, YJ; Bendell, J; Carlsen, M; Chow, KH; Chung, HC; de Miguel, MJ; Gandhi, L; Italiano, A; Lin, CC; Patnaik, A; Schmidt, S; Su, WC; Szpurka, AM; Vangerow, B; Xu, X; Yap, TA; Yu, D; Zhao, Y, 2021)	0.82
" To the best of our knowledge this is the first thrombotic coronary side effect ever reported."	( Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect? Alfonso, F; Alvarado-Casas, T; Rivero, F; Salamanca, J; Vera, A, 2021)	0.91
"While higher rates of adverse events were reported in older patients, they were manageable with dose adjustments and concomitant medication."	( Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials. André, VAM; Campone, M; Chouaki, N; Goetz, MP; Grischke, EM; Manso, L; Okera, M; San Antonio, B; Sledge, GW; Toi, M; Wildiers, H, 2021)	0.93
" The primary endpoint was toxicity per Common Terminology Criteria for Adverse Events v5."	( Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer. Barsky, AR; Clark, A; Dastgheyb, S; Dreyfuss, AD; Freedman, GM; Kim, KN; Shah, P; Taunk, NK, 2021)	0.62
"The use of RT within 2 weeks of CDK4/6 inhibitors had low acceptable toxicity and high efficacy, suggesting that it is safe for palliation of metastatic breast cancer."	( Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer. Barsky, AR; Clark, A; Dastgheyb, S; Dreyfuss, AD; Freedman, GM; Kim, KN; Shah, P; Taunk, NK, 2021)	0.62
" Safety analyses included incidence, management, and outcomes of common and clinically relevant adverse events (AEs)."	( Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study. Blancas, I; Boyle, F; Broom, R; Brown, J; Campone, M; Gumus, M; Hulstijn, M; Im, YH; Johnston, SRD; O'Shaughnessy, J; Rastogi, P; Reinisch, M; Rugo, HS; San Antonio, B; Shahir, A; Song, C; Toi, M; Tolaney, SM; Wei, R; Yamashita, T; Zagouri, F; Zimmermann, A, 2022)	1.14
" We performed an analysis of the change in serum creatine (Cr) and creatine clearance (CrCl), time to first abnormal Cr value, and Common Terminology Criteria for Adverse Events grade of increased creatinine."	( Real-world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2- advanced breast cancer. Bai, X; Hao, C; Meng, W; Tong, Z; Zhang, J, 2023)	1.18
"This study shows that abemaciclib combined with bisphosphonate would be safe for renal function in HR+/HER2- ABC patients with bone metastases."	( Real-world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2- advanced breast cancer. Bai, X; Hao, C; Meng, W; Tong, Z; Zhang, J, 2023)	1.49
"The haematopoietic cytopenia (HC) of the cyclin-dependent kinase (CDK)4/6 inhibitors was evaluated using the Food and Drug Administration Adverse Event Reporting System (FAERS)."	( Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database. Cui, X; Ren, X; Tian, L; Yan, C, )	0.13
" The frequently reported adverse effects (AEs) were anemia, increased blood creatinine levels, diarrhea, and neutropenia (90%, 83%, 83%, and 75% of the patients, respectively)."	( Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation. Hashishita, H; Kuwahara, S; Maeda, H; Takada, S; Takahashi, M; Tomioka, N; Umehara, K; Watanabe, K; Yamamoto, M, 2023)	1.17
" The current study aimed to evaluate the adverse events of abemaciclib through data mining of the Food and Drug Administration Adverse Event Reporting System (FAERS)."	( Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment. Ding, Y; Shu, Y; Wang, L; Zhang, Q, 2023)	1.44
"Reporting odds ratio and Bayesian confidence propagation neural network of information components were used to quantify the adverse event signals of abemaciclib from the third quarter of 2017 to the first quarter of 2022."	( Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment. Ding, Y; Shu, Y; Wang, L; Zhang, Q, 2023)	1.4
"A total of 6125 reports of abemaciclib as the "primary suspected" and 72 significant adverse events of abemaciclib were identified."	( Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment. Ding, Y; Shu, Y; Wang, L; Zhang, Q, 2023)	1.49
"The discovery of disproportionality signals could potentially prompt improved awareness of toxicities for abemaciclib, and the results of time to onset, serious and non-serious reports, and clinical priority analyses provided some supporting evidence for clinicians to manage adverse events."	( Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment. Ding, Y; Shu, Y; Wang, L; Zhang, Q, 2023)	1.41
" Additionally, patients receiving palbociclib plus AI and abemaciclib plus AI or fulvestrant experienced more severe adverse events (AEs), with hazard ratios (HRs) of 10."	( Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 - metastatic or advanced breast cancer patients: a network meta-analysis. Cai, J; Chen, L; Chen, Y; Ji, Z; Li, Z; Lin, W; Liu, Y; Wu, J; Zheng, D; Zheng, J; Zou, J, 2023)	1.15
"Abemaciclib plus fulvestrant or ribociclib plus AI appear to be effective and relatively safe for the treatment of HR+/HER2- metastatic or advanced BC patients."	( Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 - metastatic or advanced breast cancer patients: a network meta-analysis. Cai, J; Chen, L; Chen, Y; Ji, Z; Li, Z; Lin, W; Liu, Y; Wu, J; Zheng, D; Zheng, J; Zou, J, 2023)	2.35
" Treatment-emergent (TE) adverse events (AEs) of grade ≥3 occurred in 11 (92%) and 5 (100%) patients in the FUL and LET cohorts, respectively."	( Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial). Aogi, K; Futamura, M; Hosonaga, M; Imamura, CK; Iwasa, T; Iwata, H; Kawabata, H; Masuda, J; Masuda, N; Matsumoto, K; Miura, S; Mukohara, T; Sakai, H; Takahashi, M; Takano, T; Tanabe, Y; Tomioka, N; Tsurutani, J; Yamochi, T; Yasojima, H; Yoshimura, K, 2023)	1.14

Excerpt	Reference	Relevance
" The objectives of this study were to characterize the pharmacokinetics of abemaciclib in cancer patients using population pharmacokinetic (popPK) modeling, and to evaluate target engagement at clinically relevant dose levels."	( A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients. Chan, EM; Cronier, DM; Kulanthaivel, P; Sykes, AK; Tate, SC; Turner, PK, 2018)	0.95
"A phase I study was conducted in cancer patients which incorporated intensive pharmacokinetic sampling after single and multiple oral doses of abemaciclib."	( A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients. Chan, EM; Cronier, DM; Kulanthaivel, P; Sykes, AK; Tate, SC; Turner, PK, 2018)	0.92
"The proportion of abemaciclib pharmacokinetic variability that can be attributed to patient demographics is negligible, and as such there are currently no dose adjustments recommended for adult patients of different sex, age, or body weight."	( A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients. Chan, EM; Cronier, DM; Kulanthaivel, P; Sykes, AK; Tate, SC; Turner, PK, 2018)	1.06
" A physiologically based pharmacokinetic (PBPK) model incorporating the metabolites was developed to predict the effect of other strong and moderate CYP3A4 inhibitors and inducers."	( Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling. Dickinson, GL; Hall, SD; Kulanthaivel, P; Morse, BL; Posada, MM; Turner, PK, 2020)	0.81
" In this review, we provide an overview of the available clinical pharmacokinetic and pharmacodynamic characteristics of these novel drugs, summarize the results of food-effect and drug-drug interaction studies, and highlight exposure-response and exposure-toxicity relationships."	( Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib. Beijnen, JH; Groenland, SL; Huitema, ADR; Martínez-Chávez, A; Schinkel, AH; Steeghs, N; van Dongen, MGJ, 2020)	0.76
" Therefore, we evaluated whether ABCB1 and ABCG2 polymorphisms are pharmacokinetic predictive factors of abemaciclib."	( Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib. Ando, H; Ebi, H; Fukushima, S; Hashimoto, N; Irie, K; Iwata, H; Maeda, A; Matsuzaki, M; Morishige, JI; Okada, A; Sawaki, M, 2022)	1.17

Excerpt	Reference	Relevance
" In calu-6 xenografts, LY2835219 in combination with gemcitabine enhanced in vivo antitumor activity without a G1 cell cycle arrest, but was associated with a reduction of ribonucleotide reductase expression."	( Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Ajamie, RT; Cai, S; Chan, EM; Cronier, D; de Dios, A; Del Prado, M; Flack, RS; Gelbert, LM; Iversen, P; Kreklau, E; Lallena, MJ; Lin, X; Neubauer, BL; Sanchez-Martinez, C; Torres, R; Wishart, GN; Young, J, 2014)	0.4
" Abemaciclib antitumor activity was assessed in subcutaneous and orthotopic glioma models alone and in combination with standard of care temozolomide (TMZ)."	( Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft. Ajamie, RT; De Dios, A; Gelbert, LM; Kulanthaivel, P; Raub, TJ; Sanchez-Martinez, C; Sawada, GA; Shannon, HE; Staton, BA; Wishart, GN, 2015)	1.33
" Food and Drug Administration (FDA) for hormone receptor-positive metastatic breast cancer in combination with specific endocrine therapies."	( Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Bardia, A; Moy, B; Spring, LM; Zangardi, ML, 2017)	0.46
" Food and Drug Administration (FDA)-approved in the first- and second-line settings in combination with endocrine therapy for HR-positive metastatic breast cancer."	( Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Bardia, A; Moy, B; Spring, LM; Zangardi, ML, 2017)	0.46
" In Part A (n = 15), the maximum tolerated dose of abemaciclib was 150 mg Q12H in combination with necitumumab 800 mg."	( A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer. Barlesi, F; Besse, B; Demedts, I; Frimodt-Moller, B; Fuentes Pradera, J; Gazzah, A; Kim, JS; Robinet, G; Soldatenkova, V; Vansteenkiste, J, 2019)	1.02
"Abemaciclib when combined with ET is the first CDK4/6 inhibitor to demonstrate a significant improvement in IDFS in patients with HR+, HER2- node-positive EBC at high risk of early recurrence."	( Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). Boyle, F; Campone, M; Cicin, I; Cortés, J; Cox, J; Frenzel, M; Guarneri, V; Hamilton, E; Harbeck, N; Headley, D; Hegg, R; Hulstijn, M; Huober, J; Johnston, SRD; Martin, M; Martinez Rodriguez, JL; Neven, P; O'Shaughnessy, J; Okada, M; Rastogi, P; San Antonio, B; Shao, ZM; Smith, IC; Sohn, J; Toi, M; Tolaney, SM; Wardley, A; Wei, R; Zhang, QY, 2020)	3.44
"This phase Ia/Ib PACT study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of a new programmed cell death ligand 1 (PD-L1) inhibitor, LY3300054, as monotherapy or in combination with ramucirumab, abemaciclib, or merestinib (a type II MET kinase inhibitor) in patients with advanced, refractory solid tumors (NCT02791334)."	( Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial. Bang, YJ; Bendell, J; Carlsen, M; Chow, KH; Chung, HC; de Miguel, MJ; Gandhi, L; Italiano, A; Lin, CC; Patnaik, A; Schmidt, S; Su, WC; Szpurka, AM; Vangerow, B; Xu, X; Yap, TA; Yu, D; Zhao, Y, 2021)	0.8
" The primary objective was to determine the recommended Phase 2 dose of crenigacestat in combination with other anticancer agents (taladegib, LY3023414 [dual inhibitor of phosphoinositide 3-kinase; mechanistic target of rapamycin], or abemaciclib)."	( A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors. Anderson, B; Azaro, A; Benhadji, KA; Cassier, PA; Italiano, A; Massard, C; Merchan, J; Oakley, G; Pant, S; Tap, WD; Yu, D; Yuen, E, 2021)	1.01
"This post hoc analysis of MONARCH 2 and MONARCH 3 assesses the efficacy, safety, and pharmacokinetics (PK) of abemaciclib in combination with endocrine therapy (ET) in East Asian patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer."	( Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials. André, VAM; Chen, SC; Enatsu, S; Goetz, MP; Hae Park, I; Hardebeck, MC; Im, SA; Inoue, K; Iwata, H; Masuda, N; Sakaguchi, S; Sledge, GW; Sohn, J; Toi, M; Turner, PK, 2021)	2.28
"Adjuvant abemaciclib combined with endocrine therapy (ET) previously demonstrated clinically meaningful improvement in invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS) in hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive, high-risk early breast cancer at the second interim analysis, however follow-up was limited."	( Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study. Andersson, M; André, V; Barriga, S; Cortés, J; Del Mastro, L; Fasching, PA; Forrester, T; Goetz, MP; Guarneri, V; Hamilton, E; Harbeck, N; Hegg, R; Huang, CS; Jaliffe, GG; Johnston, SRD; Kreipe, H; Martin, M; Munoz, M; Nabinger, SC; O'Shaughnessy, J; Rastogi, P; Rugo, HS; San Antonio, B; Senkus, E; Shahir, A; Shao, ZM; Sherwood, S; Sohn, J; Steger, GG; Tamura, K; Testa, L; Toi, M; Tolaney, SM; Tryakin, A; Wei, R, 2021)	1.46
" Collectively, these results indicated that the lysosome‑targeted drug combination induces multiple organelle dysfunction and exerts a marked cytotoxic effect in PDAC cells."	( Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells. Hiramoto, M; Hirota, A; Kazama, H; Miyazaki, M; Miyazawa, K; Ogawa, M; Ota, K; Suzuki, S; Takano, N, 2022)	0.72
"nextMONARCH is an open-label, controlled, randomized, Phase 2 study of abemaciclib alone or in combination with tamoxifen in women with endocrine-refractory HR + , HER2- MBC previously treated with chemotherapy."	( nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer. Chen, SC; Chen, Y; Cortes, J; Hamilton, E; Hegg, R; Huober, J; Jerusalem, G; Manikhas, A; Martin, M; Ozyilkan, O; Petrakova, K; Zhang, W, 2022)	1.18
"This study shows that abemaciclib combined with bisphosphonate would be safe for renal function in HR+/HER2- ABC patients with bone metastases."	( Real-world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2- advanced breast cancer. Bai, X; Hao, C; Meng, W; Tong, Z; Zhang, J, 2023)	1.49
"The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Eli Lilly) of abemaciclib (Verzenios) to submit evidence for the clinical and cost effectiveness of this drug in combination with endocrine therapy (ET) for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive early breast cancer at high risk of recurrence, as part of the Institute's Single Technology Appraisal (STA) process."	( Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Ahmadu, C; Armstrong, N; Coughlan, D; Duffy, S; Kernohan, A; Kleijnen, J; McDermott, K; O'Meara, S; Orozco Leal, G; Robinson, T; Vale, L, 2023)	2.57
"This non-randomized, multicohort, phase II study evaluated the efficacy and safety of the anti-PD-1 antibody nivolumab 240 mg administered every 2 weeks in combination with the CDK4/6 inhibitor abemaciclib 150 mg twice daily and either fulvestrant (FUL) or letrozole (LET) as a first-line or second-line treatment for HR-positive HER2-negative metastatic breast cancer."	( Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial). Aogi, K; Futamura, M; Hosonaga, M; Imamura, CK; Iwasa, T; Iwata, H; Kawabata, H; Masuda, J; Masuda, N; Matsumoto, K; Miura, S; Mukohara, T; Sakai, H; Takahashi, M; Takano, T; Tanabe, Y; Tomioka, N; Tsurutani, J; Yamochi, T; Yasojima, H; Yoshimura, K, 2023)	1.33

Excerpt	Reference	Relevance
"We evaluated the safety, pharmacokinetic profile, pharmacodynamic effects, and antitumor activity of abemaciclib, an orally bioavailable inhibitor of cyclin-dependent kinases (CDK) 4 and 6, in a multicenter study including phase I dose escalation followed by tumor-specific cohorts for breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, melanoma, and colorectal cancer."	( Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors. Beckmann, RP; Beeram, M; Chan, EM; Cronier, DM; Flaherty, KT; Frenzel, M; Fulford, AD; Gandhi, L; Goldman, JW; Hilton, JF; Kulanthaivel, P; Li, LQ; Martinez, R; Nasir, A; Nguyen, TS; Papadopoulos, KP; Patnaik, A; Rasco, DW; Rosen, LS; Schade, AE; Shapiro, GI; Tolaney, SM; Tolcher, AW; Wen, PY, 2016)	0.96
" Abemaciclib (LY2835219) is an orally bioavailable CDK4/6 inhibitor under phase III clinical trials."	( Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Chen, Z; Cheng, B; Fang, X; Fu, L; To, KKW; Wang, F; Wu, T, 2017)	1.77
" In this review, we outline the preclinical and clinical advancement of these three orally bioavailable and highly selective CDK4/6 inhibitors in breast cancer."	( Recent advances of highly selective CDK4/6 inhibitors in breast cancer. Liu, Q; Mani, S; Pestell, RG; Wu, K; Xu, H; Yu, S; Yuan, X, 2017)	0.46
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."	( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019)	0.51
" An absolute bioavailability study informed the hepatic and gastric availability."	( Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling. Dickinson, GL; Hall, SD; Kulanthaivel, P; Morse, BL; Posada, MM; Turner, PK, 2020)	0.81
" Here, we developed an active targeting motif-modified, intravenously injectable, hydrophilic NP that encapsulates fulvestrant to facilitate its delivery via the bloodstream to tumors, improving bioavailability and systemic tolerability."	( Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer. Chu, T; Li, B; Li, S; Lu, Z; Nie, G; Qi, F; Song, Z; Sukumar, S; Wang, M; Wei, J; Wu, S; Xu, J; Zhang, C; Zhu, F, 2023)	0.91

Excerpt	Relevance	Reference
" However, despite documented evidence of clinical activity, limited information is available on the optimal dosing strategy of CDK4/6 inhibitors."	( Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenografts. Ajamie, RT; Beckmann, RP; Burke, T; Cai, S; Chan, EM; Cronier, DM; De Dios, A; Gelbert, LM; Tate, SC; Wishart, GN, 2014)	0.4
" The model also demonstrated that a chronic dosing strategy achieving minimum steady-state trough plasma concentrations of 200 ng/mL is required to maintain durable cell-cycle arrest."	( Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenografts. Ajamie, RT; Beckmann, RP; Burke, T; Cai, S; Chan, EM; Cronier, DM; De Dios, A; Gelbert, LM; Tate, SC; Wishart, GN, 2014)	0.4
"Our model provides mechanistic insight into the quantitative pharmacology of LY2835219 and supports the therapeutic dose and chronic dosing strategy currently adopted in clinical studies."	( Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenografts. Ajamie, RT; Beckmann, RP; Burke, T; Cai, S; Chan, EM; Cronier, DM; De Dios, A; Gelbert, LM; Tate, SC; Wishart, GN, 2014)	0.4
"8- and 21-fold, respectively, when similarly dosed in P-gp-deficient mice."	( Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft. Ajamie, RT; De Dios, A; Gelbert, LM; Kulanthaivel, P; Raub, TJ; Sanchez-Martinez, C; Sawada, GA; Shannon, HE; Staton, BA; Wishart, GN, 2015)	0.42
" The present work aims to characterise the quantitative pharmacology of the abemaciclib/vemurafenib combination using a semimechanistic pharmacokinetic/pharmacodynamic modelling approach and to identify an optimum dosing regimen for potential clinical evaluation."	( Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours. Beckmann, RP; Burke, TF; Cronier, DM; Hartman, D; Kulanthaivel, P; Tate, SC, 2016)	0.92
"The quantitative pharmacology of the abemaciclib/vemurafenib combination was successfully characterised and an optimised, clinically-relevant dosing strategy was identified."	( Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours. Beckmann, RP; Burke, TF; Cronier, DM; Hartman, D; Kulanthaivel, P; Tate, SC, 2016)	0.97
"Abemaciclib represents the first selective inhibitor of CDK4 and CDK6 with a safety profile allowing continuous dosing to achieve sustained target inhibition."	( Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors. Beckmann, RP; Beeram, M; Chan, EM; Cronier, DM; Flaherty, KT; Frenzel, M; Fulford, AD; Gandhi, L; Goldman, JW; Hilton, JF; Kulanthaivel, P; Li, LQ; Martinez, R; Nasir, A; Nguyen, TS; Papadopoulos, KP; Patnaik, A; Rasco, DW; Rosen, LS; Schade, AE; Shapiro, GI; Tolaney, SM; Tolcher, AW; Wen, PY, 2016)	2.19
" In contrast, the structurally distinct CDK4/6 inhibitor abemaciclib is dosed continuously, and has diarrhea and fatigue as dose-limiting toxicities."	( Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Hutcheson, J; Knudsen, ES; Vail, P; Witkiewicz, AK, 2017)	0.7
" It is obvious that this class of agents with their efficacy, low and easily manageable toxicity, and oral dosage is a very important treatment option for breast cancer patients."	( Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib. Kwapisz, D, 2017)	0.68
" Relevance to Patient Care and Clinical Practice: Although no head-to-head studies have been completed between the CDK4/6 inhibitors, abemaciclib may be an attractive option because of its continuous dosing and ability to be used as monotherapy."	( Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer. Lau, G; Palumbo, A; Saraceni, M, 2019)	2.16
" Areas covered: We reviewed and compared the pharmacology, clinical efficacy, and toxicity profiles of the three CDK4/6 inhibitors and discussed several challenges in the use of these drugs, particularly in identifying biomarkers, optimizing dosing strategies, and finding best combinations with other therapies."	( CDK4-6 inhibitors in breast cancer: current status and future development. Choo, JR; Lee, SC, 2018)	0.48
" These are important features that may help to improve the therapeutic dosing and efficacy of palbociclib."	( Lysosomal trapping of palbociclib and its functional implications. Blanco-Aparicio, C; Hernández-Encinas, E; Llanos, S; Megias, D; Pietrocola, F; Rovira, M; Serrano, M, 2019)	0.51
" Abemaciclib is different to the other two licensed and approved CDK 4/6 inhibitors, palbociclib and ribociclib, both in dosing schedule (continuous vs intermittent) and toxicity profile (less neutropenia, more diarrhea), yet the magnitude of clinical benefit seen in first- and second-line studies is very similar."	( Abemaciclib, a potent cyclin-dependent kinase 4 and 6 inhibitor, for treatment of ER-positive metastatic breast cancer. Johnston, SR; Lee, KA; Shepherd, ST, 2019)	2.87
" Abemaciclib's preclinical difference in selectivity for CDK4 vs CDK6 could help explain its safety profile and ability to be dosed on a continuous schedule."	( [Pharmacological Effects of CDK4 & 6 Selective Inhibitor Abemaciclib in Hormone Receptor-Positive Breast Cancer]. Buchanan, S; Enatsu, S; Hayashi, S; Maeda, K; Sakaguchi, S; Sato, A; Tamaki, C, 2019)	1.67
" However, being the least similar structurally, abemaciclib is the only CDK4/6 inhibitor with single agent activity in refractory metastatic ER + breast cancer, the ability to cross the blood brain barrier efficiently, and a distinct toxicity profile of lower myelosuppression such that it can be dosed continuously."	( A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib. Bui, NL; Chong, QY; Goh, BC; Kok, ZH; Lobie, PE; Sethi, G; Wang, L; Wong, AL; Xiang, X; Yong, WP, 2020)	1.05
" The current PBPK model, which considers changes in unbound potency-adjusted active species, can be used to inform dosing recommendations when abemaciclib is coadministered with CYP3A4 perpetrators."	( Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling. Dickinson, GL; Hall, SD; Kulanthaivel, P; Morse, BL; Posada, MM; Turner, PK, 2020)	1.01
" This study demonstrated that crenigacestat combined with different anticancer agents (taladegib, LY3023414, or abemaciclib) was poorly tolerated, leading to lowered dosing and disappointing clinical activity in patients with advanced or metastatic solid tumors."	( A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors. Anderson, B; Azaro, A; Benhadji, KA; Cassier, PA; Italiano, A; Massard, C; Merchan, J; Oakley, G; Pant, S; Tap, WD; Yu, D; Yuen, E, 2021)	1.03
" Abemaciclib has been developed for use in hormone receptor positive(HR+)breast cancer, dosed daily in combination with endocrine therapy."	( [Development of CDK4 & 6 Inhibitor Abemaciclib in Breast Cancer]. Chen, Y; Kawaguchi, T; Masuda, N; Ohno, S; Saji, S, 2021)	1.81
" We review nonclinical studies exploring mechanistic differences between the drugs, the impact of continuous dosing on treatment effect, and translational research into potential resistance mechanisms and prognostic and predictive markers."	( Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences. Barrios, C; Cameron, D; Emde, A; Gnant, M; Janni, W; Johnston, S; Martin, M; Neven, P; Srock, S, 2023)	0.91

Protein Targets (295)

Potency Measurements

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
PPM1D protein	Homo sapiens (human)	Potency	10.4353	0.0052	9.4661	32.9993	AID1347411
cytochrome P450 family 3 subfamily A polypeptide 4	Homo sapiens (human)	Potency	11.9877	0.0123	7.9835	43.2770	AID1645841
cytochrome P450 2D6	Homo sapiens (human)	Potency	18.9991	0.0010	8.3798	61.1304	AID1645840
Interferon beta	Homo sapiens (human)	Potency	10.4353	0.0033	9.1582	39.8107	AID1347411
Spike glycoprotein	Severe acute respiratory syndrome-related coronavirus	Potency	1.1869	0.0096	10.5250	35.4813	AID1479145; AID1479148
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Cyclin-T1	Homo sapiens (human)	IC50 (µMol)	0.0734	0.0010	0.5585	8.0000	AID1277161; AID1382365; AID1513684; AID1737182
Cyclin-T1	Homo sapiens (human)	Ki	0.0570	0.0030	0.2768	0.7900	AID1317308
Cyclin-K	Homo sapiens (human)	IC50 (µMol)	0.0650	0.0030	0.2656	1.3700	AID1648273
Cyclin-dependent kinase 1	Homo sapiens (human)	IC50 (µMol)	0.7569	0.0004	1.3452	10.0000	AID1239760; AID1277156; AID1366692; AID1374353; AID1382343; AID1513678; AID1551211; AID1653003; AID1732687; AID1737228
Cyclin-dependent kinase 1	Homo sapiens (human)	Ki	1.6270	0.0010	1.2551	5.0000	AID1317305
Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2	IC50 (µMol)	6.6200	0.0002	2.4585	9.9600	AID1804171
Serine/threonine-protein kinase pim-1	Homo sapiens (human)	Ki	0.0100	0.0000	0.0084	0.0160	AID1551238
Cyclin-dependent kinase 4	Homo sapiens (human)	IC50 (µMol)	0.0097	0.0006	0.5706	10.0000	AID1239759; AID1239761; AID1277158; AID1366691; AID1374354; AID1374364; AID1382342; AID1424508; AID1509614; AID1513680; AID1551213; AID1653034; AID1732739; AID1737183; AID1737184; AID1909254; AID1915587
Cyclin-dependent kinase 4	Homo sapiens (human)	Ki	0.0013	0.0006	0.7369	3.6000	AID1239763; AID1317329
G2/mitotic-specific cyclin-B1	Homo sapiens (human)	IC50 (µMol)	0.7484	0.0013	1.4518	10.0000	AID1239760; AID1277156; AID1382343; AID1513678; AID1732687; AID1737228
G2/mitotic-specific cyclin-B1	Homo sapiens (human)	Ki	1.6270	0.1900	2.3292	5.0000	AID1317305
Cyclin-A2	Homo sapiens (human)	IC50 (µMol)	0.1036	0.0004	1.0339	10.0000	AID1509616; AID1513681; AID1648274; AID1737229
G1/S-specific cyclin-D1	Homo sapiens (human)	IC50 (µMol)	0.0048	0.0006	0.5479	9.5000	AID1239759; AID1277158; AID1374364; AID1374365; AID1513680; AID1732739
G1/S-specific cyclin-D1	Homo sapiens (human)	Ki	0.0042	0.0006	0.6654	3.6000	AID1239763; AID1317329; AID1317331
G1/S-specific cyclin-E1	Homo sapiens (human)	IC50 (µMol)	0.2320	0.0010	1.0404	10.0000	AID1382342; AID1513679; AID1732740
G1/S-specific cyclin-E1	Homo sapiens (human)	Ki	0.5040	0.0005	0.5633	1.4850	AID1317332
Cyclin-dependent kinase 2	Homo sapiens (human)	IC50 (µMol)	0.2635	0.0004	1.0444	10.0000	AID1509616; AID1513679; AID1513681; AID1551212; AID1648274; AID1653004; AID1732740; AID1737229
Cyclin-dependent kinase 2	Homo sapiens (human)	Ki	0.5040	0.0005	0.6427	5.0000	AID1317332
G1/S-specific cyclin-D3	Homo sapiens (human)	IC50 (µMol)	0.0112	0.0015	0.0862	0.9250	AID1374353; AID1382364; AID1402379; AID1509614; AID1509615; AID1648272; AID1737183; AID1737184; AID1909254
G1/S-specific cyclin-D3	Homo sapiens (human)	Ki	0.0082	0.0082	0.0176	0.0270	AID1239764
Cyclin-dependent kinase 7	Homo sapiens (human)	IC50 (µMol)	2.0270	0.0001	0.9106	9.2000	AID1277160; AID1513683; AID1551216; AID1737230
Cyclin-dependent kinase 7	Homo sapiens (human)	Ki	3.9100	2.8000	3.3550	3.9100	AID1317353
Cyclin-dependent kinase 9	Homo sapiens (human)	IC50 (µMol)	0.0693	0.0010	0.6236	8.0000	AID1277161; AID1382365; AID1513684; AID1551217; AID1648273; AID1737182
Cyclin-dependent kinase 9	Homo sapiens (human)	Ki	0.0570	0.0030	0.2482	0.7900	AID1317308
Cyclin-H	Homo sapiens (human)	IC50 (µMol)	2.6027	0.0005	1.0823	9.2000	AID1277160; AID1513683; AID1737230
Cyclin-H	Homo sapiens (human)	Ki	3.9100	2.8000	3.3550	3.9100	AID1317353
CDK-activating kinase assembly factor MAT1	Homo sapiens (human)	IC50 (µMol)	3.1060	0.0030	1.6892	9.2000	AID1277160; AID1513683
CDK-activating kinase assembly factor MAT1	Homo sapiens (human)	Ki	3.9100	2.8000	3.3550	3.9100	AID1317353
Cyclin-dependent kinase 6	Homo sapiens (human)	IC50 (µMol)	0.0168	0.0019	0.8654	7.2000	AID1239761; AID1366690; AID1374355; AID1374365; AID1382364; AID1402379; AID1424509; AID1509615; AID1551215; AID1648272; AID1653035; AID1915588
Cyclin-dependent kinase 6	Homo sapiens (human)	Ki	0.0091	0.0082	0.0151	0.0270	AID1239764; AID1317331
Cyclin-dependent-like kinase 5	Homo sapiens (human)	IC50 (µMol)	0.4050	0.0002	1.1832	10.0000	AID1277159; AID1513682
Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)	IC50 (µMol)	10.9000	0.0009	1.9014	10.0000	AID1374357
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)	Ki	0.0100	0.0100	0.4108	1.5000	AID1551237
Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)	Ki	0.0100	0.0100	0.0100	0.0100	AID1551240
Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)	IC50 (µMol)	0.4050	0.0010	1.2898	10.0000	AID1277159; AID1513682
Homeodomain-interacting protein kinase 1	Homo sapiens (human)	Ki	0.0100	0.0100	0.0100	0.0100	AID1551239
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Bone morphogenetic protein receptor type-1B	Homo sapiens (human)	Kd	30.0000	0.0009	1.1413	3.7000	AID1424922
Cell division cycle 7-related protein kinase	Homo sapiens (human)	Kd	30.0000	0.5110	0.5110	0.5110	AID1424936
Serine/threonine-protein kinase PLK4	Homo sapiens (human)	Kd	30.0000	0.0008	1.5144	9.0000	AID1425121
ATP-dependent RNA helicase DDX3X	Homo sapiens (human)	Kd	30.0000	0.4350	0.4350	0.4350	AID1424975
Pyridoxal kinase	Homo sapiens (human)	Kd	30.0000	0.2860	5.0765	16.4040	AID1425106
Citron Rho-interacting kinase	Homo sapiens (human)	Kd	0.7980	0.0330	3.0646	48.8760	AID1424954
Serine/threonine-protein kinase Chk1	Homo sapiens (human)	Kd	30.0000	0.0028	1.4744	8.7000	AID1424953
Aurora kinase A	Homo sapiens (human)	Kd	30.0000	0.0001	0.7342	9.3000	AID1424917
Cyclin-G-associated kinase	Homo sapiens (human)	Kd	2.1940	0.0003	0.9086	28.6510	AID1425009
Ephrin type-B receptor 6	Homo sapiens (human)	Kd	30.0000	0.0000	1.0768	9.0000	AID1424995
Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)	Kd	30.0000	0.0260	1.3140	2.6020	AID1424896
Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)	Kd	30.0000	0.0020	1.6212	11.4330	AID1425155
Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)	Kd	30.0000	0.0940	1.3910	3.5070	AID1424926
Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.0170	0.3610	0.7050	AID1425097
Eukaryotic translation initiation factor 5B	Homo sapiens (human)	Kd	30.0000	0.2320	0.2320	0.2320	AID1424986
Rho-associated protein kinase 2	Homo sapiens (human)	Kd	30.0000	0.0002	2.7105	56.0660	AID1425158
Serine/threonine-protein kinase ULK1	Homo sapiens (human)	Kd	30.0000	0.0008	1.8410	23.2730	AID1425208
Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)	Kd	30.0000	0.0057	2.0095	12.2010	AID1424997
Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)	Kd	30.0000	0.0170	1.9737	29.9570	AID1425162
U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)	Kd	30.0000	1.3820	1.3820	1.3820	AID1425174
Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)	Kd	30.0000	0.0120	1.6396	7.2000	AID1425161
Serine/threonine-protein kinase 16	Homo sapiens (human)	Kd	0.4950	0.0017	1.2483	9.9690	AID1425179
Cyclin-dependent kinase-like 5	Homo sapiens (human)	Kd	30.0000	0.0017	1.4788	7.3000	AID1424951
Serine/threonine-protein kinase 10	Homo sapiens (human)	Kd	2.4700	0.0000	2.9234	57.4530	AID1425177
Serine/threonine-protein kinase D3	Homo sapiens (human)	Kd	1.8410	0.0089	2.2738	23.3410	AID1425137
Structural maintenance of chromosomes protein 2	Homo sapiens (human)	Kd	30.0000	0.2090	0.6575	1.1060	AID1425173
Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)	Kd	30.0000	0.1700	1.5781	8.0000	AID1425050
Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)	Kd	1.3220	0.0082	2.3645	62.7720	AID1425054
Serine/threonine-protein kinase LATS1	Homo sapiens (human)	Kd	30.0000	0.0140	1.8393	10.7330	AID1425033
Serine/threonine-protein kinase PAK 4	Homo sapiens (human)	Kd	30.0000	0.0027	2.5694	30.3710	AID1425100
Tyrosine-protein kinase ABL1	Homo sapiens (human)	Kd	30.0000	0.0000	1.0411	13.4530	AID1424890
Epidermal growth factor receptor	Homo sapiens (human)	Kd	30.0000	0.0001	1.3514	20.8270	AID1424983
High affinity nerve growth factor receptor	Homo sapiens (human)	Kd	30.0000	0.0020	1.3484	9.2000	AID1425094
Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)	Kd	30.0000	0.1840	0.1840	0.1840	AID1425011
ADP/ATP translocase 2	Homo sapiens (human)	Kd	30.0000	0.4510	0.4510	0.4510	AID1425169
Protein kinase C beta type	Homo sapiens (human)	Kd	1.6240	0.0013	2.7081	26.3240	AID1425130
Insulin receptor	Homo sapiens (human)	Kd	30.0000	0.0017	1.0823	7.9060	AID1425026
Tyrosine-protein kinase Lck	Homo sapiens (human)	Kd	30.0000	0.0002	1.1174	24.2210	AID1425034
Tyrosine-protein kinase Fyn	Homo sapiens (human)	Kd	30.0000	0.0008	1.4238	8.4000	AID1425008
Cyclin-dependent kinase 1	Homo sapiens (human)	Kd	30.0000	0.2880	1.4952	3.0490	AID1424937
Glycogen phosphorylase, liver form	Homo sapiens (human)	Kd	30.0000	2.1210	2.1210	2.1210	AID1425146
Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)	Kd	30.0000	0.0048	1.0986	7.4000	AID1425003
Tyrosine-protein kinase Yes	Homo sapiens (human)	Kd	30.0000	0.0003	1.3708	17.1520	AID1425212
Tyrosine-protein kinase Lyn	Homo sapiens (human)	Kd	30.0000	0.0006	1.0485	5.7000	AID1425037
Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)	Kd	30.0000	0.0007	0.8642	27.5420	AID1425154
Insulin-like growth factor 1 receptor	Homo sapiens (human)	Kd	30.0000	0.0010	1.9211	19.2170	AID1425022
Signal recognition particle receptor subunit alpha	Homo sapiens (human)	Kd	30.0000	0.0080	0.0080	0.0080	AID1425176
Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.2020	0.2020	0.2020	AID1424969
Hepatocyte growth factor receptor	Homo sapiens (human)	Kd	30.0000	0.0002	1.6297	8.5000	AID1425076
Tyrosine-protein kinase HCK	Homo sapiens (human)	Kd	30.0000	0.0003	2.0343	15.9930	AID1425017
Platelet-derived growth factor receptor beta	Homo sapiens (human)	Kd	30.0000	0.0001	1.0050	11.1070	AID1425104
Serine/threonine-protein kinase A-Raf	Homo sapiens (human)	Kd	30.0000	0.0470	9.6832	33.6550	AID1424915
Glycogen phosphorylase, brain form	Homo sapiens (human)	Kd	30.0000	3.5690	3.5690	3.5690	AID1425145
Breakpoint cluster region protein	Homo sapiens (human)	Kd	30.0000	0.0030	1.2196	17.3640	AID1424919
Serine/threonine-protein kinase pim-1	Homo sapiens (human)	Kd	0.0070	0.0010	1.1393	19.3160	AID1425111
Fibroblast growth factor receptor 1	Homo sapiens (human)	Kd	30.0000	0.0003	1.5581	6.2000	AID1425004
DNA topoisomerase 2-alpha	Homo sapiens (human)	Kd	30.0000	0.0640	0.2750	0.4860	AID1425202
Cyclin-dependent kinase 4	Homo sapiens (human)	Kd	0.0970	0.0033	1.6050	8.6000	AID1424946
ADP/ATP translocase 3	Homo sapiens (human)	Kd	30.0000	0.0060	0.2505	0.4950	AID1425170
Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)	Kd	30.0000	0.0002	1.5077	9.6000	AID1425175
cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)	Kd	30.0000	0.0520	1.7535	3.4550	AID1425128
Serine/threonine-protein kinase B-raf	Homo sapiens (human)	Kd	30.0000	0.0002	1.6258	26.0180	AID1424924
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)	Kd	30.0000	0.0001	2.0569	9.5000	AID1425110
Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)	Kd	30.0000	0.0040	6.7556	88.9030	AID1425093
Tyrosine-protein kinase Fer	Homo sapiens (human)	Kd	30.0000	0.0014	1.3604	8.8000	AID1425002
Protein kinase C alpha type	Homo sapiens (human)	Kd	0.5300	0.0003	1.7922	21.3520	AID1425129
cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)	Kd	30.0000	0.0039	2.9479	23.2450	AID1425123
General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)	Kd	30.0000	0.0020	1.6906	12.0220	AID1424996
Casein kinase II subunit alpha'	Homo sapiens (human)	Kd	0.0190	0.0010	2.5309	28.8720	AID1424968
Ras-related protein Rab-6A	Homo sapiens (human)	Kd	30.0000	0.0330	0.0330	0.0330	AID1425150
Ephrin type-A receptor 1	Homo sapiens (human)	Kd	30.0000	0.0041	1.8000	9.8000	AID1424987
Multifunctional protein ADE2	Homo sapiens (human)	Kd	30.0000	5.4810	5.4810	5.4810	AID1425098
cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)	Kd	30.0000	0.0020	8.5577	49.2780	AID1425125
cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)	Kd	30.0000	0.0130	0.7408	4.1000	AID1425124
Ferrochelatase, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.2430	6.4343	67.9140	AID1425001
Ribosomal protein S6 kinase beta-1	Homo sapiens (human)	Kd	30.0000	0.0013	1.1805	4.8000	AID1425164
Tyrosine-protein kinase JAK1	Homo sapiens (human)	Kd	30.0000	0.0016	1.2166	7.8000	AID1425030
Cyclin-dependent kinase 2	Homo sapiens (human)	Kd	10.4870	0.0070	1.5179	10.4870	AID1424944
Beta-adrenergic receptor kinase 1	Homo sapiens (human)	Kd	30.0000	0.1700	5.5791	22.4940	AID1424908
Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)	Kd	30.0000	4.1030	4.1030	4.1030	AID1424977
Mitogen-activated protein kinase 3	Homo sapiens (human)	Kd	30.0000	0.4300	5.2743	9.8000	AID1425061
MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)	Kd	30.0000	0.0030	3.9689	58.2400	AID1425069
Deoxycytidine kinase	Homo sapiens (human)	Kd	30.0000	0.0120	1.0875	2.1630	AID1424970
Mitogen-activated protein kinase 1	Homo sapiens (human)	Kd	30.0000	0.0001	2.7441	7.3000	AID1425056
Ephrin type-A receptor 2	Homo sapiens (human)	Kd	30.0000	0.0009	1.0752	8.1980	AID1424988
Ephrin type-B receptor 2	Homo sapiens (human)	Kd	30.0000	0.0004	3.1536	53.1980	AID1424992
Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)	Kd	30.0000	0.0009	1.5575	8.7000	AID1425207
Wee1-like protein kinase	Homo sapiens (human)	Kd	30.0000	0.0014	3.5389	65.1580	AID1425210
Heme oxygenase 2	Homo sapiens (human)	Kd	30.0000	0.1190	0.1190	0.1190	AID1425018
DnaJ homolog subfamily A member 1	Homo sapiens (human)	Kd	30.0000	0.9620	0.9620	0.9620	AID1424980
RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)	Kd	30.0000	0.0006	1.0621	4.4000	AID1424910
RAC-beta serine/threonine-protein kinase	Homo sapiens (human)	Kd	30.0000	0.0021	1.6196	8.7000	AID1424911
Dual specificity protein kinase TTK	Homo sapiens (human)	Kd	30.0000	0.0065	1.6269	8.5000	AID1425205
DNA replication licensing factor MCM4	Homo sapiens (human)	Kd	30.0000	0.6290	0.6290	0.6290	AID1425072
Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)	Kd	30.0000	0.0039	1.6429	9.6000	AID1425039
Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)	Kd	30.0000	0.0002	0.9559	9.9000	AID1425006
Bone morphogenetic protein receptor type-1A	Homo sapiens (human)	Kd	30.0000	0.0600	1.5010	7.0000	AID1424921
Activin receptor type-1B	Homo sapiens (human)	Kd	30.0000	0.0040	1.5110	15.2580	AID1424901
TGF-beta receptor type-1	Homo sapiens (human)	Kd	30.0000	0.0050	2.2785	9.6000	AID1425196
TGF-beta receptor type-2	Homo sapiens (human)	Kd	30.0000	0.0800	1.8351	6.9000	AID1425197
Tyrosine-protein kinase CSK	Homo sapiens (human)	Kd	30.0000	0.0010	3.4578	39.5530	AID1424960
Glycine--tRNA ligase	Homo sapiens (human)	Kd	30.0000	0.0400	0.0400	0.0400	AID1425010
Protein kinase C iota type	Homo sapiens (human)	Kd	30.0000	0.0260	9.3316	51.0180	AID1425133
Exosome RNA helicase MTR4	Homo sapiens (human)	Kd	30.0000	2.6070	2.6070	2.6070	AID1425168
Tyrosine-protein kinase Tec	Homo sapiens (human)	Kd	30.0000	0.0010	1.0095	8.7000	AID1425193
Tyrosine-protein kinase ABL2	Homo sapiens (human)	Kd	30.0000	0.0002	1.1249	14.9240	AID1424891
Tyrosine-protein kinase FRK	Homo sapiens (human)	Kd	30.0000	0.0003	1.2424	10.8370	AID1425007
Tyrosine-protein kinase SYK	Homo sapiens (human)	Kd	30.0000	0.0070	2.0052	9.2260	AID1425188
26S proteasome regulatory subunit 6B	Homo sapiens (human)	Kd	30.0000	0.0050	0.0050	0.0050	AID1425141
Mitogen-activated protein kinase 8	Homo sapiens (human)	Kd	3.7560	0.0110	2.0965	26.0590	AID1425063
Mitogen-activated protein kinase 9	Homo sapiens (human)	Kd	30.0000	0.0020	1.4596	8.1000	AID1425064
Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)	Kd	30.0000	0.0050	2.0462	6.6000	AID1425040
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)	Kd	30.0000	0.2080	3.6125	7.0170	AID1425113
Casein kinase I isoform alpha	Homo sapiens (human)	Kd	30.0000	0.0010	2.5756	19.3520	AID1424961
Casein kinase I isoform delta	Homo sapiens (human)	Kd	30.0000	0.0150	2.2270	18.3960	AID1424962
MAP kinase-activated protein kinase 2	Homo sapiens (human)	Kd	30.0000	0.0003	2.0274	14.7420	AID1425065
Elongation factor Tu, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.4640	0.4640	0.4640	AID1425206
Choline-phosphate cytidylyltransferase A	Homo sapiens (human)	Kd	30.0000	0.0410	0.0410	0.0410	AID1425103
Casein kinase I isoform epsilon	Homo sapiens (human)	Kd	30.0000	0.0130	1.4086	12.4090	AID1424963
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)	Kd	30.0000	1.6890	1.6890	1.6890	AID1424894
Dual specificity protein kinase CLK1	Homo sapiens (human)	Kd	0.0070	0.0020	1.8791	29.8810	AID1424955
Dual specificity protein kinase CLK3	Homo sapiens (human)	Kd	30.0000	0.0100	2.4499	9.0000	AID1424957
Glycogen synthase kinase-3 alpha	Homo sapiens (human)	Kd	0.0130	0.0060	2.4754	22.5430	AID1425013
Glycogen synthase kinase-3 beta	Homo sapiens (human)	Kd	0.0130	0.0070	1.0057	6.1680	AID1425014
Cyclin-dependent kinase 7	Homo sapiens (human)	Kd	30.0000	0.0025	1.6783	7.7000	AID1424949
Cyclin-dependent kinase 9	Homo sapiens (human)	Kd	0.1740	0.0010	1.6166	9.9010	AID1424950
Ras-related protein Rab-27A	Homo sapiens (human)	Kd	30.0000	4.4930	4.4930	4.4930	AID1425149
Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)	Kd	0.1260	0.0061	1.5252	8.5000	AID1425027
Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)	Kd	30.0000	0.0170	2.8896	37.6050	AID1425160
Serine/threonine-protein kinase Nek2	Homo sapiens (human)	Kd	30.0000	0.1100	1.5649	6.5000	AID1425086
Serine/threonine-protein kinase Nek3	Homo sapiens (human)	Kd	30.0000	0.1700	5.9368	38.0880	AID1425087
Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)	Kd	30.0000	0.0034	2.3943	6.5000	AID1425043
LIM domain kinase 1	Homo sapiens (human)	Kd	30.0000	0.0260	1.7840	21.0890	AID1425035
LIM domain kinase 2	Homo sapiens (human)	Kd	30.0000	0.0570	4.9717	52.0560	AID1425036
Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)	Kd	30.0000	3.3160	3.3160	3.3160	AID1425211
5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)	Kd	30.0000	0.0060	1.4681	10.2120	AID1425126
Ephrin type-B receptor 3	Homo sapiens (human)	Kd	30.0000	0.0069	2.1713	6.4100	AID1424993
Ephrin type-A receptor 5	Homo sapiens (human)	Kd	30.0000	0.0002	1.2100	5.9000	AID1424990
Ephrin type-B receptor 4	Homo sapiens (human)	Kd	30.0000	0.0003	2.1678	26.3990	AID1424994
Ephrin type-A receptor 4	Homo sapiens (human)	Kd	30.0000	0.0012	3.1525	43.9420	AID1424989
Adenylate kinase 2, mitochondrial	Homo sapiens (human)	Kd	30.0000	1.0360	1.0360	1.0360	AID1424909
Adenosine kinase	Homo sapiens (human)	Kd	30.0000	0.0130	1.8368	3.4930	AID1424907
Ras-related protein Rab-10	Homo sapiens (human)	Kd	30.0000	1.3480	1.3480	1.3480	AID1425148
Actin-related protein 3	Homo sapiens (human)	Kd	30.0000	0.0360	2.7735	5.5110	AID1424899
Actin-related protein 2	Homo sapiens (human)	Kd	30.0000	0.0040	0.0040	0.0040	AID1424898
GTP-binding nuclear protein Ran	Homo sapiens (human)	Kd	30.0000	0.7590	0.7590	0.7590	AID1425153
Casein kinase I isoform gamma-2	Homo sapiens (human)	Kd	30.0000	0.0460	1.4506	6.6000	AID1424965
Cyclin-dependent kinase 6	Homo sapiens (human)	Kd	0.0590	0.0320	1.2007	3.3560	AID1424948
Cyclin-dependent-like kinase 5	Homo sapiens (human)	Kd	30.0000	0.0430	1.3757	8.3000	AID1424947
Cyclin-dependent kinase 16	Homo sapiens (human)	Kd	0.0500	0.0011	1.5855	10.0000	AID1424941
Cyclin-dependent kinase 17	Homo sapiens (human)	Kd	30.0000	0.0010	0.8233	5.6000	AID1424942
ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)	Kd	30.0000	0.9830	0.9830	0.9830	AID1425108
Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)	Kd	30.0000	0.0002	1.1386	8.7730	AID1425038
DNA topoisomerase 2-beta	Homo sapiens (human)	Kd	30.0000	0.1480	1.2270	2.5970	AID1425203
Protein kinase C theta type	Homo sapiens (human)	Kd	30.0000	0.0007	1.6140	7.2000	AID1425134
Activin receptor type-1	Homo sapiens (human)	Kd	30.0000	0.0040	1.4853	16.1210	AID1424900
Macrophage-stimulating protein receptor	Homo sapiens (human)	Kd	30.0000	0.0030	2.0718	8.4000	AID1425078
Focal adhesion kinase 1	Homo sapiens (human)	Kd	30.0000	0.0005	1.2255	13.0390	AID1425142
Protein kinase C delta type	Homo sapiens (human)	Kd	0.7950	0.0002	1.1261	9.2060	AID1425131
Tyrosine-protein kinase BTK	Homo sapiens (human)	Kd	30.0000	0.0006	1.5299	10.1530	AID1424925
Activated CDC42 kinase 1	Homo sapiens (human)	Kd	30.0000	0.0020	1.7138	9.6000	AID1425201
Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)	Kd	30.0000	0.0002	1.6314	71.4840	AID1424972
Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)	Kd	30.0000	0.0031	1.4681	14.0430	AID1425052
Serine/threonine-protein kinase 4	Homo sapiens (human)	Kd	30.0000	0.0002	1.7120	25.9020	AID1425185
5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)	Kd	30.0000	0.0037	1.8913	15.3890	AID1425122
Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)	Kd	30.0000	0.0002	2.6590	65.6770	AID1425042
Mitogen-activated protein kinase 7	Homo sapiens (human)	Kd	30.0000	0.0420	2.0073	9.9000	AID1425062
Serine/threonine-protein kinase PAK 2	Homo sapiens (human)	Kd	30.0000	0.0031	2.3045	6.0000	AID1425099
Serine/threonine-protein kinase 3	Homo sapiens (human)	Kd	30.0000	0.0002	1.8602	17.5260	AID1425182
Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)	Kd	30.0000	0.0970	2.5995	12.4730	AID1425044
Rho-associated protein kinase 1	Homo sapiens (human)	Kd	30.0000	0.0003	1.7555	13.4620	AID1425157
Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)	Kd	30.0000	0.0018	1.0064	11.2690	AID1425200
Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)	Kd	0.0180	0.0005	1.0209	7.8000	AID1424929
Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)	Kd	0.0190	0.0003	1.5044	20.3010	AID1424928
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)	Kd	0.2040	0.0001	2.1016	40.2910	AID1424981
Activin receptor type-2B	Homo sapiens (human)	Kd	30.0000	0.0076	2.7328	9.9000	AID1424902
Bone morphogenetic protein receptor type-2	Homo sapiens (human)	Kd	30.0000	0.0190	2.5917	14.3770	AID1424923
Protein-tyrosine kinase 6	Homo sapiens (human)	Kd	30.0000	0.0043	1.7430	9.0000	AID1425144
cGMP-dependent protein kinase 1	Homo sapiens (human)	Kd	30.0000	0.0016	0.7072	3.8000	AID1425138
Cyclin-dependent kinase 13	Homo sapiens (human)	Kd	30.0000	0.0009	1.2571	4.5180	AID1424940
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)	Kd	30.0000	0.0051	1.1093	8.3000	AID1425023
Protein-tyrosine kinase 2-beta	Homo sapiens (human)	Kd	30.0000	0.0011	1.9450	30.4140	AID1425143
Maternal embryonic leucine zipper kinase	Homo sapiens (human)	Kd	30.0000	0.0049	2.2835	29.9330	AID1425074
Structural maintenance of chromosomes protein 1A	Homo sapiens (human)	Kd	30.0000	0.3650	0.3650	0.3650	AID1425172
Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)	Kd	30.0000	0.0030	0.0030	0.0030	AID1424952
Delta(24)-sterol reductase	Homo sapiens (human)	Kd	30.0000	0.4320	0.4320	0.4320	AID1424978
Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)	Kd	30.0000	0.0280	2.5286	22.7260	AID1425159
Dual specificity testis-specific protein kinase 1	Homo sapiens (human)	Kd	30.0000	0.0330	1.7568	5.6000	AID1425194
Myosin light chain kinase, smooth muscle	Homo sapiens (human)	Kd	30.0000	0.0030	1.2088	7.9000	AID1425081
Mitogen-activated protein kinase 11	Homo sapiens (human)	Kd	30.0000	0.0001	0.4610	3.7430	AID1425058
Serine/threonine-protein kinase STK11	Homo sapiens (human)	Kd	30.0000	0.0030	0.9949	5.9000	AID1425178
Serine/threonine-protein kinase N1	Homo sapiens (human)	Kd	30.0000	0.0013	3.1729	49.8130	AID1425117
Serine/threonine-protein kinase N2	Homo sapiens (human)	Kd	30.0000	0.0018	1.7527	9.9000	AID1425118
Mitogen-activated protein kinase 14	Homo sapiens (human)	Kd	30.0000	0.0000	0.5036	8.5000	AID1425059
Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)	Kd	30.0000	0.0300	1.9215	5.4600	AID1424930
Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)	Kd	30.0000	0.0110	1.5639	17.9840	AID1425045
MAP kinase-activated protein kinase 3	Homo sapiens (human)	Kd	30.0000	0.0020	0.0170	0.0260	AID1425066
Discoidin domain-containing receptor 2	Homo sapiens (human)	Kd	30.0000	0.0030	1.9888	42.2800	AID1424973
AP2-associated protein kinase 1	Homo sapiens (human)	Kd	0.1020	0.0012	1.3707	13.7110	AID1424889
Myosin light chain kinase 3	Homo sapiens (human)	Kd	30.0000	0.0020	1.6184	10.4240	AID1425082
Uncharacterized aarF domain-containing protein kinase 5	Homo sapiens (human)	Kd	30.0000	0.2020	0.4990	0.7960	AID1424906
Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)	Kd	30.0000	2.5660	2.5660	2.5660	AID1425019
Rab-like protein 3	Homo sapiens (human)	Kd	30.0000	4.8300	4.8300	4.8300	AID1425151
Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)	Kd	30.0000	0.0570	4.5547	14.0200	AID1424933
Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)	Kd	30.0000	0.0370	1.9625	9.5000	AID1424935
Serine/threonine-protein kinase N3	Homo sapiens (human)	Kd	30.0000	0.0990	0.7365	1.3740	AID1425119
Serine/threonine-protein kinase ULK3	Homo sapiens (human)	Kd	30.0000	0.0012	1.3350	9.9000	AID1425209
Uncharacterized protein FLJ45252	Homo sapiens (human)	Kd	0.0880	0.0030	1.2292	9.3110	AID1425147
Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)	Kd	30.0000	1.9160	3.0730	4.1470	AID1424893
Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)	Kd	30.0000	0.1160	0.7604	1.5000	AID1424998
Serine/threonine-protein kinase MARK2	Homo sapiens (human)	Kd	30.0000	0.0001	1.8425	11.1030	AID1425068
Serine/threonine-protein kinase TAO1	Homo sapiens (human)	Kd	0.1070	0.0004	2.1612	18.7570	AID1425189
STE20-related kinase adapter protein alpha	Homo sapiens (human)	Kd	30.0000	0.3160	1.7208	3.6720	AID1425186
AarF domain-containing protein kinase 1	Homo sapiens (human)	Kd	0.0400	0.0230	3.1137	22.7470	AID1424904
Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)	Kd	30.0000	0.0051	1.6413	15.4350	AID1425053
MAP kinase-activated protein kinase 5	Homo sapiens (human)	Kd	30.0000	0.0080	1.1241	3.1180	AID1425067
Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.0940	5.1673	65.3020	AID1424905
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)	Kd	30.0000	0.0030	2.7522	8.8000	AID1425115
Mitogen-activated protein kinase 15	Homo sapiens (human)	Kd	30.0000	0.0049	0.6880	4.5000	AID1425060
Serine/threonine-protein kinase Nek9	Homo sapiens (human)	Kd	30.0000	0.0160	2.7428	19.6170	AID1425089
ATP-dependent RNA helicase DDX1	Homo sapiens (human)	Kd	30.0000	0.0860	0.0860	0.0860	AID1424974
Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)	Kd	30.0000	0.0010	0.9378	5.5000	AID1425051
Aurora kinase B	Homo sapiens (human)	Kd	30.0000	0.0020	1.0614	22.8520	AID1424918
MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)	Kd	30.0000	0.0054	1.1029	4.9000	AID1425070
Serine/threonine-protein kinase Nek1	Homo sapiens (human)	Kd	30.0000	0.1700	2.4294	8.3000	AID1425085
Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)	Kd	2.5980	0.0000	3.2331	52.8470	AID1424931
EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)	Kd	30.0000	0.3110	1.9519	3.8400	AID1425204
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)	Kd	30.0000	0.0440	0.9285	2.9000	AID1425116
Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)	Kd	30.0000	0.0700	6.5647	50.5360	AID1425049
Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)	Kd	30.0000	0.0060	1.5331	9.9000	AID1425047
Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)	Kd	4.8360	0.0580	1.9224	4.8360	AID1424984
Nucleolar GTP-binding protein 1	Homo sapiens (human)	Kd	30.0000	0.0090	4.1035	8.1980	AID1425016
Serine/threonine-protein kinase D2	Homo sapiens (human)	Kd	2.0640	0.0081	2.3723	25.0190	AID1425136
NUAK family SNF1-like kinase 2	Homo sapiens (human)	Kd	30.0000	0.0001	0.6774	4.6000	AID1425095
RNA cytidine acetyltransferase	Homo sapiens (human)	Kd	30.0000	1.2400	1.2400	1.2400	AID1425083
Serine/threonine-protein kinase SIK2	Homo sapiens (human)	Kd	30.0000	0.0011	1.8165	41.7950	AID1425166
STE20-like serine/threonine-protein kinase	Homo sapiens (human)	Kd	30.0000	0.0000	3.8573	99.2320	AID1425171
Serine/threonine-protein kinase TAO3	Homo sapiens (human)	Kd	1.7210	0.0002	2.7131	14.1960	AID1425191
dCTP pyrophosphatase 1	Homo sapiens (human)	Kd	30.0000	0.5730	1.7403	3.0540	AID1424971
Dual specificity protein kinase CLK4	Homo sapiens (human)	Kd	0.0130	0.0020	1.4122	8.3000	AID1424958
Casein kinase I isoform gamma-1	Homo sapiens (human)	Kd	30.0000	0.0530	2.0622	5.7000	AID1424964
Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)	Kd	30.0000	0.0030	0.0045	0.0060	AID1425000
Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.0110	0.0110	0.0110	AID1425020
BMP-2-inducible protein kinase	Homo sapiens (human)	Kd	56.0320	0.0022	2.4097	56.0320	AID1424920
Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)	Kd	30.0000	0.0017	3.4719	34.1450	AID1425029
Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)	Kd	30.0000	0.0023	1.7034	13.6380	AID1425213
Cyclin-dependent kinase 12	Homo sapiens (human)	Kd	30.0000	0.0320	1.8032	5.6350	AID1424939
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)	Kd	30.0000	3.9200	3.9200	3.9200	AID1425084
Serine/threonine-protein kinase 26	Homo sapiens (human)	Kd	30.0000	0.0074	1.7380	8.3000	AID1425181
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)	Kd	30.0000	0.0070	0.0070	0.0070	AID1425187
Serine/threonine-protein kinase NLK	Homo sapiens (human)	Kd	30.0000	0.0060	1.0226	4.4000	AID1425090
5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)	Kd	30.0000	0.0050	1.1581	9.1280	AID1425127
Serine/threonine-protein kinase TBK1	Homo sapiens (human)	Kd	30.0000	0.0009	1.7674	49.6010	AID1425192
Septin-9	Homo sapiens (human)	Kd	30.0000	0.0100	0.2430	0.6350	AID1425165
Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)	Kd	30.0000	0.0040	2.4153	23.7620	AID1425163
TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)	Kd	30.0000	0.0047	1.3935	10.0000	AID1425199
Serine/threonine-protein kinase TAO2	Homo sapiens (human)	Kd	30.0000	0.0100	2.0176	12.9420	AID1425190
Serine/threonine-protein kinase ICK	Homo sapiens (human)	Kd	0.0530	0.0007	1.4717	9.3000	AID1425021
RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)	Kd	30.0000	0.0025	1.7646	6.2000	AID1424912
Serine/threonine-protein kinase SIK3	Homo sapiens (human)	Kd	30.0000	0.0005	1.5086	10.3180	AID1425167
Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)	Kd	30.0000	0.0024	1.3298	6.9000	AID1425046
Thyroid hormone receptor-associated protein 3	Homo sapiens (human)	Kd	30.0000	2.7460	2.7460	2.7460	AID1425198
Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)	Kd	30.0000	0.0005	1.9494	50.2140	AID1425055
Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)	Kd	30.0000	0.0110	1.4797	6.7000	AID1425156
Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)	Kd	30.0000	0.0340	3.6252	50.0050	AID1424934
Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)	Kd	30.0000	0.0070	1.7137	25.5810	AID1425028
Serine/threonine-protein kinase 24	Homo sapiens (human)	Kd	30.0000	0.0065	0.8920	4.0840	AID1425180
Casein kinase I isoform gamma-3	Homo sapiens (human)	Kd	30.0000	0.0970	2.3978	8.7000	AID1424966
Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)	Kd	30.0000	0.0390	2.3970	8.4000	AID1425048
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Cyclin-dependent kinase 4	Homo sapiens (human)	INH	6.7000	6.7000	6.7000	6.7000	AID1239762
Cyclin-dependent kinase 6	Homo sapiens (human)	INH	6.7000	6.7000	6.7000	6.7000	AID1239762
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2441)

Process	via Protein(s)	Taxonomy
positive regulation of gene expression	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
cartilage condensation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
ovarian cumulus expansion	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
osteoblast differentiation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
eye development	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
chondrocyte development	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
inflammatory response	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
central nervous system neuron differentiation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
proteoglycan biosynthetic process	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
positive regulation of bone mineralization	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
BMP signaling pathway	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
retinal ganglion cell axon guidance	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
positive regulation of chondrocyte differentiation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
ovulation cycle	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
positive regulation of osteoblast differentiation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
retina development in camera-type eye	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
endochondral bone morphogenesis	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
positive regulation of cartilage development	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
cellular response to BMP stimulus	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
negative regulation of chondrocyte proliferation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
dorsal/ventral pattern formation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
protein phosphorylation	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
cellular response to growth factor stimulus	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Cell division cycle 7-related protein kinase	Homo sapiens (human)
positive regulation of cell population proliferation	Cell division cycle 7-related protein kinase	Homo sapiens (human)
positive regulation of nuclear cell cycle DNA replication	Cell division cycle 7-related protein kinase	Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycle	Cell division cycle 7-related protein kinase	Homo sapiens (human)
cell cycle phase transition	Cell division cycle 7-related protein kinase	Homo sapiens (human)
cell division	Cell division cycle 7-related protein kinase	Homo sapiens (human)
peptidyl-serine phosphorylation	Cell division cycle 7-related protein kinase	Homo sapiens (human)
double-strand break repair via break-induced replication	Cell division cycle 7-related protein kinase	Homo sapiens (human)
signal transduction	Cell division cycle 7-related protein kinase	Homo sapiens (human)
positive regulation of centriole replication	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
centriole replication	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
positive regulation of centriole replication	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
cilium assembly	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
trophoblast giant cell differentiation	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
translational initiation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
chromosome segregation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptors	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
response to virus	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
RNA secondary structure unwinding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of gene expression	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
Wnt signaling pathway	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of translation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of cell growth	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of cell growth	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of protein-containing complex assembly	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of protein autophosphorylation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of type I interferon production	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
DNA duplex unwinding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of interferon-alpha production	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of interferon-beta production	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
stress granule assembly	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of toll-like receptor 7 signaling pathway	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of toll-like receptor 8 signaling pathway	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
intracellular signal transduction	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of translation in response to endoplasmic reticulum stress	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cytosolic ribosome assembly	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of apoptotic process	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of apoptotic process	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of viral genome replication	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
innate immune response	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of translation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of translational initiation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
lipid homeostasis	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cellular response to arsenic-containing substance	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cellular response to osmotic stress	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of chemokine (C-C motif) ligand 5 production	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of protein serine/threonine kinase activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
intrinsic apoptotic signaling pathway	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cellular response to virus	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assembly	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of non-canonical NF-kappaB signal transduction	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transduction	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of protein acetylation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
positive regulation of protein K63-linked ubiquitination	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
protein localization to cytoplasmic stress granule	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
negative regulation of gene expression	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
gamete generation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cell differentiation	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
pyridoxal 5'-phosphate salvage	Pyridoxal kinase	Homo sapiens (human)
pyridoxal metabolic process	Pyridoxal kinase	Homo sapiens (human)
pyridoxamine metabolic process	Pyridoxal kinase	Homo sapiens (human)
mitotic cell cycle	Citron Rho-interacting kinase	Homo sapiens (human)
mitotic cytokinesis	Citron Rho-interacting kinase	Homo sapiens (human)
positive regulation of cytokinesis	Citron Rho-interacting kinase	Homo sapiens (human)
negative regulation of hippo signaling	Citron Rho-interacting kinase	Homo sapiens (human)
generation of neurons	Citron Rho-interacting kinase	Homo sapiens (human)
neuron apoptotic process	Citron Rho-interacting kinase	Homo sapiens (human)
DNA damage checkpoint signaling	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
inner cell mass cell proliferation	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
DNA replication	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
DNA repair	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
chromatin remodeling	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
DNA damage response	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
nucleus organization	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
mitotic G2 DNA damage checkpoint signaling	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
regulation of double-strand break repair via homologous recombination	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
regulation of cell population proliferation	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
signal transduction in response to DNA damage	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
mitotic G2/M transition checkpoint	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
positive regulation of cell cycle	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
negative regulation of gene expression, epigenetic	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
negative regulation of mitotic nuclear division	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
regulation of mitotic centrosome separation	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
negative regulation of G0 to G1 transition	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
cellular response to mechanical stimulus	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
cellular response to caffeine	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
replicative senescence	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
apoptotic process involved in development	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
negative regulation of DNA biosynthetic process	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein phosphorylation	Aurora kinase A	Homo sapiens (human)
response to wounding	Aurora kinase A	Homo sapiens (human)
liver regeneration	Aurora kinase A	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Aurora kinase A	Homo sapiens (human)
mitotic cell cycle	Aurora kinase A	Homo sapiens (human)
chromatin remodeling	Aurora kinase A	Homo sapiens (human)
protein phosphorylation	Aurora kinase A	Homo sapiens (human)
apoptotic process	Aurora kinase A	Homo sapiens (human)
spindle organization	Aurora kinase A	Homo sapiens (human)
spindle assembly involved in female meiosis I	Aurora kinase A	Homo sapiens (human)
mitotic centrosome separation	Aurora kinase A	Homo sapiens (human)
anterior/posterior axis specification	Aurora kinase A	Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycle	Aurora kinase A	Homo sapiens (human)
negative regulation of gene expression	Aurora kinase A	Homo sapiens (human)
peptidyl-serine phosphorylation	Aurora kinase A	Homo sapiens (human)
regulation of protein stability	Aurora kinase A	Homo sapiens (human)
negative regulation of protein binding	Aurora kinase A	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Aurora kinase A	Homo sapiens (human)
negative regulation of apoptotic process	Aurora kinase A	Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic process	Aurora kinase A	Homo sapiens (human)
positive regulation of mitotic nuclear division	Aurora kinase A	Homo sapiens (human)
positive regulation of mitotic cell cycle	Aurora kinase A	Homo sapiens (human)
regulation of centrosome cycle	Aurora kinase A	Homo sapiens (human)
protein autophosphorylation	Aurora kinase A	Homo sapiens (human)
cell division	Aurora kinase A	Homo sapiens (human)
centrosome localization	Aurora kinase A	Homo sapiens (human)
cilium disassembly	Aurora kinase A	Homo sapiens (human)
protein localization to centrosome	Aurora kinase A	Homo sapiens (human)
positive regulation of mitochondrial fission	Aurora kinase A	Homo sapiens (human)
positive regulation of oocyte maturation	Aurora kinase A	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	Aurora kinase A	Homo sapiens (human)
neuron projection extension	Aurora kinase A	Homo sapiens (human)
mitotic spindle organization	Aurora kinase A	Homo sapiens (human)
regulation of cytokinesis	Aurora kinase A	Homo sapiens (human)
receptor-mediated endocytosis	Cyclin-G-associated kinase	Homo sapiens (human)
endoplasmic reticulum organization	Cyclin-G-associated kinase	Homo sapiens (human)
Golgi organization	Cyclin-G-associated kinase	Homo sapiens (human)
negative regulation of neuron projection development	Cyclin-G-associated kinase	Homo sapiens (human)
synaptic vesicle uncoating	Cyclin-G-associated kinase	Homo sapiens (human)
protein localization to Golgi apparatus	Cyclin-G-associated kinase	Homo sapiens (human)
intracellular transport	Cyclin-G-associated kinase	Homo sapiens (human)
clathrin coat assembly	Cyclin-G-associated kinase	Homo sapiens (human)
chaperone cofactor-dependent protein refolding	Cyclin-G-associated kinase	Homo sapiens (human)
clathrin coat disassembly	Cyclin-G-associated kinase	Homo sapiens (human)
clathrin-dependent endocytosis	Cyclin-G-associated kinase	Homo sapiens (human)
protein localization to plasma membrane	Cyclin-G-associated kinase	Homo sapiens (human)
Golgi to lysosome transport	Cyclin-G-associated kinase	Homo sapiens (human)
regulation of clathrin coat assembly	Cyclin-G-associated kinase	Homo sapiens (human)
protein phosphorylation	Ephrin type-B receptor 6	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-B receptor 6	Homo sapiens (human)
axon guidance	Ephrin type-B receptor 6	Homo sapiens (human)
fatty acid beta-oxidation using acyl-CoA oxidase	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
lipid homeostasis	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
toll-like receptor 2 signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of cytokine-mediated signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
adaptive immune response	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of T-helper 1 type immune response	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
apoptotic process	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
inflammatory response	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
signal transduction	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
canonical NF-kappaB signal transduction	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
JNK cascade	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylation	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cytokine-mediated signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of protein ubiquitination	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of protein binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of chemokine production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of interferon-alpha production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of interferon-beta production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of type II interferon production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of interleukin-1 beta production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of interleukin-12 production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of interleukin-2 production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of interleukin-6 production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of tumor necrosis factor production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of stress-activated MAPK cascade	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
immature T cell proliferation in thymus	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of immature T cell proliferation in thymus	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
toll-like receptor 4 signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
CD4-positive, alpha-beta T cell proliferation	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
defense response to bacterium	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of apoptotic process	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
response to exogenous dsRNA	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
innate immune response	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of T-helper 1 cell differentiation	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of JNK cascade	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
defense response to Gram-positive bacterium	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
T cell receptor signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
protein homooligomerization	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
stress-activated MAPK cascade	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of macrophage cytokine production	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
ERK1 and ERK2 cascade	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
nucleotide-binding oligomerization domain containing 1 signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
nucleotide-binding oligomerization domain containing 2 signaling pathway	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
response to interleukin-1	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
response to interleukin-12	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
response to interleukin-18	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cellular response to lipoteichoic acid	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cellular response to peptidoglycan	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cellular response to muramyl dipeptide	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
activation of cysteine-type endopeptidase activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
xenophagy	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of protein K63-linked ubiquitination	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of xenophagy	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of CD4-positive, alpha-beta T cell proliferation	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
chromatin remodeling	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
apoptotic process	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
chromosome segregation	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
regulation of sister chromatid cohesion	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
mitotic spindle assembly checkpoint signaling	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
cell division	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
regulation of chromosome segregation	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
meiotic sister chromatid cohesion, centromeric	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
mitochondrion organization	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial genome maintenance	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial fission	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
neural tube closure	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
apoptotic process	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrion organization	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
inner mitochondrial membrane organization	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
visual perception	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial fusion	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
axonal transport of mitochondrion	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
positive regulation of interleukin-17 production	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
cristae formation	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
negative regulation of apoptotic process	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
GTP metabolic process	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
protein complex oligomerization	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
membrane fusion	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
negative regulation of release of cytochrome c from mitochondria	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
cellular senescence	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
membrane tubulation	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial inner membrane fusion	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
positive regulation of T-helper 17 cell lineage commitment	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Cyclin-T1	Homo sapiens (human)
transcription by RNA polymerase II	Cyclin-T1	Homo sapiens (human)
response to xenobiotic stimulus	Cyclin-T1	Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase II	Cyclin-T1	Homo sapiens (human)
positive regulation by host of viral transcription	Cyclin-T1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cyclin-T1	Homo sapiens (human)
cell division	Cyclin-T1	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Cyclin-T1	Homo sapiens (human)
positive regulation of DNA-templated transcription, elongation	Cyclin-T1	Homo sapiens (human)
regulation of translational initiation	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
ribosome assembly	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
translational initiation	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
epithelial to mesenchymal transition	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of protein phosphorylation	Rho-associated protein kinase 2	Homo sapiens (human)
response to ischemia	Rho-associated protein kinase 2	Homo sapiens (human)
aortic valve morphogenesis	Rho-associated protein kinase 2	Homo sapiens (human)
protein phosphorylation	Rho-associated protein kinase 2	Homo sapiens (human)
smooth muscle contraction	Rho-associated protein kinase 2	Homo sapiens (human)
canonical NF-kappaB signal transduction	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of endothelial cell migration	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of cardiac muscle hypertrophy	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of gene expression	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of gene expression	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of centrosome duplication	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of angiogenesis	Rho-associated protein kinase 2	Homo sapiens (human)
actin cytoskeleton organization	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of cell adhesion	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of cell migration	Rho-associated protein kinase 2	Homo sapiens (human)
cortical actin cytoskeleton organization	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of nervous system process	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of connective tissue growth factor production	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of actin cytoskeleton organization	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of myosin-light-chain-phosphatase activity	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of circadian rhythm	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of MAPK cascade	Rho-associated protein kinase 2	Homo sapiens (human)
modulation by host of viral process	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of nitric oxide biosynthetic process	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of keratinocyte differentiation	Rho-associated protein kinase 2	Homo sapiens (human)
rhythmic process	Rho-associated protein kinase 2	Homo sapiens (human)
centrosome duplication	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of stress fiber assembly	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of stress fiber assembly	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of focal adhesion assembly	Rho-associated protein kinase 2	Homo sapiens (human)
mRNA destabilization	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of biomineral tissue development	Rho-associated protein kinase 2	Homo sapiens (human)
cellular response to testosterone stimulus	Rho-associated protein kinase 2	Homo sapiens (human)
response to transforming growth factor beta	Rho-associated protein kinase 2	Homo sapiens (human)
protein localization to plasma membrane	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of fibroblast growth factor production	Rho-associated protein kinase 2	Homo sapiens (human)
blood vessel diameter maintenance	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of angiotensin-activated signaling pathway	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of protein localization to lysosome	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of cellular response to hypoxia	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of amyloid-beta formation	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of protein localization to early endosome	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of amyloid precursor protein catabolic process	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of establishment of endothelial barrier	Rho-associated protein kinase 2	Homo sapiens (human)
negative regulation of bicellular tight junction assembly	Rho-associated protein kinase 2	Homo sapiens (human)
cellular response to acetylcholine	Rho-associated protein kinase 2	Homo sapiens (human)
positive regulation of connective tissue replacement	Rho-associated protein kinase 2	Homo sapiens (human)
response to angiotensin	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of establishment of cell polarity	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of cell motility	Rho-associated protein kinase 2	Homo sapiens (human)
actomyosin structure organization	Rho-associated protein kinase 2	Homo sapiens (human)
peptidyl-threonine phosphorylation	Rho-associated protein kinase 2	Homo sapiens (human)
mitotic cytokinesis	Rho-associated protein kinase 2	Homo sapiens (human)
embryonic morphogenesis	Rho-associated protein kinase 2	Homo sapiens (human)
regulation of cell junction assembly	Rho-associated protein kinase 2	Homo sapiens (human)
Rho protein signal transduction	Rho-associated protein kinase 2	Homo sapiens (human)
autophagosome assembly	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
autophagy	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
protein localization	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
negative regulation of cell population proliferation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
positive regulation of autophagy	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathway	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
macroautophagy	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
regulation of macroautophagy	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
neuron projection regeneration	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
neuron projection development	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
negative regulation of protein-containing complex assembly	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
cellular response to nutrient levels	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
response to starvation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
regulation of protein lipidation	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
positive regulation of autophagosome assembly	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
axon extension	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
autophagy of mitochondrion	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
reticulophagy	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
piecemeal microautophagy of the nucleus	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
negative regulation of collateral sprouting	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
endothelial cell proliferation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
mRNA catabolic process	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
regulation of macroautophagy	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
positive regulation of RNA splicing	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
cellular response to unfolded protein	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
response to endoplasmic reticulum stress	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulus	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
peptidyl-serine autophosphorylation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
IRE1-mediated unfolded protein response	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
positive regulation of JUN kinase activity	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
mRNA splicing, via endonucleolytic cleavage and ligation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
cellular response to hydrogen peroxide	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
cellular response to glucose stimulus	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
positive regulation of endoplasmic reticulum unfolded protein response	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
insulin metabolic process	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
peptidyl-serine trans-autophosphorylation	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
negative regulation of cytokine production	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
chromatin remodeling	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
regulation of DNA-templated transcription	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
protein phosphorylation	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
inflammatory response	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
axon guidance	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
positive regulation of CREB transcription factor activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
intracellular signal transduction	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
post-translational protein modification	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
negative regulation of DNA-templated transcription	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
interleukin-1-mediated signaling pathway	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
regulation of postsynapse organization	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
peptidyl-serine phosphorylation	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
cis assembly of pre-catalytic spliceosome	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
mRNA splicing, via spliceosome	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
osteoblast differentiation	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
negative regulation of cytokine production	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
chromatin remodeling	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
regulation of DNA-templated transcription	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
protein phosphorylation	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
inflammatory response	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
positive regulation of CREB transcription factor activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
intracellular signal transduction	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
post-translational protein modification	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
interleukin-1-mediated signaling pathway	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
peptidyl-serine phosphorylation	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Serine/threonine-protein kinase 16	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase 16	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Serine/threonine-protein kinase 16	Homo sapiens (human)
DNA damage response	Cyclin-K	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Cyclin-K	Homo sapiens (human)
transcription by RNA polymerase II	Cyclin-K	Homo sapiens (human)
regulation of signal transduction	Cyclin-K	Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase II	Cyclin-K	Homo sapiens (human)
negative regulation by host of viral genome replication	Cyclin-K	Homo sapiens (human)
cell division	Cyclin-K	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Cyclin-K	Homo sapiens (human)
positive regulation of DNA-templated transcription, elongation	Cyclin-K	Homo sapiens (human)
neuron migration	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase-like 5	Homo sapiens (human)
positive regulation of GTPase activity	Cyclin-dependent kinase-like 5	Homo sapiens (human)
positive regulation of axon extension	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein autophosphorylation	Cyclin-dependent kinase-like 5	Homo sapiens (human)
regulation of dendrite development	Cyclin-dependent kinase-like 5	Homo sapiens (human)
positive regulation of dendrite morphogenesis	Cyclin-dependent kinase-like 5	Homo sapiens (human)
modulation of chemical synaptic transmission	Cyclin-dependent kinase-like 5	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase-like 5	Homo sapiens (human)
positive regulation of dendritic spine development	Cyclin-dependent kinase-like 5	Homo sapiens (human)
regulation of postsynapse organization	Cyclin-dependent kinase-like 5	Homo sapiens (human)
regulation of cilium assembly	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase 10	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase 10	Homo sapiens (human)
lymphocyte aggregation	Serine/threonine-protein kinase 10	Homo sapiens (human)
regulation of lymphocyte migration	Serine/threonine-protein kinase 10	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase D3	Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathway	Serine/threonine-protein kinase D3	Homo sapiens (human)
sphingolipid biosynthetic process	Serine/threonine-protein kinase D3	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase D3	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	Serine/threonine-protein kinase D3	Homo sapiens (human)
mitotic chromosome condensation	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
meiotic chromosome condensation	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
meiotic chromosome segregation	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
cell division	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
kinetochore organization	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
positive regulation of chromosome segregation	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
positive regulation of chromosome separation	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
positive regulation of chromosome condensation	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
signal transduction	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
cellular response to stress	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
microvillus assembly	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
negative regulation of cell-matrix adhesion	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of cell migration	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of ARF protein signal transduction	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of hippo signaling	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
negative regulation of apoptotic process	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of GTPase activity	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
regulation of JNK cascade	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of keratinocyte migration	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of focal adhesion assembly	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
positive regulation of focal adhesion disassembly	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
regulation of MAPK cascade	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
neuron projection morphogenesis	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
sister chromatid segregation	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
inner cell mass cell fate commitment	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
inner cell mass cellular morphogenesis	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
hormone-mediated signaling pathway	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of transforming growth factor beta receptor signaling pathway	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
keratinocyte differentiation	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of actin filament polymerization	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of intracellular estrogen receptor signaling pathway	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
hippo signaling	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of protein-containing complex assembly	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
negative regulation of cyclin-dependent protein serine/threonine kinase activity	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
cytoplasmic sequestering of protein	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
cell division	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
mammary gland epithelial cell differentiation	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
negative regulation of protein localization to nucleus	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of ubiquitin-dependent protein catabolic process	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
positive regulation of apoptotic process	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of organ growth	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
regulation of cell growth	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cytoskeleton organization	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cell migration	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
positive regulation of angiogenesis	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
dendritic spine development	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cellular response to organic cyclic compound	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cell-cell adhesion	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
negative regulation of endothelial cell apoptotic process	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
regulation of MAPK cascade	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
response to oxidative stress	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of phospholipase C activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
mitotic cell cycle	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neural tube closure	Tyrosine-protein kinase ABL1	Homo sapiens (human)
B-1 B cell homeostasis	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of protein phosphorylation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
B cell proliferation involved in immune response	Tyrosine-protein kinase ABL1	Homo sapiens (human)
transitional one stage B cell differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
mismatch repair	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of DNA-templated transcription	Tyrosine-protein kinase ABL1	Homo sapiens (human)
autophagy	Tyrosine-protein kinase ABL1	Homo sapiens (human)
DNA damage response	Tyrosine-protein kinase ABL1	Homo sapiens (human)
integrin-mediated signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
canonical NF-kappaB signal transduction	Tyrosine-protein kinase ABL1	Homo sapiens (human)
associative learning	Tyrosine-protein kinase ABL1	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage	Tyrosine-protein kinase ABL1	Homo sapiens (human)
response to xenobiotic stimulus	Tyrosine-protein kinase ABL1	Homo sapiens (human)
post-embryonic development	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of autophagy	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of endothelial cell migration	Tyrosine-protein kinase ABL1	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cerebellum morphogenesis	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of cell-cell adhesion	Tyrosine-protein kinase ABL1	Homo sapiens (human)
microspike assembly	Tyrosine-protein kinase ABL1	Homo sapiens (human)
actin cytoskeleton organization	Tyrosine-protein kinase ABL1	Homo sapiens (human)
actin filament polymerization	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of endocytosis	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of cell adhesion	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuron differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
BMP signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of BMP signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of axon extension	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of microtubule polymerization	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of Cdc42 protein signal transduction	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of type II interferon production	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of interleukin-2 production	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of actin cytoskeleton organization	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of osteoblast proliferation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
substrate adhesion-dependent cell spreading	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cellular response to oxidative stress	Tyrosine-protein kinase ABL1	Homo sapiens (human)
response to endoplasmic reticulum stress	Tyrosine-protein kinase ABL1	Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein modification process	Tyrosine-protein kinase ABL1	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuropilin signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
signal transduction in response to DNA damage	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of apoptotic process	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of neuron apoptotic process	Tyrosine-protein kinase ABL1	Homo sapiens (human)
endothelial cell migration	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of T cell differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of vasoconstriction	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of mitotic cell cycle	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of mitotic cell cycle	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Tyrosine-protein kinase ABL1	Homo sapiens (human)
alpha-beta T cell differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein autophosphorylation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of fibroblast proliferation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
spleen development	Tyrosine-protein kinase ABL1	Homo sapiens (human)
thymus development	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
activated T cell proliferation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
T cell receptor signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
B cell receptor signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuromuscular process controlling balance	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosol	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of oxidoreductase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuron apoptotic process	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
myoblast proliferation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of stress fiber assembly	Tyrosine-protein kinase ABL1	Homo sapiens (human)
establishment of localization in cell	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of cell cycle	Tyrosine-protein kinase ABL1	Homo sapiens (human)
mitochondrial depolarization	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of focal adhesion assembly	Tyrosine-protein kinase ABL1	Homo sapiens (human)
Bergmann glial cell differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cardiac muscle cell proliferation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuroepithelial cell differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cellular response to hydrogen peroxide	Tyrosine-protein kinase ABL1	Homo sapiens (human)
ERK1 and ERK2 cascade	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascade	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Tyrosine-protein kinase ABL1	Homo sapiens (human)
DNA conformation change	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cellular response to lipopolysaccharide	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Tyrosine-protein kinase ABL1	Homo sapiens (human)
response to epinephrine	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of protein serine/threonine kinase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesis	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cellular senescence	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cell-cell adhesion	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of dendrite development	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreading	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of long-term synaptic potentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of hematopoietic stem cell differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of extracellular matrix organization	Tyrosine-protein kinase ABL1	Homo sapiens (human)
podocyte apoptotic process	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cellular response to dopamine	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of establishment of T cell polarity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
DN4 thymocyte differentiation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein localization to cytoplasmic microtubule plus-end	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of microtubule binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of actin filament binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of modification of synaptic structure	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of blood vessel branching	Tyrosine-protein kinase ABL1	Homo sapiens (human)
activation of protein kinase C activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombination	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of Wnt signaling pathway, planar cell polarity pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
regulation of cell motility	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of endothelial cell apoptotic process	Tyrosine-protein kinase ABL1	Homo sapiens (human)
positive regulation of T cell migration	Tyrosine-protein kinase ABL1	Homo sapiens (human)
negative regulation of cellular senescence	Tyrosine-protein kinase ABL1	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cell surface receptor signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of cell population proliferation	Epidermal growth factor receptor	Homo sapiens (human)
MAPK cascade	Epidermal growth factor receptor	Homo sapiens (human)
ossification	Epidermal growth factor receptor	Homo sapiens (human)
embryonic placenta development	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of protein phosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
hair follicle development	Epidermal growth factor receptor	Homo sapiens (human)
translation	Epidermal growth factor receptor	Homo sapiens (human)
signal transduction	Epidermal growth factor receptor	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
activation of phospholipase C activity	Epidermal growth factor receptor	Homo sapiens (human)
salivary gland morphogenesis	Epidermal growth factor receptor	Homo sapiens (human)
midgut development	Epidermal growth factor receptor	Homo sapiens (human)
learning or memory	Epidermal growth factor receptor	Homo sapiens (human)
circadian rhythm	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of cell population proliferation	Epidermal growth factor receptor	Homo sapiens (human)
diterpenoid metabolic process	Epidermal growth factor receptor	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
cerebral cortex cell migration	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of cell growth	Epidermal growth factor receptor	Homo sapiens (human)
lung development	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of cell migration	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of superoxide anion generation	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
response to cobalamin	Epidermal growth factor receptor	Homo sapiens (human)
response to hydroxyisoflavone	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to reactive oxygen species	Epidermal growth factor receptor	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
ERBB2-EGFR signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
negative regulation of protein catabolic process	Epidermal growth factor receptor	Homo sapiens (human)
vasodilation	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of phosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
ovulation cycle	Epidermal growth factor receptor	Homo sapiens (human)
hydrogen peroxide metabolic process	Epidermal growth factor receptor	Homo sapiens (human)
negative regulation of apoptotic process	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of MAP kinase activity	Epidermal growth factor receptor	Homo sapiens (human)
tongue development	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activity	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of DNA repair	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of DNA replication	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of bone resorption	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of DNA-templated transcription	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of vasoconstriction	Epidermal growth factor receptor	Homo sapiens (human)
negative regulation of mitotic cell cycle	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Epidermal growth factor receptor	Homo sapiens (human)
regulation of JNK cascade	Epidermal growth factor receptor	Homo sapiens (human)
symbiont entry into host cell	Epidermal growth factor receptor	Homo sapiens (human)
protein autophosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
astrocyte activation	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of fibroblast proliferation	Epidermal growth factor receptor	Homo sapiens (human)
digestive tract morphogenesis	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	Epidermal growth factor receptor	Homo sapiens (human)
neuron projection morphogenesis	Epidermal growth factor receptor	Homo sapiens (human)
epithelial cell proliferation	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of epithelial cell proliferation	Epidermal growth factor receptor	Homo sapiens (human)
regulation of peptidyl-tyrosine phosphorylation	Epidermal growth factor receptor	Homo sapiens (human)
protein insertion into membrane	Epidermal growth factor receptor	Homo sapiens (human)
response to calcium ion	Epidermal growth factor receptor	Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergic	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of glial cell proliferation	Epidermal growth factor receptor	Homo sapiens (human)
morphogenesis of an epithelial fold	Epidermal growth factor receptor	Homo sapiens (human)
eyelid development in camera-type eye	Epidermal growth factor receptor	Homo sapiens (human)
response to UV-A	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of mucus secretion	Epidermal growth factor receptor	Homo sapiens (human)
regulation of ERK1 and ERK2 cascade	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to amino acid stimulus	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to mechanical stimulus	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to cadmium ion	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to epidermal growth factor stimulus	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to estradiol stimulus	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to xenobiotic stimulus	Epidermal growth factor receptor	Homo sapiens (human)
cellular response to dexamethasone stimulus	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
liver regeneration	Epidermal growth factor receptor	Homo sapiens (human)
cell-cell adhesion	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of protein kinase C activity	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transduction	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of prolactin secretion	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of miRNA transcription	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of protein localization to plasma membrane	Epidermal growth factor receptor	Homo sapiens (human)
negative regulation of cardiocyte differentiation	Epidermal growth factor receptor	Homo sapiens (human)
neurogenesis	Epidermal growth factor receptor	Homo sapiens (human)
multicellular organism development	Epidermal growth factor receptor	Homo sapiens (human)
positive regulation of kinase activity	Epidermal growth factor receptor	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Epidermal growth factor receptor	Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STAT	Interferon beta	Homo sapiens (human)
response to exogenous dsRNA	Interferon beta	Homo sapiens (human)
B cell activation involved in immune response	Interferon beta	Homo sapiens (human)
cell surface receptor signaling pathway	Interferon beta	Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STAT	Interferon beta	Homo sapiens (human)
response to virus	Interferon beta	Homo sapiens (human)
positive regulation of autophagy	Interferon beta	Homo sapiens (human)
cytokine-mediated signaling pathway	Interferon beta	Homo sapiens (human)
natural killer cell activation	Interferon beta	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT protein	Interferon beta	Homo sapiens (human)
cellular response to interferon-beta	Interferon beta	Homo sapiens (human)
B cell proliferation	Interferon beta	Homo sapiens (human)
negative regulation of viral genome replication	Interferon beta	Homo sapiens (human)
innate immune response	Interferon beta	Homo sapiens (human)
positive regulation of innate immune response	Interferon beta	Homo sapiens (human)
regulation of MHC class I biosynthetic process	Interferon beta	Homo sapiens (human)
negative regulation of T cell differentiation	Interferon beta	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Interferon beta	Homo sapiens (human)
defense response to virus	Interferon beta	Homo sapiens (human)
type I interferon-mediated signaling pathway	Interferon beta	Homo sapiens (human)
neuron cellular homeostasis	Interferon beta	Homo sapiens (human)
cellular response to exogenous dsRNA	Interferon beta	Homo sapiens (human)
cellular response to virus	Interferon beta	Homo sapiens (human)
negative regulation of Lewy body formation	Interferon beta	Homo sapiens (human)
negative regulation of T-helper 2 cell cytokine production	Interferon beta	Homo sapiens (human)
positive regulation of apoptotic signaling pathway	Interferon beta	Homo sapiens (human)
response to exogenous dsRNA	Interferon beta	Homo sapiens (human)
B cell differentiation	Interferon beta	Homo sapiens (human)
natural killer cell activation involved in immune response	Interferon beta	Homo sapiens (human)
adaptive immune response	Interferon beta	Homo sapiens (human)
T cell activation involved in immune response	Interferon beta	Homo sapiens (human)
humoral immune response	Interferon beta	Homo sapiens (human)
cellular response to amyloid-beta	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of protein phosphorylation	High affinity nerve growth factor receptor	Homo sapiens (human)
protein phosphorylation	High affinity nerve growth factor receptor	Homo sapiens (human)
axon guidance	High affinity nerve growth factor receptor	Homo sapiens (human)
learning or memory	High affinity nerve growth factor receptor	Homo sapiens (human)
circadian rhythm	High affinity nerve growth factor receptor	Homo sapiens (human)
negative regulation of cell population proliferation	High affinity nerve growth factor receptor	Homo sapiens (human)
response to xenobiotic stimulus	High affinity nerve growth factor receptor	Homo sapiens (human)
programmed cell death involved in cell development	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of neuron projection development	High affinity nerve growth factor receptor	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	High affinity nerve growth factor receptor	Homo sapiens (human)
olfactory nerve development	High affinity nerve growth factor receptor	Homo sapiens (human)
B cell differentiation	High affinity nerve growth factor receptor	Homo sapiens (human)
response to nutrient levels	High affinity nerve growth factor receptor	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	High affinity nerve growth factor receptor	Homo sapiens (human)
nerve growth factor signaling pathway	High affinity nerve growth factor receptor	Homo sapiens (human)
mechanoreceptor differentiation	High affinity nerve growth factor receptor	Homo sapiens (human)
negative regulation of apoptotic process	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of programmed cell death	High affinity nerve growth factor receptor	Homo sapiens (human)
negative regulation of neuron apoptotic process	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of GTPase activity	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of Ras protein signal transduction	High affinity nerve growth factor receptor	Homo sapiens (human)
protein autophosphorylation	High affinity nerve growth factor receptor	Homo sapiens (human)
neurotrophin TRK receptor signaling pathway	High affinity nerve growth factor receptor	Homo sapiens (human)
ephrin receptor signaling pathway	High affinity nerve growth factor receptor	Homo sapiens (human)
sympathetic nervous system development	High affinity nerve growth factor receptor	Homo sapiens (human)
response to axon injury	High affinity nerve growth factor receptor	Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of pain	High affinity nerve growth factor receptor	Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of pain	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	High affinity nerve growth factor receptor	Homo sapiens (human)
neuron apoptotic process	High affinity nerve growth factor receptor	Homo sapiens (human)
response to hydrostatic pressure	High affinity nerve growth factor receptor	Homo sapiens (human)
response to electrical stimulus	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of synapse assembly	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergic	High affinity nerve growth factor receptor	Homo sapiens (human)
Sertoli cell development	High affinity nerve growth factor receptor	Homo sapiens (human)
axonogenesis involved in innervation	High affinity nerve growth factor receptor	Homo sapiens (human)
behavioral response to formalin induced pain	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	High affinity nerve growth factor receptor	Homo sapiens (human)
cellular response to nicotine	High affinity nerve growth factor receptor	Homo sapiens (human)
cellular response to nerve growth factor stimulus	High affinity nerve growth factor receptor	Homo sapiens (human)
multicellular organism development	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of kinase activity	High affinity nerve growth factor receptor	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	High affinity nerve growth factor receptor	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	High affinity nerve growth factor receptor	Homo sapiens (human)
signal transduction	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
negative regulation of adenylate cyclase activity	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
response to nutrient	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
cell population proliferation	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of cell population proliferation	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of cell migration	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of superoxide anion generation	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of urine volume	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
negative regulation of calcium ion-dependent exocytosis	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of insulin receptor signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
negative regulation of synaptic transmission	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
cell division	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
regulation of calcium ion transport	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
positive regulation of neural precursor cell proliferation	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
negative regulation of apoptotic signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
gamma-aminobutyric acid signaling pathway	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
chromosome segregation	ADP/ATP translocase 2	Homo sapiens (human)
positive regulation of cell population proliferation	ADP/ATP translocase 2	Homo sapiens (human)
adenine transport	ADP/ATP translocase 2	Homo sapiens (human)
B cell differentiation	ADP/ATP translocase 2	Homo sapiens (human)
erythrocyte differentiation	ADP/ATP translocase 2	Homo sapiens (human)
regulation of mitochondrial membrane permeability	ADP/ATP translocase 2	Homo sapiens (human)
adenine nucleotide transport	ADP/ATP translocase 2	Homo sapiens (human)
mitochondrial ADP transmembrane transport	ADP/ATP translocase 2	Homo sapiens (human)
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	ADP/ATP translocase 2	Homo sapiens (human)
positive regulation of mitophagy	ADP/ATP translocase 2	Homo sapiens (human)
proton transmembrane transport	ADP/ATP translocase 2	Homo sapiens (human)
mitochondrial ATP transmembrane transport	ADP/ATP translocase 2	Homo sapiens (human)
cellular response to leukemia inhibitory factor	ADP/ATP translocase 2	Homo sapiens (human)
adaptive thermogenesis	ADP/ATP translocase 2	Homo sapiens (human)
adaptive immune response	Protein kinase C beta type	Homo sapiens (human)
chromatin remodeling	Protein kinase C beta type	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Protein kinase C beta type	Homo sapiens (human)
protein phosphorylation	Protein kinase C beta type	Homo sapiens (human)
calcium ion transport	Protein kinase C beta type	Homo sapiens (human)
intracellular calcium ion homeostasis	Protein kinase C beta type	Homo sapiens (human)
apoptotic process	Protein kinase C beta type	Homo sapiens (human)
mitotic nuclear membrane disassembly	Protein kinase C beta type	Homo sapiens (human)
signal transduction	Protein kinase C beta type	Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway	Protein kinase C beta type	Homo sapiens (human)
response to xenobiotic stimulus	Protein kinase C beta type	Homo sapiens (human)
response to glucose	Protein kinase C beta type	Homo sapiens (human)
regulation of glucose transmembrane transport	Protein kinase C beta type	Homo sapiens (human)
negative regulation of glucose transmembrane transport	Protein kinase C beta type	Homo sapiens (human)
regulation of dopamine secretion	Protein kinase C beta type	Homo sapiens (human)
dibenzo-p-dioxin metabolic process	Protein kinase C beta type	Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathway	Protein kinase C beta type	Homo sapiens (human)
positive regulation of insulin secretion	Protein kinase C beta type	Homo sapiens (human)
response to vitamin D	Protein kinase C beta type	Homo sapiens (human)
regulation of growth	Protein kinase C beta type	Homo sapiens (human)
B cell activation	Protein kinase C beta type	Homo sapiens (human)
positive regulation of odontogenesis of dentin-containing tooth	Protein kinase C beta type	Homo sapiens (human)
lipoprotein transport	Protein kinase C beta type	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Protein kinase C beta type	Homo sapiens (human)
post-translational protein modification	Protein kinase C beta type	Homo sapiens (human)
response to ethanol	Protein kinase C beta type	Homo sapiens (human)
positive regulation of angiogenesis	Protein kinase C beta type	Homo sapiens (human)
positive regulation of DNA-templated transcription	Protein kinase C beta type	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Protein kinase C beta type	Homo sapiens (human)
B cell receptor signaling pathway	Protein kinase C beta type	Homo sapiens (human)
positive regulation of B cell receptor signaling pathway	Protein kinase C beta type	Homo sapiens (human)
cellular response to carbohydrate stimulus	Protein kinase C beta type	Homo sapiens (human)
presynaptic modulation of chemical synaptic transmission	Protein kinase C beta type	Homo sapiens (human)
regulation of synaptic vesicle exocytosis	Protein kinase C beta type	Homo sapiens (human)
peptidyl-serine phosphorylation	Protein kinase C beta type	Homo sapiens (human)
intracellular signal transduction	Protein kinase C beta type	Homo sapiens (human)
positive regulation of MAP kinase activity	Insulin receptor	Homo sapiens (human)
positive regulation of protein phosphorylation	Insulin receptor	Homo sapiens (human)
positive regulation of receptor internalization	Insulin receptor	Homo sapiens (human)
heart morphogenesis	Insulin receptor	Homo sapiens (human)
regulation of DNA-templated transcription	Insulin receptor	Homo sapiens (human)
protein phosphorylation	Insulin receptor	Homo sapiens (human)
receptor-mediated endocytosis	Insulin receptor	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Insulin receptor	Homo sapiens (human)
learning	Insulin receptor	Homo sapiens (human)
memory	Insulin receptor	Homo sapiens (human)
positive regulation of cell population proliferation	Insulin receptor	Homo sapiens (human)
insulin receptor signaling pathway	Insulin receptor	Homo sapiens (human)
epidermis development	Insulin receptor	Homo sapiens (human)
male gonad development	Insulin receptor	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Insulin receptor	Homo sapiens (human)
male sex determination	Insulin receptor	Homo sapiens (human)
adrenal gland development	Insulin receptor	Homo sapiens (human)
positive regulation of cell migration	Insulin receptor	Homo sapiens (human)
exocrine pancreas development	Insulin receptor	Homo sapiens (human)
receptor internalization	Insulin receptor	Homo sapiens (human)
activation of protein kinase activity	Insulin receptor	Homo sapiens (human)
activation of protein kinase B activity	Insulin receptor	Homo sapiens (human)
cellular response to insulin stimulus	Insulin receptor	Homo sapiens (human)
glucose homeostasis	Insulin receptor	Homo sapiens (human)
positive regulation of protein-containing complex disassembly	Insulin receptor	Homo sapiens (human)
positive regulation of MAPK cascade	Insulin receptor	Homo sapiens (human)
positive regulation of nitric oxide biosynthetic process	Insulin receptor	Homo sapiens (human)
positive regulation of glycogen biosynthetic process	Insulin receptor	Homo sapiens (human)
positive regulation of glycolytic process	Insulin receptor	Homo sapiens (human)
positive regulation of mitotic nuclear division	Insulin receptor	Homo sapiens (human)
positive regulation of DNA-templated transcription	Insulin receptor	Homo sapiens (human)
regulation of embryonic development	Insulin receptor	Homo sapiens (human)
positive regulation of glucose import	Insulin receptor	Homo sapiens (human)
symbiont entry into host cell	Insulin receptor	Homo sapiens (human)
protein autophosphorylation	Insulin receptor	Homo sapiens (human)
positive regulation of developmental growth	Insulin receptor	Homo sapiens (human)
positive regulation of meiotic cell cycle	Insulin receptor	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Insulin receptor	Homo sapiens (human)
positive regulation of respiratory burst	Insulin receptor	Homo sapiens (human)
cellular response to growth factor stimulus	Insulin receptor	Homo sapiens (human)
dendritic spine maintenance	Insulin receptor	Homo sapiens (human)
amyloid-beta clearance	Insulin receptor	Homo sapiens (human)
transport across blood-brain barrier	Insulin receptor	Homo sapiens (human)
neuron projection maintenance	Insulin receptor	Homo sapiens (human)
regulation of female gonad development	Insulin receptor	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Insulin receptor	Homo sapiens (human)
multicellular organism development	Insulin receptor	Homo sapiens (human)
positive regulation of kinase activity	Insulin receptor	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Lck	Homo sapiens (human)
intracellular zinc ion homeostasis	Tyrosine-protein kinase Lck	Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process	Tyrosine-protein kinase Lck	Homo sapiens (human)
response to xenobiotic stimulus	Tyrosine-protein kinase Lck	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Lck	Homo sapiens (human)
hemopoiesis	Tyrosine-protein kinase Lck	Homo sapiens (human)
platelet activation	Tyrosine-protein kinase Lck	Homo sapiens (human)
T cell differentiation	Tyrosine-protein kinase Lck	Homo sapiens (human)
T cell costimulation	Tyrosine-protein kinase Lck	Homo sapiens (human)
positive regulation of heterotypic cell-cell adhesion	Tyrosine-protein kinase Lck	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase Lck	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Tyrosine-protein kinase Lck	Homo sapiens (human)
Fc-gamma receptor signaling pathway	Tyrosine-protein kinase Lck	Homo sapiens (human)
T cell receptor signaling pathway	Tyrosine-protein kinase Lck	Homo sapiens (human)
positive regulation of T cell receptor signaling pathway	Tyrosine-protein kinase Lck	Homo sapiens (human)
positive regulation of T cell activation	Tyrosine-protein kinase Lck	Homo sapiens (human)
leukocyte migration	Tyrosine-protein kinase Lck	Homo sapiens (human)
release of sequestered calcium ion into cytosol	Tyrosine-protein kinase Lck	Homo sapiens (human)
regulation of lymphocyte activation	Tyrosine-protein kinase Lck	Homo sapiens (human)
positive regulation of leukocyte cell-cell adhesion	Tyrosine-protein kinase Lck	Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway	Tyrosine-protein kinase Lck	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase Lck	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase Lck	Homo sapiens (human)
B cell receptor signaling pathway	Tyrosine-protein kinase Lck	Homo sapiens (human)
response to singlet oxygen	Tyrosine-protein kinase Fyn	Homo sapiens (human)
neuron migration	Tyrosine-protein kinase Fyn	Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
adaptive immune response	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Tyrosine-protein kinase Fyn	Homo sapiens (human)
heart process	Tyrosine-protein kinase Fyn	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Fyn	Homo sapiens (human)
calcium ion transport	Tyrosine-protein kinase Fyn	Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
axon guidance	Tyrosine-protein kinase Fyn	Homo sapiens (human)
learning	Tyrosine-protein kinase Fyn	Homo sapiens (human)
feeding behavior	Tyrosine-protein kinase Fyn	Homo sapiens (human)
regulation of cell shape	Tyrosine-protein kinase Fyn	Homo sapiens (human)
gene expression	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of gene expression	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of hydrogen peroxide biosynthetic process	Tyrosine-protein kinase Fyn	Homo sapiens (human)
positive regulation of neuron projection development	Tyrosine-protein kinase Fyn	Homo sapiens (human)
protein ubiquitination	Tyrosine-protein kinase Fyn	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Fyn	Homo sapiens (human)
protein catabolic process	Tyrosine-protein kinase Fyn	Homo sapiens (human)
forebrain development	Tyrosine-protein kinase Fyn	Homo sapiens (human)
T cell costimulation	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of protein ubiquitination	Tyrosine-protein kinase Fyn	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cellular response to platelet-derived growth factor stimulus	Tyrosine-protein kinase Fyn	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of protein catabolic process	Tyrosine-protein kinase Fyn	Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT protein	Tyrosine-protein kinase Fyn	Homo sapiens (human)
response to ethanol	Tyrosine-protein kinase Fyn	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
ephrin receptor signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
dendrite morphogenesis	Tyrosine-protein kinase Fyn	Homo sapiens (human)
regulation of peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Fyn	Homo sapiens (human)
activated T cell proliferation	Tyrosine-protein kinase Fyn	Homo sapiens (human)
modulation of chemical synaptic transmission	Tyrosine-protein kinase Fyn	Homo sapiens (human)
T cell receptor signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
leukocyte migration	Tyrosine-protein kinase Fyn	Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of pain	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cellular response to hydrogen peroxide	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Tyrosine-protein kinase Fyn	Homo sapiens (human)
positive regulation of protein targeting to membrane	Tyrosine-protein kinase Fyn	Homo sapiens (human)
dendritic spine maintenance	Tyrosine-protein kinase Fyn	Homo sapiens (human)
positive regulation of protein localization to nucleus	Tyrosine-protein kinase Fyn	Homo sapiens (human)
regulation of glutamate receptor signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
negative regulation of dendritic spine maintenance	Tyrosine-protein kinase Fyn	Homo sapiens (human)
response to amyloid-beta	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cellular response to amyloid-beta	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cellular response to L-glutamate	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cellular response to glycine	Tyrosine-protein kinase Fyn	Homo sapiens (human)
positive regulation of protein localization to membrane	Tyrosine-protein kinase Fyn	Homo sapiens (human)
regulation of calcium ion import across plasma membrane	Tyrosine-protein kinase Fyn	Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity	Tyrosine-protein kinase Fyn	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cell differentiation	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase Fyn	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Cyclin-dependent kinase 1	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 1	Homo sapiens (human)
microtubule cytoskeleton organization	Cyclin-dependent kinase 1	Homo sapiens (human)
DNA replication	Cyclin-dependent kinase 1	Homo sapiens (human)
DNA repair	Cyclin-dependent kinase 1	Homo sapiens (human)
chromatin remodeling	Cyclin-dependent kinase 1	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 1	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 1	Homo sapiens (human)
apoptotic process	Cyclin-dependent kinase 1	Homo sapiens (human)
DNA damage response	Cyclin-dependent kinase 1	Homo sapiens (human)
mitotic nuclear membrane disassembly	Cyclin-dependent kinase 1	Homo sapiens (human)
centrosome cycle	Cyclin-dependent kinase 1	Homo sapiens (human)
pronuclear fusion	Cyclin-dependent kinase 1	Homo sapiens (human)
response to xenobiotic stimulus	Cyclin-dependent kinase 1	Homo sapiens (human)
response to toxic substance	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of gene expression	Cyclin-dependent kinase 1	Homo sapiens (human)
negative regulation of gene expression	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 1	Homo sapiens (human)
regulation of Schwann cell differentiation	Cyclin-dependent kinase 1	Homo sapiens (human)
response to amine	Cyclin-dependent kinase 1	Homo sapiens (human)
response to activity	Cyclin-dependent kinase 1	Homo sapiens (human)
cell migration	Cyclin-dependent kinase 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Cyclin-dependent kinase 1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Cyclin-dependent kinase 1	Homo sapiens (human)
chromosome condensation	Cyclin-dependent kinase 1	Homo sapiens (human)
epithelial cell differentiation	Cyclin-dependent kinase 1	Homo sapiens (human)
animal organ regeneration	Cyclin-dependent kinase 1	Homo sapiens (human)
protein localization to kinetochore	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of protein import into nucleus	Cyclin-dependent kinase 1	Homo sapiens (human)
regulation of circadian rhythm	Cyclin-dependent kinase 1	Homo sapiens (human)
negative regulation of apoptotic process	Cyclin-dependent kinase 1	Homo sapiens (human)
response to ethanol	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of DNA replication	Cyclin-dependent kinase 1	Homo sapiens (human)
regulation of embryonic development	Cyclin-dependent kinase 1	Homo sapiens (human)
response to cadmium ion	Cyclin-dependent kinase 1	Homo sapiens (human)
response to copper ion	Cyclin-dependent kinase 1	Homo sapiens (human)
symbiont entry into host cell	Cyclin-dependent kinase 1	Homo sapiens (human)
fibroblast proliferation	Cyclin-dependent kinase 1	Homo sapiens (human)
rhythmic process	Cyclin-dependent kinase 1	Homo sapiens (human)
response to axon injury	Cyclin-dependent kinase 1	Homo sapiens (human)
cell division	Cyclin-dependent kinase 1	Homo sapiens (human)
ventricular cardiac muscle cell development	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of cardiac muscle cell proliferation	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of mitotic sister chromatid segregation	Cyclin-dependent kinase 1	Homo sapiens (human)
protein-containing complex assembly	Cyclin-dependent kinase 1	Homo sapiens (human)
cellular response to hydrogen peroxide	Cyclin-dependent kinase 1	Homo sapiens (human)
ERK1 and ERK2 cascade	Cyclin-dependent kinase 1	Homo sapiens (human)
cellular response to organic cyclic compound	Cyclin-dependent kinase 1	Homo sapiens (human)
Golgi disassembly	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of protein localization to nucleus	Cyclin-dependent kinase 1	Homo sapiens (human)
regulation of attachment of mitotic spindle microtubules to kinetochore	Cyclin-dependent kinase 1	Homo sapiens (human)
microtubule cytoskeleton organization involved in mitosis	Cyclin-dependent kinase 1	Homo sapiens (human)
positive regulation of mitochondrial ATP synthesis coupled electron transport	Cyclin-dependent kinase 1	Homo sapiens (human)
mitotic G2 DNA damage checkpoint signaling	Cyclin-dependent kinase 1	Homo sapiens (human)
protein deubiquitination	Cyclin-dependent kinase 1	Homo sapiens (human)
glycogen metabolic process	Glycogen phosphorylase, liver form	Homo sapiens (human)
5-phosphoribose 1-diphosphate biosynthetic process	Glycogen phosphorylase, liver form	Homo sapiens (human)
response to bacterium	Glycogen phosphorylase, liver form	Homo sapiens (human)
glucose homeostasis	Glycogen phosphorylase, liver form	Homo sapiens (human)
necroptotic process	Glycogen phosphorylase, liver form	Homo sapiens (human)
glycogen catabolic process	Glycogen phosphorylase, liver form	Homo sapiens (human)
microtubule bundle formation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
centrosome cycle	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of cell shape	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
positive regulation of neuron projection development	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of cell adhesion	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
positive regulation of microtubule polymerization	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of cell population proliferation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of mast cell degranulation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of cell differentiation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
positive regulation of myeloid cell differentiation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
positive regulation of monocyte differentiation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
protein autophosphorylation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
myoblast proliferation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
cardiac muscle cell proliferation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of vesicle-mediated transport	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
cellular response to vitamin D	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
regulation of cell motility	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
chemotaxis	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
cell adhesion	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Tyrosine-protein kinase Yes	Homo sapiens (human)
regulation of glucose transmembrane transport	Tyrosine-protein kinase Yes	Homo sapiens (human)
T cell costimulation	Tyrosine-protein kinase Yes	Homo sapiens (human)
cellular response to platelet-derived growth factor stimulus	Tyrosine-protein kinase Yes	Homo sapiens (human)
protein modification process	Tyrosine-protein kinase Yes	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Tyrosine-protein kinase Yes	Homo sapiens (human)
regulation of vascular permeability	Tyrosine-protein kinase Yes	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Tyrosine-protein kinase Yes	Homo sapiens (human)
ephrin receptor signaling pathway	Tyrosine-protein kinase Yes	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Yes	Homo sapiens (human)
leukocyte migration	Tyrosine-protein kinase Yes	Homo sapiens (human)
cellular response to retinoic acid	Tyrosine-protein kinase Yes	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Tyrosine-protein kinase Yes	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase Yes	Homo sapiens (human)
cell differentiation	Tyrosine-protein kinase Yes	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase Yes	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Yes	Homo sapiens (human)
DNA damage checkpoint signaling	Tyrosine-protein kinase Lyn	Homo sapiens (human)
B cell homeostasis	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of cytokine production	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of protein phosphorylation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of protein phosphorylation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of protein phosphorylation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
hematopoietic progenitor cell differentiation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
adaptive immune response	Tyrosine-protein kinase Lyn	Homo sapiens (human)
Fc receptor mediated stimulatory signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
tolerance induction to self antigen	Tyrosine-protein kinase Lyn	Homo sapiens (human)
histamine secretion by mast cell	Tyrosine-protein kinase Lyn	Homo sapiens (human)
platelet degranulation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of myeloid leukocyte differentiation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
immune response-regulating cell surface receptor signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
Fc receptor mediated inhibitory signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of B cell apoptotic process	Tyrosine-protein kinase Lyn	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
DNA damage response	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to sterol depletion	Tyrosine-protein kinase Lyn	Homo sapiens (human)
signal transduction	Tyrosine-protein kinase Lyn	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of cell population proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of cell population proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to xenobiotic stimulus	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to toxic substance	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to hormone	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to carbohydrate	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of neuron projection development	Tyrosine-protein kinase Lyn	Homo sapiens (human)
oligodendrocyte development	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to organic cyclic compound	Tyrosine-protein kinase Lyn	Homo sapiens (human)
fatty acid transport	Tyrosine-protein kinase Lyn	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
erythrocyte differentiation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
eosinophil differentiation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of cell migration	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of B cell proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
T cell costimulation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to insulin	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of mast cell activation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of cell adhesion mediated by integrin	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of toll-like receptor 2 signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
toll-like receptor 4 signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of toll-like receptor 4 signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
cellular response to heat	Tyrosine-protein kinase Lyn	Homo sapiens (human)
interleukin-5-mediated signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Tyrosine-protein kinase Lyn	Homo sapiens (human)
C-X-C chemokine receptor CXCR4 signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT protein	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to amino acid	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of mast cell degranulation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of MAP kinase activity	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of MAPK cascade	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of erythrocyte differentiation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
protein autophosphorylation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
ephrin receptor signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
response to axon injury	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of immune response	Tyrosine-protein kinase Lyn	Homo sapiens (human)
B cell receptor signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of B cell receptor signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
leukocyte migration	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of glial cell proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of Fc receptor mediated stimulatory signaling pathway	Tyrosine-protein kinase Lyn	Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STAT	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of ERK1 and ERK2 cascade	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascade	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of oligodendrocyte progenitor proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of mast cell proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of mast cell proliferation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
cellular response to retinoic acid	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of monocyte chemotaxis	Tyrosine-protein kinase Lyn	Homo sapiens (human)
regulation of platelet aggregation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
dendritic cell differentiation	Tyrosine-protein kinase Lyn	Homo sapiens (human)
negative regulation of intracellular signal transduction	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process	Tyrosine-protein kinase Lyn	Homo sapiens (human)
positive regulation of dendritic cell apoptotic process	Tyrosine-protein kinase Lyn	Homo sapiens (human)
neuron projection development	Tyrosine-protein kinase Lyn	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase Lyn	Homo sapiens (human)
MAPK cascade	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
ureteric bud development	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
neural crest cell migration	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
embryonic epithelial tube formation	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
protein phosphorylation	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
homophilic cell adhesion via plasma membrane adhesion molecules	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
neuron cell-cell adhesion	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
signal transduction	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
axon guidance	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
posterior midgut development	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
response to xenobiotic stimulus	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of gene expression	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of neuron projection development	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of neuron maturation	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
regulation of cell adhesion	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of cell migration	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT protein	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
membrane protein proteolysis	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of cell adhesion mediated by integrin	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
ureter maturation	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
glial cell-derived neurotrophic factor receptor signaling pathway	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
neuron maturation	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of MAPK cascade	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of cell size	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of DNA-templated transcription	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
response to pain	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
enteric nervous system development	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
regulation of axonogenesis	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
retina development in camera-type eye	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
innervation	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
Peyer's patch morphogenesis	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
cellular response to retinoic acid	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of metanephric glomerulus development	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
lymphocyte migration into lymphoid organs	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
GDF15-GFRAL signaling pathway	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
positive regulation of kinase activity	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
multicellular organism development	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cardiac atrium development	Insulin-like growth factor 1 receptor	Homo sapiens (human)
immune response	Insulin-like growth factor 1 receptor	Homo sapiens (human)
signal transduction	Insulin-like growth factor 1 receptor	Homo sapiens (human)
axonogenesis	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of cell population proliferation	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin receptor signaling pathway	Insulin-like growth factor 1 receptor	Homo sapiens (human)
negative regulation of muscle cell apoptotic process	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cerebellum development	Insulin-like growth factor 1 receptor	Homo sapiens (human)
hippocampus development	Insulin-like growth factor 1 receptor	Homo sapiens (human)
establishment of cell polarity	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of cell migration	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of cytokinesis	Insulin-like growth factor 1 receptor	Homo sapiens (human)
response to vitamin E	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of osteoblast proliferation	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to zinc ion starvation	Insulin-like growth factor 1 receptor	Homo sapiens (human)
response to nicotine	Insulin-like growth factor 1 receptor	Homo sapiens (human)
negative regulation of apoptotic process	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of protein-containing complex disassembly	Insulin-like growth factor 1 receptor	Homo sapiens (human)
response to alkaloid	Insulin-like growth factor 1 receptor	Homo sapiens (human)
negative regulation of MAPK cascade	Insulin-like growth factor 1 receptor	Homo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transduction	Insulin-like growth factor 1 receptor	Homo sapiens (human)
estrous cycle	Insulin-like growth factor 1 receptor	Homo sapiens (human)
transcytosis	Insulin-like growth factor 1 receptor	Homo sapiens (human)
response to ethanol	Insulin-like growth factor 1 receptor	Homo sapiens (human)
regulation of JNK cascade	Insulin-like growth factor 1 receptor	Homo sapiens (human)
protein autophosphorylation	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of axon regeneration	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of DNA metabolic process	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to mechanical stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to estradiol stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to progesterone stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to testosterone stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to dexamethasone stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of steroid hormone biosynthetic process	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular senescence	Insulin-like growth factor 1 receptor	Homo sapiens (human)
dendritic spine maintenance	Insulin-like growth factor 1 receptor	Homo sapiens (human)
amyloid-beta clearance	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of cold-induced thermogenesis	Insulin-like growth factor 1 receptor	Homo sapiens (human)
response to L-glutamate	Insulin-like growth factor 1 receptor	Homo sapiens (human)
negative regulation of hepatocyte apoptotic process	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to aldosterone	Insulin-like growth factor 1 receptor	Homo sapiens (human)
negative regulation of cholangiocyte apoptotic process	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to angiotensin	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to amyloid-beta	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to insulin-like growth factor stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
multicellular organism development	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of kinase activity	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cellular response to glucose stimulus	Insulin-like growth factor 1 receptor	Homo sapiens (human)
positive regulation of MAPK cascade	Insulin-like growth factor 1 receptor	Homo sapiens (human)
cotranslational protein targeting to membrane	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
intracellular protein transport	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
protein targeting to ER	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
mitochondrial electron transport, ubiquinol to cytochrome c	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
response to glucagon	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
cellular respiration	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
proton transmembrane transport	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
endothelial cell morphogenesis	Hepatocyte growth factor receptor	Homo sapiens (human)
signal transduction	Hepatocyte growth factor receptor	Homo sapiens (human)
cell surface receptor signaling pathway	Hepatocyte growth factor receptor	Homo sapiens (human)
negative regulation of autophagy	Hepatocyte growth factor receptor	Homo sapiens (human)
positive regulation of microtubule polymerization	Hepatocyte growth factor receptor	Homo sapiens (human)
negative regulation of Rho protein signal transduction	Hepatocyte growth factor receptor	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Hepatocyte growth factor receptor	Homo sapiens (human)
hepatocyte growth factor receptor signaling pathway	Hepatocyte growth factor receptor	Homo sapiens (human)
branching morphogenesis of an epithelial tube	Hepatocyte growth factor receptor	Homo sapiens (human)
positive chemotaxis	Hepatocyte growth factor receptor	Homo sapiens (human)
negative regulation of stress fiber assembly	Hepatocyte growth factor receptor	Homo sapiens (human)
excitatory postsynaptic potential	Hepatocyte growth factor receptor	Homo sapiens (human)
establishment of skin barrier	Hepatocyte growth factor receptor	Homo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathway	Hepatocyte growth factor receptor	Homo sapiens (human)
semaphorin-plexin signaling pathway	Hepatocyte growth factor receptor	Homo sapiens (human)
negative regulation of hydrogen peroxide-mediated programmed cell death	Hepatocyte growth factor receptor	Homo sapiens (human)
negative regulation of guanyl-nucleotide exchange factor activity	Hepatocyte growth factor receptor	Homo sapiens (human)
positive regulation of endothelial cell chemotaxis	Hepatocyte growth factor receptor	Homo sapiens (human)
liver development	Hepatocyte growth factor receptor	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Hepatocyte growth factor receptor	Homo sapiens (human)
phagocytosis	Hepatocyte growth factor receptor	Homo sapiens (human)
multicellular organism development	Hepatocyte growth factor receptor	Homo sapiens (human)
neuron differentiation	Hepatocyte growth factor receptor	Homo sapiens (human)
positive regulation of kinase activity	Hepatocyte growth factor receptor	Homo sapiens (human)
cell migration	Hepatocyte growth factor receptor	Homo sapiens (human)
pancreas development	Hepatocyte growth factor receptor	Homo sapiens (human)
nervous system development	Hepatocyte growth factor receptor	Homo sapiens (human)
leukocyte migration involved in immune response	Tyrosine-protein kinase HCK	Homo sapiens (human)
innate immune response-activating signaling pathway	Tyrosine-protein kinase HCK	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Tyrosine-protein kinase HCK	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase HCK	Homo sapiens (human)
inflammatory response	Tyrosine-protein kinase HCK	Homo sapiens (human)
cell adhesion	Tyrosine-protein kinase HCK	Homo sapiens (human)
integrin-mediated signaling pathway	Tyrosine-protein kinase HCK	Homo sapiens (human)
mesoderm development	Tyrosine-protein kinase HCK	Homo sapiens (human)
positive regulation of cell population proliferation	Tyrosine-protein kinase HCK	Homo sapiens (human)
regulation of cell shape	Tyrosine-protein kinase HCK	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase HCK	Homo sapiens (human)
cytokine-mediated signaling pathway	Tyrosine-protein kinase HCK	Homo sapiens (human)
positive regulation of actin filament polymerization	Tyrosine-protein kinase HCK	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Tyrosine-protein kinase HCK	Homo sapiens (human)
regulation of actin cytoskeleton organization	Tyrosine-protein kinase HCK	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase HCK	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Tyrosine-protein kinase HCK	Homo sapiens (human)
negative regulation of apoptotic process	Tyrosine-protein kinase HCK	Homo sapiens (human)
leukocyte degranulation	Tyrosine-protein kinase HCK	Homo sapiens (human)
respiratory burst after phagocytosis	Tyrosine-protein kinase HCK	Homo sapiens (human)
protein autophosphorylation	Tyrosine-protein kinase HCK	Homo sapiens (human)
regulation of inflammatory response	Tyrosine-protein kinase HCK	Homo sapiens (human)
regulation of phagocytosis	Tyrosine-protein kinase HCK	Homo sapiens (human)
regulation of DNA-binding transcription factor activity	Tyrosine-protein kinase HCK	Homo sapiens (human)
type II interferon-mediated signaling pathway	Tyrosine-protein kinase HCK	Homo sapiens (human)
regulation of podosome assembly	Tyrosine-protein kinase HCK	Homo sapiens (human)
cell differentiation	Tyrosine-protein kinase HCK	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase HCK	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase HCK	Homo sapiens (human)
signal transduction	Platelet-derived growth factor receptor beta	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of cell population proliferation	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of phospholipase C activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of smooth muscle cell migration	Platelet-derived growth factor receptor beta	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of cell migration	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of phosphoprotein phosphatase activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
regulation of actin cytoskeleton organization	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cell migration involved in vasculogenesis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathway	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway	Platelet-derived growth factor receptor beta	Homo sapiens (human)
aorta morphogenesis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cellular response to platelet-derived growth factor stimulus	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of MAP kinase activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of mitotic nuclear division	Platelet-derived growth factor receptor beta	Homo sapiens (human)
phosphatidylinositol metabolic process	Platelet-derived growth factor receptor beta	Homo sapiens (human)
protein autophosphorylation	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet-derived growth factor receptor signaling pathway	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of calcium-mediated signaling	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of chemotaxis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cardiac myofibril assembly	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cell chemotaxis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cell migration involved in coronary angiogenesis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
retina vasculature development in camera-type eye	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Platelet-derived growth factor receptor beta	Homo sapiens (human)
smooth muscle cell chemotaxis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
metanephric glomerular mesangial cell proliferation involved in metanephros development	Platelet-derived growth factor receptor beta	Homo sapiens (human)
metanephric glomerular capillary formation	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of calcium ion import	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of DNA biosynthetic process	Platelet-derived growth factor receptor beta	Homo sapiens (human)
positive regulation of kinase activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
angiogenesis	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Platelet-derived growth factor receptor beta	Homo sapiens (human)
multicellular organism development	Platelet-derived growth factor receptor beta	Homo sapiens (human)
regulation of TOR signaling	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
regulation of proteasomal ubiquitin-dependent protein catabolic process	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
protein modification process	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
negative regulation of apoptotic process	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
MAPK cascade	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
glycogen catabolic process	Glycogen phosphorylase, brain form	Homo sapiens (human)
negative regulation of cellular extravasation	Breakpoint cluster region protein	Homo sapiens (human)
renal system process	Breakpoint cluster region protein	Homo sapiens (human)
protein phosphorylation	Breakpoint cluster region protein	Homo sapiens (human)
phagocytosis	Breakpoint cluster region protein	Homo sapiens (human)
signal transduction	Breakpoint cluster region protein	Homo sapiens (human)
small GTPase-mediated signal transduction	Breakpoint cluster region protein	Homo sapiens (human)
brain development	Breakpoint cluster region protein	Homo sapiens (human)
actin cytoskeleton organization	Breakpoint cluster region protein	Homo sapiens (human)
keratinocyte differentiation	Breakpoint cluster region protein	Homo sapiens (human)
regulation of Rho protein signal transduction	Breakpoint cluster region protein	Homo sapiens (human)
inner ear morphogenesis	Breakpoint cluster region protein	Homo sapiens (human)
regulation of vascular permeability	Breakpoint cluster region protein	Homo sapiens (human)
neutrophil degranulation	Breakpoint cluster region protein	Homo sapiens (human)
negative regulation of neutrophil degranulation	Breakpoint cluster region protein	Homo sapiens (human)
focal adhesion assembly	Breakpoint cluster region protein	Homo sapiens (human)
homeostasis of number of cells	Breakpoint cluster region protein	Homo sapiens (human)
negative regulation of inflammatory response	Breakpoint cluster region protein	Homo sapiens (human)
positive regulation of phagocytosis	Breakpoint cluster region protein	Homo sapiens (human)
modulation of chemical synaptic transmission	Breakpoint cluster region protein	Homo sapiens (human)
neuromuscular process controlling balance	Breakpoint cluster region protein	Homo sapiens (human)
regulation of small GTPase mediated signal transduction	Breakpoint cluster region protein	Homo sapiens (human)
regulation of cell cycle	Breakpoint cluster region protein	Homo sapiens (human)
definitive hemopoiesis	Breakpoint cluster region protein	Homo sapiens (human)
negative regulation of respiratory burst	Breakpoint cluster region protein	Homo sapiens (human)
negative regulation of blood vessel remodeling	Breakpoint cluster region protein	Homo sapiens (human)
intracellular protein transmembrane transport	Breakpoint cluster region protein	Homo sapiens (human)
cellular response to lipopolysaccharide	Breakpoint cluster region protein	Homo sapiens (human)
activation of GTPase activity	Breakpoint cluster region protein	Homo sapiens (human)
macrophage migration	Breakpoint cluster region protein	Homo sapiens (human)
negative regulation of macrophage migration	Breakpoint cluster region protein	Homo sapiens (human)
negative regulation of reactive oxygen species metabolic process	Breakpoint cluster region protein	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
regulation of transmembrane transporter activity	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
negative regulation of apoptotic process	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
negative regulation of DNA-binding transcription factor activity	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
negative regulation of innate immune response	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
positive regulation of DNA-templated transcription	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
protein stabilization	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
positive regulation of cardiac muscle cell proliferation	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
vitamin D receptor signaling pathway	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
cellular response to type II interferon	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
positive regulation of brown fat cell differentiation	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
regulation of hematopoietic stem cell proliferation	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
positive regulation of TORC1 signaling	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
positive regulation of cardioblast proliferation	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
cellular detoxification	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
positive regulation of cell population proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
fibroblast growth factor receptor signaling pathway	Fibroblast growth factor receptor 1	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Fibroblast growth factor receptor 1	Homo sapiens (human)
MAPK cascade	Fibroblast growth factor receptor 1	Homo sapiens (human)
skeletal system development	Fibroblast growth factor receptor 1	Homo sapiens (human)
angiogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
ureteric bud development	Fibroblast growth factor receptor 1	Homo sapiens (human)
in utero embryonic development	Fibroblast growth factor receptor 1	Homo sapiens (human)
organ induction	Fibroblast growth factor receptor 1	Homo sapiens (human)
neuron migration	Fibroblast growth factor receptor 1	Homo sapiens (human)
epithelial to mesenchymal transition	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of mesenchymal cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
chondrocyte differentiation	Fibroblast growth factor receptor 1	Homo sapiens (human)
protein phosphorylation	Fibroblast growth factor receptor 1	Homo sapiens (human)
sensory perception of sound	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of cell population proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
fibroblast growth factor receptor signaling pathway	Fibroblast growth factor receptor 1	Homo sapiens (human)
mesenchymal cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
gene expression	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of phospholipase activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of phospholipase C activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
regulation of phosphate transport	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of neuron projection development	Fibroblast growth factor receptor 1	Homo sapiens (human)
cell migration	Fibroblast growth factor receptor 1	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Fibroblast growth factor receptor 1	Homo sapiens (human)
ventricular zone neuroblast division	Fibroblast growth factor receptor 1	Homo sapiens (human)
cell projection assembly	Fibroblast growth factor receptor 1	Homo sapiens (human)
embryonic limb morphogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
midbrain development	Fibroblast growth factor receptor 1	Homo sapiens (human)
neuron projection development	Fibroblast growth factor receptor 1	Homo sapiens (human)
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	Fibroblast growth factor receptor 1	Homo sapiens (human)
inner ear morphogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
outer ear morphogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
middle ear morphogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
chordate embryonic development	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of MAP kinase activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of MAPK cascade	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	Fibroblast growth factor receptor 1	Homo sapiens (human)
cellular response to fibroblast growth factor stimulus	Fibroblast growth factor receptor 1	Homo sapiens (human)
regulation of cell differentiation	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of neuron differentiation	Fibroblast growth factor receptor 1	Homo sapiens (human)
protein autophosphorylation	Fibroblast growth factor receptor 1	Homo sapiens (human)
phosphatidylinositol-mediated signaling	Fibroblast growth factor receptor 1	Homo sapiens (human)
paraxial mesoderm development	Fibroblast growth factor receptor 1	Homo sapiens (human)
regulation of lateral mesodermal cell fate specification	Fibroblast growth factor receptor 1	Homo sapiens (human)
cell maturation	Fibroblast growth factor receptor 1	Homo sapiens (human)
skeletal system morphogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
stem cell differentiation	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Fibroblast growth factor receptor 1	Homo sapiens (human)
calcium ion homeostasis	Fibroblast growth factor receptor 1	Homo sapiens (human)
cardiac muscle cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of cardiac muscle cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
auditory receptor cell development	Fibroblast growth factor receptor 1	Homo sapiens (human)
branching involved in salivary gland morphogenesis	Fibroblast growth factor receptor 1	Homo sapiens (human)
lung-associated mesenchyme development	Fibroblast growth factor receptor 1	Homo sapiens (human)
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	Fibroblast growth factor receptor 1	Homo sapiens (human)
vitamin D3 metabolic process	Fibroblast growth factor receptor 1	Homo sapiens (human)
diphosphate metabolic process	Fibroblast growth factor receptor 1	Homo sapiens (human)
cementum mineralization	Fibroblast growth factor receptor 1	Homo sapiens (human)
stem cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	Fibroblast growth factor receptor 1	Homo sapiens (human)
negative regulation of fibroblast growth factor production	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of mitotic cell cycle DNA replication	Fibroblast growth factor receptor 1	Homo sapiens (human)
response to sodium phosphate	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of vascular endothelial cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of stem cell proliferation	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of parathyroid hormone secretion	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of endothelial cell chemotaxis	Fibroblast growth factor receptor 1	Homo sapiens (human)
regulation of extrinsic apoptotic signaling pathway in absence of ligand	Fibroblast growth factor receptor 1	Homo sapiens (human)
multicellular organism development	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of cell differentiation	Fibroblast growth factor receptor 1	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Fibroblast growth factor receptor 1	Homo sapiens (human)
positive regulation of kinase activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
hematopoietic progenitor cell differentiation	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA topological change	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA ligation	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA damage response	DNA topoisomerase 2-alpha	Homo sapiens (human)
chromosome segregation	DNA topoisomerase 2-alpha	Homo sapiens (human)
female meiotic nuclear division	DNA topoisomerase 2-alpha	Homo sapiens (human)
apoptotic chromosome condensation	DNA topoisomerase 2-alpha	Homo sapiens (human)
embryonic cleavage	DNA topoisomerase 2-alpha	Homo sapiens (human)
regulation of circadian rhythm	DNA topoisomerase 2-alpha	Homo sapiens (human)
positive regulation of apoptotic process	DNA topoisomerase 2-alpha	Homo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	DNA topoisomerase 2-alpha	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	DNA topoisomerase 2-alpha	Homo sapiens (human)
rhythmic process	DNA topoisomerase 2-alpha	Homo sapiens (human)
negative regulation of DNA duplex unwinding	DNA topoisomerase 2-alpha	Homo sapiens (human)
resolution of meiotic recombination intermediates	DNA topoisomerase 2-alpha	Homo sapiens (human)
sister chromatid segregation	DNA topoisomerase 2-alpha	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Cyclin-dependent kinase 4	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 4	Homo sapiens (human)
positive regulation of cell population proliferation	Cyclin-dependent kinase 4	Homo sapiens (human)
response to xenobiotic stimulus	Cyclin-dependent kinase 4	Homo sapiens (human)
regulation of gene expression	Cyclin-dependent kinase 4	Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 4	Homo sapiens (human)
positive regulation of fibroblast proliferation	Cyclin-dependent kinase 4	Homo sapiens (human)
cell division	Cyclin-dependent kinase 4	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 4	Homo sapiens (human)
regulation of transcription initiation by RNA polymerase II	Cyclin-dependent kinase 4	Homo sapiens (human)
regulation of type B pancreatic cell proliferation	Cyclin-dependent kinase 4	Homo sapiens (human)
cellular response to lipopolysaccharide	Cyclin-dependent kinase 4	Homo sapiens (human)
cellular response to interleukin-4	Cyclin-dependent kinase 4	Homo sapiens (human)
cellular response to phorbol 13-acetate 12-myristate	Cyclin-dependent kinase 4	Homo sapiens (human)
cellular response to ionomycin	Cyclin-dependent kinase 4	Homo sapiens (human)
response to organic substance	Cyclin-dependent kinase 4	Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 4	Homo sapiens (human)
signal transduction	Cyclin-dependent kinase 4	Homo sapiens (human)
apoptotic process	ADP/ATP translocase 3	Homo sapiens (human)
mitochondrial ADP transmembrane transport	ADP/ATP translocase 3	Homo sapiens (human)
mitochondrial ATP transmembrane transport	ADP/ATP translocase 3	Homo sapiens (human)
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	ADP/ATP translocase 3	Homo sapiens (human)
GMP biosynthetic process	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
GTP biosynthetic process	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
circadian rhythm	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
lymphocyte proliferation	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
cellular response to interleukin-4	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
'de novo' XMP biosynthetic process	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
primary ovarian follicle growth	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of cytokine production	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
signal transduction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
signal complex assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
integrin-mediated signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
spermatogenesis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
learning or memory	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to xenobiotic stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to mechanical stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to acidic pH	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of gene expression	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of epithelial cell migration	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of epithelial cell migration	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of glucose metabolic process	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of protein processing	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
skeletal muscle cell proliferation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of smooth muscle cell migration	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
macroautophagy	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of cell-cell adhesion	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
platelet activation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
forebrain development	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
T cell costimulation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of protein-containing complex assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
protein destabilization	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to nutrient levels	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of telomere maintenance via telomerase	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to insulin stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of intracellular estrogen receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of integrin activation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of toll-like receptor 3 signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
adherens junction organization	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
substrate adhesion-dependent cell spreading	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of dephosphorylation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of hippo signaling	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
intracellular signal transduction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
entry of bacterium into host cell	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
osteoclast development	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to platelet-derived growth factor stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
ERBB2 signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
angiotensin-activated signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
odontogenesis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of apoptotic process	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of apoptotic process	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of vascular permeability	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
stress fiber assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
transcytosis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of bone resorption	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
bone resorption	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of Notch signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of bone resorption	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of Ras protein signal transduction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of insulin receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
protein autophosphorylation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
platelet-derived growth factor receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
neurotrophin TRK receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
ephrin receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
focal adhesion assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
oogenesis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
progesterone receptor signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
leukocyte migration	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of small GTPase mediated signal transduction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of protein transport	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to mineralocorticoid	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
myoblast proliferation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to electrical stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of focal adhesion assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of mitochondrial depolarization	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of telomerase activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
uterus development	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
branching involved in mammary gland duct morphogenesis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of cell projection assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
intestinal epithelial cell development	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
interleukin-6-mediated signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to hydrogen peroxide	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
response to interleukin-1	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to lipopolysaccharide	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to peptide hormone stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to progesterone stimulus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to fatty acid	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to hypoxia	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to fluid shear stress	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of podosome assembly	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
DNA biosynthetic process	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of protein serine/threonine kinase activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of heart rate by cardiac conduction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cell-cell adhesion	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of protein localization to nucleus	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of non-membrane spanning protein tyrosine kinase activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of TORC1 signaling	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cellular response to prolactin	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of male germ cell proliferation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of ovarian follicle development	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of lamellipodium morphogenesis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
positive regulation of platelet-derived growth factor receptor-beta signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of early endosome to late endosome transport	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of anoikis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of caveolin-mediated endocytosis	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cell differentiation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cell adhesion	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
innate immune response	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
protein phosphorylation	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
symbiont entry into host cell	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
regulation of protein phosphorylation	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
intracellular signal transduction	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
negative regulation of cAMP/PKA signal transduction	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
negative regulation of cAMP-dependent protein kinase activity	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
G2/M transition of mitotic cell cycle	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
in utero embryonic development	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
mitotic spindle organization	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
mitotic metaphase chromosome alignment	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycle	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
positive regulation of mitotic cell cycle	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
positive regulation of fibroblast proliferation	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cell division	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
positive regulation of attachment of spindle microtubules to kinetochore	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
regulation of mitotic cell cycle spindle assembly checkpoint	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
positive regulation of mitochondrial ATP synthesis coupled electron transport	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
mitotic cell cycle phase transition	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
MAPK cascade	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
myeloid progenitor cell differentiation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
visual learning	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
animal organ morphogenesis	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of gene expression	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
negative regulation of fibroblast migration	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of glucose transmembrane transport	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
synaptic vesicle exocytosis	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
thyroid gland development	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
T cell differentiation in thymus	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
substrate adhesion-dependent cell spreading	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
somatic stem cell population maintenance	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
regulation of cell population proliferation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
negative regulation of apoptotic process	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
stress fiber assembly	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
CD4-positive, alpha-beta T cell differentiation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
response to peptide hormone	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
negative regulation of neuron apoptotic process	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
regulation of T cell differentiation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
thymus development	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of axon regeneration	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of axonogenesis	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
T cell receptor signaling pathway	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of stress fiber assembly	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
response to cAMP	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
long-term synaptic potentiation	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
head morphogenesis	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
face development	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
ERK1 and ERK2 cascade	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cellular response to calcium ion	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cellular response to xenobiotic stimulus	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
endothelial cell apoptotic process	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
establishment of protein localization to membrane	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreading	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cellular response to nerve growth factor stimulus	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
negative regulation of synaptic vesicle exocytosis	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
negative regulation of endothelial cell apoptotic process	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
glycogen metabolic process	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
glycogen biosynthetic process	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
glycogen catabolic process	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
generation of precursor metabolites and energy	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
protein phosphorylation	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
positive regulation of glycogen catabolic process	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
quinone catabolic process	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
microtubule cytoskeleton organization	Tyrosine-protein kinase Fer	Homo sapiens (human)
regulation of protein phosphorylation	Tyrosine-protein kinase Fer	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Fer	Homo sapiens (human)
tyrosine phosphorylation of STAT protein	Tyrosine-protein kinase Fer	Homo sapiens (human)
germ cell development	Tyrosine-protein kinase Fer	Homo sapiens (human)
positive regulation of cell population proliferation	Tyrosine-protein kinase Fer	Homo sapiens (human)
insulin receptor signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
regulation of lamellipodium assembly	Tyrosine-protein kinase Fer	Homo sapiens (human)
regulation of fibroblast migration	Tyrosine-protein kinase Fer	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase Fer	Homo sapiens (human)
cytokine-mediated signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
actin cytoskeleton organization	Tyrosine-protein kinase Fer	Homo sapiens (human)
positive regulation of cell migration	Tyrosine-protein kinase Fer	Homo sapiens (human)
positive regulation of actin filament polymerization	Tyrosine-protein kinase Fer	Homo sapiens (human)
response to lipopolysaccharide	Tyrosine-protein kinase Fer	Homo sapiens (human)
negative regulation of mast cell activation involved in immune response	Tyrosine-protein kinase Fer	Homo sapiens (human)
adherens junction assembly	Tyrosine-protein kinase Fer	Homo sapiens (human)
substrate adhesion-dependent cell spreading	Tyrosine-protein kinase Fer	Homo sapiens (human)
cellular response to reactive oxygen species	Tyrosine-protein kinase Fer	Homo sapiens (human)
extracellular matrix-cell signaling	Tyrosine-protein kinase Fer	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase Fer	Homo sapiens (human)
cellular response to macrophage colony-stimulating factor stimulus	Tyrosine-protein kinase Fer	Homo sapiens (human)
response to platelet-derived growth factor	Tyrosine-protein kinase Fer	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
Kit signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
regulation of epidermal growth factor receptor signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
cell-cell adhesion mediated by cadherin	Tyrosine-protein kinase Fer	Homo sapiens (human)
protein autophosphorylation	Tyrosine-protein kinase Fer	Homo sapiens (human)
platelet-derived growth factor receptor signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
diapedesis	Tyrosine-protein kinase Fer	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Tyrosine-protein kinase Fer	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Tyrosine-protein kinase Fer	Homo sapiens (human)
Sertoli cell development	Tyrosine-protein kinase Fer	Homo sapiens (human)
interleukin-6-mediated signaling pathway	Tyrosine-protein kinase Fer	Homo sapiens (human)
seminiferous tubule development	Tyrosine-protein kinase Fer	Homo sapiens (human)
adherens junction disassembly	Tyrosine-protein kinase Fer	Homo sapiens (human)
cell adhesion	Tyrosine-protein kinase Fer	Homo sapiens (human)
chemotaxis	Tyrosine-protein kinase Fer	Homo sapiens (human)
angiogenesis	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of endothelial cell proliferation	Protein kinase C alpha type	Homo sapiens (human)
desmosome assembly	Protein kinase C alpha type	Homo sapiens (human)
chromatin remodeling	Protein kinase C alpha type	Homo sapiens (human)
protein phosphorylation	Protein kinase C alpha type	Homo sapiens (human)
mitotic nuclear membrane disassembly	Protein kinase C alpha type	Homo sapiens (human)
cell adhesion	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of endothelial cell migration	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of cardiac muscle hypertrophy	Protein kinase C alpha type	Homo sapiens (human)
peptidyl-serine phosphorylation	Protein kinase C alpha type	Homo sapiens (human)
peptidyl-threonine phosphorylation	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of cell migration	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathway	Protein kinase C alpha type	Homo sapiens (human)
negative regulation of glial cell apoptotic process	Protein kinase C alpha type	Homo sapiens (human)
regulation of mRNA stability	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	Protein kinase C alpha type	Homo sapiens (human)
post-translational protein modification	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of macrophage differentiation	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of angiogenesis	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of bone resorption	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of cell adhesion	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of mitotic cell cycle	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Protein kinase C alpha type	Homo sapiens (human)
response to interleukin-1	Protein kinase C alpha type	Homo sapiens (human)
regulation of platelet aggregation	Protein kinase C alpha type	Homo sapiens (human)
apoptotic signaling pathway	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of angiotensin-activated signaling pathway	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of dense core granule biogenesis	Protein kinase C alpha type	Homo sapiens (human)
intracellular signal transduction	Protein kinase C alpha type	Homo sapiens (human)
positive regulation of insulin secretion	Protein kinase C alpha type	Homo sapiens (human)
mesoderm formation	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
neural tube closure	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of heart rate	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
renal water homeostasis	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
mRNA processing	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein phosphorylation	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein export from nucleus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathway	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of macroautophagy	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
peptidyl-serine phosphorylation	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cytokine-mediated signaling pathway	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
positive regulation of insulin secretion	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
negative regulation of interleukin-2 production	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
high-density lipoprotein particle assembly	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cellular response to heat	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
mitochondrial protein catabolic process	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of osteoblast differentiation	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
positive regulation of gluconeogenesis	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
negative regulation of smoothened signaling pathway	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
positive regulation of protein export from nucleus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
sperm capacitation	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
positive regulation of calcium-mediated signaling	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of cell cycle	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of cardiac muscle contraction	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of proteasomal protein catabolic process	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cellular response to cold	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of protein processing	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cellular response to glucose stimulus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cellular response to parathyroid hormone stimulus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cellular response to glucagon stimulus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cellular response to epinephrine stimulus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cell communication by electrical coupling involved in cardiac conduction	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmission	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of cardiac conduction	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
negative regulation of TORC1 signaling	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
negative regulation of glycolytic process through fructose-6-phosphate	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein localization to lipid droplet	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
regulation of bicellular tight junction assembly	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein kinase A signaling	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
response to hypoxia	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
in utero embryonic development	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription-coupled nucleotide-excision repair	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
nucleotide-excision repair	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
regulation of transcription by RNA polymerase II	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription elongation by RNA polymerase I	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription by RNA polymerase II	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription initiation at RNA polymerase II promoter	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
apoptotic process	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
response to oxidative stress	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
chromosome segregation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
determination of adult lifespan	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
UV protection	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
post-embryonic development	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
spinal cord development	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
extracellular matrix organization	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
bone mineralization	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
central nervous system myelin formation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
DNA duplex unwinding	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
multicellular organism growth	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
hair cell differentiation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
embryonic cleavage	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
erythrocyte maturation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
embryonic organ development	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
hair follicle maturation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
hematopoietic stem cell differentiation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
hematopoietic stem cell proliferation	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediator	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
regulation of mitotic cell cycle phase transition	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
positive regulation of mitotic recombination	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
double-strand break repair	Casein kinase II subunit alpha'	Homo sapiens (human)
apoptotic process	Casein kinase II subunit alpha'	Homo sapiens (human)
spermatogenesis	Casein kinase II subunit alpha'	Homo sapiens (human)
Wnt signaling pathway	Casein kinase II subunit alpha'	Homo sapiens (human)
cerebral cortex development	Casein kinase II subunit alpha'	Homo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic process	Casein kinase II subunit alpha'	Homo sapiens (human)
liver regeneration	Casein kinase II subunit alpha'	Homo sapiens (human)
regulation of mitophagy	Casein kinase II subunit alpha'	Homo sapiens (human)
positive regulation of protein targeting to mitochondrion	Casein kinase II subunit alpha'	Homo sapiens (human)
regulation of chromosome separation	Casein kinase II subunit alpha'	Homo sapiens (human)
negative regulation of apoptotic signaling pathway	Casein kinase II subunit alpha'	Homo sapiens (human)
peptidyl-threonine phosphorylation	Casein kinase II subunit alpha'	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase II subunit alpha'	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Cyclin-A2	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Cyclin-A2	Homo sapiens (human)
regulation of DNA replication	Cyclin-A2	Homo sapiens (human)
DNA-templated transcription	Cyclin-A2	Homo sapiens (human)
Ras protein signal transduction	Cyclin-A2	Homo sapiens (human)
animal organ regeneration	Cyclin-A2	Homo sapiens (human)
response to glucagon	Cyclin-A2	Homo sapiens (human)
cellular response to platelet-derived growth factor stimulus	Cyclin-A2	Homo sapiens (human)
post-translational protein modification	Cyclin-A2	Homo sapiens (human)
cellular response to leptin stimulus	Cyclin-A2	Homo sapiens (human)
cell cycle G1/S phase transition	Cyclin-A2	Homo sapiens (human)
positive regulation of DNA-templated transcription	Cyclin-A2	Homo sapiens (human)
positive regulation of fibroblast proliferation	Cyclin-A2	Homo sapiens (human)
cell division	Cyclin-A2	Homo sapiens (human)
cellular response to cocaine	Cyclin-A2	Homo sapiens (human)
cellular response to luteinizing hormone stimulus	Cyclin-A2	Homo sapiens (human)
cellular response to estradiol stimulus	Cyclin-A2	Homo sapiens (human)
cellular response to hypoxia	Cyclin-A2	Homo sapiens (human)
cellular response to nitric oxide	Cyclin-A2	Homo sapiens (human)
cochlea development	Cyclin-A2	Homo sapiens (human)
cellular response to insulin-like growth factor stimulus	Cyclin-A2	Homo sapiens (human)
positive regulation of DNA biosynthetic process	Cyclin-A2	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Cyclin-A2	Homo sapiens (human)
mitotic cell cycle phase transition	Cyclin-A2	Homo sapiens (human)
peptidyl-cysteine methylation	Ras-related protein Rab-6A	Homo sapiens (human)
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum	Ras-related protein Rab-6A	Homo sapiens (human)
antigen processing and presentation	Ras-related protein Rab-6A	Homo sapiens (human)
neuron projection development	Ras-related protein Rab-6A	Homo sapiens (human)
protein localization to Golgi apparatus	Ras-related protein Rab-6A	Homo sapiens (human)
early endosome to Golgi transport	Ras-related protein Rab-6A	Homo sapiens (human)
minus-end-directed organelle transport along microtubule	Ras-related protein Rab-6A	Homo sapiens (human)
protein localization to Golgi membrane	Ras-related protein Rab-6A	Homo sapiens (human)
intracellular protein transport	Ras-related protein Rab-6A	Homo sapiens (human)
intra-Golgi vesicle-mediated transport	Ras-related protein Rab-6A	Homo sapiens (human)
retrograde transport, endosome to Golgi	Ras-related protein Rab-6A	Homo sapiens (human)
positive regulation of cell-matrix adhesion	Ephrin type-A receptor 1	Homo sapiens (human)
negative regulation of protein kinase activity	Ephrin type-A receptor 1	Homo sapiens (human)
cell surface receptor signaling pathway	Ephrin type-A receptor 1	Homo sapiens (human)
positive regulation of cell population proliferation	Ephrin type-A receptor 1	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Ephrin type-A receptor 1	Homo sapiens (human)
positive regulation of cell migration	Ephrin type-A receptor 1	Homo sapiens (human)
negative regulation of cell migration	Ephrin type-A receptor 1	Homo sapiens (human)
substrate adhesion-dependent cell spreading	Ephrin type-A receptor 1	Homo sapiens (human)
regulation of GTPase activity	Ephrin type-A receptor 1	Homo sapiens (human)
positive regulation of angiogenesis	Ephrin type-A receptor 1	Homo sapiens (human)
protein autophosphorylation	Ephrin type-A receptor 1	Homo sapiens (human)
positive regulation of stress fiber assembly	Ephrin type-A receptor 1	Homo sapiens (human)
activation of GTPase activity	Ephrin type-A receptor 1	Homo sapiens (human)
positive regulation of kinase activity	Ephrin type-A receptor 1	Homo sapiens (human)
multicellular organism development	Ephrin type-A receptor 1	Homo sapiens (human)
angiogenesis	Ephrin type-A receptor 1	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-A receptor 1	Homo sapiens (human)
GMP biosynthetic process	Multifunctional protein ADE2	Homo sapiens (human)
'de novo' IMP biosynthetic process	Multifunctional protein ADE2	Homo sapiens (human)
purine nucleobase biosynthetic process	Multifunctional protein ADE2	Homo sapiens (human)
'de novo' AMP biosynthetic process	Multifunctional protein ADE2	Homo sapiens (human)
'de novo' XMP biosynthetic process	Multifunctional protein ADE2	Homo sapiens (human)
renal water homeostasis	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
spermatogenesis	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
male gonad development	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
high-density lipoprotein particle assembly	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
protein kinase A signaling	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
neural tube closure	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
renal water homeostasis	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
protein phosphorylation	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
signal transduction	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathway	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
high-density lipoprotein particle assembly	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
negative regulation of smoothened signaling pathway	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
regulation of protein processing	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
negative regulation of TORC1 signaling	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
protein kinase A signaling	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
generation of precursor metabolites and energy	Ferrochelatase, mitochondrial	Homo sapiens (human)
heme biosynthetic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
heme A biosynthetic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
heme B biosynthetic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
cholesterol metabolic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to xenobiotic stimulus	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to light stimulus	Ferrochelatase, mitochondrial	Homo sapiens (human)
detection of UV	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to lead ion	Ferrochelatase, mitochondrial	Homo sapiens (human)
regulation of eIF2 alpha phosphorylation by heme	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to insecticide	Ferrochelatase, mitochondrial	Homo sapiens (human)
erythrocyte differentiation	Ferrochelatase, mitochondrial	Homo sapiens (human)
very-low-density lipoprotein particle assembly	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to ethanol	Ferrochelatase, mitochondrial	Homo sapiens (human)
protoporphyrinogen IX metabolic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to arsenic-containing substance	Ferrochelatase, mitochondrial	Homo sapiens (human)
regulation of hemoglobin biosynthetic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
heme O biosynthetic process	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to methylmercury	Ferrochelatase, mitochondrial	Homo sapiens (human)
multicellular organismal-level iron ion homeostasis	Ferrochelatase, mitochondrial	Homo sapiens (human)
response to platinum ion	Ferrochelatase, mitochondrial	Homo sapiens (human)
cellular response to dexamethasone stimulus	Ferrochelatase, mitochondrial	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
behavioral fear response	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
skeletal muscle contraction	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
apoptotic process	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
signal transduction	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
germ cell development	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
long-term memory	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to xenobiotic stimulus	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to mechanical stimulus	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to toxic substance	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to glucose	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
skeletal muscle atrophy	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to electrical stimulus involved in regulation of muscle adaptation	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of smooth muscle cell migration	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cell migration	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
peptidyl-serine phosphorylation	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to nutrient levels	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cellular response to nutrient	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
TOR signaling	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to lipopolysaccharide	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to testosterone	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to glucagon	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to tumor necrosis factor	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
negative regulation of apoptotic process	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to L-leucine	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
long-chain fatty acid import into cell	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to ethanol	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of translation	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of mitotic cell cycle	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of translational initiation	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
regulation of glucose import	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
phosphatidylinositol-mediated signaling	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of skeletal muscle tissue growth	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
modulation of chemical synaptic transmission	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cellular response to type II interferon	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cellular response to growth factor stimulus	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cellular response to dexamethasone stimulus	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
positive regulation of TORC1 signaling	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cellular response to insulin stimulus	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
response to antibiotic	Tyrosine-protein kinase JAK1	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STAT	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cytokine-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
positive regulation of homotypic cell-cell adhesion	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-15-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-4-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-2-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-9-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-11-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
type III interferon-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
type II interferon-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
type I interferon-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-6-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
T-helper 17 cell lineage commitment	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cellular response to virus	Tyrosine-protein kinase JAK1	Homo sapiens (human)
interleukin-10-mediated signaling pathway	Tyrosine-protein kinase JAK1	Homo sapiens (human)
protein localization to cell-cell junction	Tyrosine-protein kinase JAK1	Homo sapiens (human)
positive regulation of protein localization to nucleus	Tyrosine-protein kinase JAK1	Homo sapiens (human)
positive regulation of sprouting angiogenesis	Tyrosine-protein kinase JAK1	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase JAK1	Homo sapiens (human)
tyrosine phosphorylation of STAT protein	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cell differentiation	Tyrosine-protein kinase JAK1	Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STAT	Tyrosine-protein kinase JAK1	Homo sapiens (human)
G1/S transition of mitotic cell cycle	G1/S-specific cyclin-D1	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	G1/S-specific cyclin-D1	Homo sapiens (human)
re-entry into mitotic cell cycle	G1/S-specific cyclin-D1	Homo sapiens (human)
positive regulation of protein phosphorylation	G1/S-specific cyclin-D1	Homo sapiens (human)
DNA damage response	G1/S-specific cyclin-D1	Homo sapiens (human)
lactation	G1/S-specific cyclin-D1	Homo sapiens (human)
response to xenobiotic stimulus	G1/S-specific cyclin-D1	Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycle	G1/S-specific cyclin-D1	Homo sapiens (human)
Wnt signaling pathway	G1/S-specific cyclin-D1	Homo sapiens (human)
neuron differentiation	G1/S-specific cyclin-D1	Homo sapiens (human)
negative regulation of epithelial cell differentiation	G1/S-specific cyclin-D1	Homo sapiens (human)
endoplasmic reticulum unfolded protein response	G1/S-specific cyclin-D1	Homo sapiens (human)
mitotic G1 DNA damage checkpoint signaling	G1/S-specific cyclin-D1	Homo sapiens (human)
mammary gland epithelial cell proliferation	G1/S-specific cyclin-D1	Homo sapiens (human)
positive regulation of mammary gland epithelial cell proliferation	G1/S-specific cyclin-D1	Homo sapiens (human)
negative regulation of neuron apoptotic process	G1/S-specific cyclin-D1	Homo sapiens (human)
response to leptin	G1/S-specific cyclin-D1	Homo sapiens (human)
fat cell differentiation	G1/S-specific cyclin-D1	Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activity	G1/S-specific cyclin-D1	Homo sapiens (human)
cell division	G1/S-specific cyclin-D1	Homo sapiens (human)
mammary gland alveolus development	G1/S-specific cyclin-D1	Homo sapiens (human)
response to UV-A	G1/S-specific cyclin-D1	Homo sapiens (human)
liver regeneration	G1/S-specific cyclin-D1	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	G1/S-specific cyclin-D1	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	G1/S-specific cyclin-D1	Homo sapiens (human)
protein phosphorylation	G1/S-specific cyclin-E1	Homo sapiens (human)
G1/S transition of mitotic cell cycle	G1/S-specific cyclin-E1	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	G1/S-specific cyclin-E1	Homo sapiens (human)
telomere maintenance	G1/S-specific cyclin-E1	Homo sapiens (human)
DNA replication initiation	G1/S-specific cyclin-E1	Homo sapiens (human)
homologous chromosome pairing at meiosis	G1/S-specific cyclin-E1	Homo sapiens (human)
Wnt signaling pathway	G1/S-specific cyclin-E1	Homo sapiens (human)
regulation of protein localization	G1/S-specific cyclin-E1	Homo sapiens (human)
cell division	G1/S-specific cyclin-E1	Homo sapiens (human)
positive regulation of mesenchymal stem cell proliferation	G1/S-specific cyclin-E1	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	G1/S-specific cyclin-E1	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	G1/S-specific cyclin-E1	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Cyclin-dependent kinase 2	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 2	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 2	Homo sapiens (human)
DNA replication	Cyclin-dependent kinase 2	Homo sapiens (human)
DNA repair	Cyclin-dependent kinase 2	Homo sapiens (human)
chromatin remodeling	Cyclin-dependent kinase 2	Homo sapiens (human)
DNA-templated transcription	Cyclin-dependent kinase 2	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 2	Homo sapiens (human)
potassium ion transport	Cyclin-dependent kinase 2	Homo sapiens (human)
centriole replication	Cyclin-dependent kinase 2	Homo sapiens (human)
Ras protein signal transduction	Cyclin-dependent kinase 2	Homo sapiens (human)
regulation of mitotic cell cycle	Cyclin-dependent kinase 2	Homo sapiens (human)
positive regulation of cell population proliferation	Cyclin-dependent kinase 2	Homo sapiens (human)
peptidyl-serine phosphorylation	Cyclin-dependent kinase 2	Homo sapiens (human)
positive regulation of heterochromatin formation	Cyclin-dependent kinase 2	Homo sapiens (human)
mitotic G1 DNA damage checkpoint signaling	Cyclin-dependent kinase 2	Homo sapiens (human)
positive regulation of DNA-templated DNA replication initiation	Cyclin-dependent kinase 2	Homo sapiens (human)
telomere maintenance in response to DNA damage	Cyclin-dependent kinase 2	Homo sapiens (human)
post-translational protein modification	Cyclin-dependent kinase 2	Homo sapiens (human)
positive regulation of DNA replication	Cyclin-dependent kinase 2	Homo sapiens (human)
positive regulation of DNA-templated transcription	Cyclin-dependent kinase 2	Homo sapiens (human)
centrosome duplication	Cyclin-dependent kinase 2	Homo sapiens (human)
cell division	Cyclin-dependent kinase 2	Homo sapiens (human)
meiotic cell cycle	Cyclin-dependent kinase 2	Homo sapiens (human)
cellular response to nitric oxide	Cyclin-dependent kinase 2	Homo sapiens (human)
cellular senescence	Cyclin-dependent kinase 2	Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic process	Cyclin-dependent kinase 2	Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 2	Homo sapiens (human)
signal transduction	Cyclin-dependent kinase 2	Homo sapiens (human)
regulation of gene expression	Cyclin-dependent kinase 2	Homo sapiens (human)
response to organic substance	Cyclin-dependent kinase 2	Homo sapiens (human)
desensitization of G protein-coupled receptor signaling pathway	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
negative regulation of the force of heart contraction by chemical signal	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
tachykinin receptor signaling pathway	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
heart development	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
viral genome replication	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
receptor internalization	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
positive regulation of catecholamine secretion	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
negative regulation of striated muscle contraction	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
symbiont entry into host cell	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
cardiac muscle contraction	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
negative regulation of relaxation of smooth muscle	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
regulation of the force of heart contraction	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
protein phosphorylation	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
P-body assembly	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
miRNA-mediated gene silencing by inhibition of translation	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
negative regulation of translation	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
viral RNA genome packaging	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
stem cell population maintenance	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
neuron differentiation	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
P-body assembly	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
negative regulation of neuron differentiation	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
stress granule assembly	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
positive regulation of macrophage chemotaxis	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of macrophage proliferation	Mitogen-activated protein kinase 3	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase 3	Homo sapiens (human)
DNA-templated transcription	Mitogen-activated protein kinase 3	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase 3	Homo sapiens (human)
apoptotic process	Mitogen-activated protein kinase 3	Homo sapiens (human)
insulin receptor signaling pathway	Mitogen-activated protein kinase 3	Homo sapiens (human)
Schwann cell development	Mitogen-activated protein kinase 3	Homo sapiens (human)
phosphorylation	Mitogen-activated protein kinase 3	Homo sapiens (human)
sensory perception of pain	Mitogen-activated protein kinase 3	Homo sapiens (human)
regulation of ossification	Mitogen-activated protein kinase 3	Homo sapiens (human)
BMP signaling pathway	Mitogen-activated protein kinase 3	Homo sapiens (human)
regulation of cellular pH	Mitogen-activated protein kinase 3	Homo sapiens (human)
thyroid gland development	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of cyclase activity	Mitogen-activated protein kinase 3	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Mitogen-activated protein kinase 3	Homo sapiens (human)
regulation of stress-activated MAPK cascade	Mitogen-activated protein kinase 3	Homo sapiens (human)
cellular response to amino acid starvation	Mitogen-activated protein kinase 3	Homo sapiens (human)
cellular response to reactive oxygen species	Mitogen-activated protein kinase 3	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Mitogen-activated protein kinase 3	Homo sapiens (human)
ERBB2-ERBB3 signaling pathway	Mitogen-activated protein kinase 3	Homo sapiens (human)
outer ear morphogenesis	Mitogen-activated protein kinase 3	Homo sapiens (human)
myelination	Mitogen-activated protein kinase 3	Homo sapiens (human)
signal transduction in response to DNA damage	Mitogen-activated protein kinase 3	Homo sapiens (human)
response to exogenous dsRNA	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Mitogen-activated protein kinase 3	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	Mitogen-activated protein kinase 3	Homo sapiens (human)
thymus development	Mitogen-activated protein kinase 3	Homo sapiens (human)
modulation of chemical synaptic transmission	Mitogen-activated protein kinase 3	Homo sapiens (human)
cartilage development	Mitogen-activated protein kinase 3	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase 3	Homo sapiens (human)
regulation of cytoskeleton organization	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of telomerase activity	Mitogen-activated protein kinase 3	Homo sapiens (human)
Bergmann glial cell differentiation	Mitogen-activated protein kinase 3	Homo sapiens (human)
face development	Mitogen-activated protein kinase 3	Homo sapiens (human)
lung morphogenesis	Mitogen-activated protein kinase 3	Homo sapiens (human)
trachea formation	Mitogen-activated protein kinase 3	Homo sapiens (human)
cardiac neural crest cell development involved in heart development	Mitogen-activated protein kinase 3	Homo sapiens (human)
ERK1 and ERK2 cascade	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Mitogen-activated protein kinase 3	Homo sapiens (human)
interleukin-1-mediated signaling pathway	Mitogen-activated protein kinase 3	Homo sapiens (human)
response to epidermal growth factor	Mitogen-activated protein kinase 3	Homo sapiens (human)
cellular response to mechanical stimulus	Mitogen-activated protein kinase 3	Homo sapiens (human)
cellular response to cadmium ion	Mitogen-activated protein kinase 3	Homo sapiens (human)
cellular response to tumor necrosis factor	Mitogen-activated protein kinase 3	Homo sapiens (human)
caveolin-mediated endocytosis	Mitogen-activated protein kinase 3	Homo sapiens (human)
regulation of Golgi inheritance	Mitogen-activated protein kinase 3	Homo sapiens (human)
xenophagy	Mitogen-activated protein kinase 3	Homo sapiens (human)
negative regulation of TORC1 signaling	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of telomere capping	Mitogen-activated protein kinase 3	Homo sapiens (human)
positive regulation of xenophagy	Mitogen-activated protein kinase 3	Homo sapiens (human)
regulation of early endosome to late endosome transport	Mitogen-activated protein kinase 3	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase 3	Homo sapiens (human)
protein phosphorylation	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
peptidyl-serine phosphorylation	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
positive regulation of protein binding	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
negative regulation of hippo signaling	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
peptidyl-serine autophosphorylation	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
negative regulation of protein localization to nucleus	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
intracellular signal transduction	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
pyrimidine nucleotide metabolic process	Deoxycytidine kinase	Homo sapiens (human)
CMP biosynthetic process	Deoxycytidine kinase	Homo sapiens (human)
dAMP salvage	Deoxycytidine kinase	Homo sapiens (human)
nucleoside phosphate biosynthetic process	Deoxycytidine kinase	Homo sapiens (human)
positive regulation of macrophage chemotaxis	Mitogen-activated protein kinase 1	Homo sapiens (human)
positive regulation of macrophage proliferation	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Mitogen-activated protein kinase 1	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase 1	Homo sapiens (human)
apoptotic process	Mitogen-activated protein kinase 1	Homo sapiens (human)
chemotaxis	Mitogen-activated protein kinase 1	Homo sapiens (human)
DNA damage response	Mitogen-activated protein kinase 1	Homo sapiens (human)
signal transduction	Mitogen-activated protein kinase 1	Homo sapiens (human)
chemical synaptic transmission	Mitogen-activated protein kinase 1	Homo sapiens (human)
learning or memory	Mitogen-activated protein kinase 1	Homo sapiens (human)
insulin receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylation	Mitogen-activated protein kinase 1	Homo sapiens (human)
Schwann cell development	Mitogen-activated protein kinase 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Mitogen-activated protein kinase 1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Mitogen-activated protein kinase 1	Homo sapiens (human)
cytosine metabolic process	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of ossification	Mitogen-activated protein kinase 1	Homo sapiens (human)
androgen receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of cellular pH	Mitogen-activated protein kinase 1	Homo sapiens (human)
thyroid gland development	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of protein stability	Mitogen-activated protein kinase 1	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of stress-activated MAPK cascade	Mitogen-activated protein kinase 1	Homo sapiens (human)
mammary gland epithelial cell proliferation	Mitogen-activated protein kinase 1	Homo sapiens (human)
cellular response to amino acid starvation	Mitogen-activated protein kinase 1	Homo sapiens (human)
cellular response to reactive oxygen species	Mitogen-activated protein kinase 1	Homo sapiens (human)
response to nicotine	Mitogen-activated protein kinase 1	Homo sapiens (human)
ERBB signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
ERBB2-ERBB3 signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
outer ear morphogenesis	Mitogen-activated protein kinase 1	Homo sapiens (human)
myelination	Mitogen-activated protein kinase 1	Homo sapiens (human)
response to exogenous dsRNA	Mitogen-activated protein kinase 1	Homo sapiens (human)
steroid hormone mediated signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
negative regulation of cell differentiation	Mitogen-activated protein kinase 1	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
thymus development	Mitogen-activated protein kinase 1	Homo sapiens (human)
progesterone receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
T cell receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
B cell receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of cytoskeleton organization	Mitogen-activated protein kinase 1	Homo sapiens (human)
positive regulation of telomerase activity	Mitogen-activated protein kinase 1	Homo sapiens (human)
Bergmann glial cell differentiation	Mitogen-activated protein kinase 1	Homo sapiens (human)
long-term synaptic potentiation	Mitogen-activated protein kinase 1	Homo sapiens (human)
face development	Mitogen-activated protein kinase 1	Homo sapiens (human)
lung morphogenesis	Mitogen-activated protein kinase 1	Homo sapiens (human)
trachea formation	Mitogen-activated protein kinase 1	Homo sapiens (human)
labyrinthine layer blood vessel development	Mitogen-activated protein kinase 1	Homo sapiens (human)
cardiac neural crest cell development involved in heart development	Mitogen-activated protein kinase 1	Homo sapiens (human)
ERK1 and ERK2 cascade	Mitogen-activated protein kinase 1	Homo sapiens (human)
response to epidermal growth factor	Mitogen-activated protein kinase 1	Homo sapiens (human)
cellular response to cadmium ion	Mitogen-activated protein kinase 1	Homo sapiens (human)
cellular response to tumor necrosis factor	Mitogen-activated protein kinase 1	Homo sapiens (human)
caveolin-mediated endocytosis	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of Golgi inheritance	Mitogen-activated protein kinase 1	Homo sapiens (human)
positive regulation of telomere capping	Mitogen-activated protein kinase 1	Homo sapiens (human)
regulation of early endosome to late endosome transport	Mitogen-activated protein kinase 1	Homo sapiens (human)
cell surface receptor signaling pathway	Mitogen-activated protein kinase 1	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase 1	Homo sapiens (human)
skeletal system development	Ephrin type-A receptor 2	Homo sapiens (human)
vasculogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
osteoblast differentiation	Ephrin type-A receptor 2	Homo sapiens (human)
blood vessel endothelial cell proliferation involved in sprouting angiogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
inflammatory response	Ephrin type-A receptor 2	Homo sapiens (human)
cell adhesion	Ephrin type-A receptor 2	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage	Ephrin type-A receptor 2	Homo sapiens (human)
regulation of lamellipodium assembly	Ephrin type-A receptor 2	Homo sapiens (human)
notochord formation	Ephrin type-A receptor 2	Homo sapiens (human)
cell migration	Ephrin type-A receptor 2	Homo sapiens (human)
negative regulation of angiogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
neural tube development	Ephrin type-A receptor 2	Homo sapiens (human)
neuron differentiation	Ephrin type-A receptor 2	Homo sapiens (human)
keratinocyte differentiation	Ephrin type-A receptor 2	Homo sapiens (human)
osteoclast differentiation	Ephrin type-A receptor 2	Homo sapiens (human)
positive regulation of cell migration	Ephrin type-A receptor 2	Homo sapiens (human)
negative regulation of chemokine production	Ephrin type-A receptor 2	Homo sapiens (human)
mammary gland epithelial cell proliferation	Ephrin type-A receptor 2	Homo sapiens (human)
regulation of cell adhesion mediated by integrin	Ephrin type-A receptor 2	Homo sapiens (human)
post-anal tail morphogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
regulation of blood vessel endothelial cell migration	Ephrin type-A receptor 2	Homo sapiens (human)
regulation of angiogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
cAMP metabolic process	Ephrin type-A receptor 2	Homo sapiens (human)
symbiont entry into host cell	Ephrin type-A receptor 2	Homo sapiens (human)
bone remodeling	Ephrin type-A receptor 2	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-A receptor 2	Homo sapiens (human)
axial mesoderm formation	Ephrin type-A receptor 2	Homo sapiens (human)
cell motility	Ephrin type-A receptor 2	Homo sapiens (human)
defense response to Gram-positive bacterium	Ephrin type-A receptor 2	Homo sapiens (human)
notochord cell development	Ephrin type-A receptor 2	Homo sapiens (human)
cell chemotaxis	Ephrin type-A receptor 2	Homo sapiens (human)
branching involved in mammary gland duct morphogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
lens fiber cell morphogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
regulation of ERK1 and ERK2 cascade	Ephrin type-A receptor 2	Homo sapiens (human)
response to growth factor	Ephrin type-A receptor 2	Homo sapiens (human)
protein localization to plasma membrane	Ephrin type-A receptor 2	Homo sapiens (human)
activation of GTPase activity	Ephrin type-A receptor 2	Homo sapiens (human)
negative regulation of lymphangiogenesis	Ephrin type-A receptor 2	Homo sapiens (human)
positive regulation of protein localization to plasma membrane	Ephrin type-A receptor 2	Homo sapiens (human)
positive regulation of bicellular tight junction assembly	Ephrin type-A receptor 2	Homo sapiens (human)
pericyte cell differentiation	Ephrin type-A receptor 2	Homo sapiens (human)
positive regulation of kinase activity	Ephrin type-A receptor 2	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Ephrin type-A receptor 2	Homo sapiens (human)
multicellular organism development	Ephrin type-A receptor 2	Homo sapiens (human)
negative regulation of protein kinase activity	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of autophagosome assembly	Ephrin type-B receptor 2	Homo sapiens (human)
angiogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
urogenital system development	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of protein phosphorylation	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of immunoglobulin production	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of cell adhesion	Ephrin type-B receptor 2	Homo sapiens (human)
nervous system development	Ephrin type-B receptor 2	Homo sapiens (human)
axon guidance	Ephrin type-B receptor 2	Homo sapiens (human)
axonal fasciculation	Ephrin type-B receptor 2	Homo sapiens (human)
learning or memory	Ephrin type-B receptor 2	Homo sapiens (human)
learning	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of gene expression	Ephrin type-B receptor 2	Homo sapiens (human)
phosphorylation	Ephrin type-B receptor 2	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Ephrin type-B receptor 2	Homo sapiens (human)
optic nerve morphogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
hindbrain tangential cell migration	Ephrin type-B receptor 2	Homo sapiens (human)
central nervous system projection neuron axonogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
corpus callosum development	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of blood coagulation	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of cell migration	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of B cell proliferation	Ephrin type-B receptor 2	Homo sapiens (human)
retinal ganglion cell axon guidance	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of synaptic plasticity	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of tumor necrosis factor production	Ephrin type-B receptor 2	Homo sapiens (human)
B cell activation	Ephrin type-B receptor 2	Homo sapiens (human)
inner ear morphogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of receptor signaling pathway via JAK-STAT	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of Ras protein signal transduction	Ephrin type-B receptor 2	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of neuronal synaptic plasticity	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of long-term neuronal synaptic plasticity	Ephrin type-B receptor 2	Homo sapiens (human)
camera-type eye morphogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of axonogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of body fluid levels	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of filopodium assembly	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of synapse assembly	Ephrin type-B receptor 2	Homo sapiens (human)
roof of mouth development	Ephrin type-B receptor 2	Homo sapiens (human)
dendritic spine development	Ephrin type-B receptor 2	Homo sapiens (human)
dendritic spine morphogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of dendritic spine morphogenesis	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascade	Ephrin type-B receptor 2	Homo sapiens (human)
cellular response to lipopolysaccharide	Ephrin type-B receptor 2	Homo sapiens (human)
commissural neuron axon guidance	Ephrin type-B receptor 2	Homo sapiens (human)
postsynaptic membrane assembly	Ephrin type-B receptor 2	Homo sapiens (human)
trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission	Ephrin type-B receptor 2	Homo sapiens (human)
neuron projection retraction	Ephrin type-B receptor 2	Homo sapiens (human)
vesicle-mediated intercellular transport	Ephrin type-B receptor 2	Homo sapiens (human)
tight junction assembly	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of cytokine production involved in inflammatory response	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of long-term synaptic potentiation	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of protein localization to plasma membrane	Ephrin type-B receptor 2	Homo sapiens (human)
cellular response to amyloid-beta	Ephrin type-B receptor 2	Homo sapiens (human)
negative regulation of NMDA glutamate receptor activity	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of NMDA glutamate receptor activity	Ephrin type-B receptor 2	Homo sapiens (human)
positive regulation of protein localization to cell surface	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of T-helper 17 type immune response	Ephrin type-B receptor 2	Homo sapiens (human)
regulation of behavioral fear response	Ephrin type-B receptor 2	Homo sapiens (human)
protein phosphorylation	Ephrin type-B receptor 2	Homo sapiens (human)
protein phosphorylation	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
immune response	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STAT	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cytokine-mediated signaling pathway	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of type II interferon production	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of interleukin-17 production	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of natural killer cell proliferation	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
interleukin-12-mediated signaling pathway	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
type III interferon-mediated signaling pathway	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of T cell proliferation	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STAT	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of NK T cell proliferation	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
type II interferon-mediated signaling pathway	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
type I interferon-mediated signaling pathway	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cellular response to virus	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
interleukin-10-mediated signaling pathway	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of protein localization to nucleus	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
positive regulation of T-helper 17 type immune response	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
intracellular signal transduction	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cell differentiation	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STAT	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
G1/S transition of mitotic cell cycle	G1/S-specific cyclin-D3	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	G1/S-specific cyclin-D3	Homo sapiens (human)
positive regulation of protein phosphorylation	G1/S-specific cyclin-D3	Homo sapiens (human)
signal transduction	G1/S-specific cyclin-D3	Homo sapiens (human)
T cell proliferation	G1/S-specific cyclin-D3	Homo sapiens (human)
regulation of cell population proliferation	G1/S-specific cyclin-D3	Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activity	G1/S-specific cyclin-D3	Homo sapiens (human)
cell division	G1/S-specific cyclin-D3	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	G1/S-specific cyclin-D3	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	G1/S-specific cyclin-D3	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Wee1-like protein kinase	Homo sapiens (human)
microtubule cytoskeleton organization	Wee1-like protein kinase	Homo sapiens (human)
negative regulation of G2/M transition of mitotic cell cycle	Wee1-like protein kinase	Homo sapiens (human)
establishment of cell polarity	Wee1-like protein kinase	Homo sapiens (human)
positive regulation of DNA replication	Wee1-like protein kinase	Homo sapiens (human)
neuron projection morphogenesis	Wee1-like protein kinase	Homo sapiens (human)
cell division	Wee1-like protein kinase	Homo sapiens (human)
negative regulation of G1/S transition of mitotic cell cycle	Wee1-like protein kinase	Homo sapiens (human)
protein phosphorylation	Wee1-like protein kinase	Homo sapiens (human)
response to hypoxia	Heme oxygenase 2	Homo sapiens (human)
response to oxidative stress	Heme oxygenase 2	Homo sapiens (human)
heme catabolic process	Heme oxygenase 2	Homo sapiens (human)
heme oxidation	Heme oxygenase 2	Homo sapiens (human)
S-adenosylmethionine biosynthetic process	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
one-carbon metabolic process	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
protein hexamerization	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
protein heterooligomerization	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
cellular response to methionine	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
positive regulation of TORC1 signaling	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
cellular response to leukemia inhibitory factor	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
protein folding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
response to unfolded protein	DnaJ homolog subfamily A member 1	Homo sapiens (human)
spermatogenesis	DnaJ homolog subfamily A member 1	Homo sapiens (human)
response to heat	DnaJ homolog subfamily A member 1	Homo sapiens (human)
flagellated sperm motility	DnaJ homolog subfamily A member 1	Homo sapiens (human)
androgen receptor signaling pathway	DnaJ homolog subfamily A member 1	Homo sapiens (human)
negative regulation of protein ubiquitination	DnaJ homolog subfamily A member 1	Homo sapiens (human)
positive regulation of apoptotic process	DnaJ homolog subfamily A member 1	Homo sapiens (human)
negative regulation of apoptotic process	DnaJ homolog subfamily A member 1	Homo sapiens (human)
negative regulation of JUN kinase activity	DnaJ homolog subfamily A member 1	Homo sapiens (human)
regulation of protein transport	DnaJ homolog subfamily A member 1	Homo sapiens (human)
protein localization to mitochondrion	DnaJ homolog subfamily A member 1	Homo sapiens (human)
negative regulation of establishment of protein localization to mitochondrion	DnaJ homolog subfamily A member 1	Homo sapiens (human)
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway	DnaJ homolog subfamily A member 1	Homo sapiens (human)
protein refolding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
protein phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
activation-induced cell death of T cells	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
intracellular signal transduction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
osteoblast differentiation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
maternal placenta development	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of endothelial cell proliferation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cell migration involved in sprouting angiogenesis	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
sphingosine-1-phosphate receptor signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
glycogen biosynthetic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of glycogen biosynthetic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
glucose metabolic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of translation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of protein kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein import into nucleus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
nitric oxide biosynthetic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
inflammatory response	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to oxidative stress	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
signal transduction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
G protein-coupled receptor signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
canonical NF-kappaB signal transduction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cell population proliferation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
insulin receptor signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
apoptotic mitochondrial changes	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to heat	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
gene expression	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of autophagy	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of endothelial cell migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of gene expression	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of gene expression	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of long-chain fatty acid import across plasma membrane	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
fibroblast migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of fibroblast migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of sodium ion transport	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of glucose metabolic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of endopeptidase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of neuron projection development	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of macroautophagy	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein ubiquitination	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
peptidyl-serine phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
peptidyl-threonine phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
virus-mediated perturbation of host defense response	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cytokine-mediated signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
mammalian oogenesis stage	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cell differentiation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cell growth	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of cell migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cell migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
T cell costimulation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of protein ubiquitination	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of myelination	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
TOR signaling	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of fatty acid beta-oxidation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of endodeoxyribonuclease activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of protein binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to food	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
peripheral nervous system myelin maintenance	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to insulin stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to fluid shear stress	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to reactive oxygen species	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
interleukin-18-mediated signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to decreased oxygen levels	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
non-canonical NF-kappaB signal transduction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
glucose homeostasis	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of apoptotic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of apoptotic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
anoikis	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of mRNA stability	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transduction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of nitric oxide biosynthetic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of fat cell differentiation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of glycogen biosynthetic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of Notch signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of proteolysis	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of DNA-templated transcription	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of glucose import	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of organ growth	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein autophosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of lipid biosynthetic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
behavioral response to pain	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of nitric-oxide synthase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
striated muscle cell differentiation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein metabolic process	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
excitatory postsynaptic potential	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to growth hormone	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
mammary gland epithelial cell differentiation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
labyrinthine layer blood vessel development	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to UV-A	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to growth factor	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to cadmium ion	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to tumor necrosis factor	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to epidermal growth factor stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to prostaglandin E stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of protein serine/threonine kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
establishment of protein localization to mitochondrion	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
maintenance of protein location in mitochondrion	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of release of cytochrome c from mitochondria	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to granulocyte macrophage colony-stimulating factor stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
execution phase of apoptosis	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of postsynapse organization	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of tRNA methylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to oxidised low-density lipoprotein particle stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of protein localization to lysosome	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of cGAS/STING signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein localization to nucleus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to peptide	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of cilium assembly	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of leukocyte cell-cell adhesion	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein localization to plasma membrane	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of I-kappaB phosphorylation	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of TORC1 signaling	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein localization to endoplasmic reticulum	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cellular response to nerve growth factor stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
response to insulin-like growth factor stimulus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein localization to cell surface	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
regulation of type B pancreatic cell development	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of lymphocyte migration	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
intracellular signal transduction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
glycogen biosynthetic process	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
glucose metabolic process	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
regulation of translation	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
signal transduction	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
insulin receptor signaling pathway	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of long-chain fatty acid import across plasma membrane	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of glucose metabolic process	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
regulation of cell migration	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cell migration	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of fatty acid beta-oxidation	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
peripheral nervous system myelin maintenance	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
cellular response to insulin stimulus	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
protein modification process	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
fat cell differentiation	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of glycogen biosynthetic process	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of glucose import	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
regulation of cell cycle	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
mammary gland epithelial cell differentiation	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
cellular response to high light intensity	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
organic substance transport	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
protein localization to plasma membrane	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of protein targeting to membrane	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
retinal rod cell apoptotic process	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cell motility	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
intracellular signal transduction	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
peptidyl-serine phosphorylation	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
spindle organization	Dual specificity protein kinase TTK	Homo sapiens (human)
mitotic spindle organization	Dual specificity protein kinase TTK	Homo sapiens (human)
positive regulation of cell population proliferation	Dual specificity protein kinase TTK	Homo sapiens (human)
female meiosis chromosome segregation	Dual specificity protein kinase TTK	Homo sapiens (human)
protein localization to meiotic spindle midzone	Dual specificity protein kinase TTK	Homo sapiens (human)
chromosome segregation	Dual specificity protein kinase TTK	Homo sapiens (human)
peptidyl-serine phosphorylation	Dual specificity protein kinase TTK	Homo sapiens (human)
protein localization to kinetochore	Dual specificity protein kinase TTK	Homo sapiens (human)
mitotic spindle assembly checkpoint signaling	Dual specificity protein kinase TTK	Homo sapiens (human)
meiotic spindle assembly checkpoint signaling	Dual specificity protein kinase TTK	Homo sapiens (human)
DNA replication	DNA replication licensing factor MCM4	Homo sapiens (human)
DNA unwinding involved in DNA replication	DNA replication licensing factor MCM4	Homo sapiens (human)
regulation of DNA-templated DNA replication initiation	DNA replication licensing factor MCM4	Homo sapiens (human)
double-strand break repair via break-induced replication	DNA replication licensing factor MCM4	Homo sapiens (human)
DNA strand elongation involved in DNA replication	DNA replication licensing factor MCM4	Homo sapiens (human)
mitotic DNA replication initiation	DNA replication licensing factor MCM4	Homo sapiens (human)
heart development	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
positive regulation of gene expression	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
Schwann cell development	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
thyroid gland development	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
regulation of stress-activated MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
peptidyl-serine autophosphorylation	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
ERBB2-ERBB3 signaling pathway	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
myelination	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
positive regulation of DNA-templated transcription	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
thymus development	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
regulation of axon regeneration	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
positive regulation of axonogenesis	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
face development	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
trachea formation	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
epithelial cell proliferation involved in lung morphogenesis	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
ERK1 and ERK2 cascade	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
positive regulation of protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
regulation of Golgi inheritance	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
positive regulation of cell motility	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
regulation of early endosome to late endosome transport	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
hemopoiesis	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
leukocyte homeostasis	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
myeloid progenitor cell differentiation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
pro-B cell differentiation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
positive regulation of cell population proliferation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
response to organonitrogen compound	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
cytokine-mediated signaling pathway	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
B cell differentiation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
animal organ regeneration	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
common myeloid progenitor cell proliferation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
vascular endothelial growth factor signaling pathway	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT protein	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
regulation of apoptotic process	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
positive regulation of MAP kinase activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
positive regulation of MAPK cascade	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
lymphocyte proliferation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
protein autophosphorylation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
cellular response to cytokine stimulus	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
cellular response to glucocorticoid stimulus	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
dendritic cell differentiation	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
positive regulation of kinase activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
multicellular organism development	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
regulation of cardiac muscle cell apoptotic process	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
regulation of neural crest cell differentiation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of gene expression	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
negative regulation of gene expression	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of transforming growth factor beta2 production	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
angiogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
osteoblast differentiation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
in utero embryonic development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
mesoderm formation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
somitogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
Mullerian duct regression	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of mesenchymal cell proliferation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
chondrocyte differentiation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
outflow tract septum morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
outflow tract morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
cardiac conduction system development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
atrioventricular valve development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
mitral valve morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
tricuspid valve morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
endocardial cushion morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
cardiac right ventricle morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
ventricular trabecula myocardium morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
ventricular compact myocardium morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
endocardial cushion formation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
immune response	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
ectoderm development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
dorsal/ventral axis specification	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
neural crest cell development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
negative regulation of smooth muscle cell migration	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
central nervous system neuron differentiation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
pituitary gland development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
neural plate mediolateral regionalization	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
lung development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of bone mineralization	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
BMP signaling pathway	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
somatic stem cell population maintenance	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
hindlimb morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
dorsal aorta morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
odontogenesis of dentin-containing tooth	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
embryonic digit morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of osteoblast differentiation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
paraxial mesoderm structural organization	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
lateral mesoderm development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
regulation of lateral mesodermal cell fate specification	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
mesendoderm development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
embryonic organ development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
developmental growth	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
epithelial cell proliferation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of epithelial cell proliferation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
negative regulation of neurogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
negative regulation of muscle cell differentiation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
roof of mouth development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
regulation of cardiac muscle cell proliferation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of cardiac muscle cell proliferation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of SMAD protein signal transduction	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
ventricular septum morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
heart formation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
atrioventricular node cell development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
pharyngeal arch artery morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
cellular response to BMP stimulus	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of miRNA transcription	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of cardiac ventricle development	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
fibrous ring of heart morphogenesis	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
regulation of cellular senescence	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
protein phosphorylation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
dorsal/ventral pattern formation	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
cellular response to growth factor stimulus	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Activin receptor type-1B	Homo sapiens (human)
in utero embryonic development	Activin receptor type-1B	Homo sapiens (human)
hair follicle development	Activin receptor type-1B	Homo sapiens (human)
regulation of DNA-templated transcription	Activin receptor type-1B	Homo sapiens (human)
signal transduction	Activin receptor type-1B	Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathway	Activin receptor type-1B	Homo sapiens (human)
positive regulation of gene expression	Activin receptor type-1B	Homo sapiens (human)
negative regulation of gene expression	Activin receptor type-1B	Homo sapiens (human)
peptidyl-threonine phosphorylation	Activin receptor type-1B	Homo sapiens (human)
negative regulation of cell growth	Activin receptor type-1B	Homo sapiens (human)
activin receptor signaling pathway	Activin receptor type-1B	Homo sapiens (human)
positive regulation of activin receptor signaling pathway	Activin receptor type-1B	Homo sapiens (human)
nodal signaling pathway	Activin receptor type-1B	Homo sapiens (human)
positive regulation of erythrocyte differentiation	Activin receptor type-1B	Homo sapiens (human)
protein autophosphorylation	Activin receptor type-1B	Homo sapiens (human)
extrinsic apoptotic signaling pathway	Activin receptor type-1B	Homo sapiens (human)
positive regulation of trophoblast cell migration	Activin receptor type-1B	Homo sapiens (human)
cellular response to growth factor stimulus	Activin receptor type-1B	Homo sapiens (human)
protein phosphorylation	Activin receptor type-1B	Homo sapiens (human)
nervous system development	Activin receptor type-1B	Homo sapiens (human)
proepicardium development	TGF-beta receptor type-1	Homo sapiens (human)
negative regulation of cell migration	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of extracellular matrix assembly	TGF-beta receptor type-1	Homo sapiens (human)
skeletal system development	TGF-beta receptor type-1	Homo sapiens (human)
in utero embryonic development	TGF-beta receptor type-1	Homo sapiens (human)
kidney development	TGF-beta receptor type-1	Homo sapiens (human)
blastocyst development	TGF-beta receptor type-1	Homo sapiens (human)
epithelial to mesenchymal transition	TGF-beta receptor type-1	Homo sapiens (human)
endothelial cell proliferation	TGF-beta receptor type-1	Homo sapiens (human)
negative regulation of endothelial cell proliferation	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of endothelial cell proliferation	TGF-beta receptor type-1	Homo sapiens (human)
lens development in camera-type eye	TGF-beta receptor type-1	Homo sapiens (human)
ventricular trabecula myocardium morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
ventricular compact myocardium morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
regulation of DNA-templated transcription	TGF-beta receptor type-1	Homo sapiens (human)
apoptotic process	TGF-beta receptor type-1	Homo sapiens (human)
signal transduction	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	TGF-beta receptor type-1	Homo sapiens (human)
heart development	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of cell population proliferation	TGF-beta receptor type-1	Homo sapiens (human)
germ cell migration	TGF-beta receptor type-1	Homo sapiens (human)
male gonad development	TGF-beta receptor type-1	Homo sapiens (human)
post-embryonic development	TGF-beta receptor type-1	Homo sapiens (human)
anterior/posterior pattern specification	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of gene expression	TGF-beta receptor type-1	Homo sapiens (human)
regulation of epithelial to mesenchymal transition	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of epithelial to mesenchymal transition	TGF-beta receptor type-1	Homo sapiens (human)
peptidyl-serine phosphorylation	TGF-beta receptor type-1	Homo sapiens (human)
collagen fibril organization	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of cell growth	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of cell migration	TGF-beta receptor type-1	Homo sapiens (human)
regulation of protein ubiquitination	TGF-beta receptor type-1	Homo sapiens (human)
negative regulation of chondrocyte differentiation	TGF-beta receptor type-1	Homo sapiens (human)
activin receptor signaling pathway	TGF-beta receptor type-1	Homo sapiens (human)
intracellular signal transduction	TGF-beta receptor type-1	Homo sapiens (human)
myofibroblast differentiation	TGF-beta receptor type-1	Homo sapiens (human)
wound healing	TGF-beta receptor type-1	Homo sapiens (human)
endothelial cell activation	TGF-beta receptor type-1	Homo sapiens (human)
extracellular structure organization	TGF-beta receptor type-1	Homo sapiens (human)
endothelial cell migration	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of DNA-templated transcription	TGF-beta receptor type-1	Homo sapiens (human)
filopodium assembly	TGF-beta receptor type-1	Homo sapiens (human)
thymus development	TGF-beta receptor type-1	Homo sapiens (human)
neuron fate commitment	TGF-beta receptor type-1	Homo sapiens (human)
embryonic cranial skeleton morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
skeletal system morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
mesenchymal cell differentiation	TGF-beta receptor type-1	Homo sapiens (human)
artery morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
cell motility	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of filopodium assembly	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of stress fiber assembly	TGF-beta receptor type-1	Homo sapiens (human)
regulation of cell cycle	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	TGF-beta receptor type-1	Homo sapiens (human)
parathyroid gland development	TGF-beta receptor type-1	Homo sapiens (human)
roof of mouth development	TGF-beta receptor type-1	Homo sapiens (human)
pharyngeal system development	TGF-beta receptor type-1	Homo sapiens (human)
regulation of cardiac muscle cell proliferation	TGF-beta receptor type-1	Homo sapiens (human)
cardiac epithelial to mesenchymal transition	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of SMAD protein signal transduction	TGF-beta receptor type-1	Homo sapiens (human)
ventricular septum morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
angiogenesis involved in coronary vascular morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
coronary artery morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
response to cholesterol	TGF-beta receptor type-1	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of mesenchymal stem cell proliferation	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of vasculature development	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of tight junction disassembly	TGF-beta receptor type-1	Homo sapiens (human)
epicardium morphogenesis	TGF-beta receptor type-1	Homo sapiens (human)
positive regulation of apoptotic signaling pathway	TGF-beta receptor type-1	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway	TGF-beta receptor type-1	Homo sapiens (human)
protein phosphorylation	TGF-beta receptor type-1	Homo sapiens (human)
cellular response to growth factor stimulus	TGF-beta receptor type-1	Homo sapiens (human)
nervous system development	TGF-beta receptor type-1	Homo sapiens (human)
cell proliferation involved in endocardial cushion morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
superior endocardial cushion morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
blood vessel development	TGF-beta receptor type-2	Homo sapiens (human)
branching involved in blood vessel morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
vasculogenesis	TGF-beta receptor type-2	Homo sapiens (human)
in utero embryonic development	TGF-beta receptor type-2	Homo sapiens (human)
epithelial to mesenchymal transition	TGF-beta receptor type-2	Homo sapiens (human)
heart looping	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of mesenchymal cell proliferation	TGF-beta receptor type-2	Homo sapiens (human)
lens development in camera-type eye	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of tolerance induction to self antigen	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of B cell tolerance induction	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of T cell tolerance induction	TGF-beta receptor type-2	Homo sapiens (human)
outflow tract septum morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
membranous septum morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
outflow tract morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
aortic valve morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
atrioventricular valve morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
tricuspid valve morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
cardiac left ventricle morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
endocardial cushion fusion	TGF-beta receptor type-2	Homo sapiens (human)
growth plate cartilage chondrocyte growth	TGF-beta receptor type-2	Homo sapiens (human)
apoptotic process	TGF-beta receptor type-2	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	TGF-beta receptor type-2	Homo sapiens (human)
Notch signaling pathway	TGF-beta receptor type-2	Homo sapiens (human)
smoothened signaling pathway	TGF-beta receptor type-2	Homo sapiens (human)
gastrulation	TGF-beta receptor type-2	Homo sapiens (human)
brain development	TGF-beta receptor type-2	Homo sapiens (human)
heart development	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of cell population proliferation	TGF-beta receptor type-2	Homo sapiens (human)
response to xenobiotic stimulus	TGF-beta receptor type-2	Homo sapiens (human)
regulation of gene expression	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of epithelial cell migration	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of epithelial to mesenchymal transition	TGF-beta receptor type-2	Homo sapiens (human)
activation of protein kinase activity	TGF-beta receptor type-2	Homo sapiens (human)
activin receptor signaling pathway	TGF-beta receptor type-2	Homo sapiens (human)
embryonic hemopoiesis	TGF-beta receptor type-2	Homo sapiens (human)
aorta morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
regulation of cell population proliferation	TGF-beta receptor type-2	Homo sapiens (human)
myeloid dendritic cell differentiation	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of angiogenesis	TGF-beta receptor type-2	Homo sapiens (human)
embryonic cranial skeleton morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
artery morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of NK T cell differentiation	TGF-beta receptor type-2	Homo sapiens (human)
roof of mouth development	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of SMAD protein signal transduction	TGF-beta receptor type-2	Homo sapiens (human)
SMAD protein signal transduction	TGF-beta receptor type-2	Homo sapiens (human)
ventricular septum morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
bronchus morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
trachea formation	TGF-beta receptor type-2	Homo sapiens (human)
mammary gland morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
lung lobe morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
Langerhans cell differentiation	TGF-beta receptor type-2	Homo sapiens (human)
secondary palate development	TGF-beta receptor type-2	Homo sapiens (human)
response to cholesterol	TGF-beta receptor type-2	Homo sapiens (human)
regulation of stem cell proliferation	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	TGF-beta receptor type-2	Homo sapiens (human)
inferior endocardial cushion morphogenesis	TGF-beta receptor type-2	Homo sapiens (human)
lens fiber cell apoptotic process	TGF-beta receptor type-2	Homo sapiens (human)
miRNA transport	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	TGF-beta receptor type-2	Homo sapiens (human)
positive regulation of CD4-positive, alpha-beta T cell proliferation	TGF-beta receptor type-2	Homo sapiens (human)
regulation of stem cell differentiation	TGF-beta receptor type-2	Homo sapiens (human)
cellular response to growth factor stimulus	TGF-beta receptor type-2	Homo sapiens (human)
protein phosphorylation	TGF-beta receptor type-2	Homo sapiens (human)
adaptive immune response	Tyrosine-protein kinase CSK	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of cell population proliferation	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of low-density lipoprotein particle clearance	Tyrosine-protein kinase CSK	Homo sapiens (human)
T cell costimulation	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of interleukin-6 production	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of Golgi to plasma membrane protein transport	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of bone resorption	Tyrosine-protein kinase CSK	Homo sapiens (human)
oligodendrocyte differentiation	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of phagocytosis	Tyrosine-protein kinase CSK	Homo sapiens (human)
T cell receptor signaling pathway	Tyrosine-protein kinase CSK	Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascade	Tyrosine-protein kinase CSK	Homo sapiens (human)
cellular response to peptide hormone stimulus	Tyrosine-protein kinase CSK	Homo sapiens (human)
regulation of Fc receptor mediated stimulatory signaling pathway	Tyrosine-protein kinase CSK	Homo sapiens (human)
adherens junction organization	Tyrosine-protein kinase CSK	Homo sapiens (human)
tRNA aminoacylation for protein translation	Glycine--tRNA ligase	Homo sapiens (human)
diadenosine tetraphosphate biosynthetic process	Glycine--tRNA ligase	Homo sapiens (human)
mitochondrial glycyl-tRNA aminoacylation	Glycine--tRNA ligase	Homo sapiens (human)
protein phosphorylation	Protein kinase C iota type	Homo sapiens (human)
protein targeting to membrane	Protein kinase C iota type	Homo sapiens (human)
cytoskeleton organization	Protein kinase C iota type	Homo sapiens (human)
actin filament organization	Protein kinase C iota type	Homo sapiens (human)
positive regulation of neuron projection development	Protein kinase C iota type	Homo sapiens (human)
vesicle-mediated transport	Protein kinase C iota type	Homo sapiens (human)
cell migration	Protein kinase C iota type	Homo sapiens (human)
cellular response to insulin stimulus	Protein kinase C iota type	Homo sapiens (human)
negative regulation of glial cell apoptotic process	Protein kinase C iota type	Homo sapiens (human)
establishment of apical/basal cell polarity	Protein kinase C iota type	Homo sapiens (human)
eye photoreceptor cell development	Protein kinase C iota type	Homo sapiens (human)
negative regulation of apoptotic process	Protein kinase C iota type	Homo sapiens (human)
negative regulation of neuron apoptotic process	Protein kinase C iota type	Homo sapiens (human)
establishment or maintenance of epithelial cell apical/basal polarity	Protein kinase C iota type	Homo sapiens (human)
cell-cell junction organization	Protein kinase C iota type	Homo sapiens (human)
positive regulation of Notch signaling pathway	Protein kinase C iota type	Homo sapiens (human)
positive regulation of glucose import	Protein kinase C iota type	Homo sapiens (human)
secretion	Protein kinase C iota type	Homo sapiens (human)
Golgi vesicle budding	Protein kinase C iota type	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Protein kinase C iota type	Homo sapiens (human)
positive regulation of glial cell proliferation	Protein kinase C iota type	Homo sapiens (human)
membrane organization	Protein kinase C iota type	Homo sapiens (human)
cellular response to chemical stress	Protein kinase C iota type	Homo sapiens (human)
response to interleukin-1	Protein kinase C iota type	Homo sapiens (human)
regulation of postsynaptic membrane neurotransmitter receptor levels	Protein kinase C iota type	Homo sapiens (human)
positive regulation of protein localization to plasma membrane	Protein kinase C iota type	Homo sapiens (human)
positive regulation of endothelial cell apoptotic process	Protein kinase C iota type	Homo sapiens (human)
intracellular signal transduction	Protein kinase C iota type	Homo sapiens (human)
peptidyl-serine phosphorylation	Protein kinase C iota type	Homo sapiens (human)
mRNA splicing, via spliceosome	Exosome RNA helicase MTR4	Homo sapiens (human)
maturation of 5.8S rRNA	Exosome RNA helicase MTR4	Homo sapiens (human)
rRNA processing	Exosome RNA helicase MTR4	Homo sapiens (human)
RNA catabolic process	Exosome RNA helicase MTR4	Homo sapiens (human)
DNA damage response	Exosome RNA helicase MTR4	Homo sapiens (human)
snRNA catabolic process	Exosome RNA helicase MTR4	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase Tec	Homo sapiens (human)
integrin-mediated signaling pathway	Tyrosine-protein kinase Tec	Homo sapiens (human)
regulation of platelet activation	Tyrosine-protein kinase Tec	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase Tec	Homo sapiens (human)
tissue regeneration	Tyrosine-protein kinase Tec	Homo sapiens (human)
B cell receptor signaling pathway	Tyrosine-protein kinase Tec	Homo sapiens (human)
adaptive immune response	Tyrosine-protein kinase Tec	Homo sapiens (human)
T cell receptor signaling pathway	Tyrosine-protein kinase Tec	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	Tyrosine-protein kinase ABL2	Homo sapiens (human)
positive regulation of phospholipase C activity	Tyrosine-protein kinase ABL2	Homo sapiens (human)
negative regulation of Rho protein signal transduction	Tyrosine-protein kinase ABL2	Homo sapiens (human)
exploration behavior	Tyrosine-protein kinase ABL2	Homo sapiens (human)
cell adhesion	Tyrosine-protein kinase ABL2	Homo sapiens (human)
signal transduction	Tyrosine-protein kinase ABL2	Homo sapiens (human)
regulation of autophagy	Tyrosine-protein kinase ABL2	Homo sapiens (human)
positive regulation of neuron projection development	Tyrosine-protein kinase ABL2	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase ABL2	Homo sapiens (human)
regulation of endocytosis	Tyrosine-protein kinase ABL2	Homo sapiens (human)
regulation of cell adhesion	Tyrosine-protein kinase ABL2	Homo sapiens (human)
regulation of actin cytoskeleton organization	Tyrosine-protein kinase ABL2	Homo sapiens (human)
protein modification process	Tyrosine-protein kinase ABL2	Homo sapiens (human)
positive regulation of oxidoreductase activity	Tyrosine-protein kinase ABL2	Homo sapiens (human)
cellular response to retinoic acid	Tyrosine-protein kinase ABL2	Homo sapiens (human)
positive regulation of establishment of T cell polarity	Tyrosine-protein kinase ABL2	Homo sapiens (human)
regulation of cell motility	Tyrosine-protein kinase ABL2	Homo sapiens (human)
positive regulation of T cell migration	Tyrosine-protein kinase ABL2	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Tyrosine-protein kinase ABL2	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase ABL2	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Tyrosine-protein kinase FRK	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase FRK	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase FRK	Homo sapiens (human)
cell differentiation	Tyrosine-protein kinase FRK	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase FRK	Homo sapiens (human)
protein import into nucleus	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of DNA-binding transcription factor activity	Tyrosine-protein kinase SYK	Homo sapiens (human)
angiogenesis	Tyrosine-protein kinase SYK	Homo sapiens (human)
cell activation	Tyrosine-protein kinase SYK	Homo sapiens (human)
lymph vessel development	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of receptor internalization	Tyrosine-protein kinase SYK	Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
adaptive immune response	Tyrosine-protein kinase SYK	Homo sapiens (human)
macrophage activation involved in immune response	Tyrosine-protein kinase SYK	Homo sapiens (human)
neutrophil activation involved in immune response	Tyrosine-protein kinase SYK	Homo sapiens (human)
leukocyte activation involved in immune response	Tyrosine-protein kinase SYK	Homo sapiens (human)
serotonin secretion by platelet	Tyrosine-protein kinase SYK	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase SYK	Homo sapiens (human)
leukocyte cell-cell adhesion	Tyrosine-protein kinase SYK	Homo sapiens (human)
integrin-mediated signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
animal organ morphogenesis	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of platelet activation	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase SYK	Homo sapiens (human)
leukotriene biosynthetic process	Tyrosine-protein kinase SYK	Homo sapiens (human)
calcium-mediated signaling	Tyrosine-protein kinase SYK	Homo sapiens (human)
platelet activation	Tyrosine-protein kinase SYK	Homo sapiens (human)
B cell differentiation	Tyrosine-protein kinase SYK	Homo sapiens (human)
neutrophil chemotaxis	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of protein-containing complex assembly	Tyrosine-protein kinase SYK	Homo sapiens (human)
receptor internalization	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of type I interferon production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of granulocyte macrophage colony-stimulating factor production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of interleukin-10 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of interleukin-12 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of interleukin-3 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of interleukin-4 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of interleukin-6 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of interleukin-8 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of tumor necrosis factor production	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of mast cell cytokine production	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of superoxide anion generation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of superoxide anion generation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of cell adhesion mediated by integrin	Tyrosine-protein kinase SYK	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase SYK	Homo sapiens (human)
collagen-activated tyrosine kinase receptor signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Tyrosine-protein kinase SYK	Homo sapiens (human)
interleukin-3-mediated signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
gamma-delta T cell differentiation	Tyrosine-protein kinase SYK	Homo sapiens (human)
defense response to bacterium	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	Tyrosine-protein kinase SYK	Homo sapiens (human)
mast cell degranulation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of mast cell degranulation	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of neutrophil degranulation	Tyrosine-protein kinase SYK	Homo sapiens (human)
beta selection	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of MAPK cascade	Tyrosine-protein kinase SYK	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of B cell differentiation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of gamma-delta T cell differentiation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of bone resorption	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of alpha-beta T cell differentiation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of alpha-beta T cell proliferation	Tyrosine-protein kinase SYK	Homo sapiens (human)
blood vessel morphogenesis	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of phagocytosis	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of calcium-mediated signaling	Tyrosine-protein kinase SYK	Homo sapiens (human)
B cell receptor signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of killing of cells of another organism	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of ERK1 and ERK2 cascade	Tyrosine-protein kinase SYK	Homo sapiens (human)
cellular response to molecule of fungal origin	Tyrosine-protein kinase SYK	Homo sapiens (human)
cellular response to lipid	Tyrosine-protein kinase SYK	Homo sapiens (human)
cellular response to low-density lipoprotein particle stimulus	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of monocyte chemotactic protein-1 production	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of arachidonic acid secretion	Tyrosine-protein kinase SYK	Homo sapiens (human)
regulation of platelet aggregation	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of cold-induced thermogenesis	Tyrosine-protein kinase SYK	Homo sapiens (human)
positive regulation of TORC1 signaling	Tyrosine-protein kinase SYK	Homo sapiens (human)
cellular response to lectin	Tyrosine-protein kinase SYK	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Tyrosine-protein kinase SYK	Homo sapiens (human)
cell differentiation	Tyrosine-protein kinase SYK	Homo sapiens (human)
blastocyst development	26S proteasome regulatory subunit 6B	Homo sapiens (human)
proteolysis	26S proteasome regulatory subunit 6B	Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic process	26S proteasome regulatory subunit 6B	Homo sapiens (human)
positive regulation of proteasomal protein catabolic process	26S proteasome regulatory subunit 6B	Homo sapiens (human)
JUN phosphorylation	Mitogen-activated protein kinase 8	Homo sapiens (human)
response to UV	Mitogen-activated protein kinase 8	Homo sapiens (human)
negative regulation of apoptotic process	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular response to lipopolysaccharide	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase 8	Homo sapiens (human)
response to oxidative stress	Mitogen-activated protein kinase 8	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase 8	Homo sapiens (human)
JUN phosphorylation	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of gene expression	Mitogen-activated protein kinase 8	Homo sapiens (human)
regulation of macroautophagy	Mitogen-activated protein kinase 8	Homo sapiens (human)
peptidyl-serine phosphorylation	Mitogen-activated protein kinase 8	Homo sapiens (human)
peptidyl-threonine phosphorylation	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of cyclase activity	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of cell killing	Mitogen-activated protein kinase 8	Homo sapiens (human)
negative regulation of protein binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
regulation of protein localization	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular response to amino acid starvation	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular response to oxidative stress	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular response to reactive oxygen species	Mitogen-activated protein kinase 8	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Mitogen-activated protein kinase 8	Homo sapiens (human)
regulation of circadian rhythm	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of apoptotic process	Mitogen-activated protein kinase 8	Homo sapiens (human)
negative regulation of apoptotic process	Mitogen-activated protein kinase 8	Homo sapiens (human)
rhythmic process	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of protein metabolic process	Mitogen-activated protein kinase 8	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular response to mechanical stimulus	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular response to cadmium ion	Mitogen-activated protein kinase 8	Homo sapiens (human)
cellular senescence	Mitogen-activated protein kinase 8	Homo sapiens (human)
energy homeostasis	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assembly	Mitogen-activated protein kinase 8	Homo sapiens (human)
response to mechanical stimulus	Mitogen-activated protein kinase 8	Homo sapiens (human)
positive regulation of establishment of protein localization to mitochondrion	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase 9	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of gene expression	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of macrophage derived foam cell differentiation	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of protein ubiquitination	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Mitogen-activated protein kinase 9	Homo sapiens (human)
cellular response to reactive oxygen species	Mitogen-activated protein kinase 9	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Mitogen-activated protein kinase 9	Homo sapiens (human)
regulation of circadian rhythm	Mitogen-activated protein kinase 9	Homo sapiens (human)
rhythmic process	Mitogen-activated protein kinase 9	Homo sapiens (human)
modulation of chemical synaptic transmission	Mitogen-activated protein kinase 9	Homo sapiens (human)
protein localization to tricellular tight junction	Mitogen-activated protein kinase 9	Homo sapiens (human)
cellular response to cadmium ion	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of podosome assembly	Mitogen-activated protein kinase 9	Homo sapiens (human)
cellular senescence	Mitogen-activated protein kinase 9	Homo sapiens (human)
inflammatory response to wounding	Mitogen-activated protein kinase 9	Homo sapiens (human)
apoptotic signaling pathway	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of cytokine production involved in inflammatory response	Mitogen-activated protein kinase 9	Homo sapiens (human)
positive regulation of apoptotic signaling pathway	Mitogen-activated protein kinase 9	Homo sapiens (human)
regulation of cytokine production	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
response to ischemia	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
inflammatory response	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
signal transduction	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
heart development	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
stress-activated protein kinase signaling cascade	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
negative regulation of hippo signaling	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulus	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
p38MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
positive regulation of MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
positive regulation of protein kinase activity	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
positive regulation of DNA-templated transcription	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic process	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
cardiac muscle contraction	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
cellular response to lipopolysaccharide	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
cellular response to sorbitol	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
cellular senescence	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
regulation of autophagy	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
megakaryocyte development	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
autophagosome-lysosome fusion	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
vesicle-mediated cholesterol transport	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
positive regulation of autophagosome assembly	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic process	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
protein phosphorylation	Casein kinase I isoform alpha	Homo sapiens (human)
Golgi organization	Casein kinase I isoform alpha	Homo sapiens (human)
cell surface receptor signaling pathway	Casein kinase I isoform alpha	Homo sapiens (human)
Wnt signaling pathway	Casein kinase I isoform alpha	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase I isoform alpha	Homo sapiens (human)
viral protein processing	Casein kinase I isoform alpha	Homo sapiens (human)
cellular response to nutrient	Casein kinase I isoform alpha	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Casein kinase I isoform alpha	Homo sapiens (human)
positive regulation of Rho protein signal transduction	Casein kinase I isoform alpha	Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic process	Casein kinase I isoform alpha	Homo sapiens (human)
intermediate filament cytoskeleton organization	Casein kinase I isoform alpha	Homo sapiens (human)
cell division	Casein kinase I isoform alpha	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Casein kinase I isoform alpha	Homo sapiens (human)
negative regulation of NLRP3 inflammasome complex assembly	Casein kinase I isoform alpha	Homo sapiens (human)
positive regulation of TORC1 signaling	Casein kinase I isoform alpha	Homo sapiens (human)
signal transduction	Casein kinase I isoform alpha	Homo sapiens (human)
microtubule nucleation	Casein kinase I isoform delta	Homo sapiens (human)
Golgi organization	Casein kinase I isoform delta	Homo sapiens (human)
protein localization to Golgi apparatus	Casein kinase I isoform delta	Homo sapiens (human)
protein localization to cilium	Casein kinase I isoform delta	Homo sapiens (human)
protein localization to centrosome	Casein kinase I isoform delta	Homo sapiens (human)
non-motile cilium assembly	Casein kinase I isoform delta	Homo sapiens (human)
positive regulation of protein phosphorylation	Casein kinase I isoform delta	Homo sapiens (human)
protein phosphorylation	Casein kinase I isoform delta	Homo sapiens (human)
Wnt signaling pathway	Casein kinase I isoform delta	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Casein kinase I isoform delta	Homo sapiens (human)
circadian regulation of gene expression	Casein kinase I isoform delta	Homo sapiens (human)
regulation of circadian rhythm	Casein kinase I isoform delta	Homo sapiens (human)
COPII vesicle coating	Casein kinase I isoform delta	Homo sapiens (human)
spindle assembly	Casein kinase I isoform delta	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Casein kinase I isoform delta	Homo sapiens (human)
midbrain dopaminergic neuron differentiation	Casein kinase I isoform delta	Homo sapiens (human)
cellular response to nerve growth factor stimulus	Casein kinase I isoform delta	Homo sapiens (human)
positive regulation of non-canonical Wnt signaling pathway	Casein kinase I isoform delta	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase I isoform delta	Homo sapiens (human)
signal transduction	Casein kinase I isoform delta	Homo sapiens (human)
non-motile cilium assembly	Casein kinase I isoform delta	Homo sapiens (human)
endocytosis	Casein kinase I isoform delta	Homo sapiens (human)
MAPK cascade	MAP kinase-activated protein kinase 2	Homo sapiens (human)
toll-like receptor signaling pathway	MAP kinase-activated protein kinase 2	Homo sapiens (human)
protein phosphorylation	MAP kinase-activated protein kinase 2	Homo sapiens (human)
leukotriene metabolic process	MAP kinase-activated protein kinase 2	Homo sapiens (human)
inflammatory response	MAP kinase-activated protein kinase 2	Homo sapiens (human)
DNA damage response	MAP kinase-activated protein kinase 2	Homo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathway	MAP kinase-activated protein kinase 2	Homo sapiens (human)
peptidyl-serine phosphorylation	MAP kinase-activated protein kinase 2	Homo sapiens (human)
response to lipopolysaccharide	MAP kinase-activated protein kinase 2	Homo sapiens (human)
regulation of interleukin-6 production	MAP kinase-activated protein kinase 2	Homo sapiens (human)
regulation of tumor necrosis factor production	MAP kinase-activated protein kinase 2	Homo sapiens (human)
positive regulation of tumor necrosis factor production	MAP kinase-activated protein kinase 2	Homo sapiens (human)
response to cytokine	MAP kinase-activated protein kinase 2	Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulus	MAP kinase-activated protein kinase 2	Homo sapiens (human)
p38MAPK cascade	MAP kinase-activated protein kinase 2	Homo sapiens (human)
regulation of mRNA stability	MAP kinase-activated protein kinase 2	Homo sapiens (human)
macropinocytosis	MAP kinase-activated protein kinase 2	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	MAP kinase-activated protein kinase 2	Homo sapiens (human)
inner ear development	MAP kinase-activated protein kinase 2	Homo sapiens (human)
positive regulation of macrophage cytokine production	MAP kinase-activated protein kinase 2	Homo sapiens (human)
3'-UTR-mediated mRNA stabilization	MAP kinase-activated protein kinase 2	Homo sapiens (human)
regulation of cellular response to heat	MAP kinase-activated protein kinase 2	Homo sapiens (human)
protein autophosphorylation	MAP kinase-activated protein kinase 2	Homo sapiens (human)
intracellular signal transduction	MAP kinase-activated protein kinase 2	Homo sapiens (human)
translational elongation	Elongation factor Tu, mitochondrial	Homo sapiens (human)
response to ethanol	Elongation factor Tu, mitochondrial	Homo sapiens (human)
mitochondrial translational elongation	Elongation factor Tu, mitochondrial	Homo sapiens (human)
phosphatidylcholine biosynthetic process	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
CDP-choline pathway	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
DNA repair	Casein kinase I isoform epsilon	Homo sapiens (human)
protein phosphorylation	Casein kinase I isoform epsilon	Homo sapiens (human)
protein localization	Casein kinase I isoform epsilon	Homo sapiens (human)
negative regulation of Wnt signaling pathway	Casein kinase I isoform epsilon	Homo sapiens (human)
negative regulation of protein binding	Casein kinase I isoform epsilon	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Casein kinase I isoform epsilon	Homo sapiens (human)
regulation of protein localization	Casein kinase I isoform epsilon	Homo sapiens (human)
circadian regulation of gene expression	Casein kinase I isoform epsilon	Homo sapiens (human)
regulation of circadian rhythm	Casein kinase I isoform epsilon	Homo sapiens (human)
circadian behavior	Casein kinase I isoform epsilon	Homo sapiens (human)
canonical Wnt signaling pathway	Casein kinase I isoform epsilon	Homo sapiens (human)
positive regulation of amyloid-beta formation	Casein kinase I isoform epsilon	Homo sapiens (human)
cellular response to nerve growth factor stimulus	Casein kinase I isoform epsilon	Homo sapiens (human)
positive regulation of non-canonical Wnt signaling pathway	Casein kinase I isoform epsilon	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase I isoform epsilon	Homo sapiens (human)
endocytosis	Casein kinase I isoform epsilon	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Casein kinase I isoform epsilon	Homo sapiens (human)
signal transduction	Casein kinase I isoform epsilon	Homo sapiens (human)
temperature homeostasis	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
response to cold	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
energy derivation by oxidation of organic compounds	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
epithelial cell differentiation	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
fatty acid beta-oxidation using acyl-CoA dehydrogenase	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
negative regulation of fatty acid biosynthetic process	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
negative regulation of fatty acid oxidation	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
regulation of cholesterol metabolic process	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
regulation of RNA splicing	Dual specificity protein kinase CLK1	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Dual specificity protein kinase CLK1	Homo sapiens (human)
protein phosphorylation	Dual specificity protein kinase CLK3	Homo sapiens (human)
regulation of RNA splicing	Dual specificity protein kinase CLK3	Homo sapiens (human)
regulation of systemic arterial blood pressure	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cardiac left ventricle morphogenesis	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
glycogen metabolic process	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
protein phosphorylation	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
dopamine receptor signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
nervous system development	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
insulin receptor signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of autophagy	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of gene expression	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylation	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of UDP-glucose catabolic process	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
Wnt signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cell migration	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
peptidyl-threonine phosphorylation	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
viral protein processing	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of protein ubiquitination	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of TOR signaling	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cellular response to insulin stimulus	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cellular response to interleukin-3	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic process	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of glycogen biosynthetic process	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of protein catabolic process	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of heart contraction	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of glucose import	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
excitatory postsynaptic potential	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell development	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cellular response to lithium ion	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cellular response to glucocorticoid stimulus	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
extrinsic apoptotic signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligand	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
autosome genomic imprinting	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
regulation of mitophagy	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of amyloid-beta formation	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of protein targeting to mitochondrion	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of glycogen synthase activity, transferring glucose-1-phosphate	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of type B pancreatic cell development	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
negative regulation of glycogen (starch) synthase activity	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of glycogen (starch) synthase activity	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cell differentiation	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
regulation of microtubule cytoskeleton organization	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
regulation of neuron projection development	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
positive regulation of gene expression	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of gene expression	Glycogen synthase kinase-3 beta	Homo sapiens (human)
ER overload response	Glycogen synthase kinase-3 beta	Homo sapiens (human)
peptidyl-serine phosphorylation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
intracellular signal transduction	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of apoptotic process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein export from nucleus	Glycogen synthase kinase-3 beta	Homo sapiens (human)
epithelial to mesenchymal transition	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of cell-matrix adhesion	Glycogen synthase kinase-3 beta	Homo sapiens (human)
glycogen metabolic process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein phosphorylation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
mitochondrion organization	Glycogen synthase kinase-3 beta	Homo sapiens (human)
dopamine receptor signaling pathway	Glycogen synthase kinase-3 beta	Homo sapiens (human)
circadian rhythm	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of autophagy	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of gene expression	Glycogen synthase kinase-3 beta	Homo sapiens (human)
peptidyl-serine phosphorylation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
peptidyl-threonine phosphorylation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
viral protein processing	Glycogen synthase kinase-3 beta	Homo sapiens (human)
hippocampus development	Glycogen synthase kinase-3 beta	Homo sapiens (human)
establishment of cell polarity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
maintenance of cell polarity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of cell migration	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of axon extension	Glycogen synthase kinase-3 beta	Homo sapiens (human)
neuron projection development	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of protein-containing complex assembly	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein-containing complex assembly	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein ubiquitination	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of phosphoprotein phosphatase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of microtubule-based process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
intracellular signal transduction	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cellular response to interleukin-3	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of circadian rhythm	Glycogen synthase kinase-3 beta	Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of GTPase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of cell differentiation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of osteoblast differentiation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of glycogen biosynthetic process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of cilium assembly	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein catabolic process	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein autophosphorylation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of protein export from nucleus	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of dendrite morphogenesis	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of axonogenesis	Glycogen synthase kinase-3 beta	Homo sapiens (human)
canonical Wnt signaling pathway	Glycogen synthase kinase-3 beta	Homo sapiens (human)
excitatory postsynaptic potential	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of microtubule cytoskeleton organization	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of calcineurin-NFAT signaling cascade	Glycogen synthase kinase-3 beta	Homo sapiens (human)
superior temporal gyrus development	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cellular response to retinoic acid	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Glycogen synthase kinase-3 beta	Homo sapiens (human)
extrinsic apoptotic signaling pathway	Glycogen synthase kinase-3 beta	Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligand	Glycogen synthase kinase-3 beta	Homo sapiens (human)
presynaptic modulation of chemical synaptic transmission	Glycogen synthase kinase-3 beta	Homo sapiens (human)
neuron projection organization	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of microtubule anchoring at centrosome	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of cellular response to heat	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of protein localization to nucleus	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of long-term synaptic potentiation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of protein acetylation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein localization to cilium	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of dopaminergic neuron differentiation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cellular response to amyloid-beta	Glycogen synthase kinase-3 beta	Homo sapiens (human)
positive regulation of protein localization to centrosome	Glycogen synthase kinase-3 beta	Homo sapiens (human)
beta-catenin destruction complex disassembly	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of type B pancreatic cell development	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of glycogen (starch) synthase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of mesenchymal stem cell differentiation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
negative regulation of TOR signaling	Glycogen synthase kinase-3 beta	Homo sapiens (human)
regulation of neuron projection development	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cell differentiation	Glycogen synthase kinase-3 beta	Homo sapiens (human)
insulin receptor signaling pathway	Glycogen synthase kinase-3 beta	Homo sapiens (human)
DNA repair	Cyclin-dependent kinase 7	Homo sapiens (human)
transcription by RNA polymerase II	Cyclin-dependent kinase 7	Homo sapiens (human)
transcription initiation at RNA polymerase II promoter	Cyclin-dependent kinase 7	Homo sapiens (human)
snRNA transcription by RNA polymerase II	Cyclin-dependent kinase 7	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 7	Homo sapiens (human)
protein stabilization	Cyclin-dependent kinase 7	Homo sapiens (human)
cell division	Cyclin-dependent kinase 7	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 7	Homo sapiens (human)
regulation of G1/S transition of mitotic cell cycle	Cyclin-dependent kinase 7	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 7	Homo sapiens (human)
regulation of mitotic cell cycle	Cyclin-dependent kinase 9	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 9	Homo sapiens (human)
DNA repair	Cyclin-dependent kinase 9	Homo sapiens (human)
regulation of DNA repair	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription by RNA polymerase II	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription initiation at RNA polymerase II promoter	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription elongation by RNA polymerase II	Cyclin-dependent kinase 9	Homo sapiens (human)
cell population proliferation	Cyclin-dependent kinase 9	Homo sapiens (human)
replication fork processing	Cyclin-dependent kinase 9	Homo sapiens (human)
regulation of mRNA 3'-end processing	Cyclin-dependent kinase 9	Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase II	Cyclin-dependent kinase 9	Homo sapiens (human)
positive regulation by host of viral transcription	Cyclin-dependent kinase 9	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 9	Homo sapiens (human)
regulation of muscle cell differentiation	Cyclin-dependent kinase 9	Homo sapiens (human)
nucleus localization	Cyclin-dependent kinase 9	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 9	Homo sapiens (human)
cellular response to cytokine stimulus	Cyclin-dependent kinase 9	Homo sapiens (human)
negative regulation of protein localization to chromatin	Cyclin-dependent kinase 9	Homo sapiens (human)
positive regulation of protein localization to chromatin	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription elongation-coupled chromatin remodeling	Cyclin-dependent kinase 9	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 9	Homo sapiens (human)
exocytosis	Ras-related protein Rab-27A	Homo sapiens (human)
blood coagulation	Ras-related protein Rab-27A	Homo sapiens (human)
protein secretion	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of gene expression	Ras-related protein Rab-27A	Homo sapiens (human)
antigen processing and presentation	Ras-related protein Rab-27A	Homo sapiens (human)
melanocyte differentiation	Ras-related protein Rab-27A	Homo sapiens (human)
melanosome localization	Ras-related protein Rab-27A	Homo sapiens (human)
melanosome transport	Ras-related protein Rab-27A	Homo sapiens (human)
multivesicular body organization	Ras-related protein Rab-27A	Homo sapiens (human)
cytotoxic T cell degranulation	Ras-related protein Rab-27A	Homo sapiens (human)
natural killer cell degranulation	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of exocytosis	Ras-related protein Rab-27A	Homo sapiens (human)
synaptic vesicle transport	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of phagocytosis	Ras-related protein Rab-27A	Homo sapiens (human)
multivesicular body sorting pathway	Ras-related protein Rab-27A	Homo sapiens (human)
complement-dependent cytotoxicity	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of regulated secretory pathway	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic process	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of constitutive secretory pathway	Ras-related protein Rab-27A	Homo sapiens (human)
exosomal secretion	Ras-related protein Rab-27A	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein autophosphorylation	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
regulation of cytokine-mediated signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
toll-like receptor signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
canonical NF-kappaB signal transduction	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
JNK cascade	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
positive regulation of type I interferon production	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
response to lipopolysaccharide	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
toll-like receptor 2 signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
toll-like receptor 9 signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
cellular response to heat	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
interleukin-33-mediated signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein autophosphorylation	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
type I interferon-mediated signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
interleukin-1-mediated signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
response to interleukin-1	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
cellular response to hypoxia	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cell	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
toll-like receptor 4 signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
positive regulation of MAP kinase activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
cellular response to lipopolysaccharide	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
intracellular signal transduction	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
Toll signaling pathway	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
innate immune response	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
skeletal system development	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
toll-like receptor signaling pathway	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
signal transduction	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
chemical synaptic transmission	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
central nervous system development	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
peptidyl-serine phosphorylation	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
positive regulation of cell growth	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
response to lipopolysaccharide	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
intracellular signal transduction	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
negative regulation of apoptotic process	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
regulation of translation in response to stress	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
positive regulation of cell differentiation	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Cyclin-H	Homo sapiens (human)
transcription initiation at RNA polymerase II promoter	Cyclin-H	Homo sapiens (human)
protein stabilization	Cyclin-H	Homo sapiens (human)
regulation of G1/S transition of mitotic cell cycle	Cyclin-H	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Cyclin-H	Homo sapiens (human)
G1/S transition of mitotic cell cycle	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
nucleotide-excision repair	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
regulation of transcription by RNA polymerase II	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
transcription initiation at RNA polymerase II promoter	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
adult heart development	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
ventricular system development	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
negative regulation of apoptotic process	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
response to calcium ion	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
regulation of G1/S transition of mitotic cell cycle	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
DNA repair	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
mitotic cell cycle	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
blastocyst development	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
chromosome segregation	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
regulation of mitotic nuclear division	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
regulation of mitotic centrosome separation	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
spindle assembly	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
centrosome separation	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
cell division	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
meiotic cell cycle	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
positive regulation of telomerase activity	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
regulation of attachment of spindle microtubules to kinetochore	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
mitotic spindle assembly	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
negative regulation of centriole-centriole cohesion	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
positive regulation of telomere capping	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
mitotic cell cycle	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
establishment of cell polarity	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
neuron projection morphogenesis	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
cell division	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
regulation of tubulin deacetylation	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
osteoblast differentiation	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
positive regulation of protein phosphorylation	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
response to ischemia	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
apoptotic process	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
signal transduction	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
response to xenobiotic stimulus	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
ovulation cycle process	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
stress-activated protein kinase signaling cascade	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
positive regulation of prostaglandin secretion	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
p38MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
signal transduction in response to DNA damage	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
positive regulation of apoptotic process	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
positive regulation of MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
stress-activated MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
regulation of cell cycle	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic process	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
cardiac muscle contraction	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
bone development	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
cellular response to sorbitol	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
cellular senescence	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
negative regulation of cold-induced thermogenesis	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
protein phosphorylation	LIM domain kinase 1	Homo sapiens (human)
signal transduction	LIM domain kinase 1	Homo sapiens (human)
Rho protein signal transduction	LIM domain kinase 1	Homo sapiens (human)
nervous system development	LIM domain kinase 1	Homo sapiens (human)
positive regulation of actin filament bundle assembly	LIM domain kinase 1	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	LIM domain kinase 1	Homo sapiens (human)
stress fiber assembly	LIM domain kinase 1	Homo sapiens (human)
positive regulation of axon extension	LIM domain kinase 1	Homo sapiens (human)
axon extension	LIM domain kinase 1	Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activity	LIM domain kinase 1	Homo sapiens (human)
positive regulation of stress fiber assembly	LIM domain kinase 1	Homo sapiens (human)
actin cytoskeleton organization	LIM domain kinase 1	Homo sapiens (human)
positive regulation of protein phosphorylation	LIM domain kinase 2	Homo sapiens (human)
protein phosphorylation	LIM domain kinase 2	Homo sapiens (human)
spermatogenesis	LIM domain kinase 2	Homo sapiens (human)
phosphorylation	LIM domain kinase 2	Homo sapiens (human)
astral microtubule organization	LIM domain kinase 2	Homo sapiens (human)
establishment of vesicle localization	LIM domain kinase 2	Homo sapiens (human)
head development	LIM domain kinase 2	Homo sapiens (human)
cornea development in camera-type eye	LIM domain kinase 2	Homo sapiens (human)
positive regulation of protein localization to nucleus	LIM domain kinase 2	Homo sapiens (human)
negative regulation of cilium assembly	LIM domain kinase 2	Homo sapiens (human)
actin cytoskeleton organization	LIM domain kinase 2	Homo sapiens (human)
tyrosyl-tRNA aminoacylation	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
apoptotic process	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
response to starvation	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
regulation of glycolytic process	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
protein phosphorylation	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
fatty acid biosynthetic process	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
signal transduction	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
spermatogenesis	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
positive regulation of gene expression	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
cellular response to nutrient levels	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
positive regulation of protein kinase activity	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
import into nucleus	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
regulation of catalytic activity	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
angiogenesis	Ephrin type-B receptor 3	Homo sapiens (human)
urogenital system development	Ephrin type-B receptor 3	Homo sapiens (human)
axon guidance	Ephrin type-B receptor 3	Homo sapiens (human)
axonal fasciculation	Ephrin type-B receptor 3	Homo sapiens (human)
cell migration	Ephrin type-B receptor 3	Homo sapiens (human)
central nervous system projection neuron axonogenesis	Ephrin type-B receptor 3	Homo sapiens (human)
corpus callosum development	Ephrin type-B receptor 3	Homo sapiens (human)
regulation of cell-cell adhesion	Ephrin type-B receptor 3	Homo sapiens (human)
retinal ganglion cell axon guidance	Ephrin type-B receptor 3	Homo sapiens (human)
substrate adhesion-dependent cell spreading	Ephrin type-B receptor 3	Homo sapiens (human)
regulation of GTPase activity	Ephrin type-B receptor 3	Homo sapiens (human)
protein autophosphorylation	Ephrin type-B receptor 3	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-B receptor 3	Homo sapiens (human)
thymus development	Ephrin type-B receptor 3	Homo sapiens (human)
digestive tract morphogenesis	Ephrin type-B receptor 3	Homo sapiens (human)
regulation of axonogenesis	Ephrin type-B receptor 3	Homo sapiens (human)
positive regulation of synapse assembly	Ephrin type-B receptor 3	Homo sapiens (human)
roof of mouth development	Ephrin type-B receptor 3	Homo sapiens (human)
dendritic spine development	Ephrin type-B receptor 3	Homo sapiens (human)
dendritic spine morphogenesis	Ephrin type-B receptor 3	Homo sapiens (human)
protein phosphorylation	Ephrin type-B receptor 3	Homo sapiens (human)
axon guidance	Ephrin type-A receptor 5	Homo sapiens (human)
cAMP-mediated signaling	Ephrin type-A receptor 5	Homo sapiens (human)
hippocampus development	Ephrin type-A receptor 5	Homo sapiens (human)
positive regulation of CREB transcription factor activity	Ephrin type-A receptor 5	Homo sapiens (human)
regulation of actin cytoskeleton organization	Ephrin type-A receptor 5	Homo sapiens (human)
regulation of GTPase activity	Ephrin type-A receptor 5	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-A receptor 5	Homo sapiens (human)
neuron development	Ephrin type-A receptor 5	Homo sapiens (human)
regulation of insulin secretion involved in cellular response to glucose stimulus	Ephrin type-A receptor 5	Homo sapiens (human)
protein phosphorylation	Ephrin type-A receptor 5	Homo sapiens (human)
angiogenesis	Ephrin type-B receptor 4	Homo sapiens (human)
cell migration involved in sprouting angiogenesis	Ephrin type-B receptor 4	Homo sapiens (human)
heart morphogenesis	Ephrin type-B receptor 4	Homo sapiens (human)
cell adhesion	Ephrin type-B receptor 4	Homo sapiens (human)
protein autophosphorylation	Ephrin type-B receptor 4	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-B receptor 4	Homo sapiens (human)
multicellular organism development	Ephrin type-B receptor 4	Homo sapiens (human)
positive regulation of kinase activity	Ephrin type-B receptor 4	Homo sapiens (human)
negative regulation of cellular response to hypoxia	Ephrin type-A receptor 4	Homo sapiens (human)
cell adhesion	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of cell adhesion	Ephrin type-A receptor 4	Homo sapiens (human)
adult walking behavior	Ephrin type-A receptor 4	Homo sapiens (human)
motor neuron axon guidance	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of cell population proliferation	Ephrin type-A receptor 4	Homo sapiens (human)
glial cell migration	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of epithelial to mesenchymal transition	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of neuron projection development	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of translation	Ephrin type-A receptor 4	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Ephrin type-A receptor 4	Homo sapiens (human)
corticospinal tract morphogenesis	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of cell migration	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of cell migration	Ephrin type-A receptor 4	Homo sapiens (human)
adherens junction organization	Ephrin type-A receptor 4	Homo sapiens (human)
regulation of GTPase activity	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of cell adhesion	Ephrin type-A receptor 4	Homo sapiens (human)
protein autophosphorylation	Ephrin type-A receptor 4	Homo sapiens (human)
ephrin receptor signaling pathway	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of axon regeneration	Ephrin type-A receptor 4	Homo sapiens (human)
regulation of astrocyte differentiation	Ephrin type-A receptor 4	Homo sapiens (human)
regulation of axonogenesis	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of dendrite morphogenesis	Ephrin type-A receptor 4	Homo sapiens (human)
protein stabilization	Ephrin type-A receptor 4	Homo sapiens (human)
regulation of dendritic spine morphogenesis	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of protein tyrosine kinase activity	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascade	Ephrin type-A receptor 4	Homo sapiens (human)
nephric duct morphogenesis	Ephrin type-A receptor 4	Homo sapiens (human)
cochlea development	Ephrin type-A receptor 4	Homo sapiens (human)
fasciculation of sensory neuron axon	Ephrin type-A receptor 4	Homo sapiens (human)
fasciculation of motor neuron axon	Ephrin type-A receptor 4	Homo sapiens (human)
neuron projection guidance	Ephrin type-A receptor 4	Homo sapiens (human)
synapse pruning	Ephrin type-A receptor 4	Homo sapiens (human)
neuron projection fasciculation	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of long-term synaptic potentiation	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of amyloid-beta formation	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process	Ephrin type-A receptor 4	Homo sapiens (human)
negative regulation of proteolysis involved in protein catabolic process	Ephrin type-A receptor 4	Homo sapiens (human)
cellular response to amyloid-beta	Ephrin type-A receptor 4	Homo sapiens (human)
regulation of modification of synaptic structure	Ephrin type-A receptor 4	Homo sapiens (human)
regulation of synapse pruning	Ephrin type-A receptor 4	Homo sapiens (human)
positive regulation of Rho guanyl-nucleotide exchange factor activity	Ephrin type-A receptor 4	Homo sapiens (human)
protein phosphorylation	Ephrin type-A receptor 4	Homo sapiens (human)
axon guidance	Ephrin type-A receptor 4	Homo sapiens (human)
ADP biosynthetic process	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
nucleobase-containing small molecule interconversion	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
AMP metabolic process	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
ATP metabolic process	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
nucleoside monophosphate phosphorylation	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
purine ribonucleoside salvage	Adenosine kinase	Homo sapiens (human)
dATP biosynthetic process	Adenosine kinase	Homo sapiens (human)
ribonucleoside monophosphate biosynthetic process	Adenosine kinase	Homo sapiens (human)
GMP salvage	Adenosine kinase	Homo sapiens (human)
AMP salvage	Adenosine kinase	Homo sapiens (human)
dAMP salvage	Adenosine kinase	Homo sapiens (human)
purine nucleobase metabolic process	Adenosine kinase	Homo sapiens (human)
Golgi to plasma membrane transport	Ras-related protein Rab-10	Homo sapiens (human)
axonogenesis	Ras-related protein Rab-10	Homo sapiens (human)
vesicle-mediated transport	Ras-related protein Rab-10	Homo sapiens (human)
endosomal transport	Ras-related protein Rab-10	Homo sapiens (human)
antigen processing and presentation	Ras-related protein Rab-10	Homo sapiens (human)
polarized epithelial cell differentiation	Ras-related protein Rab-10	Homo sapiens (human)
cellular response to insulin stimulus	Ras-related protein Rab-10	Homo sapiens (human)
Golgi to plasma membrane protein transport	Ras-related protein Rab-10	Homo sapiens (human)
regulated exocytosis	Ras-related protein Rab-10	Homo sapiens (human)
establishment of neuroblast polarity	Ras-related protein Rab-10	Homo sapiens (human)
endoplasmic reticulum tubular network organization	Ras-related protein Rab-10	Homo sapiens (human)
protein localization to plasma membrane	Ras-related protein Rab-10	Homo sapiens (human)
establishment of protein localization to membrane	Ras-related protein Rab-10	Homo sapiens (human)
establishment of protein localization to endoplasmic reticulum membrane	Ras-related protein Rab-10	Homo sapiens (human)
cell-cell adhesion	Ras-related protein Rab-10	Homo sapiens (human)
protein localization to basolateral plasma membrane	Ras-related protein Rab-10	Homo sapiens (human)
exocytosis	Ras-related protein Rab-10	Homo sapiens (human)
protein secretion	Ras-related protein Rab-10	Homo sapiens (human)
establishment or maintenance of cell polarity	Actin-related protein 3	Homo sapiens (human)
asymmetric cell division	Actin-related protein 3	Homo sapiens (human)
positive regulation of lamellipodium assembly	Actin-related protein 3	Homo sapiens (human)
meiotic chromosome movement towards spindle pole	Actin-related protein 3	Homo sapiens (human)
meiotic cytokinesis	Actin-related protein 3	Homo sapiens (human)
Arp2/3 complex-mediated actin nucleation	Actin-related protein 3	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Actin-related protein 3	Homo sapiens (human)
spindle localization	Actin-related protein 3	Homo sapiens (human)
cilium assembly	Actin-related protein 3	Homo sapiens (human)
actin polymerization-dependent cell motility	Actin-related protein 3	Homo sapiens (human)
cellular response to type II interferon	Actin-related protein 3	Homo sapiens (human)
regulation of double-strand break repair via nonhomologous end joining	Actin-related protein 2	Homo sapiens (human)
cilium assembly	Actin-related protein 2	Homo sapiens (human)
establishment or maintenance of cell polarity	Actin-related protein 2	Homo sapiens (human)
asymmetric cell division	Actin-related protein 2	Homo sapiens (human)
positive regulation of lamellipodium assembly	Actin-related protein 2	Homo sapiens (human)
meiotic chromosome movement towards spindle pole	Actin-related protein 2	Homo sapiens (human)
cytosolic transport	Actin-related protein 2	Homo sapiens (human)
meiotic cytokinesis	Actin-related protein 2	Homo sapiens (human)
Arp2/3 complex-mediated actin nucleation	Actin-related protein 2	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Actin-related protein 2	Homo sapiens (human)
spindle localization	Actin-related protein 2	Homo sapiens (human)
cellular response to type II interferon	Actin-related protein 2	Homo sapiens (human)
positive regulation of double-strand break repair via homologous recombination	Actin-related protein 2	Homo sapiens (human)
ribosomal large subunit export from nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
ribosomal small subunit export from nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
mitotic sister chromatid segregation	GTP-binding nuclear protein Ran	Homo sapiens (human)
mitotic cell cycle	GTP-binding nuclear protein Ran	Homo sapiens (human)
DNA metabolic process	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein import into nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein export from nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
mitotic spindle organization	GTP-binding nuclear protein Ran	Homo sapiens (human)
spermatid development	GTP-binding nuclear protein Ran	Homo sapiens (human)
viral process	GTP-binding nuclear protein Ran	Homo sapiens (human)
hippocampus development	GTP-binding nuclear protein Ran	Homo sapiens (human)
actin cytoskeleton organization	GTP-binding nuclear protein Ran	Homo sapiens (human)
positive regulation of protein binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
pre-miRNA export from nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
positive regulation of protein import into nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
GTP metabolic process	GTP-binding nuclear protein Ran	Homo sapiens (human)
cell division	GTP-binding nuclear protein Ran	Homo sapiens (human)
snRNA import into nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
cellular response to mineralocorticoid stimulus	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein localization to nucleolus	GTP-binding nuclear protein Ran	Homo sapiens (human)
ribosomal subunit export from nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein phosphorylation	Casein kinase I isoform gamma-2	Homo sapiens (human)
Wnt signaling pathway	Casein kinase I isoform gamma-2	Homo sapiens (human)
sphingolipid biosynthetic process	Casein kinase I isoform gamma-2	Homo sapiens (human)
signal transduction	Casein kinase I isoform gamma-2	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase I isoform gamma-2	Homo sapiens (human)
endocytosis	Casein kinase I isoform gamma-2	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Casein kinase I isoform gamma-2	Homo sapiens (human)
G1/S transition of mitotic cell cycle	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 6	Homo sapiens (human)
positive regulation of cell-matrix adhesion	Cyclin-dependent kinase 6	Homo sapiens (human)
type B pancreatic cell development	Cyclin-dependent kinase 6	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 6	Homo sapiens (human)
Notch signaling pathway	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of cell population proliferation	Cyclin-dependent kinase 6	Homo sapiens (human)
response to virus	Cyclin-dependent kinase 6	Homo sapiens (human)
regulation of gene expression	Cyclin-dependent kinase 6	Homo sapiens (human)
positive regulation of gene expression	Cyclin-dependent kinase 6	Homo sapiens (human)
astrocyte development	Cyclin-dependent kinase 6	Homo sapiens (human)
dentate gyrus development	Cyclin-dependent kinase 6	Homo sapiens (human)
lateral ventricle development	Cyclin-dependent kinase 6	Homo sapiens (human)
T cell differentiation in thymus	Cyclin-dependent kinase 6	Homo sapiens (human)
gliogenesis	Cyclin-dependent kinase 6	Homo sapiens (human)
cell dedifferentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of cell differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of myeloid cell differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
regulation of erythrocyte differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of monocyte differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of osteoblast differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of cell cycle	Cyclin-dependent kinase 6	Homo sapiens (human)
positive regulation of fibroblast proliferation	Cyclin-dependent kinase 6	Homo sapiens (human)
generation of neurons	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of epithelial cell proliferation	Cyclin-dependent kinase 6	Homo sapiens (human)
cell division	Cyclin-dependent kinase 6	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 6	Homo sapiens (human)
hematopoietic stem cell differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
regulation of hematopoietic stem cell differentiation	Cyclin-dependent kinase 6	Homo sapiens (human)
regulation of cell motility	Cyclin-dependent kinase 6	Homo sapiens (human)
negative regulation of cellular senescence	Cyclin-dependent kinase 6	Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycle	Cyclin-dependent kinase 6	Homo sapiens (human)
response to organic substance	Cyclin-dependent kinase 6	Homo sapiens (human)
signal transduction	Cyclin-dependent kinase 6	Homo sapiens (human)
microtubule cytoskeleton organization	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuron migration	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synaptic transmission, dopaminergic	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
intracellular protein transport	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cell-matrix adhesion	Cyclin-dependent-like kinase 5	Homo sapiens (human)
chemical synaptic transmission	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synapse assembly	Cyclin-dependent-like kinase 5	Homo sapiens (human)
skeletal muscle tissue development	Cyclin-dependent-like kinase 5	Homo sapiens (human)
motor neuron axon guidance	Cyclin-dependent-like kinase 5	Homo sapiens (human)
visual learning	Cyclin-dependent-like kinase 5	Homo sapiens (human)
Schwann cell development	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synaptic vesicle exocytosis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of macroautophagy	Cyclin-dependent-like kinase 5	Homo sapiens (human)
phosphorylation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
peptidyl-serine phosphorylation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
peptidyl-threonine phosphorylation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
sensory perception of pain	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cerebellar cortex formation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
hippocampus development	Cyclin-dependent-like kinase 5	Homo sapiens (human)
layer formation in cerebral cortex	Cyclin-dependent-like kinase 5	Homo sapiens (human)
central nervous system neuron development	Cyclin-dependent-like kinase 5	Homo sapiens (human)
corpus callosum development	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuron differentiation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of cell migration	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of axon extension	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuron projection development	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of protein ubiquitination	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of synaptic plasticity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
receptor catabolic process	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synaptic transmission, glutamatergic	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein localization to synapse	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of apoptotic process	Cyclin-dependent-like kinase 5	Homo sapiens (human)
receptor clustering	Cyclin-dependent-like kinase 5	Homo sapiens (human)
positive regulation of neuron apoptotic process	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of cell cycle	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of proteolysis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of DNA-templated transcription	Cyclin-dependent-like kinase 5	Homo sapiens (human)
positive regulation of calcium ion-dependent exocytosis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
negative regulation of protein export from nucleus	Cyclin-dependent-like kinase 5	Homo sapiens (human)
behavioral response to cocaine	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of synaptic plasticity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synaptic vesicle endocytosis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
rhythmic process	Cyclin-dependent-like kinase 5	Homo sapiens (human)
axon extension	Cyclin-dependent-like kinase 5	Homo sapiens (human)
oligodendrocyte differentiation	Cyclin-dependent-like kinase 5	Homo sapiens (human)
dendrite morphogenesis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cell division	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuron apoptotic process	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of synaptic transmission, glutamatergic	Cyclin-dependent-like kinase 5	Homo sapiens (human)
excitatory postsynaptic potential	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of dendritic spine morphogenesis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
calcium ion import	Cyclin-dependent-like kinase 5	Homo sapiens (human)
positive regulation of protein targeting to membrane	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of protein localization to plasma membrane	Cyclin-dependent-like kinase 5	Homo sapiens (human)
regulation of synaptic vesicle recycling	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cellular response to amyloid-beta	Cyclin-dependent-like kinase 5	Homo sapiens (human)
axonogenesis	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synaptic vesicle transport	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 16	Homo sapiens (human)
exocytosis	Cyclin-dependent kinase 16	Homo sapiens (human)
spermatogenesis	Cyclin-dependent kinase 16	Homo sapiens (human)
positive regulation of autophagy	Cyclin-dependent kinase 16	Homo sapiens (human)
growth hormone secretion	Cyclin-dependent kinase 16	Homo sapiens (human)
neuron projection development	Cyclin-dependent kinase 16	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 16	Homo sapiens (human)
regulation of insulin secretion involved in cellular response to glucose stimulus	Cyclin-dependent kinase 16	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 17	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 17	Homo sapiens (human)
cellular response to leukemia inhibitory factor	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
canonical glycolysis	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
fructose 1,6-bisphosphate metabolic process	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
fructose 6-phosphate metabolic process	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
chemotaxis	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
signal transduction	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
heart development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
negative regulation of cell population proliferation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
positive regulation of gene expression	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
Schwann cell development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
cerebellar cortex formation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
keratinocyte differentiation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
thyroid gland development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
regulation of stress-activated MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
endodermal cell differentiation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
ERBB2-ERBB3 signaling pathway	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
myelination	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
type B pancreatic cell proliferation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
positive regulation of DNA-templated transcription	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
thymus development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
regulation of axon regeneration	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
cell motility	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
positive regulation of axonogenesis	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
Bergmann glial cell differentiation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
face development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
trachea formation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
epithelial cell proliferation involved in lung morphogenesis	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
placenta blood vessel development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
labyrinthine layer development	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
ERK1 and ERK2 cascade	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
positive regulation of protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
regulation of Golgi inheritance	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
cellular senescence	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
positive regulation of endodermal cell differentiation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
regulation of early endosome to late endosome transport	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
neuron differentiation	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
neuron migration	DNA topoisomerase 2-beta	Homo sapiens (human)
DNA topological change	DNA topoisomerase 2-beta	Homo sapiens (human)
axonogenesis	DNA topoisomerase 2-beta	Homo sapiens (human)
B cell differentiation	DNA topoisomerase 2-beta	Homo sapiens (human)
forebrain development	DNA topoisomerase 2-beta	Homo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	DNA topoisomerase 2-beta	Homo sapiens (human)
cellular response to hydrogen peroxide	DNA topoisomerase 2-beta	Homo sapiens (human)
cellular response to ATP	DNA topoisomerase 2-beta	Homo sapiens (human)
cellular senescence	DNA topoisomerase 2-beta	Homo sapiens (human)
positive regulation of double-strand break repair via nonhomologous end joining	DNA topoisomerase 2-beta	Homo sapiens (human)
sister chromatid segregation	DNA topoisomerase 2-beta	Homo sapiens (human)
resolution of meiotic recombination intermediates	DNA topoisomerase 2-beta	Homo sapiens (human)
regulation of cell growth	Protein kinase C theta type	Homo sapiens (human)
regulation of DNA-templated transcription	Protein kinase C theta type	Homo sapiens (human)
protein phosphorylation	Protein kinase C theta type	Homo sapiens (human)
membrane protein ectodomain proteolysis	Protein kinase C theta type	Homo sapiens (human)
inflammatory response	Protein kinase C theta type	Homo sapiens (human)
axon guidance	Protein kinase C theta type	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Protein kinase C theta type	Homo sapiens (human)
positive regulation of interleukin-17 production	Protein kinase C theta type	Homo sapiens (human)
positive regulation of interleukin-2 production	Protein kinase C theta type	Homo sapiens (human)
positive regulation of interleukin-4 production	Protein kinase C theta type	Homo sapiens (human)
intracellular signal transduction	Protein kinase C theta type	Homo sapiens (human)
CD4-positive, alpha-beta T cell proliferation	Protein kinase C theta type	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Protein kinase C theta type	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Protein kinase C theta type	Homo sapiens (human)
positive regulation of T cell activation	Protein kinase C theta type	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Protein kinase C theta type	Homo sapiens (human)
positive regulation of telomerase activity	Protein kinase C theta type	Homo sapiens (human)
cell chemotaxis	Protein kinase C theta type	Homo sapiens (human)
negative regulation of T cell apoptotic process	Protein kinase C theta type	Homo sapiens (human)
regulation of platelet aggregation	Protein kinase C theta type	Homo sapiens (human)
positive regulation of telomere capping	Protein kinase C theta type	Homo sapiens (human)
positive regulation of T-helper 17 type immune response	Protein kinase C theta type	Homo sapiens (human)
positive regulation of CD4-positive, alpha-beta T cell proliferation	Protein kinase C theta type	Homo sapiens (human)
positive regulation of T-helper 2 cell activation	Protein kinase C theta type	Homo sapiens (human)
peptidyl-serine phosphorylation	Protein kinase C theta type	Homo sapiens (human)
outflow tract septum morphogenesis	Activin receptor type-1	Homo sapiens (human)
branching involved in blood vessel morphogenesis	Activin receptor type-1	Homo sapiens (human)
in utero embryonic development	Activin receptor type-1	Homo sapiens (human)
gastrulation with mouth forming second	Activin receptor type-1	Homo sapiens (human)
mesoderm formation	Activin receptor type-1	Homo sapiens (human)
neural crest cell migration	Activin receptor type-1	Homo sapiens (human)
acute inflammatory response	Activin receptor type-1	Homo sapiens (human)
embryonic heart tube morphogenesis	Activin receptor type-1	Homo sapiens (human)
atrioventricular valve morphogenesis	Activin receptor type-1	Homo sapiens (human)
mitral valve morphogenesis	Activin receptor type-1	Homo sapiens (human)
endocardial cushion formation	Activin receptor type-1	Homo sapiens (human)
endocardial cushion fusion	Activin receptor type-1	Homo sapiens (human)
atrial septum primum morphogenesis	Activin receptor type-1	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Activin receptor type-1	Homo sapiens (human)
germ cell development	Activin receptor type-1	Homo sapiens (human)
determination of left/right symmetry	Activin receptor type-1	Homo sapiens (human)
negative regulation of signal transduction	Activin receptor type-1	Homo sapiens (human)
regulation of ossification	Activin receptor type-1	Homo sapiens (human)
positive regulation of cell migration	Activin receptor type-1	Homo sapiens (human)
positive regulation of bone mineralization	Activin receptor type-1	Homo sapiens (human)
BMP signaling pathway	Activin receptor type-1	Homo sapiens (human)
activin receptor signaling pathway	Activin receptor type-1	Homo sapiens (human)
negative regulation of activin receptor signaling pathway	Activin receptor type-1	Homo sapiens (human)
positive regulation of osteoblast differentiation	Activin receptor type-1	Homo sapiens (human)
positive regulation of DNA-templated transcription	Activin receptor type-1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Activin receptor type-1	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Activin receptor type-1	Homo sapiens (human)
smooth muscle cell differentiation	Activin receptor type-1	Homo sapiens (human)
pharyngeal system development	Activin receptor type-1	Homo sapiens (human)
positive regulation of SMAD protein signal transduction	Activin receptor type-1	Homo sapiens (human)
ventricular septum morphogenesis	Activin receptor type-1	Homo sapiens (human)
cardiac muscle cell fate commitment	Activin receptor type-1	Homo sapiens (human)
endocardial cushion cell fate commitment	Activin receptor type-1	Homo sapiens (human)
positive regulation of cardiac epithelial to mesenchymal transition	Activin receptor type-1	Homo sapiens (human)
cellular response to BMP stimulus	Activin receptor type-1	Homo sapiens (human)
positive regulation of determination of dorsal identity	Activin receptor type-1	Homo sapiens (human)
negative regulation of G1/S transition of mitotic cell cycle	Activin receptor type-1	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway	Activin receptor type-1	Homo sapiens (human)
dorsal/ventral pattern formation	Activin receptor type-1	Homo sapiens (human)
heart development	Activin receptor type-1	Homo sapiens (human)
protein phosphorylation	Activin receptor type-1	Homo sapiens (human)
cellular response to growth factor stimulus	Activin receptor type-1	Homo sapiens (human)
defense response	Macrophage-stimulating protein receptor	Homo sapiens (human)
signal transduction	Macrophage-stimulating protein receptor	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Macrophage-stimulating protein receptor	Homo sapiens (human)
single fertilization	Macrophage-stimulating protein receptor	Homo sapiens (human)
positive regulation of cell population proliferation	Macrophage-stimulating protein receptor	Homo sapiens (human)
response to virus	Macrophage-stimulating protein receptor	Homo sapiens (human)
macrophage colony-stimulating factor signaling pathway	Macrophage-stimulating protein receptor	Homo sapiens (human)
positive regulation of MAP kinase activity	Macrophage-stimulating protein receptor	Homo sapiens (human)
innate immune response	Macrophage-stimulating protein receptor	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Macrophage-stimulating protein receptor	Homo sapiens (human)
nervous system development	Macrophage-stimulating protein receptor	Homo sapiens (human)
cell migration	Macrophage-stimulating protein receptor	Homo sapiens (human)
phagocytosis	Macrophage-stimulating protein receptor	Homo sapiens (human)
positive regulation of kinase activity	Macrophage-stimulating protein receptor	Homo sapiens (human)
multicellular organism development	Macrophage-stimulating protein receptor	Homo sapiens (human)
positive regulation of macrophage chemotaxis	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of macrophage proliferation	Focal adhesion kinase 1	Homo sapiens (human)
angiogenesis	Focal adhesion kinase 1	Homo sapiens (human)
placenta development	Focal adhesion kinase 1	Homo sapiens (human)
regulation of protein phosphorylation	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of protein phosphorylation	Focal adhesion kinase 1	Homo sapiens (human)
heart morphogenesis	Focal adhesion kinase 1	Homo sapiens (human)
signal complex assembly	Focal adhesion kinase 1	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
integrin-mediated signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
axon guidance	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of cell population proliferation	Focal adhesion kinase 1	Homo sapiens (human)
regulation of cell shape	Focal adhesion kinase 1	Homo sapiens (human)
regulation of endothelial cell migration	Focal adhesion kinase 1	Homo sapiens (human)
regulation of epithelial cell migration	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of epithelial cell migration	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of epithelial to mesenchymal transition	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of fibroblast migration	Focal adhesion kinase 1	Homo sapiens (human)
cell migration	Focal adhesion kinase 1	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Focal adhesion kinase 1	Homo sapiens (human)
negative regulation of cell-cell adhesion	Focal adhesion kinase 1	Homo sapiens (human)
establishment of cell polarity	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of cell migration	Focal adhesion kinase 1	Homo sapiens (human)
regulation of cell adhesion mediated by integrin	Focal adhesion kinase 1	Homo sapiens (human)
detection of muscle stretch	Focal adhesion kinase 1	Homo sapiens (human)
netrin-activated signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Focal adhesion kinase 1	Homo sapiens (human)
regulation of cell population proliferation	Focal adhesion kinase 1	Homo sapiens (human)
negative regulation of apoptotic process	Focal adhesion kinase 1	Homo sapiens (human)
regulation of GTPase activity	Focal adhesion kinase 1	Homo sapiens (human)
regulation of osteoblast differentiation	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of protein kinase activity	Focal adhesion kinase 1	Homo sapiens (human)
protein autophosphorylation	Focal adhesion kinase 1	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
ephrin receptor signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
cell motility	Focal adhesion kinase 1	Homo sapiens (human)
regulation of cytoskeleton organization	Focal adhesion kinase 1	Homo sapiens (human)
regulation of focal adhesion assembly	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Focal adhesion kinase 1	Homo sapiens (human)
growth hormone receptor signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of wound healing	Focal adhesion kinase 1	Homo sapiens (human)
regulation of substrate adhesion-dependent cell spreading	Focal adhesion kinase 1	Homo sapiens (human)
positive regulation of ubiquitin-dependent protein catabolic process	Focal adhesion kinase 1	Homo sapiens (human)
negative regulation of anoikis	Focal adhesion kinase 1	Homo sapiens (human)
protein phosphorylation	Focal adhesion kinase 1	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Focal adhesion kinase 1	Homo sapiens (human)
regulation of cell adhesion	Focal adhesion kinase 1	Homo sapiens (human)
microtubule cytoskeleton organization	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of cell-matrix adhesion	Protein kinase C zeta type	Homo sapiens (human)
protein phosphorylation	Protein kinase C zeta type	Homo sapiens (human)
inflammatory response	Protein kinase C zeta type	Homo sapiens (human)
signal transduction	Protein kinase C zeta type	Homo sapiens (human)
cell surface receptor signaling pathway	Protein kinase C zeta type	Homo sapiens (human)
long-term memory	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of cell population proliferation	Protein kinase C zeta type	Homo sapiens (human)
cell migration	Protein kinase C zeta type	Homo sapiens (human)
peptidyl-serine phosphorylation	Protein kinase C zeta type	Homo sapiens (human)
establishment of cell polarity	Protein kinase C zeta type	Homo sapiens (human)
negative regulation of protein-containing complex assembly	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of interleukin-10 production	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of interleukin-13 production	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of interleukin-4 production	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of interleukin-5 production	Protein kinase C zeta type	Homo sapiens (human)
cellular response to insulin stimulus	Protein kinase C zeta type	Homo sapiens (human)
negative regulation of apoptotic process	Protein kinase C zeta type	Homo sapiens (human)
establishment or maintenance of epithelial cell apical/basal polarity	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of T-helper 2 cell differentiation	Protein kinase C zeta type	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of insulin receptor signaling pathway	Protein kinase C zeta type	Homo sapiens (human)
vesicle transport along microtubule	Protein kinase C zeta type	Homo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylation	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of protein transport	Protein kinase C zeta type	Homo sapiens (human)
membrane depolarization	Protein kinase C zeta type	Homo sapiens (human)
membrane hyperpolarization	Protein kinase C zeta type	Homo sapiens (human)
long-term synaptic potentiation	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Protein kinase C zeta type	Homo sapiens (human)
protein kinase C signaling	Protein kinase C zeta type	Homo sapiens (human)
protein localization to plasma membrane	Protein kinase C zeta type	Homo sapiens (human)
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	Protein kinase C zeta type	Homo sapiens (human)
neuron projection extension	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of excitatory postsynaptic potential	Protein kinase C zeta type	Homo sapiens (human)
positive regulation of T-helper 2 cell cytokine production	Protein kinase C zeta type	Homo sapiens (human)
intracellular signal transduction	Protein kinase C zeta type	Homo sapiens (human)
protein phosphorylation	Protein kinase C delta type	Homo sapiens (human)
apoptotic process	Protein kinase C delta type	Homo sapiens (human)
DNA damage response	Protein kinase C delta type	Homo sapiens (human)
signal transduction	Protein kinase C delta type	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stress	Protein kinase C delta type	Homo sapiens (human)
regulation of signaling receptor activity	Protein kinase C delta type	Homo sapiens (human)
immunoglobulin mediated immune response	Protein kinase C delta type	Homo sapiens (human)
peptidyl-serine phosphorylation	Protein kinase C delta type	Homo sapiens (human)
peptidyl-threonine phosphorylation	Protein kinase C delta type	Homo sapiens (human)
termination of signal transduction	Protein kinase C delta type	Homo sapiens (human)
negative regulation of actin filament polymerization	Protein kinase C delta type	Homo sapiens (human)
positive regulation of endodeoxyribonuclease activity	Protein kinase C delta type	Homo sapiens (human)
negative regulation of protein binding	Protein kinase C delta type	Homo sapiens (human)
activation of protein kinase activity	Protein kinase C delta type	Homo sapiens (human)
positive regulation of superoxide anion generation	Protein kinase C delta type	Homo sapiens (human)
regulation of actin cytoskeleton organization	Protein kinase C delta type	Homo sapiens (human)
negative regulation of glial cell apoptotic process	Protein kinase C delta type	Homo sapiens (human)
cellular response to UV	Protein kinase C delta type	Homo sapiens (human)
positive regulation of protein dephosphorylation	Protein kinase C delta type	Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosis	Protein kinase C delta type	Homo sapiens (human)
B cell proliferation	Protein kinase C delta type	Homo sapiens (human)
neutrophil activation	Protein kinase C delta type	Homo sapiens (human)
positive regulation of protein import into nucleus	Protein kinase C delta type	Homo sapiens (human)
defense response to bacterium	Protein kinase C delta type	Homo sapiens (human)
negative regulation of MAP kinase activity	Protein kinase C delta type	Homo sapiens (human)
regulation of mRNA stability	Protein kinase C delta type	Homo sapiens (human)
post-translational protein modification	Protein kinase C delta type	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Protein kinase C delta type	Homo sapiens (human)
negative regulation of inflammatory response	Protein kinase C delta type	Homo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylation	Protein kinase C delta type	Homo sapiens (human)
protein stabilization	Protein kinase C delta type	Homo sapiens (human)
negative regulation of filopodium assembly	Protein kinase C delta type	Homo sapiens (human)
cell chemotaxis	Protein kinase C delta type	Homo sapiens (human)
cellular response to hydrogen peroxide	Protein kinase C delta type	Homo sapiens (human)
cellular response to hydroperoxide	Protein kinase C delta type	Homo sapiens (human)
negative regulation of platelet aggregation	Protein kinase C delta type	Homo sapiens (human)
cellular senescence	Protein kinase C delta type	Homo sapiens (human)
positive regulation of phospholipid scramblase activity	Protein kinase C delta type	Homo sapiens (human)
cellular response to angiotensin	Protein kinase C delta type	Homo sapiens (human)
regulation of ceramide biosynthetic process	Protein kinase C delta type	Homo sapiens (human)
positive regulation of ceramide biosynthetic process	Protein kinase C delta type	Homo sapiens (human)
positive regulation of glucosylceramide catabolic process	Protein kinase C delta type	Homo sapiens (human)
positive regulation of sphingomyelin catabolic process	Protein kinase C delta type	Homo sapiens (human)
positive regulation of apoptotic signaling pathway	Protein kinase C delta type	Homo sapiens (human)
intracellular signal transduction	Protein kinase C delta type	Homo sapiens (human)
neutrophil homeostasis	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of type III hypersensitivity	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of type I hypersensitivity	Tyrosine-protein kinase BTK	Homo sapiens (human)
adaptive immune response	Tyrosine-protein kinase BTK	Homo sapiens (human)
B cell affinity maturation	Tyrosine-protein kinase BTK	Homo sapiens (human)
histamine secretion by mast cell	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of immunoglobulin production	Tyrosine-protein kinase BTK	Homo sapiens (human)
regulation of B cell cytokine production	Tyrosine-protein kinase BTK	Homo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway	Tyrosine-protein kinase BTK	Homo sapiens (human)
regulation of B cell apoptotic process	Tyrosine-protein kinase BTK	Homo sapiens (human)
protein phosphorylation	Tyrosine-protein kinase BTK	Homo sapiens (human)
mesoderm development	Tyrosine-protein kinase BTK	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Tyrosine-protein kinase BTK	Homo sapiens (human)
calcium-mediated signaling	Tyrosine-protein kinase BTK	Homo sapiens (human)
proteoglycan catabolic process	Tyrosine-protein kinase BTK	Homo sapiens (human)
negative regulation of B cell proliferation	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of B cell proliferation	Tyrosine-protein kinase BTK	Homo sapiens (human)
response to lipopolysaccharide	Tyrosine-protein kinase BTK	Homo sapiens (human)
negative regulation of interleukin-10 production	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of interleukin-6 production	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of tumor necrosis factor production	Tyrosine-protein kinase BTK	Homo sapiens (human)
cellular response to reactive oxygen species	Tyrosine-protein kinase BTK	Homo sapiens (human)
intracellular signal transduction	Tyrosine-protein kinase BTK	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Tyrosine-protein kinase BTK	Homo sapiens (human)
B cell activation	Tyrosine-protein kinase BTK	Homo sapiens (human)
innate immune response	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of B cell differentiation	Tyrosine-protein kinase BTK	Homo sapiens (human)
cell maturation	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of phagocytosis	Tyrosine-protein kinase BTK	Homo sapiens (human)
B cell receptor signaling pathway	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Tyrosine-protein kinase BTK	Homo sapiens (human)
monocyte proliferation	Tyrosine-protein kinase BTK	Homo sapiens (human)
cellular response to molecule of fungal origin	Tyrosine-protein kinase BTK	Homo sapiens (human)
apoptotic signaling pathway	Tyrosine-protein kinase BTK	Homo sapiens (human)
cellular response to interleukin-7	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of interleukin-17A production	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assembly	Tyrosine-protein kinase BTK	Homo sapiens (human)
positive regulation of synoviocyte proliferation	Tyrosine-protein kinase BTK	Homo sapiens (human)
eosinophil homeostasis	Tyrosine-protein kinase BTK	Homo sapiens (human)
T cell receptor signaling pathway	Tyrosine-protein kinase BTK	Homo sapiens (human)
endocytosis	Activated CDC42 kinase 1	Homo sapiens (human)
cell surface receptor signaling pathway	Activated CDC42 kinase 1	Homo sapiens (human)
small GTPase-mediated signal transduction	Activated CDC42 kinase 1	Homo sapiens (human)
phosphorylation	Activated CDC42 kinase 1	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Activated CDC42 kinase 1	Homo sapiens (human)
regulation of clathrin-dependent endocytosis	Activated CDC42 kinase 1	Homo sapiens (human)
protein phosphorylation	Activated CDC42 kinase 1	Homo sapiens (human)
regulation of cell growth	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
regulation of cell-matrix adhesion	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
cell adhesion	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
embryo implantation	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
lactation	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
cell population proliferation	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
negative regulation of cell population proliferation	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
regulation of extracellular matrix disassembly	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
smooth muscle cell migration	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
collagen-activated tyrosine kinase receptor signaling pathway	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
ear development	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
wound healing, spreading of cells	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
protein autophosphorylation	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
branching involved in mammary gland duct morphogenesis	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
mammary gland alveolus development	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
smooth muscle cell-matrix adhesion	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
axon development	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
neuron projection extension	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
multicellular organism development	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
positive regulation of kinase activity	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
positive regulation of neuron projection development	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
regulation of heart rate by cardiac conduction	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
regulation of heart rate by hormone	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
regulation of membrane potential	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
positive regulation of DNA-templated transcription	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
potassium ion homeostasis	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
cardiac muscle contraction	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
regulation of membrane repolarization	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
regulation of ventricular cardiac muscle cell membrane repolarization	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
cellular response to xenobiotic stimulus	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
potassium ion transmembrane transport	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
ventricular cardiac muscle cell action potential	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
membrane repolarization	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
membrane depolarization during action potential	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
membrane repolarization during action potential	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
membrane repolarization during cardiac muscle cell action potential	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
regulation of heart rate by cardiac conduction	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
potassium ion export across plasma membrane	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
membrane repolarization during ventricular cardiac muscle cell action potential	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
regulation of potassium ion transmembrane transport	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
negative regulation of potassium ion transmembrane transport	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
positive regulation of potassium ion transmembrane transport	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
negative regulation of potassium ion export across plasma membrane	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
potassium ion import across plasma membrane	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
vesicle targeting	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
immune response	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
positive regulation of JUN kinase activity	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
innate immune response	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
positive regulation of JNK cascade	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
cell morphogenesis	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of protein phosphorylation	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of protein binding	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein stabilization	Serine/threonine-protein kinase 4	Homo sapiens (human)
branching involved in blood vessel morphogenesis	Serine/threonine-protein kinase 4	Homo sapiens (human)
neural tube formation	Serine/threonine-protein kinase 4	Homo sapiens (human)
endocardium development	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein import into nucleus	Serine/threonine-protein kinase 4	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase 4	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase 4	Homo sapiens (human)
central nervous system development	Serine/threonine-protein kinase 4	Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptors	Serine/threonine-protein kinase 4	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase 4	Homo sapiens (human)
keratinocyte differentiation	Serine/threonine-protein kinase 4	Homo sapiens (human)
organ growth	Serine/threonine-protein kinase 4	Homo sapiens (human)
hippo signaling	Serine/threonine-protein kinase 4	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of apoptotic process	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of fat cell differentiation	Serine/threonine-protein kinase 4	Homo sapiens (human)
negative regulation of organ growth	Serine/threonine-protein kinase 4	Homo sapiens (human)
epithelial cell proliferation	Serine/threonine-protein kinase 4	Homo sapiens (human)
negative regulation of epithelial cell proliferation	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein tetramerization	Serine/threonine-protein kinase 4	Homo sapiens (human)
canonical Wnt signaling pathway	Serine/threonine-protein kinase 4	Homo sapiens (human)
primitive hemopoiesis	Serine/threonine-protein kinase 4	Homo sapiens (human)
cell differentiation involved in embryonic placenta development	Serine/threonine-protein kinase 4	Homo sapiens (human)
regulation of cell differentiation involved in embryonic placenta development	Serine/threonine-protein kinase 4	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Serine/threonine-protein kinase 4	Homo sapiens (human)
hepatocyte apoptotic process	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of hepatocyte apoptotic process	Serine/threonine-protein kinase 4	Homo sapiens (human)
positive regulation of substrate-dependent cell migration, cell attachment to substrate	Serine/threonine-protein kinase 4	Homo sapiens (human)
regulation of MAPK cascade	Serine/threonine-protein kinase 4	Homo sapiens (human)
lipid droplet disassembly	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
response to hypoxia	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
glucose metabolic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
chromatin remodeling	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein phosphorylation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
fatty acid biosynthetic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cholesterol biosynthetic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
autophagy	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
signal transduction	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of cell population proliferation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
lipid biosynthetic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
response to UV	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cold acclimation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
response to gamma radiation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of autophagy	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of gene expression	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of gene expression	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
response to activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
bile acid and bile salt transport	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
Wnt signaling pathway	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
fatty acid oxidation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
response to caffeine	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to nutrient levels	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of TOR signaling	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
regulation of peptidyl-serine phosphorylation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to oxidative stress	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
bile acid signaling pathway	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to glucose starvation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
glucose homeostasis	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
regulation of circadian rhythm	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of apoptotic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
response to estrogen	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of cholesterol biosynthetic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of glycolytic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of DNA-templated transcription	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of glucosylceramide biosynthetic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
rhythmic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of skeletal muscle tissue development	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of lipid catabolic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
fatty acid homeostasis	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
regulation of vesicle-mediated transport	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
motor behavior	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
CAMKK-AMPK signaling cascade	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
regulation of stress granule assembly	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
neuron cellular homeostasis	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to hydrogen peroxide	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
regulation of microtubule cytoskeleton organization	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to calcium ion	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to glucose stimulus	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to ethanol	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to prostaglandin E stimulus	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to organonitrogen compound	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to hypoxia	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cellular response to xenobiotic stimulus	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
energy homeostasis	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
regulation of bile acid secretion	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of mitochondrial transcription	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of protein localization	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of hepatocyte apoptotic process	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of protein targeting to mitochondrion	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of adipose tissue development	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of TORC1 signaling	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of tubulin deacetylation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein localization to lipid droplet	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
positive regulation of peptidyl-lysine acetylation	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
MAPK cascade	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
signal transduction	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
heart development	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
positive regulation of cell growth	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of interleukin-8 production	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of heterotypic cell-cell adhesion	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of smooth muscle cell apoptotic process	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
positive regulation of MAP kinase activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
insulin-like growth factor receptor signaling pathway	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
positive regulation of epithelial cell proliferation	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
positive regulation of protein metabolic process	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of response to cytokine stimulus	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
ERK5 cascade	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
cellular response to growth factor stimulus	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
cellular response to laminar fluid shear stress	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of cell migration involved in sprouting angiogenesis	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of chemokine (C-X-C motif) ligand 2 production	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase 7	Homo sapiens (human)
signal transduction	Mitogen-activated protein kinase 7	Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathway	Mitogen-activated protein kinase 7	Homo sapiens (human)
cell differentiation	Mitogen-activated protein kinase 7	Homo sapiens (human)
calcineurin-NFAT signaling cascade	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of heterotypic cell-cell adhesion	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of smooth muscle cell apoptotic process	Mitogen-activated protein kinase 7	Homo sapiens (human)
regulation of angiogenesis	Mitogen-activated protein kinase 7	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of inflammatory response	Mitogen-activated protein kinase 7	Homo sapiens (human)
positive regulation of protein metabolic process	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of response to cytokine stimulus	Mitogen-activated protein kinase 7	Homo sapiens (human)
cellular response to hydrogen peroxide	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of calcineurin-NFAT signaling cascade	Mitogen-activated protein kinase 7	Homo sapiens (human)
cellular response to growth factor stimulus	Mitogen-activated protein kinase 7	Homo sapiens (human)
cellular response to laminar fluid shear stress	Mitogen-activated protein kinase 7	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of endothelial cell apoptotic process	Mitogen-activated protein kinase 7	Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	Mitogen-activated protein kinase 7	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase 7	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathway	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cardiac muscle hypertrophy	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
negative regulation of protein kinase activity	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
phosphorylation	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
adherens junction assembly	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
negative regulation of apoptotic process	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
regulation of cytoskeleton organization	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
negative regulation of stress fiber assembly	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
dendritic spine development	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
bicellular tight junction assembly	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cellular response to organic cyclic compound	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein localization to cell-cell junction	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathway	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
regulation of axonogenesis	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
regulation of MAPK cascade	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
positive regulation of protein binding	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein stabilization	Serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	Serine/threonine-protein kinase 3	Homo sapiens (human)
neural tube formation	Serine/threonine-protein kinase 3	Homo sapiens (human)
endocardium development	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein import into nucleus	Serine/threonine-protein kinase 3	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase 3	Homo sapiens (human)
JNK cascade	Serine/threonine-protein kinase 3	Homo sapiens (human)
central nervous system development	Serine/threonine-protein kinase 3	Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptors	Serine/threonine-protein kinase 3	Homo sapiens (human)
organ growth	Serine/threonine-protein kinase 3	Homo sapiens (human)
hippo signaling	Serine/threonine-protein kinase 3	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of apoptotic process	Serine/threonine-protein kinase 3	Homo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transduction	Serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of fat cell differentiation	Serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of JNK cascade	Serine/threonine-protein kinase 3	Homo sapiens (human)
negative regulation of organ growth	Serine/threonine-protein kinase 3	Homo sapiens (human)
epithelial cell proliferation	Serine/threonine-protein kinase 3	Homo sapiens (human)
negative regulation of epithelial cell proliferation	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein tetramerization	Serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Serine/threonine-protein kinase 3	Homo sapiens (human)
canonical Wnt signaling pathway	Serine/threonine-protein kinase 3	Homo sapiens (human)
primitive hemopoiesis	Serine/threonine-protein kinase 3	Homo sapiens (human)
cell differentiation involved in embryonic placenta development	Serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of cell differentiation involved in embryonic placenta development	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein localization to centrosome	Serine/threonine-protein kinase 3	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Serine/threonine-protein kinase 3	Homo sapiens (human)
hepatocyte apoptotic process	Serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	Serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of MAPK cascade	Serine/threonine-protein kinase 3	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
Fc-epsilon receptor signaling pathway	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
cellular response to mechanical stimulus	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
epithelial to mesenchymal transition	Rho-associated protein kinase 1	Homo sapiens (human)
aortic valve morphogenesis	Rho-associated protein kinase 1	Homo sapiens (human)
apical constriction	Rho-associated protein kinase 1	Homo sapiens (human)
protein phosphorylation	Rho-associated protein kinase 1	Homo sapiens (human)
smooth muscle contraction	Rho-associated protein kinase 1	Homo sapiens (human)
leukocyte cell-cell adhesion	Rho-associated protein kinase 1	Homo sapiens (human)
signal transduction	Rho-associated protein kinase 1	Homo sapiens (human)
canonical NF-kappaB signal transduction	Rho-associated protein kinase 1	Homo sapiens (human)
Rho protein signal transduction	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of autophagy	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of cardiac muscle hypertrophy	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of gene expression	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of phosphatase activity	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of angiogenesis	Rho-associated protein kinase 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Rho-associated protein kinase 1	Homo sapiens (human)
membrane to membrane docking	Rho-associated protein kinase 1	Homo sapiens (human)
actin cytoskeleton organization	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of cell adhesion	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of cell migration	Rho-associated protein kinase 1	Homo sapiens (human)
cortical actin cytoskeleton organization	Rho-associated protein kinase 1	Homo sapiens (human)
neuron projection development	Rho-associated protein kinase 1	Homo sapiens (human)
bleb assembly	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of protein binding	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of actin cytoskeleton organization	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of dephosphorylation	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of myosin-light-chain-phosphatase activity	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of phosphorylation	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of MAPK cascade	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of keratinocyte differentiation	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of neuron differentiation	Rho-associated protein kinase 1	Homo sapiens (human)
leukocyte migration	Rho-associated protein kinase 1	Homo sapiens (human)
leukocyte tethering or rolling	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of membrane protein ectodomain proteolysis	Rho-associated protein kinase 1	Homo sapiens (human)
myoblast migration	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of stress fiber assembly	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of focal adhesion assembly	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of focal adhesion assembly	Rho-associated protein kinase 1	Homo sapiens (human)
mRNA destabilization	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of biomineral tissue development	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of microtubule cytoskeleton organization	Rho-associated protein kinase 1	Homo sapiens (human)
response to transforming growth factor beta	Rho-associated protein kinase 1	Homo sapiens (human)
protein localization to plasma membrane	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of synapse maturation	Rho-associated protein kinase 1	Homo sapiens (human)
podocyte cell migration	Rho-associated protein kinase 1	Homo sapiens (human)
motor neuron apoptotic process	Rho-associated protein kinase 1	Homo sapiens (human)
blood vessel diameter maintenance	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of angiotensin-activated signaling pathway	Rho-associated protein kinase 1	Homo sapiens (human)
neuron projection arborization	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of amyloid-beta clearance	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of synaptic vesicle endocytosis	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of amyloid-beta formation	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of amyloid precursor protein catabolic process	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of establishment of endothelial barrier	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of bicellular tight junction assembly	Rho-associated protein kinase 1	Homo sapiens (human)
positive regulation of connective tissue replacement	Rho-associated protein kinase 1	Homo sapiens (human)
response to angiotensin	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of establishment of cell polarity	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of cell motility	Rho-associated protein kinase 1	Homo sapiens (human)
negative regulation of motor neuron apoptotic process	Rho-associated protein kinase 1	Homo sapiens (human)
regulation of cell junction assembly	Rho-associated protein kinase 1	Homo sapiens (human)
mitotic cytokinesis	Rho-associated protein kinase 1	Homo sapiens (human)
embryonic morphogenesis	Rho-associated protein kinase 1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Rho-associated protein kinase 1	Homo sapiens (human)
actomyosin structure organization	Rho-associated protein kinase 1	Homo sapiens (human)
protein phosphorylation	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
protein autophosphorylation	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
nuclear membrane disassembly	Serine/threonine-protein kinase ATR	Homo sapiens (human)
DNA damage checkpoint signaling	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nucleobase-containing compound metabolic process	Serine/threonine-protein kinase ATR	Homo sapiens (human)
DNA replication	Serine/threonine-protein kinase ATR	Homo sapiens (human)
double-strand break repair	Serine/threonine-protein kinase ATR	Homo sapiens (human)
chromatin remodeling	Serine/threonine-protein kinase ATR	Homo sapiens (human)
DNA damage response	Serine/threonine-protein kinase ATR	Homo sapiens (human)
negative regulation of DNA replication	Serine/threonine-protein kinase ATR	Homo sapiens (human)
response to xenobiotic stimulus	Serine/threonine-protein kinase ATR	Homo sapiens (human)
response to mechanical stimulus	Serine/threonine-protein kinase ATR	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase ATR	Homo sapiens (human)
replication fork processing	Serine/threonine-protein kinase ATR	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Serine/threonine-protein kinase ATR	Homo sapiens (human)
cellular response to UV	Serine/threonine-protein kinase ATR	Homo sapiens (human)
interstrand cross-link repair	Serine/threonine-protein kinase ATR	Homo sapiens (human)
positive regulation of DNA damage response, signal transduction by p53 class mediator	Serine/threonine-protein kinase ATR	Homo sapiens (human)
mitotic G2/M transition checkpoint	Serine/threonine-protein kinase ATR	Homo sapiens (human)
response to arsenic-containing substance	Serine/threonine-protein kinase ATR	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase ATR	Homo sapiens (human)
protein localization to chromosome, telomeric region	Serine/threonine-protein kinase ATR	Homo sapiens (human)
cellular response to gamma radiation	Serine/threonine-protein kinase ATR	Homo sapiens (human)
replicative senescence	Serine/threonine-protein kinase ATR	Homo sapiens (human)
establishment of RNA localization to telomere	Serine/threonine-protein kinase ATR	Homo sapiens (human)
establishment of protein-containing complex localization to telomere	Serine/threonine-protein kinase ATR	Homo sapiens (human)
regulation of cellular response to heat	Serine/threonine-protein kinase ATR	Homo sapiens (human)
positive regulation of telomerase catalytic core complex assembly	Serine/threonine-protein kinase ATR	Homo sapiens (human)
regulation of double-strand break repair	Serine/threonine-protein kinase ATR	Homo sapiens (human)
DNA repair	Serine/threonine-protein kinase ATR	Homo sapiens (human)
telomere maintenance	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nervous system development	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
regulation of neuron projection development	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
regulation of skeletal muscle adaptation	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
insulin secretion	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
cell differentiation	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
regulation of calcium ion transport	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
regulation of cell growth	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of the force of heart contraction	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of membrane depolarization	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
protein phosphorylation	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of heart contraction	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
positive regulation of cardiac muscle hypertrophy	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of cell communication by electrical coupling	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic process	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
peptidyl-serine phosphorylation	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
peptidyl-threonine phosphorylation	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
endoplasmic reticulum calcium ion homeostasis	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
protein autophosphorylation	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
relaxation of cardiac muscle	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of ryanodine-sensitive calcium-release channel activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of cellular localization	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
cellular response to calcium ion	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
cardiac muscle cell contraction	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of heart rate by cardiac conduction	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of cardiac muscle cell action potential	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of cardiac muscle cell action potential involved in regulation of contraction	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of cell communication by electrical coupling involved in cardiac conduction	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of relaxation of cardiac muscle	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
negative regulation of sodium ion transmembrane transport	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
negative regulation of sodium ion transmembrane transporter activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
chromatin remodeling	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein phosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
nervous system development	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
circadian rhythm	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
peptidyl-serine phosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
peptidyl-threonine phosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
negative regulation of microtubule polymerization	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
positive regulation of RNA splicing	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
amyloid-beta formation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
peptidyl-serine autophosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediator	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein autophosphorylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
negative regulation of mRNA splicing, via spliceosome	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
negative regulation of DNA methylation-dependent heterochromatin formation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
positive regulation of protein deacetylation	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
positive regulation of DNA-templated transcription	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Activin receptor type-2B	Homo sapiens (human)
gastrulation with mouth forming second	Activin receptor type-2B	Homo sapiens (human)
kidney development	Activin receptor type-2B	Homo sapiens (human)
lymphangiogenesis	Activin receptor type-2B	Homo sapiens (human)
blood vessel remodeling	Activin receptor type-2B	Homo sapiens (human)
regulation of DNA-templated transcription	Activin receptor type-2B	Homo sapiens (human)
signal transduction	Activin receptor type-2B	Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathway	Activin receptor type-2B	Homo sapiens (human)
determination of left/right symmetry	Activin receptor type-2B	Homo sapiens (human)
mesoderm development	Activin receptor type-2B	Homo sapiens (human)
heart development	Activin receptor type-2B	Homo sapiens (human)
response to glucose	Activin receptor type-2B	Homo sapiens (human)
post-embryonic development	Activin receptor type-2B	Homo sapiens (human)
anterior/posterior pattern specification	Activin receptor type-2B	Homo sapiens (human)
insulin secretion	Activin receptor type-2B	Homo sapiens (human)
lung development	Activin receptor type-2B	Homo sapiens (human)
positive regulation of bone mineralization	Activin receptor type-2B	Homo sapiens (human)
BMP signaling pathway	Activin receptor type-2B	Homo sapiens (human)
pancreas development	Activin receptor type-2B	Homo sapiens (human)
activin receptor signaling pathway	Activin receptor type-2B	Homo sapiens (human)
positive regulation of activin receptor signaling pathway	Activin receptor type-2B	Homo sapiens (human)
organ growth	Activin receptor type-2B	Homo sapiens (human)
odontogenesis of dentin-containing tooth	Activin receptor type-2B	Homo sapiens (human)
positive regulation of osteoblast differentiation	Activin receptor type-2B	Homo sapiens (human)
embryonic foregut morphogenesis	Activin receptor type-2B	Homo sapiens (human)
skeletal system morphogenesis	Activin receptor type-2B	Homo sapiens (human)
roof of mouth development	Activin receptor type-2B	Homo sapiens (human)
lymphatic endothelial cell differentiation	Activin receptor type-2B	Homo sapiens (human)
artery development	Activin receptor type-2B	Homo sapiens (human)
venous blood vessel development	Activin receptor type-2B	Homo sapiens (human)
retina vasculature development in camera-type eye	Activin receptor type-2B	Homo sapiens (human)
negative regulation of cold-induced thermogenesis	Activin receptor type-2B	Homo sapiens (human)
cellular response to growth factor stimulus	Activin receptor type-2B	Homo sapiens (human)
protein phosphorylation	Activin receptor type-2B	Homo sapiens (human)
outflow tract septum morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
atrioventricular valve morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cardiac muscle tissue development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
pharyngeal arch artery morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of gene expression	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of SMAD protein signal transduction	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
osteoblast differentiation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
mesoderm formation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
maternal placenta development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
endothelial cell proliferation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
lymphangiogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
blood vessel remodeling	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
chondrocyte development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of systemic arterial blood pressure	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
outflow tract morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
aortic valve development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
pulmonary valve development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
mitral valve morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
tricuspid valve morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
endocardial cushion development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of cell proliferation involved in heart valve morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathway	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cellular response to starvation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
anterior/posterior pattern specification	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of epithelial cell migration	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
regulation of lung blood pressure	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
proteoglycan biosynthetic process	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of cell growth	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of bone mineralization	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
BMP signaling pathway	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
activin receptor signaling pathway	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
regulation of cell population proliferation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of osteoblast differentiation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of ossification	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of vasoconstriction	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
lung alveolus development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of smooth muscle cell proliferation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of axon extension involved in axon guidance	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of muscle cell differentiation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
limb development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
endochondral bone morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of SMAD protein signal transduction	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
ventricular septum morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
atrial septum morphogenesis	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
lung vasculature development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
lymphatic endothelial cell differentiation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
artery development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
venous blood vessel development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
positive regulation of cartilage development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
retina vasculature development in camera-type eye	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cellular response to BMP stimulus	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
endothelial cell apoptotic process	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
negative regulation of chondrocyte proliferation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
semi-lunar valve development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cellular response to growth factor stimulus	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
blood vessel development	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
protein phosphorylation	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
protein phosphorylation	Protein-tyrosine kinase 6	Homo sapiens (human)
tyrosine phosphorylation of STAT protein	Protein-tyrosine kinase 6	Homo sapiens (human)
positive regulation of neuron projection development	Protein-tyrosine kinase 6	Homo sapiens (human)
cell migration	Protein-tyrosine kinase 6	Homo sapiens (human)
ERBB2 signaling pathway	Protein-tyrosine kinase 6	Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT protein	Protein-tyrosine kinase 6	Homo sapiens (human)
positive regulation of DNA replication	Protein-tyrosine kinase 6	Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathway	Protein-tyrosine kinase 6	Homo sapiens (human)
positive regulation of cell cycle	Protein-tyrosine kinase 6	Homo sapiens (human)
negative regulation of growth	Protein-tyrosine kinase 6	Homo sapiens (human)
protein autophosphorylation	Protein-tyrosine kinase 6	Homo sapiens (human)
intestinal epithelial cell differentiation	Protein-tyrosine kinase 6	Homo sapiens (human)
negative regulation of protein tyrosine kinase activity	Protein-tyrosine kinase 6	Homo sapiens (human)
cellular response to retinoic acid	Protein-tyrosine kinase 6	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Protein-tyrosine kinase 6	Homo sapiens (human)
innate immune response	Protein-tyrosine kinase 6	Homo sapiens (human)
cell differentiation	Protein-tyrosine kinase 6	Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STAT	Protein-tyrosine kinase 6	Homo sapiens (human)
protein phosphorylation	cGMP-dependent protein kinase 1	Homo sapiens (human)
neuron migration	cGMP-dependent protein kinase 1	Homo sapiens (human)
signal transduction	cGMP-dependent protein kinase 1	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	cGMP-dependent protein kinase 1	Homo sapiens (human)
spermatid development	cGMP-dependent protein kinase 1	Homo sapiens (human)
negative regulation of inositol phosphate biosynthetic process	cGMP-dependent protein kinase 1	Homo sapiens (human)
negative regulation of glutamate secretion	cGMP-dependent protein kinase 1	Homo sapiens (human)
dendrite development	cGMP-dependent protein kinase 1	Homo sapiens (human)
cGMP-mediated signaling	cGMP-dependent protein kinase 1	Homo sapiens (human)
cerebellum development	cGMP-dependent protein kinase 1	Homo sapiens (human)
actin cytoskeleton organization	cGMP-dependent protein kinase 1	Homo sapiens (human)
forebrain development	cGMP-dependent protein kinase 1	Homo sapiens (human)
positive regulation of circadian rhythm	cGMP-dependent protein kinase 1	Homo sapiens (human)
regulation of GTPase activity	cGMP-dependent protein kinase 1	Homo sapiens (human)
collateral sprouting	cGMP-dependent protein kinase 1	Homo sapiens (human)
relaxation of vascular associated smooth muscle	cGMP-dependent protein kinase 1	Homo sapiens (human)
cell growth involved in cardiac muscle cell development	cGMP-dependent protein kinase 1	Homo sapiens (human)
negative regulation of platelet aggregation	cGMP-dependent protein kinase 1	Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell proliferation	cGMP-dependent protein kinase 1	Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell migration	cGMP-dependent protein kinase 1	Homo sapiens (human)
regulation of testosterone biosynthetic process	cGMP-dependent protein kinase 1	Homo sapiens (human)
protein kinase A signaling	cGMP-dependent protein kinase 1	Homo sapiens (human)
alternative mRNA splicing, via spliceosome	Cyclin-dependent kinase 13	Homo sapiens (human)
regulation of signal transduction	Cyclin-dependent kinase 13	Homo sapiens (human)
hemopoiesis	Cyclin-dependent kinase 13	Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase II	Cyclin-dependent kinase 13	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 13	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 13	Homo sapiens (human)
negative regulation of stem cell differentiation	Cyclin-dependent kinase 13	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 13	Homo sapiens (human)
protein phosphorylation	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
nucleocytoplasmic transport	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
signal transduction	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
nervous system development	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of neuron projection development	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
cell differentiation	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
negative regulation of protein binding	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
regulation of protein localization	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
intracellular signal transduction	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
regulation of protein binding	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of protein export from nucleus	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
regulation of muscle cell differentiation	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of muscle cell differentiation	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of synapse structural plasticity	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusion	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of dendritic spine development	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
positive regulation of protein serine/threonine kinase activity	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
immune response	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
gene expression	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
positive regulation of lipid storage	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
positive regulation of type I interferon production	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
response to interferon-beta	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
regulation of protein-containing complex assembly	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
mRNA stabilization	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
defense response to virus	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
type I interferon-mediated signaling pathway	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
positive regulation of type I interferon-mediated signaling pathway	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
interleukin-17-mediated signaling pathway	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
cellular response to virus	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
peptidyl-serine phosphorylation	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
MAPK cascade	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
oocyte maturation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to hypoxia	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of cell-matrix adhesion	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
sprouting angiogenesis	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
adaptive immune response	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
marginal zone B cell differentiation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to ischemia	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein phosphorylation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
apoptotic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cellular defense response	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
signal transduction	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cell surface receptor signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
signal complex assembly	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
integrin-mediated signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of cell population proliferation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of cell population proliferation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of cell shape	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to xenobiotic stimulus	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to mechanical stimulus	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to hormone	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to glucose	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of endothelial cell migration	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of muscle cell apoptotic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of macrophage chemotaxis	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of neuron projection development	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
glial cell proliferation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of cell adhesion	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of cell growth	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of cell migration	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of bone mineralization	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of actin filament polymerization	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cortical cytoskeleton organization	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
neuron projection development	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of actin cytoskeleton organization	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
tumor necrosis factor-mediated signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
ionotropic glutamate receptor signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to immobilization stress	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
peptidyl-tyrosine autophosphorylation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to cocaine	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to hydrogen peroxide	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
activation of Janus kinase activity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of apoptotic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
stress fiber assembly	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to cation stress	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of potassium ion transport	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of neuron apoptotic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
blood vessel endothelial cell migration	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of nitric oxide biosynthetic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
bone resorption	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to ethanol	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
negative regulation of myeloid cell differentiation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of translation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of angiogenesis	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of protein kinase activity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of JNK cascade	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein autophosphorylation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
focal adhesion assembly	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of synaptic plasticity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to cAMP	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
response to calcium ion	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergic	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
long-term synaptic potentiation	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
long-term synaptic depression	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein-containing complex assembly	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
chemokine-mediated signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cellular response to retinoic acid	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cellular response to fluid shear stress	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
endothelin receptor signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of postsynaptic density assembly	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmission	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
regulation of ubiquitin-dependent protein catabolic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of ubiquitin-dependent protein catabolic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of excitatory postsynaptic potential	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of B cell chemotaxis	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
positive regulation of DNA biosynthetic process	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
epidermal growth factor receptor signaling pathway	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
apoptotic process	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
cell population proliferation	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stress	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
hemopoiesis	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
positive regulation of apoptotic process	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
protein autophosphorylation	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
neural precursor cell proliferation	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
protein phosphorylation	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
mitotic sister chromatid segregation	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
DNA repair	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
sister chromatid cohesion	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
mitotic sister chromatid cohesion	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
response to radiation	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
establishment of mitotic sister chromatid cohesion	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
establishment of meiotic sister chromatid cohesion	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
somatic stem cell population maintenance	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
cell division	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
meiotic cell cycle	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
response to DNA damage checkpoint signaling	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
mitotic spindle assembly	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
double-strand break repair via homologous recombination	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
chromatin remodeling	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
negative regulation of gene expression	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
regulation of cell fate specification	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
negative regulation of DNA-templated transcription	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
positive regulation of DNA-templated transcription	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
regulation of synapse assembly	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
terminal button organization	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
regulation of stem cell differentiation	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
microtubule cytoskeleton organization	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuron migration	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuron cell-cell adhesion	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
axon guidance	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
axonal fasciculation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
brain development	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
embryo development ending in birth or egg hatching	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
regulation of macroautophagy	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cerebellum development	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
superior olivary nucleus maturation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
hippocampus development	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
layer formation in cerebral cortex	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuron differentiation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
positive regulation of microtubule polymerization	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuron projection development	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
regulation of actin cytoskeleton organization	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
ionotropic glutamate receptor signaling pathway	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
positive regulation of neuron apoptotic process	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
regulation of neuron differentiation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
negative regulation of DNA-templated transcription	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
ephrin receptor signaling pathway	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
rhythmic process	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
regulation of dendritic spine morphogenesis	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
G1 to G0 transition involved in cell differentiation	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
positive regulation of protein targeting to membrane	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
regulation of synaptic vesicle cycle	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cholesterol biosynthetic process	Delta(24)-sterol reductase	Homo sapiens (human)
cholesterol biosynthetic process	Delta(24)-sterol reductase	Homo sapiens (human)
Ras protein signal transduction	Delta(24)-sterol reductase	Homo sapiens (human)
protein localization	Delta(24)-sterol reductase	Homo sapiens (human)
negative regulation of cell population proliferation	Delta(24)-sterol reductase	Homo sapiens (human)
response to hormone	Delta(24)-sterol reductase	Homo sapiens (human)
tissue development	Delta(24)-sterol reductase	Homo sapiens (human)
male genitalia development	Delta(24)-sterol reductase	Homo sapiens (human)
plasminogen activation	Delta(24)-sterol reductase	Homo sapiens (human)
cholesterol biosynthetic process via desmosterol	Delta(24)-sterol reductase	Homo sapiens (human)
cholesterol biosynthetic process via lathosterol	Delta(24)-sterol reductase	Homo sapiens (human)
amyloid precursor protein catabolic process	Delta(24)-sterol reductase	Homo sapiens (human)
skin development	Delta(24)-sterol reductase	Homo sapiens (human)
membrane organization	Delta(24)-sterol reductase	Homo sapiens (human)
steroid metabolic process	Delta(24)-sterol reductase	Homo sapiens (human)
protein phosphorylation	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
signal transduction	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
chemical synaptic transmission	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
positive regulation of cell growth	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
negative regulation of TOR signaling	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
intracellular signal transduction	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
negative regulation of apoptotic process	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
regulation of translation in response to stress	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
positive regulation of cell differentiation	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
hepatocyte proliferation	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
positive regulation of hepatic stellate cell activation	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
positive regulation of DNA-templated transcription	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
peptidyl-serine phosphorylation	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
positive regulation of protein phosphorylation	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
spermatogenesis	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
negative regulation of protein autophosphorylation	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
regulation of protein localization	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
regulation of actin cytoskeleton organization	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
negative regulation of phosphorylation	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
positive regulation of stress fiber assembly	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
establishment of vesicle localization	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
negative regulation of protein serine/threonine kinase activity	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
podocyte cell migration	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreading	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
positive regulation of protein localization to nucleus	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
negative regulation of cilium assembly	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
actin cytoskeleton organization	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein phosphorylation	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
smooth muscle contraction	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
tonic smooth muscle contraction	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
positive regulation of cell migration	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
bleb assembly	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
positive regulation of calcium ion transport	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
aorta smooth muscle tissue morphogenesis	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
cellular hypotonic response	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
positive regulation of wound healing	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
positive regulation of erythrocyte differentiation	Mitogen-activated protein kinase 11	Homo sapiens (human)
osteoblast differentiation	Mitogen-activated protein kinase 11	Homo sapiens (human)
positive regulation of gene expression	Mitogen-activated protein kinase 11	Homo sapiens (human)
stress-activated protein kinase signaling cascade	Mitogen-activated protein kinase 11	Homo sapiens (human)
positive regulation of interleukin-12 production	Mitogen-activated protein kinase 11	Homo sapiens (human)
p38MAPK cascade	Mitogen-activated protein kinase 11	Homo sapiens (human)
positive regulation of muscle cell differentiation	Mitogen-activated protein kinase 11	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase 11	Homo sapiens (human)
cardiac muscle cell proliferation	Mitogen-activated protein kinase 11	Homo sapiens (human)
negative regulation of cardiac muscle cell proliferation	Mitogen-activated protein kinase 11	Homo sapiens (human)
bone development	Mitogen-activated protein kinase 11	Homo sapiens (human)
cellular response to interleukin-1	Mitogen-activated protein kinase 11	Homo sapiens (human)
cellular response to UV-B	Mitogen-activated protein kinase 11	Homo sapiens (human)
cellular senescence	Mitogen-activated protein kinase 11	Homo sapiens (human)
cellular response to virus	Mitogen-activated protein kinase 11	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase 11	Homo sapiens (human)
G1 to G0 transition	Serine/threonine-protein kinase STK11	Homo sapiens (human)
regulation of cell growth	Serine/threonine-protein kinase STK11	Homo sapiens (human)
tissue homeostasis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
vasculature development	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein dephosphorylation	Serine/threonine-protein kinase STK11	Homo sapiens (human)
autophagy	Serine/threonine-protein kinase STK11	Homo sapiens (human)
DNA damage response	Serine/threonine-protein kinase STK11	Homo sapiens (human)
spermatogenesis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
axonogenesis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
negative regulation of cell population proliferation	Serine/threonine-protein kinase STK11	Homo sapiens (human)
response to ionizing radiation	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive regulation of autophagy	Serine/threonine-protein kinase STK11	Homo sapiens (human)
response to activity	Serine/threonine-protein kinase STK11	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase STK11	Homo sapiens (human)
establishment of cell polarity	Serine/threonine-protein kinase STK11	Homo sapiens (human)
negative regulation of cell growth	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathway	Serine/threonine-protein kinase STK11	Homo sapiens (human)
activation of protein kinase activity	Serine/threonine-protein kinase STK11	Homo sapiens (human)
response to glucagon	Serine/threonine-protein kinase STK11	Homo sapiens (human)
response to lipid	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein localization to nucleus	Serine/threonine-protein kinase STK11	Homo sapiens (human)
glucose homeostasis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
anoikis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive thymic T cell selection	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive regulation of gluconeogenesis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase STK11	Homo sapiens (human)
regulation of dendrite morphogenesis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive regulation of axonogenesis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
T cell receptor signaling pathway	Serine/threonine-protein kinase STK11	Homo sapiens (human)
Golgi localization	Serine/threonine-protein kinase STK11	Homo sapiens (human)
regulation of cell cycle	Serine/threonine-protein kinase STK11	Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Serine/threonine-protein kinase STK11	Homo sapiens (human)
epithelial cell proliferation involved in prostate gland development	Serine/threonine-protein kinase STK11	Homo sapiens (human)
negative regulation of epithelial cell proliferation involved in prostate gland development	Serine/threonine-protein kinase STK11	Homo sapiens (human)
cellular response to UV-B	Serine/threonine-protein kinase STK11	Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediator	Serine/threonine-protein kinase STK11	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Serine/threonine-protein kinase STK11	Homo sapiens (human)
response to thyroid hormone	Serine/threonine-protein kinase STK11	Homo sapiens (human)
dendrite extension	Serine/threonine-protein kinase STK11	Homo sapiens (human)
negative regulation of cold-induced thermogenesis	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive regulation of protein localization to nucleus	Serine/threonine-protein kinase STK11	Homo sapiens (human)
positive regulation of vesicle transport along microtubule	Serine/threonine-protein kinase STK11	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	Serine/threonine-protein kinase STK11	Homo sapiens (human)
negative regulation of TORC1 signaling	Serine/threonine-protein kinase STK11	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase STK11	Homo sapiens (human)
regulation of Wnt signaling pathway	Serine/threonine-protein kinase STK11	Homo sapiens (human)
B cell homeostasis	Serine/threonine-protein kinase N1	Homo sapiens (human)
B cell apoptotic process	Serine/threonine-protein kinase N1	Homo sapiens (human)
negative regulation of protein phosphorylation	Serine/threonine-protein kinase N1	Homo sapiens (human)
regulation of germinal center formation	Serine/threonine-protein kinase N1	Homo sapiens (human)
regulation of immunoglobulin production	Serine/threonine-protein kinase N1	Homo sapiens (human)
renal system process	Serine/threonine-protein kinase N1	Homo sapiens (human)
chromatin remodeling	Serine/threonine-protein kinase N1	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase N1	Homo sapiens (human)
hyperosmotic response	Serine/threonine-protein kinase N1	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase N1	Homo sapiens (human)
epithelial cell migration	Serine/threonine-protein kinase N1	Homo sapiens (human)
negative regulation of B cell proliferation	Serine/threonine-protein kinase N1	Homo sapiens (human)
post-translational protein modification	Serine/threonine-protein kinase N1	Homo sapiens (human)
positive regulation of DNA-templated transcription	Serine/threonine-protein kinase N1	Homo sapiens (human)
spleen development	Serine/threonine-protein kinase N1	Homo sapiens (human)
regulation of androgen receptor signaling pathway	Serine/threonine-protein kinase N1	Homo sapiens (human)
regulation of cell motility	Serine/threonine-protein kinase N1	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase N1	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase N2	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase N2	Homo sapiens (human)
cell adhesion	Serine/threonine-protein kinase N2	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase N2	Homo sapiens (human)
epithelial cell migration	Serine/threonine-protein kinase N2	Homo sapiens (human)
cell projection organization	Serine/threonine-protein kinase N2	Homo sapiens (human)
positive regulation of cytokinesis	Serine/threonine-protein kinase N2	Homo sapiens (human)
apical junction assembly	Serine/threonine-protein kinase N2	Homo sapiens (human)
positive regulation of viral genome replication	Serine/threonine-protein kinase N2	Homo sapiens (human)
positive regulation of mitotic cell cycle	Serine/threonine-protein kinase N2	Homo sapiens (human)
cell division	Serine/threonine-protein kinase N2	Homo sapiens (human)
regulation of cell motility	Serine/threonine-protein kinase N2	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase N2	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase N2	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to lipopolysaccharide	Mitogen-activated protein kinase 14	Homo sapiens (human)
DNA damage checkpoint signaling	Mitogen-activated protein kinase 14	Homo sapiens (human)
cell morphogenesis	Mitogen-activated protein kinase 14	Homo sapiens (human)
cartilage condensation	Mitogen-activated protein kinase 14	Homo sapiens (human)
angiogenesis	Mitogen-activated protein kinase 14	Homo sapiens (human)
osteoblast differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
placenta development	Mitogen-activated protein kinase 14	Homo sapiens (human)
response to dietary excess	Mitogen-activated protein kinase 14	Homo sapiens (human)
chondrocyte differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulus	Mitogen-activated protein kinase 14	Homo sapiens (human)
glucose metabolic process	Mitogen-activated protein kinase 14	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Mitogen-activated protein kinase 14	Homo sapiens (human)
transcription by RNA polymerase II	Mitogen-activated protein kinase 14	Homo sapiens (human)
apoptotic process	Mitogen-activated protein kinase 14	Homo sapiens (human)
chemotaxis	Mitogen-activated protein kinase 14	Homo sapiens (human)
signal transduction	Mitogen-activated protein kinase 14	Homo sapiens (human)
cell surface receptor signaling pathway	Mitogen-activated protein kinase 14	Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathway	Mitogen-activated protein kinase 14	Homo sapiens (human)
skeletal muscle tissue development	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of gene expression	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of myotube differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
peptidyl-serine phosphorylation	Mitogen-activated protein kinase 14	Homo sapiens (human)
fatty acid oxidation	Mitogen-activated protein kinase 14	Homo sapiens (human)
platelet activation	Mitogen-activated protein kinase 14	Homo sapiens (human)
regulation of ossification	Mitogen-activated protein kinase 14	Homo sapiens (human)
osteoclast differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
stress-activated protein kinase signaling cascade	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of cyclase activity	Mitogen-activated protein kinase 14	Homo sapiens (human)
lipopolysaccharide-mediated signaling pathway	Mitogen-activated protein kinase 14	Homo sapiens (human)
response to muramyl dipeptide	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of interleukin-12 production	Mitogen-activated protein kinase 14	Homo sapiens (human)
response to insulin	Mitogen-activated protein kinase 14	Homo sapiens (human)
negative regulation of hippo signaling	Mitogen-activated protein kinase 14	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulus	Mitogen-activated protein kinase 14	Homo sapiens (human)
response to muscle stretch	Mitogen-activated protein kinase 14	Homo sapiens (human)
p38MAPK cascade	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of protein import into nucleus	Mitogen-activated protein kinase 14	Homo sapiens (human)
signal transduction in response to DNA damage	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of erythrocyte differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of myoblast differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Mitogen-activated protein kinase 14	Homo sapiens (human)
glucose import	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of glucose import	Mitogen-activated protein kinase 14	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Mitogen-activated protein kinase 14	Homo sapiens (human)
stem cell differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
striated muscle cell differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of muscle cell differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of cardiac muscle cell proliferation	Mitogen-activated protein kinase 14	Homo sapiens (human)
bone development	Mitogen-activated protein kinase 14	Homo sapiens (human)
3'-UTR-mediated mRNA stabilization	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to lipoteichoic acid	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to tumor necrosis factor	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to ionizing radiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to UV-B	Mitogen-activated protein kinase 14	Homo sapiens (human)
negative regulation of canonical Wnt signaling pathway	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of brown fat cell differentiation	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular senescence	Mitogen-activated protein kinase 14	Homo sapiens (human)
stress-induced premature senescence	Mitogen-activated protein kinase 14	Homo sapiens (human)
cellular response to virus	Mitogen-activated protein kinase 14	Homo sapiens (human)
regulation of synaptic membrane adhesion	Mitogen-activated protein kinase 14	Homo sapiens (human)
regulation of cytokine production involved in inflammatory response	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of myoblast fusion	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	Mitogen-activated protein kinase 14	Homo sapiens (human)
positive regulation of myeloid dendritic cell cytokine production	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
adaptive immune response	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
protein phosphorylation	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
inflammatory response	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
signal transduction	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
long-term memory	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
regulation of T cell differentiation in thymus	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
myeloid dendritic cell differentiation	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
regulation of osteoclast differentiation	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
positive regulation of DNA-templated transcription	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
protein autophosphorylation	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
peptidyl-serine phosphorylation	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
intracellular signal transduction	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
microtubule-based process	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
positive regulation of JUN kinase activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
positive regulation of neuron apoptotic process	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
cell cycle G1/S phase transition	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
positive regulation of JNK cascade	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein autophosphorylation	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
positive regulation of apoptotic process	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
MAPK cascade	MAP kinase-activated protein kinase 3	Homo sapiens (human)
toll-like receptor signaling pathway	MAP kinase-activated protein kinase 3	Homo sapiens (human)
signal transduction	MAP kinase-activated protein kinase 3	Homo sapiens (human)
peptidyl-serine phosphorylation	MAP kinase-activated protein kinase 3	Homo sapiens (human)
response to lipopolysaccharide	MAP kinase-activated protein kinase 3	Homo sapiens (human)
response to cytokine	MAP kinase-activated protein kinase 3	Homo sapiens (human)
macropinocytosis	MAP kinase-activated protein kinase 3	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	MAP kinase-activated protein kinase 3	Homo sapiens (human)
intracellular signal transduction	MAP kinase-activated protein kinase 3	Homo sapiens (human)
protein autophosphorylation	MAP kinase-activated protein kinase 3	Homo sapiens (human)
ossification	Discoidin domain-containing receptor 2	Homo sapiens (human)
endochondral bone growth	Discoidin domain-containing receptor 2	Homo sapiens (human)
cell adhesion	Discoidin domain-containing receptor 2	Homo sapiens (human)
signal transduction	Discoidin domain-containing receptor 2	Homo sapiens (human)
regulation of extracellular matrix disassembly	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of fibroblast migration	Discoidin domain-containing receptor 2	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Discoidin domain-containing receptor 2	Homo sapiens (human)
collagen fibril organization	Discoidin domain-containing receptor 2	Homo sapiens (human)
regulation of bone mineralization	Discoidin domain-containing receptor 2	Homo sapiens (human)
biomineral tissue development	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of collagen biosynthetic process	Discoidin domain-containing receptor 2	Homo sapiens (human)
regulation of tissue remodeling	Discoidin domain-containing receptor 2	Homo sapiens (human)
chondrocyte proliferation	Discoidin domain-containing receptor 2	Homo sapiens (human)
response to muscle stretch	Discoidin domain-containing receptor 2	Homo sapiens (human)
collagen-activated tyrosine kinase receptor signaling pathway	Discoidin domain-containing receptor 2	Homo sapiens (human)
negative regulation of apoptotic process	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of osteoblast differentiation	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of protein kinase activity	Discoidin domain-containing receptor 2	Homo sapiens (human)
protein autophosphorylation	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of fibroblast proliferation	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	Discoidin domain-containing receptor 2	Homo sapiens (human)
cellular response to hypoxia	Discoidin domain-containing receptor 2	Homo sapiens (human)
cellular response to transforming growth factor beta stimulus	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of extracellular matrix disassembly	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of wound healing	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle	Discoidin domain-containing receptor 2	Homo sapiens (human)
negative regulation of hydrogen peroxide-mediated programmed cell death	Discoidin domain-containing receptor 2	Homo sapiens (human)
cellular response to angiotensin	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell migration	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of hepatic stellate cell proliferation	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of hepatic stellate cell activation	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of neuron projection development	Discoidin domain-containing receptor 2	Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathway	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	Discoidin domain-containing receptor 2	Homo sapiens (human)
multicellular organism development	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of kinase activity	Discoidin domain-containing receptor 2	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Discoidin domain-containing receptor 2	Homo sapiens (human)
protein phosphorylation	AP2-associated protein kinase 1	Homo sapiens (human)
regulation of protein localization	AP2-associated protein kinase 1	Homo sapiens (human)
positive regulation of Notch signaling pathway	AP2-associated protein kinase 1	Homo sapiens (human)
protein stabilization	AP2-associated protein kinase 1	Homo sapiens (human)
membrane organization	AP2-associated protein kinase 1	Homo sapiens (human)
presynaptic endocytosis	AP2-associated protein kinase 1	Homo sapiens (human)
regulation of clathrin-dependent endocytosis	AP2-associated protein kinase 1	Homo sapiens (human)
regulation of vascular permeability involved in acute inflammatory response	Myosin light chain kinase 3	Homo sapiens (human)
protein phosphorylation	Myosin light chain kinase 3	Homo sapiens (human)
sarcomere organization	Myosin light chain kinase 3	Homo sapiens (human)
sarcomerogenesis	Myosin light chain kinase 3	Homo sapiens (human)
cardiac myofibril assembly	Myosin light chain kinase 3	Homo sapiens (human)
positive regulation of sarcomere organization	Myosin light chain kinase 3	Homo sapiens (human)
cellular response to interleukin-1	Myosin light chain kinase 3	Homo sapiens (human)
biological_process	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
cellular response to heat	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
protein stabilization	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
protein folding	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
natural killer cell differentiation	Rab-like protein 3	Homo sapiens (human)
B cell differentiation	Rab-like protein 3	Homo sapiens (human)
T cell differentiation in thymus	Rab-like protein 3	Homo sapiens (human)
regulation of Ras protein signal transduction	Rab-like protein 3	Homo sapiens (human)
protein stabilization	Rab-like protein 3	Homo sapiens (human)
regulation of protein lipidation	Rab-like protein 3	Homo sapiens (human)
intracellular protein transport	Rab-like protein 3	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
cell migration	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
actin cytoskeleton organization	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
actomyosin structure organization	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
actin cytoskeleton organization	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
actomyosin structure organization	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase N3	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase N3	Homo sapiens (human)
epithelial cell migration	Serine/threonine-protein kinase N3	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase N3	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase N3	Homo sapiens (human)
autophagy	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
smoothened signaling pathway	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
negative regulation of smoothened signaling pathway	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
positive regulation of smoothened signaling pathway	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
fibroblast activation	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
cellular senescence	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
reticulophagy	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
piecemeal microautophagy of the nucleus	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
response to starvation	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
autophagosome assembly	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
autophagy of mitochondrion	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
regulation of autophagy	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
fatty acid beta-oxidation	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
fatty acid beta-oxidation using acyl-CoA dehydrogenase	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
mRNA processing	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
rRNA catabolic process	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
apoptotic chromosome condensation	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
response to endoplasmic reticulum stress	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
negative regulation of DNA-templated transcription	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
IRE1-mediated unfolded protein response	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
autophagy of mitochondrion	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
neuron migration	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
positive regulation of neuron projection development	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
Wnt signaling pathway	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
establishment of cell polarity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
activation of protein kinase activity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
establishment or maintenance of epithelial cell apical/basal polarity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
regulation of axonogenesis	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
regulation of cytoskeleton organization	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
mitochondrion localization	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
axon development	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
regulation of microtubule cytoskeleton organization	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
establishment or maintenance of cell polarity regulating cell shape	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
regulation of microtubule binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
microtubule cytoskeleton organization	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
microtubule cytoskeleton organization	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
DNA repair	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
DNA damage response	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
negative regulation of microtubule depolymerization	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
mitotic G2 DNA damage checkpoint signaling	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
phosphorylation	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
central nervous system neuron development	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
positive regulation of stress-activated MAPK cascade	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
regulation of actin cytoskeleton organization	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
positive regulation of JNK cascade	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
regulation of cytoskeleton organization	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
neuron cellular homeostasis	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
regulation of microtubule cytoskeleton organization	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
execution phase of apoptosis	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
positive regulation of protein acetylation	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein phosphorylation	STE20-related kinase adapter protein alpha	Homo sapiens (human)
G1 to G0 transition	STE20-related kinase adapter protein alpha	Homo sapiens (human)
protein export from nucleus	STE20-related kinase adapter protein alpha	Homo sapiens (human)
activation of protein kinase activity	STE20-related kinase adapter protein alpha	Homo sapiens (human)
skeletal muscle contraction	Myosin-14	Homo sapiens (human)
mitochondrion organization	Myosin-14	Homo sapiens (human)
skeletal muscle tissue development	Myosin-14	Homo sapiens (human)
sensory perception of sound	Myosin-14	Homo sapiens (human)
regulation of cell shape	Myosin-14	Homo sapiens (human)
neuronal action potential	Myosin-14	Homo sapiens (human)
actin filament-based movement	Myosin-14	Homo sapiens (human)
actomyosin structure organization	Myosin-14	Homo sapiens (human)
vocalization behavior	Myosin-14	Homo sapiens (human)
negative regulation of mitochondrial fusion	AarF domain-containing protein kinase 1	Homo sapiens (human)
positive regulation of cristae formation	AarF domain-containing protein kinase 1	Homo sapiens (human)
mitochondrion organization	AarF domain-containing protein kinase 1	Homo sapiens (human)
lipid homeostasis	AarF domain-containing protein kinase 1	Homo sapiens (human)
protein localization	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
regulation of apoptotic process	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
U2-type prespliceosome assembly	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
eye development	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
protein phosphorylation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
cell population proliferation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
positive regulation of cell population proliferation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
anterior/posterior pattern specification	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathway	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
retina layer formation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
neuron differentiation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
adherens junction assembly	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
positive regulation of angiogenesis	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
embryonic camera-type eye morphogenesis	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
embryonic retina morphogenesis in camera-type eye	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
definitive hemopoiesis	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
lens induction in camera-type eye	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
iris morphogenesis	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
endothelial cell apoptotic process	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
extrinsic apoptotic signaling pathway	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
smoothened signaling pathway	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
response to UV	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
response to tumor necrosis factor	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
MAPK cascade	MAP kinase-activated protein kinase 5	Homo sapiens (human)
regulation of translation	MAP kinase-activated protein kinase 5	Homo sapiens (human)
signal transduction	MAP kinase-activated protein kinase 5	Homo sapiens (human)
Ras protein signal transduction	MAP kinase-activated protein kinase 5	Homo sapiens (human)
negative regulation of TOR signaling	MAP kinase-activated protein kinase 5	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein autophosphorylation	MAP kinase-activated protein kinase 5	Homo sapiens (human)
positive regulation of telomerase activity	MAP kinase-activated protein kinase 5	Homo sapiens (human)
positive regulation of dendritic spine development	MAP kinase-activated protein kinase 5	Homo sapiens (human)
cellular senescence	MAP kinase-activated protein kinase 5	Homo sapiens (human)
stress-induced premature senescence	MAP kinase-activated protein kinase 5	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	MAP kinase-activated protein kinase 5	Homo sapiens (human)
positive regulation of telomere capping	MAP kinase-activated protein kinase 5	Homo sapiens (human)
peptidyl-serine phosphorylation	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein phosphorylation	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
ubiquinone biosynthetic process	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
phosphorylation	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
regulation of autophagy	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
negative regulation of insulin receptor signaling pathway	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
positive regulation of autophagosome assembly	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic process	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase 15	Homo sapiens (human)
regulation of COPII vesicle coating	Mitogen-activated protein kinase 15	Homo sapiens (human)
DNA damage response	Mitogen-activated protein kinase 15	Homo sapiens (human)
endoplasmic reticulum organization	Mitogen-activated protein kinase 15	Homo sapiens (human)
positive regulation of cell population proliferation	Mitogen-activated protein kinase 15	Homo sapiens (human)
regulation of autophagy	Mitogen-activated protein kinase 15	Homo sapiens (human)
negative regulation of cell migration	Mitogen-activated protein kinase 15	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein autophosphorylation	Mitogen-activated protein kinase 15	Homo sapiens (human)
positive regulation of telomerase activity	Mitogen-activated protein kinase 15	Homo sapiens (human)
dopamine uptake	Mitogen-activated protein kinase 15	Homo sapiens (human)
regulation of cilium assembly	Mitogen-activated protein kinase 15	Homo sapiens (human)
positive regulation of telomere capping	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein localization to ciliary transition zone	Mitogen-activated protein kinase 15	Homo sapiens (human)
positive regulation of metaphase/anaphase transition of meiosis I	Mitogen-activated protein kinase 15	Homo sapiens (human)
positive regulation of spindle assembly	Mitogen-activated protein kinase 15	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase 15	Homo sapiens (human)
mitotic cell cycle	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
regulation of mitotic cell cycle	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
cell division	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
spliceosomal complex assembly	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
positive regulation of myeloid dendritic cell cytokine production	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
double-strand break repair	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
tRNA splicing, via endonucleolytic cleavage and ligation	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
regulation of translational initiation	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
DNA duplex unwinding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
response to exogenous dsRNA	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
innate immune response	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
defense response to virus	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
nucleic acid metabolic process	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
protein localization to cytoplasmic stress granule	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
cell population proliferation	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
peptidyl-serine phosphorylation	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
positive regulation of MAPK cascade	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
protein autophosphorylation	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
cellular response to phorbol 13-acetate 12-myristate	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Aurora kinase B	Homo sapiens (human)
mitotic cell cycle	Aurora kinase B	Homo sapiens (human)
mitotic cytokinesis	Aurora kinase B	Homo sapiens (human)
negative regulation of B cell apoptotic process	Aurora kinase B	Homo sapiens (human)
protein phosphorylation	Aurora kinase B	Homo sapiens (human)
spindle organization	Aurora kinase B	Homo sapiens (human)
attachment of spindle microtubules to kinetochore	Aurora kinase B	Homo sapiens (human)
abscission	Aurora kinase B	Homo sapiens (human)
negative regulation of protein binding	Aurora kinase B	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Aurora kinase B	Homo sapiens (human)
negative regulation of cytokinesis	Aurora kinase B	Homo sapiens (human)
positive regulation of cytokinesis	Aurora kinase B	Homo sapiens (human)
protein localization to kinetochore	Aurora kinase B	Homo sapiens (human)
cellular response to UV	Aurora kinase B	Homo sapiens (human)
cleavage furrow formation	Aurora kinase B	Homo sapiens (human)
post-translational protein modification	Aurora kinase B	Homo sapiens (human)
cell cycle G2/M phase transition	Aurora kinase B	Homo sapiens (human)
mitotic cytokinesis checkpoint signaling	Aurora kinase B	Homo sapiens (human)
negative regulation of innate immune response	Aurora kinase B	Homo sapiens (human)
protein autophosphorylation	Aurora kinase B	Homo sapiens (human)
mitotic spindle midzone assembly	Aurora kinase B	Homo sapiens (human)
positive regulation of telomerase activity	Aurora kinase B	Homo sapiens (human)
regulation of chromosome segregation	Aurora kinase B	Homo sapiens (human)
positive regulation of mitotic sister chromatid segregation	Aurora kinase B	Homo sapiens (human)
positive regulation of mitotic cell cycle spindle assembly checkpoint	Aurora kinase B	Homo sapiens (human)
mitotic spindle assembly	Aurora kinase B	Homo sapiens (human)
negative regulation of cGAS/STING signaling pathway	Aurora kinase B	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	Aurora kinase B	Homo sapiens (human)
positive regulation of mitotic sister chromatid separation	Aurora kinase B	Homo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochore	Aurora kinase B	Homo sapiens (human)
positive regulation of mitotic cytokinesis	Aurora kinase B	Homo sapiens (human)
positive regulation of telomere capping	Aurora kinase B	Homo sapiens (human)
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore	Aurora kinase B	Homo sapiens (human)
mitotic spindle organization	Aurora kinase B	Homo sapiens (human)
regulation of cytokinesis	Aurora kinase B	Homo sapiens (human)
microtubule cytoskeleton organization	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
positive regulation of cell cycle	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
microtubule cytoskeleton organization	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
microtubule bundle formation	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
protein phosphorylation	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
nervous system development	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
positive regulation of programmed cell death	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
cilium organization	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
positive regulation of cilium assembly	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
regulation of centrosome cycle	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
cell division	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assembly	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
positive regulation of protein localization to centrosome	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
intracellular signal transduction	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
cell division	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
cilium assembly	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
MAPK cascade	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
positive regulation of protein phosphorylation	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
protein phosphorylation	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
calcium-mediated signaling	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
cellular response to reactive oxygen species	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
regulation of protein kinase activity	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
positive regulation of DNA-templated transcription	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
protein autophosphorylation	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
CAMKK-AMPK signaling cascade	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
positive regulation of autophagy of mitochondrion	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
protein phosphorylation	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
tRNA processing	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
regulation of signal transduction by p53 class mediator	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
tRNA threonylcarbamoyladenosine metabolic process	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
G2/M transition of mitotic cell cycle	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
mitotic cell cycle	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
regulation of mitotic nuclear division	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
negative regulation of G2/M transition of mitotic cell cycle	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
protein phosphorylation	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
negative regulation of G2/MI transition of meiotic cell cycle	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
meiotic cell cycle	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
response to ischemia	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stress	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic process	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cellular response to amino acid starvation	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
response to endoplasmic reticulum stress	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
neuron intrinsic apoptotic signaling pathway in response to oxidative stress	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
p38MAPK cascade	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of apoptotic process	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of JUN kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
innate immune response	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of myoblast differentiation	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of protein kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of DNA-templated transcription	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of JNK cascade	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
neuron apoptotic process	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cellular response to hydrogen peroxide	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cellular response to tumor necrosis factor	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
endothelial cell apoptotic process	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cellular senescence	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
apoptotic signaling pathway	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
programmed necrotic cell death	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of p38MAPK cascade	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cellular response to reactive nitrogen species	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cellular response to stress	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
protein autophosphorylation	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
blood vessel development	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
positive regulation of cell proliferation in bone marrow	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesis	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
positive regulation of p38MAPK cascade	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
negative regulation of cellular senescence	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
acute inflammatory response	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
phagocytosis	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
negative regulation of cell population proliferation	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
regulation of eIF2 alpha phosphorylation by heme	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
macrophage differentiation	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
negative regulation of translational initiation by iron	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
protoporphyrinogen IX metabolic process	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
protein autophosphorylation	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
negative regulation of hemoglobin biosynthetic process	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
establishment of localization in cell	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
multicellular organismal-level iron ion homeostasis	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
integrated stress response signaling	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
HRI-mediated signaling	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
positive regulation of mitophagy	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
response to iron ion starvation	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
regulation of translational initiation by eIF2 alpha phosphorylation	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activity	Nucleolar GTP-binding protein 1	Homo sapiens (human)
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	Nucleolar GTP-binding protein 1	Homo sapiens (human)
osteoblast differentiation	Nucleolar GTP-binding protein 1	Homo sapiens (human)
negative regulation of DNA replication	Nucleolar GTP-binding protein 1	Homo sapiens (human)
negative regulation of cell population proliferation	Nucleolar GTP-binding protein 1	Homo sapiens (human)
negative regulation of cell-cell adhesion	Nucleolar GTP-binding protein 1	Homo sapiens (human)
negative regulation of cell migration	Nucleolar GTP-binding protein 1	Homo sapiens (human)
negative regulation of protein ubiquitination	Nucleolar GTP-binding protein 1	Homo sapiens (human)
negative regulation of collagen binding	Nucleolar GTP-binding protein 1	Homo sapiens (human)
ribosomal large subunit biogenesis	Nucleolar GTP-binding protein 1	Homo sapiens (human)
protein stabilization	Nucleolar GTP-binding protein 1	Homo sapiens (human)
angiogenesis	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of endothelial cell proliferation	Serine/threonine-protein kinase D2	Homo sapiens (human)
adaptive immune response	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase D2	Homo sapiens (human)
cell adhesion	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of endothelial cell migration	Serine/threonine-protein kinase D2	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase D2	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase D2	Homo sapiens (human)
sphingolipid biosynthetic process	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathway	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of interleukin-2 production	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of interleukin-8 production	Serine/threonine-protein kinase D2	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase D2	Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulus	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of fibroblast growth factor receptor signaling pathway	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of angiogenesis	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of cell adhesion	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase D2	Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathway	Serine/threonine-protein kinase D2	Homo sapiens (human)
T cell receptor signaling pathway	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of T cell receptor signaling pathway	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Serine/threonine-protein kinase D2	Homo sapiens (human)
endothelial tube morphogenesis	Serine/threonine-protein kinase D2	Homo sapiens (human)
regulation of T cell apoptotic process	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of DNA biosynthetic process	Serine/threonine-protein kinase D2	Homo sapiens (human)
positive regulation of endothelial cell chemotaxis	Serine/threonine-protein kinase D2	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein phosphorylation	NUAK family SNF1-like kinase 2	Homo sapiens (human)
apoptotic process	NUAK family SNF1-like kinase 2	Homo sapiens (human)
actin cytoskeleton organization	NUAK family SNF1-like kinase 2	Homo sapiens (human)
protein localization to nucleus	NUAK family SNF1-like kinase 2	Homo sapiens (human)
regulation of hippo signaling	NUAK family SNF1-like kinase 2	Homo sapiens (human)
cellular response to glucose starvation	NUAK family SNF1-like kinase 2	Homo sapiens (human)
negative regulation of apoptotic process	NUAK family SNF1-like kinase 2	Homo sapiens (human)
rRNA modification	RNA cytidine acetyltransferase	Homo sapiens (human)
regulation of translation	RNA cytidine acetyltransferase	Homo sapiens (human)
protein acetylation	RNA cytidine acetyltransferase	Homo sapiens (human)
regulation of centrosome duplication	RNA cytidine acetyltransferase	Homo sapiens (human)
negative regulation of telomere maintenance via telomerase	RNA cytidine acetyltransferase	Homo sapiens (human)
ribosomal small subunit biogenesis	RNA cytidine acetyltransferase	Homo sapiens (human)
positive regulation of translation	RNA cytidine acetyltransferase	Homo sapiens (human)
tRNA acetylation	RNA cytidine acetyltransferase	Homo sapiens (human)
rRNA acetylation involved in maturation of SSU-rRNA	RNA cytidine acetyltransferase	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
regulation of insulin receptor signaling pathway	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
apoptotic process	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
regulation of cell migration	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
cytoplasmic microtubule organization	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
regulation of apoptotic process	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
protein autophosphorylation	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
regulation of focal adhesion assembly	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
protein phosphorylation	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
MAPK cascade	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
DNA repair	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
DNA damage response	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
mitotic G2 DNA damage checkpoint signaling	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
positive regulation of stress-activated MAPK cascade	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
positive regulation of JUN kinase activity	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
negative regulation of JNK cascade	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
positive regulation of JNK cascade	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
regulation of MAPK cascade	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
neuron projection morphogenesis	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
dTTP catabolic process	dCTP pyrophosphatase 1	Homo sapiens (human)
dCTP catabolic process	dCTP pyrophosphatase 1	Homo sapiens (human)
nucleoside triphosphate catabolic process	dCTP pyrophosphatase 1	Homo sapiens (human)
DNA protection	dCTP pyrophosphatase 1	Homo sapiens (human)
regulation of RNA splicing	Dual specificity protein kinase CLK4	Homo sapiens (human)
peptidyl-tyrosine phosphorylation	Dual specificity protein kinase CLK4	Homo sapiens (human)
Wnt signaling pathway	Casein kinase I isoform gamma-1	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Casein kinase I isoform gamma-1	Homo sapiens (human)
signal transduction	Casein kinase I isoform gamma-1	Homo sapiens (human)
endocytosis	Casein kinase I isoform gamma-1	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase I isoform gamma-1	Homo sapiens (human)
translation	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
phenylalanyl-tRNA aminoacylation	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
protein heterotetramerization	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
tRNA aminoacylation for protein translation	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
aminoacyl-tRNA metabolism involved in translational fidelity	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
isoleucyl-tRNA aminoacylation	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
mitochondrial translation	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
positive regulation of Notch signaling pathway	BMP-2-inducible protein kinase	Homo sapiens (human)
regulation of clathrin-dependent endocytosis	BMP-2-inducible protein kinase	Homo sapiens (human)
regulation of bone mineralization	BMP-2-inducible protein kinase	Homo sapiens (human)
ribosomal large subunit assembly	Midasin	Homo sapiens (human)
ribosomal large subunit export from nucleus	Midasin	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
toll-like receptor signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
neutrophil mediated immunity	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
JNK cascade	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
toll-like receptor 4 signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
toll-like receptor 9 signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
interleukin-33-mediated signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
innate immune response	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
positive regulation of smooth muscle cell proliferation	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
interleukin-1-mediated signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
neutrophil migration	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
cytokine-mediated signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
Toll signaling pathway	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
cellular response to lipopolysaccharide	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
intracellular signal transduction	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
positive regulation of programmed cell death	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
GCN2-mediated signaling	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
pyroptosis	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
DNA damage checkpoint signaling	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
inflammatory response	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cytoskeleton organization	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
JNK cascade	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cell death	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cell differentiation	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
stress-activated protein kinase signaling cascade	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
p38MAPK cascade	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
embryonic digit morphogenesis	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
positive regulation of apoptotic process	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein autophosphorylation	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
stress-activated MAPK cascade	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
limb development	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cellular response to gamma radiation	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cellular response to UV-B	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
positive regulation of mitotic DNA damage checkpoint	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
peptidyl-serine phosphorylation	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
regulation of mitotic metaphase/anaphase transition	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
chromosome segregation	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
transcription by RNA polymerase II	Cyclin-dependent kinase 12	Homo sapiens (human)
mRNA processing	Cyclin-dependent kinase 12	Homo sapiens (human)
RNA splicing	Cyclin-dependent kinase 12	Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase II	Cyclin-dependent kinase 12	Homo sapiens (human)
regulation of MAP kinase activity	Cyclin-dependent kinase 12	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cyclin-dependent kinase 12	Homo sapiens (human)
protein autophosphorylation	Cyclin-dependent kinase 12	Homo sapiens (human)
regulation of cell cycle	Cyclin-dependent kinase 12	Homo sapiens (human)
negative regulation of stem cell differentiation	Cyclin-dependent kinase 12	Homo sapiens (human)
protein phosphorylation	Cyclin-dependent kinase 12	Homo sapiens (human)
aerobic respiration	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
negative regulation of cell growth	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
mitochondrial respiratory chain complex I assembly	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
cellular response to interferon-beta	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
proton motive force-driven mitochondrial ATP synthesis	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
protein insertion into mitochondrial inner membrane	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
positive regulation of protein catabolic process	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
negative regulation of DNA-templated transcription	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
cellular response to retinoic acid	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
reactive oxygen species metabolic process	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
apoptotic signaling pathway	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
extrinsic apoptotic signaling pathway	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
positive regulation of execution phase of apoptosis	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase 26	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase 26	Homo sapiens (human)
cellular response to starvation	Serine/threonine-protein kinase 26	Homo sapiens (human)
microvillus assembly	Serine/threonine-protein kinase 26	Homo sapiens (human)
negative regulation of cell migration	Serine/threonine-protein kinase 26	Homo sapiens (human)
cellular response to oxidative stress	Serine/threonine-protein kinase 26	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase 26	Homo sapiens (human)
regulation of apoptotic process	Serine/threonine-protein kinase 26	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase 26	Homo sapiens (human)
tricarboxylic acid cycle	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinate metabolic process	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinyl-CoA pathway	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinyl-CoA catabolic process	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinyl-CoA metabolic process	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
MAPK cascade	Serine/threonine-protein kinase NLK	Homo sapiens (human)
regulation of DNA-templated transcription	Serine/threonine-protein kinase NLK	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase NLK	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Serine/threonine-protein kinase NLK	Homo sapiens (human)
Wnt signaling pathway, calcium modulating pathway	Serine/threonine-protein kinase NLK	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase NLK	Homo sapiens (human)
negative regulation of Wnt signaling pathway	Serine/threonine-protein kinase NLK	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase NLK	Homo sapiens (human)
protein stabilization	Serine/threonine-protein kinase NLK	Homo sapiens (human)
cellular response to osmotic stress	Serine/threonine-protein kinase NLK	Homo sapiens (human)
negative regulation of TORC1 signaling	Serine/threonine-protein kinase NLK	Homo sapiens (human)
positive regulation of receptor signaling pathway via STAT	Serine/threonine-protein kinase NLK	Homo sapiens (human)
glycogen metabolic process	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
regulation of glycolytic process	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
negative regulation of protein kinase activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
fatty acid biosynthetic process	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
ATP biosynthetic process	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylation	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
sterol biosynthetic process	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
regulation of fatty acid metabolic process	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
cellular response to nutrient levels	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
intracellular signal transduction	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
positive regulation of protein kinase activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
regulation of fatty acid oxidation	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
regulation of glucose import	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
regulation of catalytic activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
protein phosphorylation	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
activation of innate immune response	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
cytoplasmic pattern recognition receptor signaling pathway	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
inflammatory response	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
canonical NF-kappaB signal transduction	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
response to virus	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of autophagy	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
negative regulation of gene expression	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of macroautophagy	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
peptidyl-serine phosphorylation	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
regulation of type I interferon production	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of type I interferon production	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of interferon-alpha production	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of interferon-beta production	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
toll-like receptor 4 signaling pathway	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transduction	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
dendritic cell proliferation	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
innate immune response	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
defense response to Gram-positive bacterium	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
defense response to virus	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
type I interferon-mediated signaling pathway	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of type I interferon-mediated signaling pathway	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
antiviral innate immune response	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
cGAS/STING signaling pathway	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
negative regulation of TORC1 signaling	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of TORC1 signaling	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of xenophagy	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
macroautophagy	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
positive regulation of non-motile cilium assembly	Septin-9	Homo sapiens (human)
protein localization	Septin-9	Homo sapiens (human)
cytoskeleton-dependent cytokinesis	Septin-9	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
signal transduction	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
central nervous system development	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
negative regulation of embryonic development	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascade	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
negative regulation of mesoderm development	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
peptidyl-serine phosphorylation	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
positive regulation of protein phosphorylation	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein phosphorylation	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
cytoskeleton organization	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
response to organonitrogen compound	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
Wnt signaling pathway	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
microvillus assembly	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
actin cytoskeleton organization	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
intracellular signal transduction	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
positive regulation of JNK cascade	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein autophosphorylation	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
regulation of dendrite morphogenesis	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein localization to plasma membrane	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
neuron projection morphogenesis	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
regulation of MAPK cascade	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
MAPK cascade	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
regulation of cell growth	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein targeting to membrane	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
apoptotic process	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
DNA damage response	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
mitotic G2 DNA damage checkpoint signaling	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
axonogenesis	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
regulation of cell shape	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
cell migration	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
actin cytoskeleton organization	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
positive regulation of protein autophosphorylation	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
activation of protein kinase activity	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
positive regulation of stress-activated MAPK cascade	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
regulation of actin cytoskeleton organization	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
positive regulation of MAPK cascade	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
positive regulation of JNK cascade	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
focal adhesion assembly	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
stress-activated MAPK cascade	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
basal dendrite morphogenesis	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
basal dendrite arborization	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase ICK	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase ICK	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase ICK	Homo sapiens (human)
intraciliary anterograde transport	Serine/threonine-protein kinase ICK	Homo sapiens (human)
intraciliary retrograde transport	Serine/threonine-protein kinase ICK	Homo sapiens (human)
intraciliary transport	Serine/threonine-protein kinase ICK	Homo sapiens (human)
cilium assembly	Serine/threonine-protein kinase ICK	Homo sapiens (human)
mitochondrial genome maintenance	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of endothelial cell proliferation	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
protein phosphorylation	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
signal transduction	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of TOR signaling	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of blood vessel endothelial cell migration	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of angiogenesis	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cell size	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
brain morphogenesis	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
homeostasis of number of cells within a tissue	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesis	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of vascular endothelial cell proliferation	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
positive regulation of artery morphogenesis	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
negative regulation of cellular senescence	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
intracellular signal transduction	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
peptidyl-serine phosphorylation	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
positive regulation of TORC1 signaling	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
positive regulation of TORC2 signaling	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
microtubule cytoskeleton organization	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
intracellular signal transduction	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
cellular response to mechanical stimulus	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
regulation of alternative mRNA splicing, via spliceosome	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nuclear-transcribed mRNA catabolic process	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
mRNA processing	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
circadian rhythm	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
RNA splicing	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
positive regulation of circadian rhythm	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
positive regulation of DNA-templated transcription	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
positive regulation of mRNA splicing, via spliceosome	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
mRNA stabilization	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
protein phosphorylation	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
regulation of T cell mediated cytotoxicity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of adaptive immune response	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of phosphatase activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
activation of protein kinase activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of type II interferon production	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
T cell differentiation in thymus	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein modification process	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
non-canonical NF-kappaB signal transduction	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of apoptotic process	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
T cell homeostasis	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of DNA-templated transcription	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of activated T cell proliferation	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein autophosphorylation	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
lymph node development	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
spleen development	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
thymus development	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
defense response to virus	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of necroptotic process	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of activation-induced cell death of T cells	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
necroptotic process	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
cellular response to hydrogen peroxide	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
reactive oxygen species metabolic process	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
apoptotic signaling pathway	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
programmed necrotic cell death	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
necroptotic signaling pathway	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
execution phase of necroptosis	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
amyloid fibril formation	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
signal transduction	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
cytoskeleton organization	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
establishment or maintenance of cell polarity	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
cell migration	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
actin cytoskeleton organization	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
actomyosin structure organization	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
peptidyl-threonine phosphorylation	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
positive regulation of cytokine production	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of cytokine-mediated signaling pathway	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein phosphorylation	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
response to virus	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
positive regulation of macrophage tolerance induction	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of macrophage cytokine production	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
cytokine-mediated signaling pathway	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activity	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
response to peptidoglycan	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
response to lipopolysaccharide	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of interleukin-12 production	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of interleukin-6 production	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of tumor necrosis factor production	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of toll-like receptor signaling pathway	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of protein catabolic process	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of protein-containing complex disassembly	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
regulation of protein-containing complex disassembly	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
response to exogenous dsRNA	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of MAP kinase activity	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
negative regulation of innate immune response	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
interleukin-1-mediated signaling pathway	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
response to interleukin-1	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
Toll signaling pathway	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
cellular response to lipopolysaccharide	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
intracellular signal transduction	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein phosphorylation	Serine/threonine-protein kinase 24	Homo sapiens (human)
signal transduction	Serine/threonine-protein kinase 24	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stress	Serine/threonine-protein kinase 24	Homo sapiens (human)
cellular response to starvation	Serine/threonine-protein kinase 24	Homo sapiens (human)
negative regulation of cell migration	Serine/threonine-protein kinase 24	Homo sapiens (human)
cellular response to oxidative stress	Serine/threonine-protein kinase 24	Homo sapiens (human)
protein autophosphorylation	Serine/threonine-protein kinase 24	Homo sapiens (human)
regulation of axon regeneration	Serine/threonine-protein kinase 24	Homo sapiens (human)
positive regulation of axon regeneration	Serine/threonine-protein kinase 24	Homo sapiens (human)
execution phase of apoptosis	Serine/threonine-protein kinase 24	Homo sapiens (human)
Wnt signaling pathway	Casein kinase I isoform gamma-3	Homo sapiens (human)
protein modification process	Casein kinase I isoform gamma-3	Homo sapiens (human)
peptidyl-serine phosphorylation	Casein kinase I isoform gamma-3	Homo sapiens (human)
signal transduction	Casein kinase I isoform gamma-3	Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway	Casein kinase I isoform gamma-3	Homo sapiens (human)
endocytosis	Casein kinase I isoform gamma-3	Homo sapiens (human)
MAPK cascade	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
placenta development	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
response to UV-C	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
regulation of gene expression	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
male germ-line sex determination	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
positive regulation of telomere maintenance via telomerase	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
intracellular signal transduction	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
positive regulation of JUN kinase activity	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
positive regulation of telomerase activity	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
chorionic trophoblast cell differentiation	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
positive regulation of p38MAPK cascade	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
positive regulation of telomere capping	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (482)

Process	via Protein(s)	Taxonomy
protein serine/threonine kinase activity	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
transmembrane receptor protein serine/threonine kinase activity	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
transmembrane signaling receptor activity	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
protein binding	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
ATP binding	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
BMP binding	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
SMAD binding	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
metal ion binding	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
BMP receptor activity	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
transforming growth factor beta receptor activity, type I	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
protein kinase activity	Cell division cycle 7-related protein kinase	Homo sapiens (human)
protein binding	Cell division cycle 7-related protein kinase	Homo sapiens (human)
ATP binding	Cell division cycle 7-related protein kinase	Homo sapiens (human)
kinase activity	Cell division cycle 7-related protein kinase	Homo sapiens (human)
metal ion binding	Cell division cycle 7-related protein kinase	Homo sapiens (human)
protein serine kinase activity	Cell division cycle 7-related protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	Cell division cycle 7-related protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
DNA binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
DNA helicase activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
RNA binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
RNA helicase activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
mRNA binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
GTPase activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
protein binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
ATP binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
transcription factor binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
poly(A) binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
eukaryotic initiation factor 4E binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
ATP hydrolysis activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
ribonucleoside triphosphate phosphatase activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
translation initiation factor binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
RNA strand annealing activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
signaling adaptor activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
RNA stem-loop binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
gamma-tubulin binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
ribosomal small subunit binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
CTPase activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
protein serine/threonine kinase activator activity	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cadherin binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
mRNA 5'-UTR binding	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
magnesium ion binding	Pyridoxal kinase	Homo sapiens (human)
ATP binding	Pyridoxal kinase	Homo sapiens (human)
zinc ion binding	Pyridoxal kinase	Homo sapiens (human)
pyridoxal kinase activity	Pyridoxal kinase	Homo sapiens (human)
pyridoxal phosphate binding	Pyridoxal kinase	Homo sapiens (human)
potassium ion binding	Pyridoxal kinase	Homo sapiens (human)
sodium ion binding	Pyridoxal kinase	Homo sapiens (human)
lithium ion binding	Pyridoxal kinase	Homo sapiens (human)
protein homodimerization activity	Pyridoxal kinase	Homo sapiens (human)
transcription coactivator binding	Citron Rho-interacting kinase	Homo sapiens (human)
protein serine/threonine kinase activity	Citron Rho-interacting kinase	Homo sapiens (human)
protein binding	Citron Rho-interacting kinase	Homo sapiens (human)
ATP binding	Citron Rho-interacting kinase	Homo sapiens (human)
SH3 domain binding	Citron Rho-interacting kinase	Homo sapiens (human)
protein kinase binding	Citron Rho-interacting kinase	Homo sapiens (human)
PDZ domain binding	Citron Rho-interacting kinase	Homo sapiens (human)
protein serine/threonine kinase inhibitor activity	Citron Rho-interacting kinase	Homo sapiens (human)
metal ion binding	Citron Rho-interacting kinase	Homo sapiens (human)
scaffold protein binding	Citron Rho-interacting kinase	Homo sapiens (human)
protein serine kinase activity	Citron Rho-interacting kinase	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein domain specific binding	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
histone H3T11 kinase activity	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein kinase activity	Aurora kinase A	Homo sapiens (human)
protein serine/threonine kinase activity	Aurora kinase A	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Aurora kinase A	Homo sapiens (human)
protein binding	Aurora kinase A	Homo sapiens (human)
ATP binding	Aurora kinase A	Homo sapiens (human)
protein kinase binding	Aurora kinase A	Homo sapiens (human)
ubiquitin protein ligase binding	Aurora kinase A	Homo sapiens (human)
histone H3S10 kinase activity	Aurora kinase A	Homo sapiens (human)
protein heterodimerization activity	Aurora kinase A	Homo sapiens (human)
protein serine kinase activity	Aurora kinase A	Homo sapiens (human)
molecular function activator activity	Aurora kinase A	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-G-associated kinase	Homo sapiens (human)
protein binding	Cyclin-G-associated kinase	Homo sapiens (human)
ATP binding	Cyclin-G-associated kinase	Homo sapiens (human)
cyclin binding	Cyclin-G-associated kinase	Homo sapiens (human)
protein-folding chaperone binding	Cyclin-G-associated kinase	Homo sapiens (human)
protein serine kinase activity	Cyclin-G-associated kinase	Homo sapiens (human)
clathrin binding	Cyclin-G-associated kinase	Homo sapiens (human)
ephrin receptor activity	Ephrin type-B receptor 6	Homo sapiens (human)
protein binding	Ephrin type-B receptor 6	Homo sapiens (human)
ATP binding	Ephrin type-B receptor 6	Homo sapiens (human)
signaling receptor activity	Ephrin type-B receptor 6	Homo sapiens (human)
transmembrane-ephrin receptor activity	Ephrin type-B receptor 6	Homo sapiens (human)
FAD binding	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
flavin adenine dinucleotide binding	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
pristanoyl-CoA oxidase activity	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
fatty acid binding	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
signaling receptor binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
protein binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
ATP binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
LIM domain binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
signaling adaptor activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
identical protein binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
protein homodimerization activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
CARD domain binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
caspase binding	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
protein serine kinase activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
JUN kinase kinase kinase activity	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
protein kinase activity	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
protein serine/threonine kinase activity	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
protein binding	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
ATP binding	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
protein serine kinase activity	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
histone H2A kinase activity	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
magnesium ion binding	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
GTPase activity	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
protein binding	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
GTP binding	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
phosphatidic acid binding	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
GTPase-dependent fusogenic activity	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
membrane bending activity	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
cardiolipin binding	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
microtubule binding	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
transcription cis-regulatory region binding	Cyclin-T1	Homo sapiens (human)
DNA binding	Cyclin-T1	Homo sapiens (human)
chromatin binding	Cyclin-T1	Homo sapiens (human)
protein binding	Cyclin-T1	Homo sapiens (human)
protein kinase binding	Cyclin-T1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	Cyclin-T1	Homo sapiens (human)
RNA polymerase binding	Cyclin-T1	Homo sapiens (human)
7SK snRNA binding	Cyclin-T1	Homo sapiens (human)
DNA-binding transcription factor binding	Cyclin-T1	Homo sapiens (human)
molecular condensate scaffold activity	Cyclin-T1	Homo sapiens (human)
tRNA binding	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
RNA binding	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
translation initiation factor activity	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
GTPase activity	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
protein binding	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
GTP binding	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
metal ion binding	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
protease binding	Rho-associated protein kinase 2	Homo sapiens (human)
RNA binding	Rho-associated protein kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	Rho-associated protein kinase 2	Homo sapiens (human)
structural molecule activity	Rho-associated protein kinase 2	Homo sapiens (human)
protein binding	Rho-associated protein kinase 2	Homo sapiens (human)
ATP binding	Rho-associated protein kinase 2	Homo sapiens (human)
small GTPase binding	Rho-associated protein kinase 2	Homo sapiens (human)
metal ion binding	Rho-associated protein kinase 2	Homo sapiens (human)
tau protein binding	Rho-associated protein kinase 2	Homo sapiens (human)
tau-protein kinase activity	Rho-associated protein kinase 2	Homo sapiens (human)
endopeptidase activator activity	Rho-associated protein kinase 2	Homo sapiens (human)
Rho-dependent protein serine/threonine kinase activity	Rho-associated protein kinase 2	Homo sapiens (human)
protein serine kinase activity	Rho-associated protein kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
protein-containing complex binding	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
GTPase binding	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
RNA endonuclease activity	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
platelet-derived growth factor receptor binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
enzyme binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
Hsp70 protein binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
protein homodimerization activity	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
ADP binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
Hsp90 protein binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
unfolded protein binding	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
magnesium ion binding	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
protein serine/threonine kinase activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
protein tyrosine kinase activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
protein binding	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
ATP binding	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
histone H3S10 kinase activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
histone H3S28 kinase activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
histone H2AS1 kinase activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
protein serine kinase activity	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
RNA binding	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
RNA helicase activity	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
helicase activity	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
protein binding	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
ATP binding	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
ATP hydrolysis activity	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
identical protein binding	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
magnesium ion binding	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
protein serine/threonine kinase activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
ribosomal protein S6 kinase activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
protein binding	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
ATP binding	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
histone H3S10 kinase activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
histone H3S28 kinase activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
protein serine kinase activity	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Serine/threonine-protein kinase 16	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Serine/threonine-protein kinase 16	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase 16	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase 16	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase 16	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase 16	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-K	Homo sapiens (human)
protein binding	Cyclin-K	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Cyclin-K	Homo sapiens (human)
protein kinase binding	Cyclin-K	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	Cyclin-K	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent kinase-like 5	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein binding	Cyclin-dependent kinase-like 5	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase-like 5	Homo sapiens (human)
kinase activity	Cyclin-dependent kinase-like 5	Homo sapiens (human)
small GTPase binding	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase-like 5	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase 10	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase 10	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase 10	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase 10	Homo sapiens (human)
protein homodimerization activity	Serine/threonine-protein kinase 10	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase 10	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Serine/threonine-protein kinase D3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase D3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase D3	Homo sapiens (human)
kinase activity	Serine/threonine-protein kinase D3	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase D3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase D3	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase D3	Homo sapiens (human)
single-stranded DNA binding	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
protein binding	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
ATP binding	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
ATP hydrolysis activity	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
chromatin binding	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
magnesium ion binding	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 6	Homo sapiens (human)
creatine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
microtubule binding	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
MAP kinase kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
protein kinase binding	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
nuclear estrogen receptor binding	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cadherin binding involved in cell-cell adhesion	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
supercoiled DNA binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
magnesium ion binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
four-way junction DNA binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
bubble DNA binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
phosphotyrosine residue binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
DNA binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
transcription coactivator activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
actin monomer binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
nicotinate-nucleotide adenylyltransferase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein kinase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein kinase C binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
kinase activity	Tyrosine-protein kinase ABL1	Homo sapiens (human)
SH3 domain binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
syntaxin binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
manganese ion binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuropilin binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
SH2 domain binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
ephrin receptor binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
actin filament binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
mitogen-activated protein kinase binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
proline-rich region binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
delta-catenin binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
sequence-specific double-stranded DNA binding	Tyrosine-protein kinase ABL1	Homo sapiens (human)
epidermal growth factor receptor activity	Epidermal growth factor receptor	Homo sapiens (human)
virus receptor activity	Epidermal growth factor receptor	Homo sapiens (human)
chromatin binding	Epidermal growth factor receptor	Homo sapiens (human)
double-stranded DNA binding	Epidermal growth factor receptor	Homo sapiens (human)
MAP kinase kinase kinase activity	Epidermal growth factor receptor	Homo sapiens (human)
protein tyrosine kinase activity	Epidermal growth factor receptor	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Epidermal growth factor receptor	Homo sapiens (human)
transmembrane signaling receptor activity	Epidermal growth factor receptor	Homo sapiens (human)
epidermal growth factor receptor activity	Epidermal growth factor receptor	Homo sapiens (human)
integrin binding	Epidermal growth factor receptor	Homo sapiens (human)
protein binding	Epidermal growth factor receptor	Homo sapiens (human)
calmodulin binding	Epidermal growth factor receptor	Homo sapiens (human)
ATP binding	Epidermal growth factor receptor	Homo sapiens (human)
enzyme binding	Epidermal growth factor receptor	Homo sapiens (human)
kinase binding	Epidermal growth factor receptor	Homo sapiens (human)
protein kinase binding	Epidermal growth factor receptor	Homo sapiens (human)
protein phosphatase binding	Epidermal growth factor receptor	Homo sapiens (human)
protein tyrosine kinase activator activity	Epidermal growth factor receptor	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activity	Epidermal growth factor receptor	Homo sapiens (human)
ubiquitin protein ligase binding	Epidermal growth factor receptor	Homo sapiens (human)
identical protein binding	Epidermal growth factor receptor	Homo sapiens (human)
cadherin binding	Epidermal growth factor receptor	Homo sapiens (human)
actin filament binding	Epidermal growth factor receptor	Homo sapiens (human)
ATPase binding	Epidermal growth factor receptor	Homo sapiens (human)
epidermal growth factor binding	Epidermal growth factor receptor	Homo sapiens (human)
cytokine activity	Interferon beta	Homo sapiens (human)
cytokine receptor binding	Interferon beta	Homo sapiens (human)
type I interferon receptor binding	Interferon beta	Homo sapiens (human)
protein binding	Interferon beta	Homo sapiens (human)
chloramphenicol O-acetyltransferase activity	Interferon beta	Homo sapiens (human)
protein tyrosine kinase activity	High affinity nerve growth factor receptor	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	High affinity nerve growth factor receptor	Homo sapiens (human)
GPI-linked ephrin receptor activity	High affinity nerve growth factor receptor	Homo sapiens (human)
neurotrophin p75 receptor binding	High affinity nerve growth factor receptor	Homo sapiens (human)
protein binding	High affinity nerve growth factor receptor	Homo sapiens (human)
ATP binding	High affinity nerve growth factor receptor	Homo sapiens (human)
nerve growth factor receptor activity	High affinity nerve growth factor receptor	Homo sapiens (human)
kinase binding	High affinity nerve growth factor receptor	Homo sapiens (human)
identical protein binding	High affinity nerve growth factor receptor	Homo sapiens (human)
protein homodimerization activity	High affinity nerve growth factor receptor	Homo sapiens (human)
nerve growth factor binding	High affinity nerve growth factor receptor	Homo sapiens (human)
neurotrophin binding	High affinity nerve growth factor receptor	Homo sapiens (human)
neurotrophin receptor activity	High affinity nerve growth factor receptor	Homo sapiens (human)
protein binding	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
GTP binding	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
metal ion binding	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
G-protein beta/gamma-subunit complex binding	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
G protein-coupled receptor binding	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
GTPase activity	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
adenine nucleotide transmembrane transporter activity	ADP/ATP translocase 2	Homo sapiens (human)
RNA binding	ADP/ATP translocase 2	Homo sapiens (human)
ATP:ADP antiporter activity	ADP/ATP translocase 2	Homo sapiens (human)
protein binding	ADP/ATP translocase 2	Homo sapiens (human)
proton transmembrane transporter activity	ADP/ATP translocase 2	Homo sapiens (human)
adenine transmembrane transporter activity	ADP/ATP translocase 2	Homo sapiens (human)
oxidative phosphorylation uncoupler activity	ADP/ATP translocase 2	Homo sapiens (human)
ubiquitin protein ligase binding	ADP/ATP translocase 2	Homo sapiens (human)
chromatin binding	Protein kinase C beta type	Homo sapiens (human)
protein serine/threonine kinase activity	Protein kinase C beta type	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C beta type	Homo sapiens (human)
protein kinase C binding	Protein kinase C beta type	Homo sapiens (human)
calcium channel regulator activity	Protein kinase C beta type	Homo sapiens (human)
protein binding	Protein kinase C beta type	Homo sapiens (human)
ATP binding	Protein kinase C beta type	Homo sapiens (human)
zinc ion binding	Protein kinase C beta type	Homo sapiens (human)
nuclear receptor coactivator activity	Protein kinase C beta type	Homo sapiens (human)
histone H3T6 kinase activity	Protein kinase C beta type	Homo sapiens (human)
histone binding	Protein kinase C beta type	Homo sapiens (human)
nuclear androgen receptor binding	Protein kinase C beta type	Homo sapiens (human)
protein serine kinase activity	Protein kinase C beta type	Homo sapiens (human)
amyloid-beta binding	Insulin receptor	Homo sapiens (human)
protein tyrosine kinase activity	Insulin receptor	Homo sapiens (human)
insulin receptor activity	Insulin receptor	Homo sapiens (human)
insulin-like growth factor receptor binding	Insulin receptor	Homo sapiens (human)
protein binding	Insulin receptor	Homo sapiens (human)
ATP binding	Insulin receptor	Homo sapiens (human)
GTP binding	Insulin receptor	Homo sapiens (human)
protein domain specific binding	Insulin receptor	Homo sapiens (human)
insulin-like growth factor I binding	Insulin receptor	Homo sapiens (human)
insulin-like growth factor II binding	Insulin receptor	Homo sapiens (human)
cargo receptor activity	Insulin receptor	Homo sapiens (human)
phosphatidylinositol 3-kinase binding	Insulin receptor	Homo sapiens (human)
insulin binding	Insulin receptor	Homo sapiens (human)
insulin receptor substrate binding	Insulin receptor	Homo sapiens (human)
protein-containing complex binding	Insulin receptor	Homo sapiens (human)
PTB domain binding	Insulin receptor	Homo sapiens (human)
phosphotyrosine residue binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase Lck	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Lck	Homo sapiens (human)
protein serine/threonine phosphatase activity	Tyrosine-protein kinase Lck	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
phospholipase activator activity	Tyrosine-protein kinase Lck	Homo sapiens (human)
protein kinase binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
protein phosphatase binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
SH2 domain binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
T cell receptor binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
CD4 receptor binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
CD8 receptor binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
identical protein binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
phospholipase binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
phosphatidylinositol 3-kinase binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
ATPase binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase Lck	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase Fyn	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Fyn	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
phospholipase activator activity	Tyrosine-protein kinase Fyn	Homo sapiens (human)
enzyme binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
type 5 metabotropic glutamate receptor binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
identical protein binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
alpha-tubulin binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
phospholipase binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
transmembrane transporter binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
metal ion binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
ephrin receptor binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
tau protein binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
tau-protein kinase activity	Tyrosine-protein kinase Fyn	Homo sapiens (human)
growth factor receptor binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
scaffold protein binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
disordered domain specific binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase Fyn	Homo sapiens (human)
virus receptor activity	Cyclin-dependent kinase 1	Homo sapiens (human)
chromatin binding	Cyclin-dependent kinase 1	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 1	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 1	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin binding	Cyclin-dependent kinase 1	Homo sapiens (human)
Hsp70 protein binding	Cyclin-dependent kinase 1	Homo sapiens (human)
histone kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin-dependent protein kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 1	Homo sapiens (human)
purine nucleobase binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
protein binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
ATP binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
glucose binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
glycogen phosphorylase activity	Glycogen phosphorylase, liver form	Homo sapiens (human)
AMP binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
vitamin binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
bile acid binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
identical protein binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
linear malto-oligosaccharide phosphorylase activity	Glycogen phosphorylase, liver form	Homo sapiens (human)
SHG alpha-glucan phosphorylase activity	Glycogen phosphorylase, liver form	Homo sapiens (human)
pyridoxal phosphate binding	Glycogen phosphorylase, liver form	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
microtubule binding	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
immunoglobulin receptor binding	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
phosphatidylinositol binding	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
phosphotyrosine residue binding	Tyrosine-protein kinase Yes	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase Yes	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Yes	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Yes	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Yes	Homo sapiens (human)
enzyme binding	Tyrosine-protein kinase Yes	Homo sapiens (human)
transmembrane transporter binding	Tyrosine-protein kinase Yes	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase Yes	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase Lyn	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Lyn	Homo sapiens (human)
platelet-derived growth factor receptor binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
integrin binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
kinase activity	Tyrosine-protein kinase Lyn	Homo sapiens (human)
SH3 domain binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
ubiquitin protein ligase binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
gamma-tubulin binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
glycosphingolipid binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
transmembrane transporter binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
ephrin receptor binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
phosphoprotein binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
scaffold protein binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
phosphorylation-dependent protein binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
phosphatidylinositol 3-kinase activator activity	Tyrosine-protein kinase Lyn	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase Lyn	Homo sapiens (human)
protein tyrosine kinase activity	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
calcium ion binding	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
protein binding	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
ATP binding	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
signaling receptor activity	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
G-protein alpha-subunit binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
protein tyrosine kinase activity	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin-like growth factor receptor activity	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin receptor binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
protein binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin-like growth factor binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
ATP binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin-like growth factor I binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
identical protein binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
phosphatidylinositol 3-kinase binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin receptor substrate binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
protein-containing complex binding	Insulin-like growth factor 1 receptor	Homo sapiens (human)
protein transporter activity	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin receptor activity	Insulin-like growth factor 1 receptor	Homo sapiens (human)
RNA binding	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
GTP binding	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
ATP hydrolysis activity	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
signal recognition particle binding	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
GTPase activity	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
protein binding	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
ubiquinol-cytochrome-c reductase activity	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
heme binding	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
metal ion binding	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
protein tyrosine kinase activity	Hepatocyte growth factor receptor	Homo sapiens (human)
protein binding	Hepatocyte growth factor receptor	Homo sapiens (human)
ATP binding	Hepatocyte growth factor receptor	Homo sapiens (human)
semaphorin receptor activity	Hepatocyte growth factor receptor	Homo sapiens (human)
protein phosphatase binding	Hepatocyte growth factor receptor	Homo sapiens (human)
identical protein binding	Hepatocyte growth factor receptor	Homo sapiens (human)
molecular function activator activity	Hepatocyte growth factor receptor	Homo sapiens (human)
hepatocyte growth factor receptor activity	Hepatocyte growth factor receptor	Homo sapiens (human)
phosphotyrosine residue binding	Tyrosine-protein kinase HCK	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase HCK	Homo sapiens (human)
protein binding	Tyrosine-protein kinase HCK	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase HCK	Homo sapiens (human)
lipid binding	Tyrosine-protein kinase HCK	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase HCK	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase HCK	Homo sapiens (human)
protein kinase activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
protein tyrosine kinase activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet activating factor receptor activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet-derived growth factor receptor activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet-derived growth factor beta-receptor activity	Platelet-derived growth factor receptor beta	Homo sapiens (human)
signaling receptor binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet-derived growth factor receptor binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
protein binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
ATP binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
enzyme binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
protein kinase binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
vascular endothelial growth factor binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
platelet-derived growth factor binding	Platelet-derived growth factor receptor beta	Homo sapiens (human)
3'-5'-RNA exonuclease activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoesters	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
protein guanylyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
protein kinase activity	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
MAP kinase kinase kinase activity	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
protein binding	Glycogen phosphorylase, brain form	Homo sapiens (human)
glycogen phosphorylase activity	Glycogen phosphorylase, brain form	Homo sapiens (human)
linear malto-oligosaccharide phosphorylase activity	Glycogen phosphorylase, brain form	Homo sapiens (human)
SHG alpha-glucan phosphorylase activity	Glycogen phosphorylase, brain form	Homo sapiens (human)
pyridoxal phosphate binding	Glycogen phosphorylase, brain form	Homo sapiens (human)
protein serine/threonine kinase activity	Breakpoint cluster region protein	Homo sapiens (human)
protein tyrosine kinase activity	Breakpoint cluster region protein	Homo sapiens (human)
guanyl-nucleotide exchange factor activity	Breakpoint cluster region protein	Homo sapiens (human)
GTPase activator activity	Breakpoint cluster region protein	Homo sapiens (human)
protein binding	Breakpoint cluster region protein	Homo sapiens (human)
ATP binding	Breakpoint cluster region protein	Homo sapiens (human)
protein serine kinase activity	Breakpoint cluster region protein	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
transcription factor binding	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
manganese ion binding	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
ribosomal small subunit binding	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
protein tyrosine kinase activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
fibroblast growth factor receptor activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
protein binding	Fibroblast growth factor receptor 1	Homo sapiens (human)
ATP binding	Fibroblast growth factor receptor 1	Homo sapiens (human)
heparin binding	Fibroblast growth factor receptor 1	Homo sapiens (human)
fibroblast growth factor binding	Fibroblast growth factor receptor 1	Homo sapiens (human)
SH2 domain binding	Fibroblast growth factor receptor 1	Homo sapiens (human)
identical protein binding	Fibroblast growth factor receptor 1	Homo sapiens (human)
protein homodimerization activity	Fibroblast growth factor receptor 1	Homo sapiens (human)
receptor-receptor interaction	Fibroblast growth factor receptor 1	Homo sapiens (human)
magnesium ion binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
chromatin binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
RNA binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity	DNA topoisomerase 2-alpha	Homo sapiens (human)
protein kinase C binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
protein binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
ATP binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
ATP-dependent activity, acting on DNA	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA binding, bending	DNA topoisomerase 2-alpha	Homo sapiens (human)
protein homodimerization activity	DNA topoisomerase 2-alpha	Homo sapiens (human)
ubiquitin binding	DNA topoisomerase 2-alpha	Homo sapiens (human)
protein heterodimerization activity	DNA topoisomerase 2-alpha	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 4	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 4	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 4	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	Cyclin-dependent kinase 4	Homo sapiens (human)
cyclin binding	Cyclin-dependent kinase 4	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 4	Homo sapiens (human)
ATP:ADP antiporter activity	ADP/ATP translocase 3	Homo sapiens (human)
protein binding	ADP/ATP translocase 3	Homo sapiens (human)
nucleotide binding	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
DNA binding	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
RNA binding	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
IMP dehydrogenase activity	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
protein binding	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
metal ion binding	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
protein kinase activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
protein tyrosine kinase activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
protein kinase C binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
signaling receptor binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
insulin receptor binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
integrin binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
protein binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
ATP binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
phospholipase activator activity	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
enzyme binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
heme binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
nuclear estrogen receptor binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
SH2 domain binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
phospholipase binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
transmembrane transporter binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cadherin binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
ephrin receptor binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
ATPase binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
phosphoprotein binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
BMP receptor binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
connexin binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
scaffold protein binding	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cAMP-dependent protein kinase inhibitor activity	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
protein binding	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
cAMP-dependent protein kinase regulator activity	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
protein domain specific binding	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
ubiquitin protein ligase binding	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
protein kinase A catalytic subunit binding	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
cAMP binding	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
patched binding	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
protein binding	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
protein kinase binding	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
ubiquitin-like protein ligase binding	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
MAP kinase kinase activity	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
calcium ion binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
mitogen-activated protein kinase kinase binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein-containing complex binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
scaffold protein binding	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
MAP kinase kinase kinase activity	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
protein serine/threonine kinase activity	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
phosphorylase kinase activity	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
protein binding	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
calmodulin binding	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
ATP binding	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
enzyme binding	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
tau-protein kinase activity	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
dihydronicotinamide riboside quinone reductase activity	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
protein binding	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
zinc ion binding	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
electron transfer activity	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
oxidoreductase activity	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
oxidoreductase activity, acting on other nitrogenous compounds as donors	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
chloride ion binding	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
protein homodimerization activity	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
FAD binding	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
melatonin binding	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
resveratrol binding	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
NAD(P)H dehydrogenase (quinone) activity	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Fer	Homo sapiens (human)
epidermal growth factor receptor binding	Tyrosine-protein kinase Fer	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Fer	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Fer	Homo sapiens (human)
protein phosphatase 1 binding	Tyrosine-protein kinase Fer	Homo sapiens (human)
lipid binding	Tyrosine-protein kinase Fer	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase Fer	Homo sapiens (human)
protein kinase activity	Protein kinase C alpha type	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C alpha type	Homo sapiens (human)
calcium,diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C alpha type	Homo sapiens (human)
integrin binding	Protein kinase C alpha type	Homo sapiens (human)
protein binding	Protein kinase C alpha type	Homo sapiens (human)
ATP binding	Protein kinase C alpha type	Homo sapiens (human)
zinc ion binding	Protein kinase C alpha type	Homo sapiens (human)
enzyme binding	Protein kinase C alpha type	Homo sapiens (human)
histone H3T6 kinase activity	Protein kinase C alpha type	Homo sapiens (human)
protein serine kinase activity	Protein kinase C alpha type	Homo sapiens (human)
protein serine/threonine kinase activity	Protein kinase C alpha type	Homo sapiens (human)
diacylglycerol binding	Protein kinase C alpha type	Homo sapiens (human)
magnesium ion binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein kinase activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein serine/threonine kinase activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
AMP-activated protein kinase activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cAMP-dependent protein kinase activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
ATP binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein kinase binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein domain specific binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
manganese ion binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
ubiquitin protein ligase binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein kinase A regulatory subunit binding	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
channel activator activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein serine kinase activity	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
protein binding	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
ATP binding	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
ATP hydrolysis activity	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
protein-macromolecule adaptor activity	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
5'-3' DNA helicase activity	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
metal ion binding	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
4 iron, 4 sulfur cluster binding	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
DNA helicase activity	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
damaged DNA binding	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase II subunit alpha'	Homo sapiens (human)
protein binding	Casein kinase II subunit alpha'	Homo sapiens (human)
ATP binding	Casein kinase II subunit alpha'	Homo sapiens (human)
protein serine kinase activity	Casein kinase II subunit alpha'	Homo sapiens (human)
protein binding	Cyclin-A2	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	Cyclin-A2	Homo sapiens (human)
protein kinase binding	Cyclin-A2	Homo sapiens (human)
protein domain specific binding	Cyclin-A2	Homo sapiens (human)
GTPase activity	Ras-related protein Rab-6A	Homo sapiens (human)
protein binding	Ras-related protein Rab-6A	Homo sapiens (human)
GTP binding	Ras-related protein Rab-6A	Homo sapiens (human)
protein domain specific binding	Ras-related protein Rab-6A	Homo sapiens (human)
myosin V binding	Ras-related protein Rab-6A	Homo sapiens (human)
fibronectin binding	Ephrin type-A receptor 1	Homo sapiens (human)
protein kinase activity	Ephrin type-A receptor 1	Homo sapiens (human)
transmembrane-ephrin receptor activity	Ephrin type-A receptor 1	Homo sapiens (human)
ATP binding	Ephrin type-A receptor 1	Homo sapiens (human)
protein kinase binding	Ephrin type-A receptor 1	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Ephrin type-A receptor 1	Homo sapiens (human)
phosphoribosylaminoimidazole carboxylase activity	Multifunctional protein ADE2	Homo sapiens (human)
phosphoribosylaminoimidazolesuccinocarboxamide synthase activity	Multifunctional protein ADE2	Homo sapiens (human)
protein binding	Multifunctional protein ADE2	Homo sapiens (human)
ATP binding	Multifunctional protein ADE2	Homo sapiens (human)
identical protein binding	Multifunctional protein ADE2	Homo sapiens (human)
5-amino-4-imidazole carboxylate lyase activity	Multifunctional protein ADE2	Homo sapiens (human)
cadherin binding	Multifunctional protein ADE2	Homo sapiens (human)
protein serine/threonine kinase activity	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
AMP-activated protein kinase activity	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
cAMP-dependent protein kinase activity	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
protein binding	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
ATP binding	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
protein serine kinase activity	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
protein kinase A regulatory subunit binding	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
magnesium ion binding	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
protein serine/threonine kinase activity	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
AMP-activated protein kinase activity	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
cAMP-dependent protein kinase activity	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
protein binding	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
ATP binding	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
ubiquitin protein ligase binding	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
protein serine kinase activity	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
ferrochelatase activity	Ferrochelatase, mitochondrial	Homo sapiens (human)
protein binding	Ferrochelatase, mitochondrial	Homo sapiens (human)
ferrous iron binding	Ferrochelatase, mitochondrial	Homo sapiens (human)
heme binding	Ferrochelatase, mitochondrial	Homo sapiens (human)
iron-responsive element binding	Ferrochelatase, mitochondrial	Homo sapiens (human)
identical protein binding	Ferrochelatase, mitochondrial	Homo sapiens (human)
protein homodimerization activity	Ferrochelatase, mitochondrial	Homo sapiens (human)
2 iron, 2 sulfur cluster binding	Ferrochelatase, mitochondrial	Homo sapiens (human)
protein kinase activity	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
protein serine/threonine kinase activity	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
ribosomal protein S6 kinase activity	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
protein binding	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
ATP binding	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
PDZ domain binding	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
peptide binding	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
identical protein binding	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
protein phosphatase 2A binding	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
protein serine kinase activity	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase JAK1	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase JAK1	Homo sapiens (human)
growth hormone receptor binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
protein binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
protein phosphatase binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
ubiquitin protein ligase binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
CCR5 chemokine receptor binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
metal ion binding	Tyrosine-protein kinase JAK1	Homo sapiens (human)
transcription corepressor activity	G1/S-specific cyclin-D1	Homo sapiens (human)
protein kinase activity	G1/S-specific cyclin-D1	Homo sapiens (human)
protein binding	G1/S-specific cyclin-D1	Homo sapiens (human)
enzyme binding	G1/S-specific cyclin-D1	Homo sapiens (human)
protein kinase binding	G1/S-specific cyclin-D1	Homo sapiens (human)
histone deacetylase binding	G1/S-specific cyclin-D1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	G1/S-specific cyclin-D1	Homo sapiens (human)
proline-rich region binding	G1/S-specific cyclin-D1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	G1/S-specific cyclin-D1	Homo sapiens (human)
protein binding	G1/S-specific cyclin-E1	Homo sapiens (human)
kinase activity	G1/S-specific cyclin-E1	Homo sapiens (human)
protein kinase binding	G1/S-specific cyclin-E1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	G1/S-specific cyclin-E1	Homo sapiens (human)
histone kinase activity	Cyclin-dependent kinase 2	Homo sapiens (human)
magnesium ion binding	Cyclin-dependent kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 2	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 2	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 2	Homo sapiens (human)
protein domain specific binding	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin binding	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin-dependent protein kinase activity	Cyclin-dependent kinase 2	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 2	Homo sapiens (human)
protein kinase activity	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
G protein-coupled receptor kinase activity	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
protein binding	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
ATP binding	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
alpha-2A adrenergic receptor binding	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
Edg-2 lysophosphatidic acid receptor binding	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
beta-adrenergic receptor kinase activity	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
G protein-coupled receptor binding	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
RNA binding	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
RNA helicase activity	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
helicase activity	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
protein binding	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
ATP binding	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
ATP hydrolysis activity	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
protein domain specific binding	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
cadherin binding	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
mRNA binding	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
phosphotyrosine residue binding	Mitogen-activated protein kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 3	Homo sapiens (human)
MAP kinase activity	Mitogen-activated protein kinase 3	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 3	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 3	Homo sapiens (human)
phosphatase binding	Mitogen-activated protein kinase 3	Homo sapiens (human)
identical protein binding	Mitogen-activated protein kinase 3	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 3	Homo sapiens (human)
DNA-binding transcription factor binding	Mitogen-activated protein kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
protein binding	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
ATP binding	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
tau protein binding	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
tau-protein kinase activity	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
protein serine kinase activity	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
deoxyadenosine kinase activity	Deoxycytidine kinase	Homo sapiens (human)
deoxycytidine kinase activity	Deoxycytidine kinase	Homo sapiens (human)
deoxyguanosine kinase activity	Deoxycytidine kinase	Homo sapiens (human)
ATP binding	Deoxycytidine kinase	Homo sapiens (human)
protein homodimerization activity	Deoxycytidine kinase	Homo sapiens (human)
cytidine kinase activity	Deoxycytidine kinase	Homo sapiens (human)
phosphotyrosine residue binding	Mitogen-activated protein kinase 1	Homo sapiens (human)
DNA binding	Mitogen-activated protein kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 1	Homo sapiens (human)
MAP kinase activity	Mitogen-activated protein kinase 1	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 1	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 1	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Mitogen-activated protein kinase 1	Homo sapiens (human)
phosphatase binding	Mitogen-activated protein kinase 1	Homo sapiens (human)
identical protein binding	Mitogen-activated protein kinase 1	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 1	Homo sapiens (human)
virus receptor activity	Ephrin type-A receptor 2	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Ephrin type-A receptor 2	Homo sapiens (human)
ephrin receptor activity	Ephrin type-A receptor 2	Homo sapiens (human)
protein binding	Ephrin type-A receptor 2	Homo sapiens (human)
ATP binding	Ephrin type-A receptor 2	Homo sapiens (human)
growth factor binding	Ephrin type-A receptor 2	Homo sapiens (human)
cadherin binding	Ephrin type-A receptor 2	Homo sapiens (human)
molecular function activator activity	Ephrin type-A receptor 2	Homo sapiens (human)
amyloid-beta binding	Ephrin type-B receptor 2	Homo sapiens (human)
protein tyrosine kinase activity	Ephrin type-B receptor 2	Homo sapiens (human)
transmembrane-ephrin receptor activity	Ephrin type-B receptor 2	Homo sapiens (human)
signaling receptor binding	Ephrin type-B receptor 2	Homo sapiens (human)
protein binding	Ephrin type-B receptor 2	Homo sapiens (human)
ATP binding	Ephrin type-B receptor 2	Homo sapiens (human)
axon guidance receptor activity	Ephrin type-B receptor 2	Homo sapiens (human)
identical protein binding	Ephrin type-B receptor 2	Homo sapiens (human)
protein-containing complex binding	Ephrin type-B receptor 2	Homo sapiens (human)
protein tyrosine kinase activity	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
growth hormone receptor binding	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
protein binding	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
ATP binding	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
type 1 angiotensin receptor binding	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	G1/S-specific cyclin-D3	Homo sapiens (human)
protein binding	G1/S-specific cyclin-D3	Homo sapiens (human)
protein kinase binding	G1/S-specific cyclin-D3	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	G1/S-specific cyclin-D3	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	G1/S-specific cyclin-D3	Homo sapiens (human)
magnesium ion binding	Wee1-like protein kinase	Homo sapiens (human)
protein tyrosine kinase activity	Wee1-like protein kinase	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Wee1-like protein kinase	Homo sapiens (human)
protein binding	Wee1-like protein kinase	Homo sapiens (human)
ATP binding	Wee1-like protein kinase	Homo sapiens (human)
heme oxygenase (decyclizing) activity	Heme oxygenase 2	Homo sapiens (human)
protein binding	Heme oxygenase 2	Homo sapiens (human)
metal ion binding	Heme oxygenase 2	Homo sapiens (human)
heme binding	Heme oxygenase 2	Homo sapiens (human)
methionine adenosyltransferase activity	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
protein binding	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
ATP binding	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
small molecule binding	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
identical protein binding	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
metal ion binding	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
G protein-coupled receptor binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
ATPase activator activity	DnaJ homolog subfamily A member 1	Homo sapiens (human)
protein binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
ATP binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
Hsp70 protein binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
Tat protein binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
ubiquitin protein ligase binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
metal ion binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
low-density lipoprotein particle receptor binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
unfolded protein binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
protein-folding chaperone binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
C3HC4-type RING finger domain binding	DnaJ homolog subfamily A member 1	Homo sapiens (human)
protein kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
calmodulin binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
ATP binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
enzyme binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein kinase binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
nitric-oxide synthase regulator activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein serine/threonine kinase inhibitor activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
identical protein binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein homodimerization activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
phosphatidylinositol-3,4-bisphosphate binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
14-3-3 protein binding	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
potassium channel activator activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein serine kinase activity	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
protein binding	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
ATP binding	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
metal ion binding	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
protein serine kinase activity	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
molecular function activator activity	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity protein kinase TTK	Homo sapiens (human)
protein binding	Dual specificity protein kinase TTK	Homo sapiens (human)
ATP binding	Dual specificity protein kinase TTK	Homo sapiens (human)
identical protein binding	Dual specificity protein kinase TTK	Homo sapiens (human)
kinetochore binding	Dual specificity protein kinase TTK	Homo sapiens (human)
protein serine kinase activity	Dual specificity protein kinase TTK	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity protein kinase TTK	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity protein kinase TTK	Homo sapiens (human)
DNA helicase activity	DNA replication licensing factor MCM4	Homo sapiens (human)
single-stranded DNA binding	DNA replication licensing factor MCM4	Homo sapiens (human)
protein binding	DNA replication licensing factor MCM4	Homo sapiens (human)
ATP binding	DNA replication licensing factor MCM4	Homo sapiens (human)
ATP hydrolysis activity	DNA replication licensing factor MCM4	Homo sapiens (human)
single-stranded DNA helicase activity	DNA replication licensing factor MCM4	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
MAP kinase kinase activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
MAP-kinase scaffold activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
protein binding	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
ATP binding	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
PDZ domain binding	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
protein serine/threonine kinase activator activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
metal ion binding	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
scaffold protein binding	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
protein serine kinase activity	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
protein tyrosine kinase activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
cytokine receptor activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
vascular endothelial growth factor receptor activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
protein binding	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
ATP binding	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
nuclear glucocorticoid receptor binding	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
protein-containing complex binding	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
phosphatidylinositol 3-kinase activator activity	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
growth factor binding	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
protein serine/threonine kinase activity	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
transmembrane receptor protein serine/threonine kinase activity	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
transforming growth factor beta receptor activity, type I	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
protein binding	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
ATP binding	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
BMP binding	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
protein homodimerization activity	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
SMAD binding	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
metal ion binding	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
BMP receptor activity	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
activin receptor activity	Activin receptor type-1B	Homo sapiens (human)
growth factor binding	Activin receptor type-1B	Homo sapiens (human)
activin binding	Activin receptor type-1B	Homo sapiens (human)
protein serine/threonine kinase activity	Activin receptor type-1B	Homo sapiens (human)
transmembrane receptor protein serine/threonine kinase activity	Activin receptor type-1B	Homo sapiens (human)
protein binding	Activin receptor type-1B	Homo sapiens (human)
ATP binding	Activin receptor type-1B	Homo sapiens (human)
activin receptor activity, type I	Activin receptor type-1B	Homo sapiens (human)
activin receptor activity	Activin receptor type-1B	Homo sapiens (human)
ubiquitin protein ligase binding	Activin receptor type-1B	Homo sapiens (human)
inhibin binding	Activin receptor type-1B	Homo sapiens (human)
SMAD binding	Activin receptor type-1B	Homo sapiens (human)
metal ion binding	Activin receptor type-1B	Homo sapiens (human)
I-SMAD binding	Activin receptor type-1B	Homo sapiens (human)
transforming growth factor beta receptor activity	TGF-beta receptor type-1	Homo sapiens (human)
growth factor binding	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta binding	TGF-beta receptor type-1	Homo sapiens (human)
protein kinase activity	TGF-beta receptor type-1	Homo sapiens (human)
protein serine/threonine kinase activity	TGF-beta receptor type-1	Homo sapiens (human)
transmembrane receptor protein serine/threonine kinase activity	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta receptor activity	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta receptor activity, type I	TGF-beta receptor type-1	Homo sapiens (human)
type II transforming growth factor beta receptor binding	TGF-beta receptor type-1	Homo sapiens (human)
protein binding	TGF-beta receptor type-1	Homo sapiens (human)
ATP binding	TGF-beta receptor type-1	Homo sapiens (human)
ubiquitin protein ligase binding	TGF-beta receptor type-1	Homo sapiens (human)
SMAD binding	TGF-beta receptor type-1	Homo sapiens (human)
metal ion binding	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta binding	TGF-beta receptor type-1	Homo sapiens (human)
I-SMAD binding	TGF-beta receptor type-1	Homo sapiens (human)
activin receptor activity, type I	TGF-beta receptor type-1	Homo sapiens (human)
activin binding	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta binding	TGF-beta receptor type-2	Homo sapiens (human)
transmembrane receptor protein serine/threonine kinase activity	TGF-beta receptor type-2	Homo sapiens (human)
transforming growth factor beta receptor activity	TGF-beta receptor type-2	Homo sapiens (human)
transforming growth factor beta receptor activity, type II	TGF-beta receptor type-2	Homo sapiens (human)
protein binding	TGF-beta receptor type-2	Homo sapiens (human)
ATP binding	TGF-beta receptor type-2	Homo sapiens (human)
glycosaminoglycan binding	TGF-beta receptor type-2	Homo sapiens (human)
kinase activator activity	TGF-beta receptor type-2	Homo sapiens (human)
type I transforming growth factor beta receptor binding	TGF-beta receptor type-2	Homo sapiens (human)
SMAD binding	TGF-beta receptor type-2	Homo sapiens (human)
metal ion binding	TGF-beta receptor type-2	Homo sapiens (human)
transforming growth factor beta binding	TGF-beta receptor type-2	Homo sapiens (human)
molecular adaptor activity	TGF-beta receptor type-2	Homo sapiens (human)
activin receptor activity	TGF-beta receptor type-2	Homo sapiens (human)
activin binding	TGF-beta receptor type-2	Homo sapiens (human)
protein serine/threonine kinase activity	TGF-beta receptor type-2	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase CSK	Homo sapiens (human)
protein binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
protein phosphatase binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
protein kinase A catalytic subunit binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
identical protein binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
metal ion binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
proline-rich region binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
protein tyrosine kinase binding	Tyrosine-protein kinase CSK	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase CSK	Homo sapiens (human)
bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity	Glycine--tRNA ligase	Homo sapiens (human)
glycine-tRNA ligase activity	Glycine--tRNA ligase	Homo sapiens (human)
protein binding	Glycine--tRNA ligase	Homo sapiens (human)
ATP binding	Glycine--tRNA ligase	Homo sapiens (human)
transferase activity	Glycine--tRNA ligase	Homo sapiens (human)
identical protein binding	Glycine--tRNA ligase	Homo sapiens (human)
protein dimerization activity	Glycine--tRNA ligase	Homo sapiens (human)
protein kinase activity	Protein kinase C iota type	Homo sapiens (human)
protein serine/threonine kinase activity	Protein kinase C iota type	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C iota type	Homo sapiens (human)
protein binding	Protein kinase C iota type	Homo sapiens (human)
ATP binding	Protein kinase C iota type	Homo sapiens (human)
phospholipid binding	Protein kinase C iota type	Homo sapiens (human)
metal ion binding	Protein kinase C iota type	Homo sapiens (human)
protein serine kinase activity	Protein kinase C iota type	Homo sapiens (human)
RNA binding	Exosome RNA helicase MTR4	Homo sapiens (human)
RNA helicase activity	Exosome RNA helicase MTR4	Homo sapiens (human)
protein binding	Exosome RNA helicase MTR4	Homo sapiens (human)
ATP binding	Exosome RNA helicase MTR4	Homo sapiens (human)
ATP hydrolysis activity	Exosome RNA helicase MTR4	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase Tec	Homo sapiens (human)
protein binding	Tyrosine-protein kinase Tec	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase Tec	Homo sapiens (human)
phospholipid binding	Tyrosine-protein kinase Tec	Homo sapiens (human)
metal ion binding	Tyrosine-protein kinase Tec	Homo sapiens (human)
magnesium ion binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
phosphotyrosine residue binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
actin monomer binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
protein kinase activity	Tyrosine-protein kinase ABL2	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase ABL2	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase ABL2	Homo sapiens (human)
protein binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
manganese ion binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
actin filament binding	Tyrosine-protein kinase ABL2	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase FRK	Homo sapiens (human)
protein binding	Tyrosine-protein kinase FRK	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase FRK	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase FRK	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase FRK	Homo sapiens (human)
phosphotyrosine residue binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein kinase activity	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein serine/threonine kinase activity	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase SYK	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase SYK	Homo sapiens (human)
signaling receptor binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
integrin binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
interleukin-15 receptor binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
kinase activity	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein kinase binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
phosphatase binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
Toll-like receptor binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
SH2 domain binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
phospholipase binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
scaffold protein binding	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein binding	26S proteasome regulatory subunit 6B	Homo sapiens (human)
ATP binding	26S proteasome regulatory subunit 6B	Homo sapiens (human)
ATP hydrolysis activity	26S proteasome regulatory subunit 6B	Homo sapiens (human)
proteasome-activating activity	26S proteasome regulatory subunit 6B	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 8	Homo sapiens (human)
JUN kinase activity	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
enzyme binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein phosphatase binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
histone deacetylase regulator activity	Mitogen-activated protein kinase 8	Homo sapiens (human)
histone deacetylase binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein serine/threonine kinase binding	Mitogen-activated protein kinase 8	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 9	Homo sapiens (human)
JUN kinase activity	Mitogen-activated protein kinase 9	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Mitogen-activated protein kinase 9	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 9	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 9	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 9	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
MAP kinase kinase activity	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
protein binding	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
ATP binding	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
protein kinase binding	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
protein serine kinase activity	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
protein binding	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
ATP binding	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
1-phosphatidylinositol-4-phosphate 5-kinase activity	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
1-phosphatidylinositol-5-phosphate 4-kinase activity	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
protein homodimerization activity	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
protein kinase activity	Casein kinase I isoform alpha	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase I isoform alpha	Homo sapiens (human)
protein binding	Casein kinase I isoform alpha	Homo sapiens (human)
ATP binding	Casein kinase I isoform alpha	Homo sapiens (human)
protein serine kinase activity	Casein kinase I isoform alpha	Homo sapiens (human)
protein kinase activity	Casein kinase I isoform delta	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase I isoform delta	Homo sapiens (human)
protein binding	Casein kinase I isoform delta	Homo sapiens (human)
ATP binding	Casein kinase I isoform delta	Homo sapiens (human)
cadherin binding	Casein kinase I isoform delta	Homo sapiens (human)
tau-protein kinase activity	Casein kinase I isoform delta	Homo sapiens (human)
protein serine kinase activity	Casein kinase I isoform delta	Homo sapiens (human)
protein kinase activity	MAP kinase-activated protein kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	MAP kinase-activated protein kinase 2	Homo sapiens (human)
protein binding	MAP kinase-activated protein kinase 2	Homo sapiens (human)
ATP binding	MAP kinase-activated protein kinase 2	Homo sapiens (human)
protein serine kinase activity	MAP kinase-activated protein kinase 2	Homo sapiens (human)
calcium-dependent protein serine/threonine kinase activity	MAP kinase-activated protein kinase 2	Homo sapiens (human)
calmodulin binding	MAP kinase-activated protein kinase 2	Homo sapiens (human)
calmodulin-dependent protein kinase activity	MAP kinase-activated protein kinase 2	Homo sapiens (human)
mitogen-activated protein kinase binding	MAP kinase-activated protein kinase 2	Homo sapiens (human)
RNA binding	Elongation factor Tu, mitochondrial	Homo sapiens (human)
translation elongation factor activity	Elongation factor Tu, mitochondrial	Homo sapiens (human)
GTPase activity	Elongation factor Tu, mitochondrial	Homo sapiens (human)
protein binding	Elongation factor Tu, mitochondrial	Homo sapiens (human)
GTP binding	Elongation factor Tu, mitochondrial	Homo sapiens (human)
choline-phosphate cytidylyltransferase activity	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
protein binding	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
calmodulin binding	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
identical protein binding	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
protein homodimerization activity	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
molecular function inhibitor activity	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
phosphatidylcholine binding	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
RNA binding	Casein kinase I isoform epsilon	Homo sapiens (human)
protein kinase activity	Casein kinase I isoform epsilon	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase I isoform epsilon	Homo sapiens (human)
protein binding	Casein kinase I isoform epsilon	Homo sapiens (human)
ATP binding	Casein kinase I isoform epsilon	Homo sapiens (human)
protein serine kinase activity	Casein kinase I isoform epsilon	Homo sapiens (human)
acyl-CoA dehydrogenase activity	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
long-chain fatty acyl-CoA dehydrogenase activity	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
protein binding	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
very-long-chain fatty acyl-CoA dehydrogenase activity	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
identical protein binding	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
flavin adenine dinucleotide binding	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
fatty-acyl-CoA binding	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity protein kinase CLK1	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity protein kinase CLK1	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Dual specificity protein kinase CLK1	Homo sapiens (human)
protein binding	Dual specificity protein kinase CLK1	Homo sapiens (human)
ATP binding	Dual specificity protein kinase CLK1	Homo sapiens (human)
protein serine kinase activity	Dual specificity protein kinase CLK1	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity protein kinase CLK1	Homo sapiens (human)
RNA binding	Dual specificity protein kinase CLK3	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity protein kinase CLK3	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity protein kinase CLK3	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity protein kinase CLK3	Homo sapiens (human)
protein binding	Dual specificity protein kinase CLK3	Homo sapiens (human)
ATP binding	Dual specificity protein kinase CLK3	Homo sapiens (human)
identical protein binding	Dual specificity protein kinase CLK3	Homo sapiens (human)
protein serine kinase activity	Dual specificity protein kinase CLK3	Homo sapiens (human)
protein serine/threonine kinase activity	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
signaling receptor binding	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
protein binding	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
ATP binding	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
protein kinase A catalytic subunit binding	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
tau protein binding	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
tau-protein kinase activity	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
protein serine kinase activity	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
protease binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
p53 binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein kinase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein serine/threonine kinase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
ATP binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
beta-catenin binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
kinase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein kinase binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
ubiquitin protein ligase binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein kinase A catalytic subunit binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
dynactin binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
tau protein binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
tau-protein kinase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
NF-kappaB binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor binding	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein serine kinase activity	Glycogen synthase kinase-3 beta	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 7	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent kinase 7	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 7	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 7	Homo sapiens (human)
ATP-dependent activity, acting on DNA	Cyclin-dependent kinase 7	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Cyclin-dependent kinase 7	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 7	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 7	Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription coactivator binding	Cyclin-dependent kinase 9	Homo sapiens (human)
DNA binding	Cyclin-dependent kinase 9	Homo sapiens (human)
chromatin binding	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription elongation factor activity	Cyclin-dependent kinase 9	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 9	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent kinase 9	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 9	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 9	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 9	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Cyclin-dependent kinase 9	Homo sapiens (human)
kinase activity	Cyclin-dependent kinase 9	Homo sapiens (human)
protein kinase binding	Cyclin-dependent kinase 9	Homo sapiens (human)
7SK snRNA binding	Cyclin-dependent kinase 9	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 9	Homo sapiens (human)
GTPase activity	Ras-related protein Rab-27A	Homo sapiens (human)
G protein activity	Ras-related protein Rab-27A	Homo sapiens (human)
protein binding	Ras-related protein Rab-27A	Homo sapiens (human)
GTP binding	Ras-related protein Rab-27A	Homo sapiens (human)
GDP binding	Ras-related protein Rab-27A	Homo sapiens (human)
protein domain specific binding	Ras-related protein Rab-27A	Homo sapiens (human)
myosin V binding	Ras-related protein Rab-27A	Homo sapiens (human)
protein kinase activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein binding	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
ATP binding	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
kinase activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein kinase binding	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
heat shock protein binding	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
identical protein binding	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein homodimerization activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein heterodimerization activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein serine kinase activity	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
magnesium ion binding	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
protein kinase activity	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
protein serine/threonine kinase activity	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
protein binding	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
ATP binding	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
protein kinase binding	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic process	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
protein serine kinase activity	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
ribosomal protein S6 kinase activity	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
RNA polymerase II general transcription initiation factor activity	Cyclin-H	Homo sapiens (human)
protein binding	Cyclin-H	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activity	Cyclin-H	Homo sapiens (human)
protein binding	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
zinc ion binding	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein phosphatase binding	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
MAP kinase kinase activity	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
protein binding	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
ATP binding	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
protein kinase binding	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
protein serine kinase activity	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
protein kinase activity	LIM domain kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	LIM domain kinase 1	Homo sapiens (human)
protein binding	LIM domain kinase 1	Homo sapiens (human)
ATP binding	LIM domain kinase 1	Homo sapiens (human)
heat shock protein binding	LIM domain kinase 1	Homo sapiens (human)
metal ion binding	LIM domain kinase 1	Homo sapiens (human)
protein serine kinase activity	LIM domain kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	LIM domain kinase 2	Homo sapiens (human)
protein binding	LIM domain kinase 2	Homo sapiens (human)
ATP binding	LIM domain kinase 2	Homo sapiens (human)
metal ion binding	LIM domain kinase 2	Homo sapiens (human)
protein serine kinase activity	LIM domain kinase 2	Homo sapiens (human)
tRNA binding	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
RNA binding	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
tyrosine-tRNA ligase activity	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
interleukin-8 receptor binding	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
protein binding	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
ATP binding	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
small molecule binding	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
protein kinase activity	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
cAMP-dependent protein kinase activity	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
protein binding	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
ATP binding	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
cAMP-dependent protein kinase regulator activity	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
AMP binding	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
protein kinase regulator activity	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
protein kinase binding	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
ADP binding	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
ephrin receptor activity	Ephrin type-B receptor 3	Homo sapiens (human)
protein binding	Ephrin type-B receptor 3	Homo sapiens (human)
ATP binding	Ephrin type-B receptor 3	Homo sapiens (human)
axon guidance receptor activity	Ephrin type-B receptor 3	Homo sapiens (human)
transmembrane-ephrin receptor activity	Ephrin type-B receptor 3	Homo sapiens (human)
ephrin receptor activity	Ephrin type-A receptor 5	Homo sapiens (human)
GPI-linked ephrin receptor activity	Ephrin type-A receptor 5	Homo sapiens (human)
transmembrane-ephrin receptor activity	Ephrin type-A receptor 5	Homo sapiens (human)
protein binding	Ephrin type-A receptor 5	Homo sapiens (human)
ATP binding	Ephrin type-A receptor 5	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Ephrin type-B receptor 4	Homo sapiens (human)
ephrin receptor activity	Ephrin type-B receptor 4	Homo sapiens (human)
protein binding	Ephrin type-B receptor 4	Homo sapiens (human)
ATP binding	Ephrin type-B receptor 4	Homo sapiens (human)
amyloid-beta binding	Ephrin type-A receptor 4	Homo sapiens (human)
protein kinase activity	Ephrin type-A receptor 4	Homo sapiens (human)
protein tyrosine kinase activity	Ephrin type-A receptor 4	Homo sapiens (human)
GPI-linked ephrin receptor activity	Ephrin type-A receptor 4	Homo sapiens (human)
transmembrane-ephrin receptor activity	Ephrin type-A receptor 4	Homo sapiens (human)
protein binding	Ephrin type-A receptor 4	Homo sapiens (human)
ATP binding	Ephrin type-A receptor 4	Homo sapiens (human)
kinase activity	Ephrin type-A receptor 4	Homo sapiens (human)
PH domain binding	Ephrin type-A receptor 4	Homo sapiens (human)
identical protein binding	Ephrin type-A receptor 4	Homo sapiens (human)
ephrin receptor binding	Ephrin type-A receptor 4	Homo sapiens (human)
DH domain binding	Ephrin type-A receptor 4	Homo sapiens (human)
protein tyrosine kinase binding	Ephrin type-A receptor 4	Homo sapiens (human)
adenylate kinase activity	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
protein binding	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
ATP binding	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
RNA binding	Adenosine kinase	Homo sapiens (human)
deoxyadenosine kinase activity	Adenosine kinase	Homo sapiens (human)
ATP binding	Adenosine kinase	Homo sapiens (human)
metal ion binding	Adenosine kinase	Homo sapiens (human)
adenosine kinase activity	Adenosine kinase	Homo sapiens (human)
G protein activity	Ras-related protein Rab-10	Homo sapiens (human)
protein binding	Ras-related protein Rab-10	Homo sapiens (human)
GTP binding	Ras-related protein Rab-10	Homo sapiens (human)
GDP binding	Ras-related protein Rab-10	Homo sapiens (human)
myosin V binding	Ras-related protein Rab-10	Homo sapiens (human)
cadherin binding involved in cell-cell adhesion	Ras-related protein Rab-10	Homo sapiens (human)
actin filament binding	Actin-related protein 3	Homo sapiens (human)
structural constituent of cytoskeleton	Actin-related protein 3	Homo sapiens (human)
protein binding	Actin-related protein 3	Homo sapiens (human)
ATP binding	Actin-related protein 3	Homo sapiens (human)
actin filament binding	Actin-related protein 2	Homo sapiens (human)
structural constituent of cytoskeleton	Actin-related protein 2	Homo sapiens (human)
protein binding	Actin-related protein 2	Homo sapiens (human)
ATP binding	Actin-related protein 2	Homo sapiens (human)
nuclear export signal receptor activity	GTP-binding nuclear protein Ran	Homo sapiens (human)
pre-miRNA binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
magnesium ion binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
chromatin binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
RNA binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
GTPase activity	GTP-binding nuclear protein Ran	Homo sapiens (human)
G protein activity	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
GTP binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
GDP binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein domain specific binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
cadherin binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
dynein intermediate chain binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein heterodimerization activity	GTP-binding nuclear protein Ran	Homo sapiens (human)
importin-alpha family protein binding	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase I isoform gamma-2	Homo sapiens (human)
protein binding	Casein kinase I isoform gamma-2	Homo sapiens (human)
ATP binding	Casein kinase I isoform gamma-2	Homo sapiens (human)
protein serine kinase activity	Casein kinase I isoform gamma-2	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 6	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 6	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 6	Homo sapiens (human)
cyclin binding	Cyclin-dependent kinase 6	Homo sapiens (human)
FBXO family protein binding	Cyclin-dependent kinase 6	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 6	Homo sapiens (human)
microtubule binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
p53 binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein kinase activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
ErbB-2 class receptor binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
ATP binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
kinase activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
acetylcholine receptor activator activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
ErbB-3 class receptor binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
tau protein binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
tau-protein kinase activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
Hsp90 protein binding	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein serine/threonine kinase activity	Cyclin-dependent kinase 16	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 16	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 16	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 16	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 16	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 17	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 17	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 17	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 17	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 17	Homo sapiens (human)
6-phosphofructokinase activity	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
protein binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
protein-containing complex binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
cadherin binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
metal ion binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
ATP binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
monosaccharide binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
AMP binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
identical protein binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
fructose-6-phosphate binding	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
protein kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
MAP kinase kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
MAP-kinase scaffold activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein binding	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
ATP binding	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein kinase activator activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein serine/threonine kinase activator activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
scaffold protein binding	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
protein serine kinase activity	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
DNA binding	DNA topoisomerase 2-beta	Homo sapiens (human)
chromatin binding	DNA topoisomerase 2-beta	Homo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity	DNA topoisomerase 2-beta	Homo sapiens (human)
protein binding	DNA topoisomerase 2-beta	Homo sapiens (human)
ATP binding	DNA topoisomerase 2-beta	Homo sapiens (human)
ribonucleoprotein complex binding	DNA topoisomerase 2-beta	Homo sapiens (human)
metal ion binding	DNA topoisomerase 2-beta	Homo sapiens (human)
protein kinase activity	Protein kinase C theta type	Homo sapiens (human)
protein serine/threonine kinase activity	Protein kinase C theta type	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C theta type	Homo sapiens (human)
protein binding	Protein kinase C theta type	Homo sapiens (human)
ATP binding	Protein kinase C theta type	Homo sapiens (human)
metal ion binding	Protein kinase C theta type	Homo sapiens (human)
protein serine kinase activity	Protein kinase C theta type	Homo sapiens (human)
activin receptor activity, type I	Activin receptor type-1	Homo sapiens (human)
protein kinase activity	Activin receptor type-1	Homo sapiens (human)
protein serine/threonine kinase activity	Activin receptor type-1	Homo sapiens (human)
transmembrane receptor protein serine/threonine kinase activity	Activin receptor type-1	Homo sapiens (human)
protein binding	Activin receptor type-1	Homo sapiens (human)
ATP binding	Activin receptor type-1	Homo sapiens (human)
peptide hormone binding	Activin receptor type-1	Homo sapiens (human)
protein homodimerization activity	Activin receptor type-1	Homo sapiens (human)
cadherin binding	Activin receptor type-1	Homo sapiens (human)
SMAD binding	Activin receptor type-1	Homo sapiens (human)
metal ion binding	Activin receptor type-1	Homo sapiens (human)
activin binding	Activin receptor type-1	Homo sapiens (human)
transforming growth factor beta binding	Activin receptor type-1	Homo sapiens (human)
BMP receptor activity	Activin receptor type-1	Homo sapiens (human)
protein tyrosine kinase binding	Activin receptor type-1	Homo sapiens (human)
transforming growth factor beta receptor activity, type I	Activin receptor type-1	Homo sapiens (human)
macrophage colony-stimulating factor receptor activity	Macrophage-stimulating protein receptor	Homo sapiens (human)
protein binding	Macrophage-stimulating protein receptor	Homo sapiens (human)
ATP binding	Macrophage-stimulating protein receptor	Homo sapiens (human)
enzyme binding	Macrophage-stimulating protein receptor	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Macrophage-stimulating protein receptor	Homo sapiens (human)
actin binding	Focal adhesion kinase 1	Homo sapiens (human)
protein tyrosine kinase activity	Focal adhesion kinase 1	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Focal adhesion kinase 1	Homo sapiens (human)
protein tyrosine phosphatase activity	Focal adhesion kinase 1	Homo sapiens (human)
integrin binding	Focal adhesion kinase 1	Homo sapiens (human)
protein binding	Focal adhesion kinase 1	Homo sapiens (human)
ATP binding	Focal adhesion kinase 1	Homo sapiens (human)
JUN kinase binding	Focal adhesion kinase 1	Homo sapiens (human)
protein kinase binding	Focal adhesion kinase 1	Homo sapiens (human)
protein phosphatase binding	Focal adhesion kinase 1	Homo sapiens (human)
SH2 domain binding	Focal adhesion kinase 1	Homo sapiens (human)
molecular function activator activity	Focal adhesion kinase 1	Homo sapiens (human)
protein kinase activity	Protein kinase C zeta type	Homo sapiens (human)
protein serine/threonine kinase activity	Protein kinase C zeta type	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C zeta type	Homo sapiens (human)
protein binding	Protein kinase C zeta type	Homo sapiens (human)
ATP binding	Protein kinase C zeta type	Homo sapiens (human)
potassium channel regulator activity	Protein kinase C zeta type	Homo sapiens (human)
protein kinase binding	Protein kinase C zeta type	Homo sapiens (human)
phospholipase binding	Protein kinase C zeta type	Homo sapiens (human)
insulin receptor substrate binding	Protein kinase C zeta type	Homo sapiens (human)
protein-containing complex binding	Protein kinase C zeta type	Homo sapiens (human)
metal ion binding	Protein kinase C zeta type	Homo sapiens (human)
14-3-3 protein binding	Protein kinase C zeta type	Homo sapiens (human)
protein serine kinase activity	Protein kinase C zeta type	Homo sapiens (human)
protein kinase activity	Protein kinase C delta type	Homo sapiens (human)
protein serine/threonine kinase activity	Protein kinase C delta type	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Protein kinase C delta type	Homo sapiens (human)
diacylglycerol-dependent, calcium-independent serine/threonine kinase activity	Protein kinase C delta type	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Protein kinase C delta type	Homo sapiens (human)
protein binding	Protein kinase C delta type	Homo sapiens (human)
ATP binding	Protein kinase C delta type	Homo sapiens (human)
enzyme activator activity	Protein kinase C delta type	Homo sapiens (human)
enzyme binding	Protein kinase C delta type	Homo sapiens (human)
protein kinase binding	Protein kinase C delta type	Homo sapiens (human)
insulin receptor substrate binding	Protein kinase C delta type	Homo sapiens (human)
metal ion binding	Protein kinase C delta type	Homo sapiens (human)
protein serine kinase activity	Protein kinase C delta type	Homo sapiens (human)
protein tyrosine kinase activity	Tyrosine-protein kinase BTK	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Tyrosine-protein kinase BTK	Homo sapiens (human)
protein binding	Tyrosine-protein kinase BTK	Homo sapiens (human)
ATP binding	Tyrosine-protein kinase BTK	Homo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate binding	Tyrosine-protein kinase BTK	Homo sapiens (human)
phospholipase activator activity	Tyrosine-protein kinase BTK	Homo sapiens (human)
identical protein binding	Tyrosine-protein kinase BTK	Homo sapiens (human)
phospholipase binding	Tyrosine-protein kinase BTK	Homo sapiens (human)
metal ion binding	Tyrosine-protein kinase BTK	Homo sapiens (human)
protein serine/threonine kinase activity	Activated CDC42 kinase 1	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Activated CDC42 kinase 1	Homo sapiens (human)
protein tyrosine kinase activity	Activated CDC42 kinase 1	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Activated CDC42 kinase 1	Homo sapiens (human)
GTPase inhibitor activity	Activated CDC42 kinase 1	Homo sapiens (human)
epidermal growth factor receptor binding	Activated CDC42 kinase 1	Homo sapiens (human)
protein binding	Activated CDC42 kinase 1	Homo sapiens (human)
ATP binding	Activated CDC42 kinase 1	Homo sapiens (human)
ubiquitin protein ligase binding	Activated CDC42 kinase 1	Homo sapiens (human)
identical protein binding	Activated CDC42 kinase 1	Homo sapiens (human)
metal ion binding	Activated CDC42 kinase 1	Homo sapiens (human)
WW domain binding	Activated CDC42 kinase 1	Homo sapiens (human)
protein serine kinase activity	Activated CDC42 kinase 1	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
protein binding	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
collagen binding	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
ATP binding	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
protein tyrosine kinase collagen receptor activity	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
metal ion binding	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
transcription cis-regulatory region binding	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
inward rectifier potassium channel activity	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
voltage-gated potassium channel activity	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
delayed rectifier potassium channel activity	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
protein binding	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
ubiquitin protein ligase binding	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
identical protein binding	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
protein homodimerization activity	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
C3HC4-type RING finger domain binding	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
scaffold protein binding	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
mitogen-activated protein kinase kinase kinase binding	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
MAP kinase kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase 4	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase 4	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein homodimerization activity	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein serine/threonine kinase activator activity	Serine/threonine-protein kinase 4	Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor binding	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase 4	Homo sapiens (human)
chromatin binding	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein serine/threonine kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
AMP-activated protein kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cAMP-dependent protein kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein binding	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
ATP binding	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
metal ion binding	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
tau protein binding	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
tau-protein kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein serine kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
histone H2BS36 kinase activity	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
protein kinase activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
protein binding	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
ATP binding	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
metal ion binding	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
protein serine kinase activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
MAP kinase kinase activity	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
MAP kinase activity	Mitogen-activated protein kinase 7	Homo sapiens (human)
enzyme inhibitor activity	Mitogen-activated protein kinase 7	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 7	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 7	Homo sapiens (human)
mitogen-activated protein kinase binding	Mitogen-activated protein kinase 7	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 7	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 7	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein kinase binding	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein tyrosine kinase activator activity	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cadherin binding	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase 3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase 3	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein serine/threonine kinase activator activity	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
zinc ion binding	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
protein kinase binding	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
protein kinase activity	Rho-associated protein kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Rho-associated protein kinase 1	Homo sapiens (human)
protein binding	Rho-associated protein kinase 1	Homo sapiens (human)
ATP binding	Rho-associated protein kinase 1	Homo sapiens (human)
small GTPase binding	Rho-associated protein kinase 1	Homo sapiens (human)
metal ion binding	Rho-associated protein kinase 1	Homo sapiens (human)
tau protein binding	Rho-associated protein kinase 1	Homo sapiens (human)
tau-protein kinase activity	Rho-associated protein kinase 1	Homo sapiens (human)
Rho-dependent protein serine/threonine kinase activity	Rho-associated protein kinase 1	Homo sapiens (human)
protein serine kinase activity	Rho-associated protein kinase 1	Homo sapiens (human)
protein tyrosine kinase activity	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
protein binding	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
ATP binding	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
DNA binding	Serine/threonine-protein kinase ATR	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase ATR	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase ATR	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase ATR	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase ATR	Homo sapiens (human)
MutLalpha complex binding	Serine/threonine-protein kinase ATR	Homo sapiens (human)
MutSalpha complex binding	Serine/threonine-protein kinase ATR	Homo sapiens (human)
histone H2AXS139 kinase activity	Serine/threonine-protein kinase ATR	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase ATR	Homo sapiens (human)
calcium-dependent protein serine/threonine phosphatase activity	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
protein binding	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
calmodulin binding	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
ATP binding	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
identical protein binding	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
protein homodimerization activity	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
protein serine kinase activity	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
protein serine/threonine kinase activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
protein binding	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
calmodulin binding	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
ATP binding	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
sodium channel inhibitor activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
titin binding	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
identical protein binding	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
protein homodimerization activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
transmembrane transporter binding	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
protein serine kinase activity	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
protein kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein binding	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
ATP binding	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
identical protein binding	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
tau protein binding	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
tau-protein kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
protein serine kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
histone H3T45 kinase activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
transcription coactivator activity	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
activin receptor activity, type II	Activin receptor type-2B	Homo sapiens (human)
protein serine/threonine kinase activity	Activin receptor type-2B	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Activin receptor type-2B	Homo sapiens (human)
protein binding	Activin receptor type-2B	Homo sapiens (human)
ATP binding	Activin receptor type-2B	Homo sapiens (human)
activin receptor activity, type II	Activin receptor type-2B	Homo sapiens (human)
kinase activator activity	Activin receptor type-2B	Homo sapiens (human)
growth factor binding	Activin receptor type-2B	Homo sapiens (human)
metal ion binding	Activin receptor type-2B	Homo sapiens (human)
activin binding	Activin receptor type-2B	Homo sapiens (human)
activin receptor activity	Activin receptor type-2B	Homo sapiens (human)
protein binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
ATP binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
activin receptor activity, type II	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
growth factor binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
BMP binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cadherin binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
metal ion binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
BMP receptor activity	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
protein tyrosine kinase binding	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
transforming growth factor beta receptor activity	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
protein tyrosine kinase activity	Protein-tyrosine kinase 6	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Protein-tyrosine kinase 6	Homo sapiens (human)
protein binding	Protein-tyrosine kinase 6	Homo sapiens (human)
ATP binding	Protein-tyrosine kinase 6	Homo sapiens (human)
identical protein binding	Protein-tyrosine kinase 6	Homo sapiens (human)
signaling receptor binding	Protein-tyrosine kinase 6	Homo sapiens (human)
protein kinase activity	cGMP-dependent protein kinase 1	Homo sapiens (human)
cGMP-dependent protein kinase activity	cGMP-dependent protein kinase 1	Homo sapiens (human)
calcium channel regulator activity	cGMP-dependent protein kinase 1	Homo sapiens (human)
protein binding	cGMP-dependent protein kinase 1	Homo sapiens (human)
ATP binding	cGMP-dependent protein kinase 1	Homo sapiens (human)
cGMP binding	cGMP-dependent protein kinase 1	Homo sapiens (human)
identical protein binding	cGMP-dependent protein kinase 1	Homo sapiens (human)
mitogen-activated protein kinase p38 binding	cGMP-dependent protein kinase 1	Homo sapiens (human)
protein serine kinase activity	cGMP-dependent protein kinase 1	Homo sapiens (human)
RNA binding	Cyclin-dependent kinase 13	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 13	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 13	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 13	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 13	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Cyclin-dependent kinase 13	Homo sapiens (human)
protein kinase binding	Cyclin-dependent kinase 13	Homo sapiens (human)
cyclin binding	Cyclin-dependent kinase 13	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 13	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
protein binding	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
ATP binding	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
protein serine kinase activity	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
calmodulin binding	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
K63-linked polyubiquitin modification-dependent protein binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
protein serine/threonine kinase activity	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
protein binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
ATP binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
IkappaB kinase activity	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
protein phosphatase binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
ubiquitin protein ligase binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
K48-linked polyubiquitin modification-dependent protein binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
identical protein binding	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein tyrosine kinase activity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein binding	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
ATP binding	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
ubiquitin protein ligase binding	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
glutamate receptor binding	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
3-phosphoinositide-dependent protein kinase binding	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein-containing complex binding	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
neurotransmitter receptor regulator activity	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
protein serine/threonine kinase activity	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activity	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
calcium ion binding	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
protein binding	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
ATP binding	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
lipid binding	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
protein serine kinase activity	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
chromatin binding	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
RNA binding	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
protein binding	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
ATP binding	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
ATP hydrolysis activity	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
mediator complex binding	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
protein heterodimerization activity	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
DNA binding	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
nucleosomal DNA binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
transcription coregulator binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
transcription corepressor activity	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
helicase activity	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
protein binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
ATP binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
zinc ion binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
ATP hydrolysis activity	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
histone deacetylase binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
ATP-dependent chromatin remodeler activity	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
chromatin binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
DNA binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
histone binding	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
protease binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
calcium ion binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
kinase activity	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
protein kinase binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
protein kinase activator activity	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
ionotropic glutamate receptor binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
alpha-tubulin binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
protein serine/threonine kinase activator activity	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cadherin binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
ephrin receptor binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
beta-tubulin binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
actin filament binding	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activity	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
delta24(24-1) sterol reductase activity	Delta(24)-sterol reductase	Homo sapiens (human)
protein binding	Delta(24)-sterol reductase	Homo sapiens (human)
oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor	Delta(24)-sterol reductase	Homo sapiens (human)
enzyme binding	Delta(24)-sterol reductase	Homo sapiens (human)
peptide antigen binding	Delta(24)-sterol reductase	Homo sapiens (human)
delta24-sterol reductase activity	Delta(24)-sterol reductase	Homo sapiens (human)
FAD binding	Delta(24)-sterol reductase	Homo sapiens (human)
magnesium ion binding	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
protein serine/threonine kinase activity	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
protein binding	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
ATP binding	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic process	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
protein serine kinase activity	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
ribosomal protein S6 kinase activity	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
protein kinase activity	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein binding	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
ATP binding	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein kinase binding	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
metal ion binding	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein serine kinase activity	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
actin binding	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
myosin light chain kinase activity	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
protein binding	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
calmodulin binding	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
ATP binding	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
metal ion binding	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 11	Homo sapiens (human)
MAP kinase activity	Mitogen-activated protein kinase 11	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 11	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 11	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 11	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase STK11	Homo sapiens (human)
p53 binding	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase STK11	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase STK11	Homo sapiens (human)
LRR domain binding	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein kinase activator activity	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein-containing complex binding	Serine/threonine-protein kinase STK11	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase STK11	Homo sapiens (human)
chromatin binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase N1	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein kinase C binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
nuclear receptor coactivator activity	Serine/threonine-protein kinase N1	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
histone H3T11 kinase activity	Serine/threonine-protein kinase N1	Homo sapiens (human)
histone binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
histone deacetylase binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
nuclear androgen receptor binding	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase N1	Homo sapiens (human)
RNA binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase N2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase N2	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Serine/threonine-protein kinase N2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
kinase activity	Serine/threonine-protein kinase N2	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
histone deacetylase binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
cadherin binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
RNA polymerase binding	Serine/threonine-protein kinase N2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase N2	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 14	Homo sapiens (human)
MAP kinase activity	Mitogen-activated protein kinase 14	Homo sapiens (human)
MAP kinase kinase activity	Mitogen-activated protein kinase 14	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 14	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 14	Homo sapiens (human)
enzyme binding	Mitogen-activated protein kinase 14	Homo sapiens (human)
protein phosphatase binding	Mitogen-activated protein kinase 14	Homo sapiens (human)
mitogen-activated protein kinase p38 binding	Mitogen-activated protein kinase 14	Homo sapiens (human)
NFAT protein binding	Mitogen-activated protein kinase 14	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 14	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
ATP binding	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
protein serine kinase activity	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
calmodulin binding	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
calcium-dependent protein serine/threonine kinase activity	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
JUN kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
small GTPase binding	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
mitogen-activated protein kinase kinase binding	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
mitogen-activated protein kinase kinase kinase binding	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
identical protein binding	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein homodimerization activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
protein serine/threonine kinase activity	MAP kinase-activated protein kinase 3	Homo sapiens (human)
MAP kinase kinase activity	MAP kinase-activated protein kinase 3	Homo sapiens (human)
protein binding	MAP kinase-activated protein kinase 3	Homo sapiens (human)
ATP binding	MAP kinase-activated protein kinase 3	Homo sapiens (human)
protein serine kinase activity	MAP kinase-activated protein kinase 3	Homo sapiens (human)
calcium-dependent protein serine/threonine kinase activity	MAP kinase-activated protein kinase 3	Homo sapiens (human)
calmodulin binding	MAP kinase-activated protein kinase 3	Homo sapiens (human)
calmodulin-dependent protein kinase activity	MAP kinase-activated protein kinase 3	Homo sapiens (human)
mitogen-activated protein kinase binding	MAP kinase-activated protein kinase 3	Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activity	Discoidin domain-containing receptor 2	Homo sapiens (human)
protein binding	Discoidin domain-containing receptor 2	Homo sapiens (human)
collagen binding	Discoidin domain-containing receptor 2	Homo sapiens (human)
ATP binding	Discoidin domain-containing receptor 2	Homo sapiens (human)
protein tyrosine kinase collagen receptor activity	Discoidin domain-containing receptor 2	Homo sapiens (human)
protein serine/threonine kinase activity	AP2-associated protein kinase 1	Homo sapiens (human)
Notch binding	AP2-associated protein kinase 1	Homo sapiens (human)
protein binding	AP2-associated protein kinase 1	Homo sapiens (human)
ATP binding	AP2-associated protein kinase 1	Homo sapiens (human)
AP-2 adaptor complex binding	AP2-associated protein kinase 1	Homo sapiens (human)
protein serine kinase activity	AP2-associated protein kinase 1	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Myosin light chain kinase 3	Homo sapiens (human)
myosin light chain kinase activity	Myosin light chain kinase 3	Homo sapiens (human)
protein binding	Myosin light chain kinase 3	Homo sapiens (human)
ATP binding	Myosin light chain kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Uncharacterized aarF domain-containing protein kinase 5	Homo sapiens (human)
protein binding	Uncharacterized aarF domain-containing protein kinase 5	Homo sapiens (human)
molecular_function	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
ATP hydrolysis activity	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
ATP-dependent protein folding chaperone	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
disordered domain specific binding	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
ATP binding	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
unfolded protein binding	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
protein binding	Rab-like protein 3	Homo sapiens (human)
GTP binding	Rab-like protein 3	Homo sapiens (human)
protein homodimerization activity	Rab-like protein 3	Homo sapiens (human)
GTPase activity	Rab-like protein 3	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase N3	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Serine/threonine-protein kinase N3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase N3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase N3	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase N3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase N3	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase N3	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
acyl-CoA dehydrogenase activity	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
long-chain fatty acyl-CoA dehydrogenase activity	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
protein binding	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
very-long-chain fatty acyl-CoA dehydrogenase activity	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
flavin adenine dinucleotide binding	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
medium-chain fatty acyl-CoA dehydrogenase activity	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
endonuclease activity	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
RNA endonuclease activity	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
unfolded protein binding	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
RNA binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
lipid binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein kinase activator activity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
cadherin binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
tau protein binding	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
tau-protein kinase activity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
kinase activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
transferase activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
alpha-tubulin binding	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein serine/threonine kinase activator activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
tau protein binding	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
beta-tubulin binding	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
tau-protein kinase activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
protein kinase activity	STE20-related kinase adapter protein alpha	Homo sapiens (human)
protein binding	STE20-related kinase adapter protein alpha	Homo sapiens (human)
ATP binding	STE20-related kinase adapter protein alpha	Homo sapiens (human)
kinase binding	STE20-related kinase adapter protein alpha	Homo sapiens (human)
protein kinase activator activity	STE20-related kinase adapter protein alpha	Homo sapiens (human)
protein serine/threonine kinase activator activity	STE20-related kinase adapter protein alpha	Homo sapiens (human)
microfilament motor activity	Myosin-14	Homo sapiens (human)
actin filament binding	Myosin-14	Homo sapiens (human)
calmodulin binding	Myosin-14	Homo sapiens (human)
ATP binding	Myosin-14	Homo sapiens (human)
protein serine/threonine kinase activity	AarF domain-containing protein kinase 1	Homo sapiens (human)
ATP binding	AarF domain-containing protein kinase 1	Homo sapiens (human)
RNA binding	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
RNA helicase activity	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
protein binding	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
ATP binding	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
ATP hydrolysis activity	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
protein binding	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
ATP binding	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
protein serine kinase activity	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
protein tyrosine kinase activity	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
MAP kinase kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
p53 binding	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein serine/threonine kinase activity	MAP kinase-activated protein kinase 5	Homo sapiens (human)
MAP kinase kinase activity	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein binding	MAP kinase-activated protein kinase 5	Homo sapiens (human)
ATP binding	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein serine kinase activity	MAP kinase-activated protein kinase 5	Homo sapiens (human)
calmodulin-dependent protein kinase activity	MAP kinase-activated protein kinase 5	Homo sapiens (human)
mitogen-activated protein kinase binding	MAP kinase-activated protein kinase 5	Homo sapiens (human)
calcium-dependent protein serine/threonine kinase activity	MAP kinase-activated protein kinase 5	Homo sapiens (human)
calmodulin binding	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein kinase activity	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
protein binding	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
ATP binding	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
kinase activity	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
ADP binding	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
protein binding	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
ATP binding	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
1-phosphatidylinositol-4-phosphate 5-kinase activity	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
identical protein binding	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
1-phosphatidylinositol-5-phosphate 4-kinase activity	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
chromatin binding	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase 15	Homo sapiens (human)
MAP kinase activity	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase 15	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase 15	Homo sapiens (human)
kinase activity	Mitogen-activated protein kinase 15	Homo sapiens (human)
SH3 domain binding	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase 15	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
protein kinase binding	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
protein kinase activator activity	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
DNA binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
chromatin binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
transcription coregulator activity	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
RNA binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
RNA helicase activity	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
double-stranded RNA binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
nuclease activity	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
exonuclease activity	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
protein binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
ATP binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
poly(A) binding	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
ATP hydrolysis activity	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
DNA/RNA helicase activity	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
MAP kinase kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Aurora kinase B	Homo sapiens (human)
protein serine/threonine kinase activity	Aurora kinase B	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Aurora kinase B	Homo sapiens (human)
protein binding	Aurora kinase B	Homo sapiens (human)
ATP binding	Aurora kinase B	Homo sapiens (human)
kinase binding	Aurora kinase B	Homo sapiens (human)
protein serine kinase activity	Aurora kinase B	Homo sapiens (human)
protein serine/threonine kinase activity	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
protein binding	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
ATP binding	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
microtubule binding	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
cytoskeletal anchor activity	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
gamma-tubulin binding	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
ubiquitin binding	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
tau protein binding	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
tau-protein kinase activity	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
protein serine kinase activity	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
protein tyrosine kinase activity	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
kinase activity	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
14-3-3 protein binding	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
calmodulin-dependent protein kinase activity	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
protein tyrosine kinase activity	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
calcium ion binding	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
calmodulin binding	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
ATP binding	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
protein serine kinase activity	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
p53 binding	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
protein serine/threonine kinase activity	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
protein binding	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
ATP binding	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
hydrolase activity	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
protein serine kinase activity	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
protein serine/threonine kinase activity	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
protein binding	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
ATP binding	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
kinase activity	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
metal ion binding	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
protein serine kinase activity	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
protein kinase activity	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
magnesium ion binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
JUN kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein kinase binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein phosphatase binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein domain specific binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
identical protein binding	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein homodimerization activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
metal ion binding	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
eukaryotic translation initiation factor 2alpha kinase activity	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
protein binding	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
ATP binding	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
heme binding	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
protein homodimerization activity	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
protein serine kinase activity	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
RNA binding	Nucleolar GTP-binding protein 1	Homo sapiens (human)
GTPase activity	Nucleolar GTP-binding protein 1	Homo sapiens (human)
protein binding	Nucleolar GTP-binding protein 1	Homo sapiens (human)
GTP binding	Nucleolar GTP-binding protein 1	Homo sapiens (human)
preribosome binding	Nucleolar GTP-binding protein 1	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase D2	Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activity	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein kinase C binding	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase D2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase D2	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase D2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase D2	Homo sapiens (human)
magnesium ion binding	NUAK family SNF1-like kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	NUAK family SNF1-like kinase 2	Homo sapiens (human)
protein binding	NUAK family SNF1-like kinase 2	Homo sapiens (human)
ATP binding	NUAK family SNF1-like kinase 2	Homo sapiens (human)
protein serine kinase activity	NUAK family SNF1-like kinase 2	Homo sapiens (human)
RNA binding	RNA cytidine acetyltransferase	Homo sapiens (human)
protein binding	RNA cytidine acetyltransferase	Homo sapiens (human)
ATP binding	RNA cytidine acetyltransferase	Homo sapiens (human)
N-acetyltransferase activity	RNA cytidine acetyltransferase	Homo sapiens (human)
tRNA N-acetyltransferase activity	RNA cytidine acetyltransferase	Homo sapiens (human)
DNA polymerase binding	RNA cytidine acetyltransferase	Homo sapiens (human)
mRNA N-acetyltransferase activity	RNA cytidine acetyltransferase	Homo sapiens (human)
tRNA binding	RNA cytidine acetyltransferase	Homo sapiens (human)
rRNA cytidine N-acetyltransferase activity	RNA cytidine acetyltransferase	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
protein serine/threonine kinase activity	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
protein binding	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
ATP binding	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
identical protein binding	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
protein homodimerization activity	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
cadherin binding	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
protein serine kinase activity	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
protein kinase inhibitor activity	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
transferase activity	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
magnesium ion binding	dCTP pyrophosphatase 1	Homo sapiens (human)
protein binding	dCTP pyrophosphatase 1	Homo sapiens (human)
pyrimidine deoxyribonucleotide binding	dCTP pyrophosphatase 1	Homo sapiens (human)
identical protein binding	dCTP pyrophosphatase 1	Homo sapiens (human)
nucleoside triphosphate diphosphatase activity	dCTP pyrophosphatase 1	Homo sapiens (human)
dCTP diphosphatase activity	dCTP pyrophosphatase 1	Homo sapiens (human)
protein serine/threonine kinase activity	Dual specificity protein kinase CLK4	Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity	Dual specificity protein kinase CLK4	Homo sapiens (human)
protein binding	Dual specificity protein kinase CLK4	Homo sapiens (human)
ATP binding	Dual specificity protein kinase CLK4	Homo sapiens (human)
protein serine kinase activity	Dual specificity protein kinase CLK4	Homo sapiens (human)
protein tyrosine kinase activity	Dual specificity protein kinase CLK4	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase I isoform gamma-1	Homo sapiens (human)
protein binding	Casein kinase I isoform gamma-1	Homo sapiens (human)
ATP binding	Casein kinase I isoform gamma-1	Homo sapiens (human)
protein serine kinase activity	Casein kinase I isoform gamma-1	Homo sapiens (human)
magnesium ion binding	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
RNA binding	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
phenylalanine-tRNA ligase activity	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
protein binding	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
ATP binding	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
tRNA binding	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
aminoacyl-tRNA editing activity	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
isoleucine-tRNA ligase activity	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
ATP binding	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
protein binding	BMP-2-inducible protein kinase	Homo sapiens (human)
ATP binding	BMP-2-inducible protein kinase	Homo sapiens (human)
protein serine kinase activity	BMP-2-inducible protein kinase	Homo sapiens (human)
phosphatase regulator activity	BMP-2-inducible protein kinase	Homo sapiens (human)
AP-2 adaptor complex binding	BMP-2-inducible protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	BMP-2-inducible protein kinase	Homo sapiens (human)
protein binding	Midasin	Homo sapiens (human)
ATP binding	Midasin	Homo sapiens (human)
ATP hydrolysis activity	Midasin	Homo sapiens (human)
magnesium ion binding	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
protein serine/threonine kinase activity	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
interleukin-1 receptor binding	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
protein binding	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
ATP binding	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
kinase activity	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
protein kinase binding	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
protein serine kinase activity	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
magnesium ion binding	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
RNA binding	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
JUN kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein kinase activator activity	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
ribosome binding	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
small ribosomal subunit rRNA binding	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
protein kinase activity	Cyclin-dependent kinase 12	Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activity	Cyclin-dependent kinase 12	Homo sapiens (human)
protein binding	Cyclin-dependent kinase 12	Homo sapiens (human)
ATP binding	Cyclin-dependent kinase 12	Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activity	Cyclin-dependent kinase 12	Homo sapiens (human)
protein kinase binding	Cyclin-dependent kinase 12	Homo sapiens (human)
cyclin binding	Cyclin-dependent kinase 12	Homo sapiens (human)
protein serine kinase activity	Cyclin-dependent kinase 12	Homo sapiens (human)
protein binding	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
ATP binding	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
endopeptidase activator activity	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase 26	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase 26	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase 26	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase 26	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase 26	Homo sapiens (human)
protein homodimerization activity	Serine/threonine-protein kinase 26	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase 26	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase 26	Homo sapiens (human)
magnesium ion binding	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinate-CoA ligase (ADP-forming) activity	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
protein binding	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
ATP binding	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase NLK	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase NLK	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase NLK	Homo sapiens (human)
MAP kinase activity	Serine/threonine-protein kinase NLK	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase NLK	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase NLK	Homo sapiens (human)
ubiquitin protein ligase binding	Serine/threonine-protein kinase NLK	Homo sapiens (human)
SH2 domain binding	Serine/threonine-protein kinase NLK	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase NLK	Homo sapiens (human)
DNA-binding transcription factor binding	Serine/threonine-protein kinase NLK	Homo sapiens (human)
AMP-activated protein kinase activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
cAMP-dependent protein kinase inhibitor activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
protein binding	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
ATP binding	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
cAMP-dependent protein kinase regulator activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
phosphorylase kinase regulator activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
protein kinase regulator activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
protein kinase binding	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
protein kinase activator activity	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
ADP binding	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
AMP binding	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
nucleic acid binding	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein phosphatase binding	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
identical protein binding	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
phosphoprotein binding	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
protein binding	Septin-9	Homo sapiens (human)
GTP binding	Septin-9	Homo sapiens (human)
cadherin binding	Septin-9	Homo sapiens (human)
GTPase activity	Septin-9	Homo sapiens (human)
molecular adaptor activity	Septin-9	Homo sapiens (human)
magnesium ion binding	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
protein kinase activity	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
protein binding	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
ATP binding	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
protein serine kinase activity	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
ribosomal protein S6 kinase activity	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
protein kinase activity	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein binding	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
ATP binding	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein serine kinase activity	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
MAP kinase kinase kinase activity	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
mitogen-activated protein kinase kinase binding	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
neuropilin binding	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein serine/threonine kinase activator activity	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
tau protein binding	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
tau-protein kinase activity	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase ICK	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase ICK	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase ICK	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase ICK	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase ICK	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase ICK	Homo sapiens (human)
protein kinase activity	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
protein serine/threonine kinase activity	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
protein binding	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
ATP binding	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
protein serine kinase activity	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
tau-protein kinase activity	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
protein kinase binding	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
metal ion binding	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
transcription coregulator activity	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
transcription coactivator activity	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
RNA binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
protein binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
ATP binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nuclear receptor coactivator activity	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nuclear vitamin D receptor binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nuclear thyroid hormone receptor binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
phosphoprotein binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
DNA binding	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
protein kinase activity	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
protein serine/threonine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
MAP kinase kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
transcription coactivator activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein kinase activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein binding	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
ATP binding	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
identical protein binding	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein-containing complex binding	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein serine kinase activity	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
magnesium ion binding	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
small GTPase binding	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
protein-containing complex binding	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
magnesium ion binding	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein serine/threonine kinase activity	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein binding	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
ATP binding	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein kinase binding	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein homodimerization activity	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein heterodimerization activity	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
protein kinase activity	Serine/threonine-protein kinase 24	Homo sapiens (human)
protein serine/threonine kinase activity	Serine/threonine-protein kinase 24	Homo sapiens (human)
protein binding	Serine/threonine-protein kinase 24	Homo sapiens (human)
ATP binding	Serine/threonine-protein kinase 24	Homo sapiens (human)
cadherin binding	Serine/threonine-protein kinase 24	Homo sapiens (human)
metal ion binding	Serine/threonine-protein kinase 24	Homo sapiens (human)
protein serine kinase activity	Serine/threonine-protein kinase 24	Homo sapiens (human)
protein kinase activity	Casein kinase I isoform gamma-3	Homo sapiens (human)
protein serine/threonine kinase activity	Casein kinase I isoform gamma-3	Homo sapiens (human)
ATP binding	Casein kinase I isoform gamma-3	Homo sapiens (human)
protein serine kinase activity	Casein kinase I isoform gamma-3	Homo sapiens (human)
MAP kinase kinase kinase activity	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
protein binding	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
ATP binding	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
metal ion binding	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
protein serine kinase activity	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (396)

Process	via Protein(s)	Taxonomy
plasma membrane	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
dendrite	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
neuronal cell body	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
receptor complex	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
HFE-transferrin receptor complex	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
plasma membrane	Bone morphogenetic protein receptor type-1B	Homo sapiens (human)
nucleus	Cell division cycle 7-related protein kinase	Homo sapiens (human)
nucleoplasm	Cell division cycle 7-related protein kinase	Homo sapiens (human)
cytoplasm	Cell division cycle 7-related protein kinase	Homo sapiens (human)
intercellular bridge	Cell division cycle 7-related protein kinase	Homo sapiens (human)
mitotic spindle	Cell division cycle 7-related protein kinase	Homo sapiens (human)
nucleus	Cell division cycle 7-related protein kinase	Homo sapiens (human)
cytoplasm	Cell division cycle 7-related protein kinase	Homo sapiens (human)
XY body	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
nucleolus	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
centriole	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
cleavage furrow	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
deuterosome	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
procentriole	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
procentriole replication complex	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase PLK4	Homo sapiens (human)
eukaryotic translation initiation factor 3 complex	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cytosolic small ribosomal subunit	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cytoplasm	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
extracellular region	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
nucleus	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
nucleoplasm	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cytoplasm	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
centrosome	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cytosol	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
plasma membrane	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cytoplasmic stress granule	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
lamellipodium	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
cell leading edge	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
secretory granule lumen	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
extracellular exosome	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
ficolin-1-rich granule lumen	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
NLRP3 inflammasome complex	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
nucleus	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
P granule	ATP-dependent RNA helicase DDX3X	Homo sapiens (human)
extracellular region	Pyridoxal kinase	Homo sapiens (human)
nucleus	Pyridoxal kinase	Homo sapiens (human)
nucleoplasm	Pyridoxal kinase	Homo sapiens (human)
cytosol	Pyridoxal kinase	Homo sapiens (human)
secretory granule lumen	Pyridoxal kinase	Homo sapiens (human)
specific granule lumen	Pyridoxal kinase	Homo sapiens (human)
extracellular exosome	Pyridoxal kinase	Homo sapiens (human)
cytosol	Pyridoxal kinase	Homo sapiens (human)
cytosol	Citron Rho-interacting kinase	Homo sapiens (human)
membrane	Citron Rho-interacting kinase	Homo sapiens (human)
chromosome, telomeric region	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
condensed nuclear chromosome	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
extracellular space	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
replication fork	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
intracellular membrane-bounded organelle	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
chromatin	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
protein-containing complex	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase Chk1	Homo sapiens (human)
spindle microtubule	Aurora kinase A	Homo sapiens (human)
nucleus	Aurora kinase A	Homo sapiens (human)
nucleoplasm	Aurora kinase A	Homo sapiens (human)
centrosome	Aurora kinase A	Homo sapiens (human)
centriole	Aurora kinase A	Homo sapiens (human)
spindle	Aurora kinase A	Homo sapiens (human)
cytosol	Aurora kinase A	Homo sapiens (human)
postsynaptic density	Aurora kinase A	Homo sapiens (human)
microtubule cytoskeleton	Aurora kinase A	Homo sapiens (human)
basolateral plasma membrane	Aurora kinase A	Homo sapiens (human)
midbody	Aurora kinase A	Homo sapiens (human)
spindle pole centrosome	Aurora kinase A	Homo sapiens (human)
ciliary basal body	Aurora kinase A	Homo sapiens (human)
germinal vesicle	Aurora kinase A	Homo sapiens (human)
axon hillock	Aurora kinase A	Homo sapiens (human)
pronucleus	Aurora kinase A	Homo sapiens (human)
perinuclear region of cytoplasm	Aurora kinase A	Homo sapiens (human)
mitotic spindle	Aurora kinase A	Homo sapiens (human)
meiotic spindle	Aurora kinase A	Homo sapiens (human)
mitotic spindle pole	Aurora kinase A	Homo sapiens (human)
glutamatergic synapse	Aurora kinase A	Homo sapiens (human)
spindle pole centrosome	Aurora kinase A	Homo sapiens (human)
chromosome passenger complex	Aurora kinase A	Homo sapiens (human)
spindle midzone	Aurora kinase A	Homo sapiens (human)
kinetochore	Aurora kinase A	Homo sapiens (human)
Golgi apparatus	Cyclin-G-associated kinase	Homo sapiens (human)
cytosol	Cyclin-G-associated kinase	Homo sapiens (human)
focal adhesion	Cyclin-G-associated kinase	Homo sapiens (human)
membrane	Cyclin-G-associated kinase	Homo sapiens (human)
clathrin-coated vesicle	Cyclin-G-associated kinase	Homo sapiens (human)
vesicle	Cyclin-G-associated kinase	Homo sapiens (human)
intracellular membrane-bounded organelle	Cyclin-G-associated kinase	Homo sapiens (human)
perinuclear region of cytoplasm	Cyclin-G-associated kinase	Homo sapiens (human)
presynapse	Cyclin-G-associated kinase	Homo sapiens (human)
vesicle	Cyclin-G-associated kinase	Homo sapiens (human)
cytoplasm	Cyclin-G-associated kinase	Homo sapiens (human)
intracellular membrane-bounded organelle	Cyclin-G-associated kinase	Homo sapiens (human)
extracellular region	Ephrin type-B receptor 6	Homo sapiens (human)
cytosol	Ephrin type-B receptor 6	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 6	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 6	Homo sapiens (human)
dendrite	Ephrin type-B receptor 6	Homo sapiens (human)
peroxisome	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
peroxisomal matrix	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
cytosol	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
membrane	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
peroxisome	Peroxisomal acyl-coenzyme A oxidase 3	Homo sapiens (human)
plasma membrane	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cytoplasm	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
endoplasmic reticulum	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cytosol	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
cytoskeleton	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
vesicle	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
protein-containing complex	Receptor-interacting serine/threonine-protein kinase 2	Homo sapiens (human)
kinetochore	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
nucleoplasm	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
cytosol	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
membrane	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
intracellular membrane-bounded organelle	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
outer kinetochore	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
kinetochore	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
nucleus	Mitotic checkpoint serine/threonine-protein kinase BUB1	Homo sapiens (human)
nucleoplasm	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrion	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial outer membrane	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial inner membrane	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial intermembrane space	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
cytosol	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
membrane	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial crista	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
dendrite	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
axon cytoplasm	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial intermembrane space	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
cytoplasm	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
microtubule	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
mitochondrial membrane	Dynamin-like 120 kDa protein, mitochondrial	Homo sapiens (human)
nucleolus	Cyclin-T1	Homo sapiens (human)
nucleus	Cyclin-T1	Homo sapiens (human)
nucleus	Cyclin-T1	Homo sapiens (human)
nucleoplasm	Cyclin-T1	Homo sapiens (human)
cytosol	Cyclin-T1	Homo sapiens (human)
cyclin/CDK positive transcription elongation factor complex	Cyclin-T1	Homo sapiens (human)
P-TEFb complex	Cyclin-T1	Homo sapiens (human)
nucleus	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
cytoplasm	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
cytosol	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
synapse	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
cytoplasm	Eukaryotic translation initiation factor 5B	Homo sapiens (human)
nucleus	Rho-associated protein kinase 2	Homo sapiens (human)
centrosome	Rho-associated protein kinase 2	Homo sapiens (human)
cytosol	Rho-associated protein kinase 2	Homo sapiens (human)
plasma membrane	Rho-associated protein kinase 2	Homo sapiens (human)
cytoplasmic ribonucleoprotein granule	Rho-associated protein kinase 2	Homo sapiens (human)
centrosome	Rho-associated protein kinase 2	Homo sapiens (human)
cytoskeleton	Rho-associated protein kinase 2	Homo sapiens (human)
cytoplasm	Rho-associated protein kinase 2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
phagophore assembly site	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
autophagosome membrane	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
mitochondrial outer membrane	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
autophagosome	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
endoplasmic reticulum membrane	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
axon	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
phagophore assembly site membrane	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
recycling endosome	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
omegasome membrane	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
Atg1/ULK1 kinase complex	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
phagophore assembly site	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
autophagosome	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
phagophore assembly site membrane	Serine/threonine-protein kinase ULK1	Homo sapiens (human)
nuclear inner membrane	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
mitochondrion	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
endoplasmic reticulum	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
endoplasmic reticulum membrane	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
Ire1 complex	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
AIP1-IRE1 complex	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
IRE1-TRAF2-ASK1 complex	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
IRE1-RACK1-PP2A complex	Serine/threonine-protein kinase/endoribonuclease IRE1	Homo sapiens (human)
nucleus	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase alpha-5	Homo sapiens (human)
nucleus	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
nucleoplasm	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
membrane	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
U4/U6 x U5 tri-snRNP complex	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
spliceosomal complex	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
U5 snRNP	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
U2-type precatalytic spliceosome	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
U2-type catalytic step 1 spliceosome	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
catalytic step 2 spliceosome	U5 small nuclear ribonucleoprotein 200 kDa helicase	Homo sapiens (human)
nucleus	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
cytosol	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
synapse	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-4	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase 16	Homo sapiens (human)
Golgi-associated vesicle	Serine/threonine-protein kinase 16	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase 16	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase 16	Homo sapiens (human)
perinuclear region of cytoplasm	Serine/threonine-protein kinase 16	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase 16	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 16	Homo sapiens (human)
cyclin K-CDK12 complex	Cyclin-K	Homo sapiens (human)
cyclin K-CDK13 complex	Cyclin-K	Homo sapiens (human)
nucleoplasm	Cyclin-K	Homo sapiens (human)
nucleus	Cyclin-K	Homo sapiens (human)
cyclin/CDK positive transcription elongation factor complex	Cyclin-K	Homo sapiens (human)
ruffle membrane	Cyclin-dependent kinase-like 5	Homo sapiens (human)
glutamatergic synapse	Cyclin-dependent kinase-like 5	Homo sapiens (human)
nucleus	Cyclin-dependent kinase-like 5	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase-like 5	Homo sapiens (human)
centrosome	Cyclin-dependent kinase-like 5	Homo sapiens (human)
dendrite cytoplasm	Cyclin-dependent kinase-like 5	Homo sapiens (human)
ciliary basal body	Cyclin-dependent kinase-like 5	Homo sapiens (human)
dendritic growth cone	Cyclin-dependent kinase-like 5	Homo sapiens (human)
perinuclear region of cytoplasm	Cyclin-dependent kinase-like 5	Homo sapiens (human)
ciliary tip	Cyclin-dependent kinase-like 5	Homo sapiens (human)
postsynaptic density, intracellular component	Cyclin-dependent kinase-like 5	Homo sapiens (human)
nucleus	Cyclin-dependent kinase-like 5	Homo sapiens (human)
dendrite cytoplasm	Cyclin-dependent kinase-like 5	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase 10	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase 10	Homo sapiens (human)
specific granule membrane	Serine/threonine-protein kinase 10	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase 10	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 10	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase D3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase D3	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase D3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase D3	Homo sapiens (human)
nuclear chromosome	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
condensed chromosome	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
condensed nuclear chromosome	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
condensin complex	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
nucleus	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
nucleoplasm	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
nucleolus	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
cytoplasm	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
cytosol	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
extracellular exosome	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
condensed chromosome	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
chromatin	Structural maintenance of chromosomes protein 2	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
focal adhesion	Mitogen-activated protein kinase kinase kinase kinase 4	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
spindle pole	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
midbody	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
spindle pole	Serine/threonine-protein kinase LATS1	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
adherens junction	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
focal adhesion	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase PAK 4	Homo sapiens (human)
ruffle	Tyrosine-protein kinase ABL1	Homo sapiens (human)
nucleus	Tyrosine-protein kinase ABL1	Homo sapiens (human)
nucleoplasm	Tyrosine-protein kinase ABL1	Homo sapiens (human)
nucleolus	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase ABL1	Homo sapiens (human)
mitochondrion	Tyrosine-protein kinase ABL1	Homo sapiens (human)
cytosol	Tyrosine-protein kinase ABL1	Homo sapiens (human)
actin cytoskeleton	Tyrosine-protein kinase ABL1	Homo sapiens (human)
nuclear body	Tyrosine-protein kinase ABL1	Homo sapiens (human)
dendrite	Tyrosine-protein kinase ABL1	Homo sapiens (human)
growth cone	Tyrosine-protein kinase ABL1	Homo sapiens (human)
nuclear membrane	Tyrosine-protein kinase ABL1	Homo sapiens (human)
neuronal cell body	Tyrosine-protein kinase ABL1	Homo sapiens (human)
perinuclear region of cytoplasm	Tyrosine-protein kinase ABL1	Homo sapiens (human)
postsynapse	Tyrosine-protein kinase ABL1	Homo sapiens (human)
protein-containing complex	Tyrosine-protein kinase ABL1	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase ABL1	Homo sapiens (human)
endosome	Epidermal growth factor receptor	Homo sapiens (human)
plasma membrane	Epidermal growth factor receptor	Homo sapiens (human)
ruffle membrane	Epidermal growth factor receptor	Homo sapiens (human)
Golgi membrane	Epidermal growth factor receptor	Homo sapiens (human)
extracellular space	Epidermal growth factor receptor	Homo sapiens (human)
nucleus	Epidermal growth factor receptor	Homo sapiens (human)
cytoplasm	Epidermal growth factor receptor	Homo sapiens (human)
endosome	Epidermal growth factor receptor	Homo sapiens (human)
endoplasmic reticulum membrane	Epidermal growth factor receptor	Homo sapiens (human)
plasma membrane	Epidermal growth factor receptor	Homo sapiens (human)
focal adhesion	Epidermal growth factor receptor	Homo sapiens (human)
cell surface	Epidermal growth factor receptor	Homo sapiens (human)
endosome membrane	Epidermal growth factor receptor	Homo sapiens (human)
membrane	Epidermal growth factor receptor	Homo sapiens (human)
basolateral plasma membrane	Epidermal growth factor receptor	Homo sapiens (human)
apical plasma membrane	Epidermal growth factor receptor	Homo sapiens (human)
cell junction	Epidermal growth factor receptor	Homo sapiens (human)
clathrin-coated endocytic vesicle membrane	Epidermal growth factor receptor	Homo sapiens (human)
early endosome membrane	Epidermal growth factor receptor	Homo sapiens (human)
nuclear membrane	Epidermal growth factor receptor	Homo sapiens (human)
membrane raft	Epidermal growth factor receptor	Homo sapiens (human)
perinuclear region of cytoplasm	Epidermal growth factor receptor	Homo sapiens (human)
multivesicular body, internal vesicle lumen	Epidermal growth factor receptor	Homo sapiens (human)
intracellular vesicle	Epidermal growth factor receptor	Homo sapiens (human)
protein-containing complex	Epidermal growth factor receptor	Homo sapiens (human)
receptor complex	Epidermal growth factor receptor	Homo sapiens (human)
Shc-EGFR complex	Epidermal growth factor receptor	Homo sapiens (human)
basal plasma membrane	Epidermal growth factor receptor	Homo sapiens (human)
extracellular space	Interferon beta	Homo sapiens (human)
extracellular region	Interferon beta	Homo sapiens (human)
early endosome	High affinity nerve growth factor receptor	Homo sapiens (human)
late endosome	High affinity nerve growth factor receptor	Homo sapiens (human)
plasma membrane	High affinity nerve growth factor receptor	Homo sapiens (human)
cell surface	High affinity nerve growth factor receptor	Homo sapiens (human)
endosome membrane	High affinity nerve growth factor receptor	Homo sapiens (human)
dendrite	High affinity nerve growth factor receptor	Homo sapiens (human)
early endosome membrane	High affinity nerve growth factor receptor	Homo sapiens (human)
late endosome membrane	High affinity nerve growth factor receptor	Homo sapiens (human)
neuronal cell body	High affinity nerve growth factor receptor	Homo sapiens (human)
recycling endosome membrane	High affinity nerve growth factor receptor	Homo sapiens (human)
protein-containing complex	High affinity nerve growth factor receptor	Homo sapiens (human)
receptor complex	High affinity nerve growth factor receptor	Homo sapiens (human)
axon	High affinity nerve growth factor receptor	Homo sapiens (human)
plasma membrane	High affinity nerve growth factor receptor	Homo sapiens (human)
nucleoplasm	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
cytoplasm	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
centrosome	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
cytosol	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
plasma membrane	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
membrane	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
dendrite	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
midbody	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
cell body	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
synapse	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
extracellular exosome	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
neuronal dense core vesicle	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
extracellular vesicle	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
heterotrimeric G-protein complex	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
cytoplasm	Guanine nucleotide-binding protein G(i) subunit alpha-2	Homo sapiens (human)
nucleus	ADP/ATP translocase 2	Homo sapiens (human)
mitochondrion	ADP/ATP translocase 2	Homo sapiens (human)
mitochondrial inner membrane	ADP/ATP translocase 2	Homo sapiens (human)
plasma membrane	ADP/ATP translocase 2	Homo sapiens (human)
membrane	ADP/ATP translocase 2	Homo sapiens (human)
mitochondrial nucleoid	ADP/ATP translocase 2	Homo sapiens (human)
mitochondrial permeability transition pore complex	ADP/ATP translocase 2	Homo sapiens (human)
MMXD complex	ADP/ATP translocase 2	Homo sapiens (human)
nucleus	Protein kinase C beta type	Homo sapiens (human)
nucleoplasm	Protein kinase C beta type	Homo sapiens (human)
cytoplasm	Protein kinase C beta type	Homo sapiens (human)
centrosome	Protein kinase C beta type	Homo sapiens (human)
cytosol	Protein kinase C beta type	Homo sapiens (human)
plasma membrane	Protein kinase C beta type	Homo sapiens (human)
brush border membrane	Protein kinase C beta type	Homo sapiens (human)
calyx of Held	Protein kinase C beta type	Homo sapiens (human)
extracellular exosome	Protein kinase C beta type	Homo sapiens (human)
presynaptic cytosol	Protein kinase C beta type	Homo sapiens (human)
spectrin	Protein kinase C beta type	Homo sapiens (human)
nuclear envelope	Insulin receptor	Homo sapiens (human)
nuclear lumen	Insulin receptor	Homo sapiens (human)
lysosome	Insulin receptor	Homo sapiens (human)
late endosome	Insulin receptor	Homo sapiens (human)
plasma membrane	Insulin receptor	Homo sapiens (human)
caveola	Insulin receptor	Homo sapiens (human)
external side of plasma membrane	Insulin receptor	Homo sapiens (human)
endosome membrane	Insulin receptor	Homo sapiens (human)
membrane	Insulin receptor	Homo sapiens (human)
dendrite membrane	Insulin receptor	Homo sapiens (human)
neuronal cell body membrane	Insulin receptor	Homo sapiens (human)
extracellular exosome	Insulin receptor	Homo sapiens (human)
insulin receptor complex	Insulin receptor	Homo sapiens (human)
receptor complex	Insulin receptor	Homo sapiens (human)
plasma membrane	Insulin receptor	Homo sapiens (human)
axon	Insulin receptor	Homo sapiens (human)
pericentriolar material	Tyrosine-protein kinase Lck	Homo sapiens (human)
immunological synapse	Tyrosine-protein kinase Lck	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Lck	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Lck	Homo sapiens (human)
membrane raft	Tyrosine-protein kinase Lck	Homo sapiens (human)
extracellular exosome	Tyrosine-protein kinase Lck	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Lck	Homo sapiens (human)
membrane raft	Tyrosine-protein kinase Fyn	Homo sapiens (human)
dendrite	Tyrosine-protein kinase Fyn	Homo sapiens (human)
nucleus	Tyrosine-protein kinase Fyn	Homo sapiens (human)
mitochondrion	Tyrosine-protein kinase Fyn	Homo sapiens (human)
endosome	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Fyn	Homo sapiens (human)
actin filament	Tyrosine-protein kinase Fyn	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Fyn	Homo sapiens (human)
postsynaptic density	Tyrosine-protein kinase Fyn	Homo sapiens (human)
dendrite	Tyrosine-protein kinase Fyn	Homo sapiens (human)
perikaryon	Tyrosine-protein kinase Fyn	Homo sapiens (human)
cell body	Tyrosine-protein kinase Fyn	Homo sapiens (human)
membrane raft	Tyrosine-protein kinase Fyn	Homo sapiens (human)
perinuclear region of cytoplasm	Tyrosine-protein kinase Fyn	Homo sapiens (human)
perinuclear endoplasmic reticulum	Tyrosine-protein kinase Fyn	Homo sapiens (human)
glial cell projection	Tyrosine-protein kinase Fyn	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Tyrosine-protein kinase Fyn	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Fyn	Homo sapiens (human)
mitochondrial matrix	Cyclin-dependent kinase 1	Homo sapiens (human)
chromosome, telomeric region	Cyclin-dependent kinase 1	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 1	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 1	Homo sapiens (human)
mitochondrion	Cyclin-dependent kinase 1	Homo sapiens (human)
endoplasmic reticulum membrane	Cyclin-dependent kinase 1	Homo sapiens (human)
centrosome	Cyclin-dependent kinase 1	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 1	Homo sapiens (human)
spindle microtubule	Cyclin-dependent kinase 1	Homo sapiens (human)
membrane	Cyclin-dependent kinase 1	Homo sapiens (human)
midbody	Cyclin-dependent kinase 1	Homo sapiens (human)
extracellular exosome	Cyclin-dependent kinase 1	Homo sapiens (human)
mitotic spindle	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin A1-CDK1 complex	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin A2-CDK1 complex	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin B1-CDK1 complex	Cyclin-dependent kinase 1	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 1	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 1	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 1	Homo sapiens (human)
extracellular region	Glycogen phosphorylase, liver form	Homo sapiens (human)
cytosol	Glycogen phosphorylase, liver form	Homo sapiens (human)
secretory granule lumen	Glycogen phosphorylase, liver form	Homo sapiens (human)
extracellular exosome	Glycogen phosphorylase, liver form	Homo sapiens (human)
ficolin-1-rich granule lumen	Glycogen phosphorylase, liver form	Homo sapiens (human)
cytoplasm	Glycogen phosphorylase, liver form	Homo sapiens (human)
cytoplasmic vesicle	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
Golgi apparatus	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
focal adhesion	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
cytoplasmic side of plasma membrane	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
microtubule cytoskeleton	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Fes/Fps	Homo sapiens (human)
Golgi apparatus	Tyrosine-protein kinase Yes	Homo sapiens (human)
centrosome	Tyrosine-protein kinase Yes	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Yes	Homo sapiens (human)
actin filament	Tyrosine-protein kinase Yes	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Yes	Homo sapiens (human)
focal adhesion	Tyrosine-protein kinase Yes	Homo sapiens (human)
extracellular exosome	Tyrosine-protein kinase Yes	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Yes	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Lyn	Homo sapiens (human)
cytoplasmic side of plasma membrane	Tyrosine-protein kinase Lyn	Homo sapiens (human)
nucleus	Tyrosine-protein kinase Lyn	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase Lyn	Homo sapiens (human)
lysosomal membrane	Tyrosine-protein kinase Lyn	Homo sapiens (human)
Golgi apparatus	Tyrosine-protein kinase Lyn	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Lyn	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Lyn	Homo sapiens (human)
adherens junction	Tyrosine-protein kinase Lyn	Homo sapiens (human)
mitochondrial crista	Tyrosine-protein kinase Lyn	Homo sapiens (human)
endocytic vesicle membrane	Tyrosine-protein kinase Lyn	Homo sapiens (human)
intracellular membrane-bounded organelle	Tyrosine-protein kinase Lyn	Homo sapiens (human)
membrane raft	Tyrosine-protein kinase Lyn	Homo sapiens (human)
perinuclear region of cytoplasm	Tyrosine-protein kinase Lyn	Homo sapiens (human)
extracellular exosome	Tyrosine-protein kinase Lyn	Homo sapiens (human)
glutamatergic synapse	Tyrosine-protein kinase Lyn	Homo sapiens (human)
postsynaptic specialization, intracellular component	Tyrosine-protein kinase Lyn	Homo sapiens (human)
integrin alpha2-beta1 complex	Tyrosine-protein kinase Lyn	Homo sapiens (human)
plasma membrane	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
early endosome	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
plasma membrane	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
endosome membrane	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
dendrite	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
neuronal cell body	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
receptor complex	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
plasma membrane protein complex	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
axon	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)
plasma membrane	Insulin-like growth factor 1 receptor	Homo sapiens (human)
caveola	Insulin-like growth factor 1 receptor	Homo sapiens (human)
membrane	Insulin-like growth factor 1 receptor	Homo sapiens (human)
T-tubule	Insulin-like growth factor 1 receptor	Homo sapiens (human)
neuronal cell body	Insulin-like growth factor 1 receptor	Homo sapiens (human)
intracellular membrane-bounded organelle	Insulin-like growth factor 1 receptor	Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complex	Insulin-like growth factor 1 receptor	Homo sapiens (human)
receptor complex	Insulin-like growth factor 1 receptor	Homo sapiens (human)
protein kinase complex	Insulin-like growth factor 1 receptor	Homo sapiens (human)
axon	Insulin-like growth factor 1 receptor	Homo sapiens (human)
plasma membrane	Insulin-like growth factor 1 receptor	Homo sapiens (human)
insulin receptor complex	Insulin-like growth factor 1 receptor	Homo sapiens (human)
signal recognition particle receptor complex	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
endoplasmic reticulum membrane	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
membrane	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
extracellular exosome	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
endoplasmic reticulum membrane	Signal recognition particle receptor subunit alpha	Homo sapiens (human)
nucleus	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
mitochondrion	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
mitochondrial inner membrane	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
mitochondrial respiratory chain complex III	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
membrane	Cytochrome c1, heme protein, mitochondrial	Homo sapiens (human)
extracellular region	Hepatocyte growth factor receptor	Homo sapiens (human)
plasma membrane	Hepatocyte growth factor receptor	Homo sapiens (human)
basal plasma membrane	Hepatocyte growth factor receptor	Homo sapiens (human)
cell surface	Hepatocyte growth factor receptor	Homo sapiens (human)
membrane	Hepatocyte growth factor receptor	Homo sapiens (human)
postsynapse	Hepatocyte growth factor receptor	Homo sapiens (human)
basal plasma membrane	Hepatocyte growth factor receptor	Homo sapiens (human)
plasma membrane	Hepatocyte growth factor receptor	Homo sapiens (human)
receptor complex	Hepatocyte growth factor receptor	Homo sapiens (human)
actin filament	Tyrosine-protein kinase HCK	Homo sapiens (human)
nucleus	Tyrosine-protein kinase HCK	Homo sapiens (human)
lysosome	Tyrosine-protein kinase HCK	Homo sapiens (human)
Golgi apparatus	Tyrosine-protein kinase HCK	Homo sapiens (human)
cytosol	Tyrosine-protein kinase HCK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase HCK	Homo sapiens (human)
caveola	Tyrosine-protein kinase HCK	Homo sapiens (human)
focal adhesion	Tyrosine-protein kinase HCK	Homo sapiens (human)
cytoplasmic side of plasma membrane	Tyrosine-protein kinase HCK	Homo sapiens (human)
transport vesicle	Tyrosine-protein kinase HCK	Homo sapiens (human)
cell projection	Tyrosine-protein kinase HCK	Homo sapiens (human)
intracellular membrane-bounded organelle	Tyrosine-protein kinase HCK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase HCK	Homo sapiens (human)
nucleus	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cytoplasm	Platelet-derived growth factor receptor beta	Homo sapiens (human)
Golgi apparatus	Platelet-derived growth factor receptor beta	Homo sapiens (human)
plasma membrane	Platelet-derived growth factor receptor beta	Homo sapiens (human)
focal adhesion	Platelet-derived growth factor receptor beta	Homo sapiens (human)
membrane	Platelet-derived growth factor receptor beta	Homo sapiens (human)
apical plasma membrane	Platelet-derived growth factor receptor beta	Homo sapiens (human)
cytoplasmic vesicle	Platelet-derived growth factor receptor beta	Homo sapiens (human)
lysosomal lumen	Platelet-derived growth factor receptor beta	Homo sapiens (human)
intracellular membrane-bounded organelle	Platelet-derived growth factor receptor beta	Homo sapiens (human)
plasma membrane	Platelet-derived growth factor receptor beta	Homo sapiens (human)
receptor complex	Platelet-derived growth factor receptor beta	Homo sapiens (human)
double membrane vesicle viral factory outer membrane	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
cellular_component	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
mitochondrion	Serine/threonine-protein kinase A-Raf	Homo sapiens (human)
extracellular region	Glycogen phosphorylase, brain form	Homo sapiens (human)
cytoplasm	Glycogen phosphorylase, brain form	Homo sapiens (human)
membrane	Glycogen phosphorylase, brain form	Homo sapiens (human)
azurophil granule lumen	Glycogen phosphorylase, brain form	Homo sapiens (human)
extracellular exosome	Glycogen phosphorylase, brain form	Homo sapiens (human)
cytoplasm	Glycogen phosphorylase, brain form	Homo sapiens (human)
cytosol	Breakpoint cluster region protein	Homo sapiens (human)
plasma membrane	Breakpoint cluster region protein	Homo sapiens (human)
postsynaptic density	Breakpoint cluster region protein	Homo sapiens (human)
membrane	Breakpoint cluster region protein	Homo sapiens (human)
axon	Breakpoint cluster region protein	Homo sapiens (human)
dendritic spine	Breakpoint cluster region protein	Homo sapiens (human)
extracellular exosome	Breakpoint cluster region protein	Homo sapiens (human)
protein-containing complex	Breakpoint cluster region protein	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Breakpoint cluster region protein	Homo sapiens (human)
glutamatergic synapse	Breakpoint cluster region protein	Homo sapiens (human)
membrane	Breakpoint cluster region protein	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
nucleolus	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase pim-1	Homo sapiens (human)
extracellular region	Fibroblast growth factor receptor 1	Homo sapiens (human)
nucleus	Fibroblast growth factor receptor 1	Homo sapiens (human)
cytosol	Fibroblast growth factor receptor 1	Homo sapiens (human)
plasma membrane	Fibroblast growth factor receptor 1	Homo sapiens (human)
membrane	Fibroblast growth factor receptor 1	Homo sapiens (human)
cytoplasmic vesicle	Fibroblast growth factor receptor 1	Homo sapiens (human)
receptor complex	Fibroblast growth factor receptor 1	Homo sapiens (human)
plasma membrane	Fibroblast growth factor receptor 1	Homo sapiens (human)
nucleolus	DNA topoisomerase 2-alpha	Homo sapiens (human)
nuclear chromosome	DNA topoisomerase 2-alpha	Homo sapiens (human)
centriole	DNA topoisomerase 2-alpha	Homo sapiens (human)
chromosome, centromeric region	DNA topoisomerase 2-alpha	Homo sapiens (human)
condensed chromosome	DNA topoisomerase 2-alpha	Homo sapiens (human)
male germ cell nucleus	DNA topoisomerase 2-alpha	Homo sapiens (human)
nucleus	DNA topoisomerase 2-alpha	Homo sapiens (human)
nucleoplasm	DNA topoisomerase 2-alpha	Homo sapiens (human)
nucleolus	DNA topoisomerase 2-alpha	Homo sapiens (human)
cytoplasm	DNA topoisomerase 2-alpha	Homo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex	DNA topoisomerase 2-alpha	Homo sapiens (human)
protein-containing complex	DNA topoisomerase 2-alpha	Homo sapiens (human)
ribonucleoprotein complex	DNA topoisomerase 2-alpha	Homo sapiens (human)
nucleus	DNA topoisomerase 2-alpha	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 4	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 4	Homo sapiens (human)
nucleolus	Cyclin-dependent kinase 4	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 4	Homo sapiens (human)
bicellular tight junction	Cyclin-dependent kinase 4	Homo sapiens (human)
nuclear membrane	Cyclin-dependent kinase 4	Homo sapiens (human)
cyclin D1-CDK4 complex	Cyclin-dependent kinase 4	Homo sapiens (human)
cyclin D2-CDK4 complex	Cyclin-dependent kinase 4	Homo sapiens (human)
cyclin D3-CDK4 complex	Cyclin-dependent kinase 4	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 4	Homo sapiens (human)
chromatin	Cyclin-dependent kinase 4	Homo sapiens (human)
transcription regulator complex	Cyclin-dependent kinase 4	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 4	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 4	Homo sapiens (human)
nucleus	ADP/ATP translocase 3	Homo sapiens (human)
mitochondrion	ADP/ATP translocase 3	Homo sapiens (human)
mitochondrial inner membrane	ADP/ATP translocase 3	Homo sapiens (human)
membrane	ADP/ATP translocase 3	Homo sapiens (human)
TIM23 mitochondrial import inner membrane translocase complex	ADP/ATP translocase 3	Homo sapiens (human)
extracellular region	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
nucleus	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
cytoplasm	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
peroxisomal membrane	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
cytosol	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
membrane	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
secretory granule lumen	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
extracellular exosome	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
ficolin-1-rich granule lumen	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
cytoplasm	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens (human)
podosome	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
nucleoplasm	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cytoplasm	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
mitochondrion	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
mitochondrial inner membrane	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
lysosome	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
late endosome	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cytosol	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
actin filament	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
plasma membrane	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
caveola	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
focal adhesion	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
cell junction	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
ruffle membrane	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
neuronal cell body	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
dendritic growth cone	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
membrane raft	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
perinuclear region of cytoplasm	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
extracellular exosome	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
synaptic membrane	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
glutamatergic synapse	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
postsynaptic specialization, intracellular component	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
dendritic filopodium	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
plasma membrane	Proto-oncogene tyrosine-protein kinase Src	Homo sapiens (human)
axoneme	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
cytoplasm	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
centrosome	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
plasma membrane	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
focal adhesion	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
membrane	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
plasma membrane raft	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
extracellular exosome	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
ciliary base	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
cAMP-dependent protein kinase complex	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
nucleotide-activated protein kinase complex	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
protein-containing complex	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase type II-alpha regulatory subunit	Homo sapiens (human)
mitochondrial matrix	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
spindle pole	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
nucleus	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
nucleoplasm	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cytoplasm	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
centrosome	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cytosol	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
membrane	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cyclin B1-CDK1 complex	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
outer kinetochore	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
cytoplasm	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
nucleus	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
centrosome	G2/mitotic-specific cyclin-B1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
neuron projection	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
intracellular membrane-bounded organelle	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cell body	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
presynapse	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
mitochondrion	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase B-raf	Homo sapiens (human)
cytosol	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
phosphorylase kinase complex	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	Homo sapiens (human)
nucleoplasm	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
cytosol	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
extracellular exosome	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
cytosol	Ribosyldihydronicotinamide dehydrogenase [quinone]	Homo sapiens (human)
actin cytoskeleton	Tyrosine-protein kinase Fer	Homo sapiens (human)
microtubule cytoskeleton	Tyrosine-protein kinase Fer	Homo sapiens (human)
lamellipodium	Tyrosine-protein kinase Fer	Homo sapiens (human)
cell junction	Tyrosine-protein kinase Fer	Homo sapiens (human)
nucleus	Tyrosine-protein kinase Fer	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase Fer	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Fer	Homo sapiens (human)
adherens junction	Tyrosine-protein kinase Fer	Homo sapiens (human)
cell cortex	Tyrosine-protein kinase Fer	Homo sapiens (human)
cytoplasmic side of plasma membrane	Tyrosine-protein kinase Fer	Homo sapiens (human)
chromatin	Tyrosine-protein kinase Fer	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Fer	Homo sapiens (human)
ciliary basal body	Protein kinase C alpha type	Homo sapiens (human)
nucleoplasm	Protein kinase C alpha type	Homo sapiens (human)
cytoplasm	Protein kinase C alpha type	Homo sapiens (human)
mitochondrion	Protein kinase C alpha type	Homo sapiens (human)
endoplasmic reticulum	Protein kinase C alpha type	Homo sapiens (human)
cytosol	Protein kinase C alpha type	Homo sapiens (human)
plasma membrane	Protein kinase C alpha type	Homo sapiens (human)
mitochondrial membrane	Protein kinase C alpha type	Homo sapiens (human)
perinuclear region of cytoplasm	Protein kinase C alpha type	Homo sapiens (human)
extracellular exosome	Protein kinase C alpha type	Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complex	Protein kinase C alpha type	Homo sapiens (human)
axoneme	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cytoplasm	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
acrosomal vesicle	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
nucleus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
nucleoplasm	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cytoplasm	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
mitochondrial matrix	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
centrosome	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
plasma membrane	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
nuclear speck	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
neuromuscular junction	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
sperm flagellum	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
dendritic spine	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
plasma membrane raft	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
perinuclear region of cytoplasm	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
extracellular exosome	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
ciliary base	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
glutamatergic synapse	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cAMP-dependent protein kinase complex	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
calcium channel complex	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
nucleus	cAMP-dependent protein kinase catalytic subunit alpha	Homo sapiens (human)
nucleus	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
nucleoplasm	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
cytoplasm	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
spindle	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
cytosol	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription factor TFIIH core complex	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription factor TFIID complex	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
transcription factor TFIIH holo complex	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
CAK-ERCC2 complex	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
MMXD complex	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
nucleus	General transcription and DNA repair factor IIH helicase subunit XPD	Homo sapiens (human)
PcG protein complex	Casein kinase II subunit alpha'	Homo sapiens (human)
acrosomal vesicle	Casein kinase II subunit alpha'	Homo sapiens (human)
nucleus	Casein kinase II subunit alpha'	Homo sapiens (human)
nucleoplasm	Casein kinase II subunit alpha'	Homo sapiens (human)
cytosol	Casein kinase II subunit alpha'	Homo sapiens (human)
protein kinase CK2 complex	Casein kinase II subunit alpha'	Homo sapiens (human)
chromatin	Casein kinase II subunit alpha'	Homo sapiens (human)
cytosol	Casein kinase II subunit alpha'	Homo sapiens (human)
nucleus	Casein kinase II subunit alpha'	Homo sapiens (human)
female pronucleus	Cyclin-A2	Homo sapiens (human)
male pronucleus	Cyclin-A2	Homo sapiens (human)
nucleus	Cyclin-A2	Homo sapiens (human)
nucleoplasm	Cyclin-A2	Homo sapiens (human)
cytoplasm	Cyclin-A2	Homo sapiens (human)
cytosol	Cyclin-A2	Homo sapiens (human)
cyclin A2-CDK1 complex	Cyclin-A2	Homo sapiens (human)
cyclin A2-CDK2 complex	Cyclin-A2	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-A2	Homo sapiens (human)
nucleus	Cyclin-A2	Homo sapiens (human)
centrosome	Cyclin-A2	Homo sapiens (human)
cytoplasm	Cyclin-A2	Homo sapiens (human)
Golgi membrane	Ras-related protein Rab-6A	Homo sapiens (human)
acrosomal membrane	Ras-related protein Rab-6A	Homo sapiens (human)
endoplasmic reticulum membrane	Ras-related protein Rab-6A	Homo sapiens (human)
Golgi apparatus	Ras-related protein Rab-6A	Homo sapiens (human)
trans-Golgi network	Ras-related protein Rab-6A	Homo sapiens (human)
cytosol	Ras-related protein Rab-6A	Homo sapiens (human)
plasma membrane	Ras-related protein Rab-6A	Homo sapiens (human)
membrane	Ras-related protein Rab-6A	Homo sapiens (human)
secretory granule membrane	Ras-related protein Rab-6A	Homo sapiens (human)
cytoplasmic vesicle	Ras-related protein Rab-6A	Homo sapiens (human)
trans-Golgi network membrane	Ras-related protein Rab-6A	Homo sapiens (human)
extracellular exosome	Ras-related protein Rab-6A	Homo sapiens (human)
endosome to plasma membrane transport vesicle	Ras-related protein Rab-6A	Homo sapiens (human)
Golgi apparatus	Ras-related protein Rab-6A	Homo sapiens (human)
endomembrane system	Ras-related protein Rab-6A	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 1	Homo sapiens (human)
receptor complex	Ephrin type-A receptor 1	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 1	Homo sapiens (human)
cytoplasm	Multifunctional protein ADE2	Homo sapiens (human)
cytosol	Multifunctional protein ADE2	Homo sapiens (human)
membrane	Multifunctional protein ADE2	Homo sapiens (human)
extracellular exosome	Multifunctional protein ADE2	Homo sapiens (human)
nucleoplasm	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
ciliary base	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
nucleus	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
cAMP-dependent protein kinase complex	cAMP-dependent protein kinase catalytic subunit gamma	Homo sapiens (human)
nucleoplasm	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
centrosome	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
plasma membrane	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
extracellular exosome	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
ciliary base	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
cAMP-dependent protein kinase complex	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
cytosol	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
nucleus	cAMP-dependent protein kinase catalytic subunit beta	Homo sapiens (human)
mitochondrial inner membrane	Ferrochelatase, mitochondrial	Homo sapiens (human)
mitochondrial matrix	Ferrochelatase, mitochondrial	Homo sapiens (human)
mitochondrion	Ferrochelatase, mitochondrial	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
mitochondrion	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
mitochondrial outer membrane	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cytosol	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cell surface	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
neuron projection	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
perinuclear region of cytoplasm	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
postsynapse	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
glutamatergic synapse	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase beta-1	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase JAK1	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cytoplasmic side of plasma membrane	Tyrosine-protein kinase JAK1	Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membrane	Tyrosine-protein kinase JAK1	Homo sapiens (human)
nucleus	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase JAK1	Homo sapiens (human)
endosome	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cytosol	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cytoskeleton	Tyrosine-protein kinase JAK1	Homo sapiens (human)
focal adhesion	Tyrosine-protein kinase JAK1	Homo sapiens (human)
cytosol	Tyrosine-protein kinase JAK1	Homo sapiens (human)
nucleus	G1/S-specific cyclin-D1	Homo sapiens (human)
nucleoplasm	G1/S-specific cyclin-D1	Homo sapiens (human)
cytosol	G1/S-specific cyclin-D1	Homo sapiens (human)
bicellular tight junction	G1/S-specific cyclin-D1	Homo sapiens (human)
nuclear membrane	G1/S-specific cyclin-D1	Homo sapiens (human)
cyclin D1-CDK4 complex	G1/S-specific cyclin-D1	Homo sapiens (human)
cyclin D1-CDK6 complex	G1/S-specific cyclin-D1	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	G1/S-specific cyclin-D1	Homo sapiens (human)
transcription repressor complex	G1/S-specific cyclin-D1	Homo sapiens (human)
centrosome	G1/S-specific cyclin-D1	Homo sapiens (human)
cytoplasm	G1/S-specific cyclin-D1	Homo sapiens (human)
nucleus	G1/S-specific cyclin-D1	Homo sapiens (human)
nucleus	G1/S-specific cyclin-E1	Homo sapiens (human)
nucleoplasm	G1/S-specific cyclin-E1	Homo sapiens (human)
cytosol	G1/S-specific cyclin-E1	Homo sapiens (human)
cyclin E1-CDK2 complex	G1/S-specific cyclin-E1	Homo sapiens (human)
centrosome	G1/S-specific cyclin-E1	Homo sapiens (human)
nucleus	G1/S-specific cyclin-E1	Homo sapiens (human)
cytoplasm	G1/S-specific cyclin-E1	Homo sapiens (human)
chromosome, telomeric region	Cyclin-dependent kinase 2	Homo sapiens (human)
condensed chromosome	Cyclin-dependent kinase 2	Homo sapiens (human)
X chromosome	Cyclin-dependent kinase 2	Homo sapiens (human)
Y chromosome	Cyclin-dependent kinase 2	Homo sapiens (human)
male germ cell nucleus	Cyclin-dependent kinase 2	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 2	Homo sapiens (human)
nuclear envelope	Cyclin-dependent kinase 2	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 2	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 2	Homo sapiens (human)
endosome	Cyclin-dependent kinase 2	Homo sapiens (human)
centrosome	Cyclin-dependent kinase 2	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 2	Homo sapiens (human)
Cajal body	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin A1-CDK2 complex	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin A2-CDK2 complex	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin E1-CDK2 complex	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin E2-CDK2 complex	Cyclin-dependent kinase 2	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 2	Homo sapiens (human)
transcription regulator complex	Cyclin-dependent kinase 2	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 2	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 2	Homo sapiens (human)
cytoplasm	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
cytosol	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
plasma membrane	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
cilium	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
membrane	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
presynapse	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
postsynapse	Beta-adrenergic receptor kinase 1	Homo sapiens (human)
P-body	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
nucleus	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
cytoplasm	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
cytosol	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
cytoplasmic stress granule	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
membrane	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
cytoplasmic ribonucleoprotein granule	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
RISC complex	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
cytoplasmic stress granule	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
P-body	Probable ATP-dependent RNA helicase DDX6	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 3	Homo sapiens (human)
nuclear envelope	Mitogen-activated protein kinase 3	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 3	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 3	Homo sapiens (human)
mitochondrion	Mitogen-activated protein kinase 3	Homo sapiens (human)
early endosome	Mitogen-activated protein kinase 3	Homo sapiens (human)
late endosome	Mitogen-activated protein kinase 3	Homo sapiens (human)
endoplasmic reticulum lumen	Mitogen-activated protein kinase 3	Homo sapiens (human)
Golgi apparatus	Mitogen-activated protein kinase 3	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 3	Homo sapiens (human)
cytoskeleton	Mitogen-activated protein kinase 3	Homo sapiens (human)
plasma membrane	Mitogen-activated protein kinase 3	Homo sapiens (human)
caveola	Mitogen-activated protein kinase 3	Homo sapiens (human)
focal adhesion	Mitogen-activated protein kinase 3	Homo sapiens (human)
pseudopodium	Mitogen-activated protein kinase 3	Homo sapiens (human)
glutamatergic synapse	Mitogen-activated protein kinase 3	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 3	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 3	Homo sapiens (human)
cytoplasm	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
cytosol	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
plasma membrane	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
dendrite	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
extracellular exosome	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
plasma membrane	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
cytoplasm	MAP/microtubule affinity-regulating kinase 3	Homo sapiens (human)
nucleoplasm	Deoxycytidine kinase	Homo sapiens (human)
cytosol	Deoxycytidine kinase	Homo sapiens (human)
mitochondrion	Deoxycytidine kinase	Homo sapiens (human)
cytoplasm	Deoxycytidine kinase	Homo sapiens (human)
extracellular region	Mitogen-activated protein kinase 1	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 1	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 1	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 1	Homo sapiens (human)
mitochondrion	Mitogen-activated protein kinase 1	Homo sapiens (human)
early endosome	Mitogen-activated protein kinase 1	Homo sapiens (human)
late endosome	Mitogen-activated protein kinase 1	Homo sapiens (human)
endoplasmic reticulum lumen	Mitogen-activated protein kinase 1	Homo sapiens (human)
Golgi apparatus	Mitogen-activated protein kinase 1	Homo sapiens (human)
centrosome	Mitogen-activated protein kinase 1	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 1	Homo sapiens (human)
cytoskeleton	Mitogen-activated protein kinase 1	Homo sapiens (human)
plasma membrane	Mitogen-activated protein kinase 1	Homo sapiens (human)
caveola	Mitogen-activated protein kinase 1	Homo sapiens (human)
focal adhesion	Mitogen-activated protein kinase 1	Homo sapiens (human)
pseudopodium	Mitogen-activated protein kinase 1	Homo sapiens (human)
azurophil granule lumen	Mitogen-activated protein kinase 1	Homo sapiens (human)
synapse	Mitogen-activated protein kinase 1	Homo sapiens (human)
mitotic spindle	Mitogen-activated protein kinase 1	Homo sapiens (human)
ficolin-1-rich granule lumen	Mitogen-activated protein kinase 1	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 1	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 1	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 2	Homo sapiens (human)
focal adhesion	Ephrin type-A receptor 2	Homo sapiens (human)
cell surface	Ephrin type-A receptor 2	Homo sapiens (human)
lamellipodium	Ephrin type-A receptor 2	Homo sapiens (human)
leading edge membrane	Ephrin type-A receptor 2	Homo sapiens (human)
lamellipodium membrane	Ephrin type-A receptor 2	Homo sapiens (human)
ruffle membrane	Ephrin type-A receptor 2	Homo sapiens (human)
tight junction	Ephrin type-A receptor 2	Homo sapiens (human)
receptor complex	Ephrin type-A receptor 2	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 2	Homo sapiens (human)
extracellular region	Ephrin type-B receptor 2	Homo sapiens (human)
nucleoplasm	Ephrin type-B receptor 2	Homo sapiens (human)
cytosol	Ephrin type-B receptor 2	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 2	Homo sapiens (human)
cell surface	Ephrin type-B receptor 2	Homo sapiens (human)
axon	Ephrin type-B receptor 2	Homo sapiens (human)
dendrite	Ephrin type-B receptor 2	Homo sapiens (human)
presynaptic membrane	Ephrin type-B receptor 2	Homo sapiens (human)
neuronal cell body	Ephrin type-B receptor 2	Homo sapiens (human)
dendritic spine	Ephrin type-B receptor 2	Homo sapiens (human)
postsynaptic membrane	Ephrin type-B receptor 2	Homo sapiens (human)
hippocampal mossy fiber to CA3 synapse	Ephrin type-B receptor 2	Homo sapiens (human)
postsynapse	Ephrin type-B receptor 2	Homo sapiens (human)
glutamatergic synapse	Ephrin type-B receptor 2	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 2	Homo sapiens (human)
dendrite	Ephrin type-B receptor 2	Homo sapiens (human)
plasma membrane	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cytoplasmic side of plasma membrane	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
extrinsic component of plasma membrane	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membrane	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
nucleus	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cytoplasm	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cytosol	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cytoskeleton	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
plasma membrane	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
interleukin-12 receptor complex	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
extracellular exosome	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
interleukin-23 receptor complex	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
cytosol	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens (human)
nucleoplasm	G1/S-specific cyclin-D3	Homo sapiens (human)
cytosol	G1/S-specific cyclin-D3	Homo sapiens (human)
cyclin D3-CDK4 complex	G1/S-specific cyclin-D3	Homo sapiens (human)
cyclin D3-CDK6 complex	G1/S-specific cyclin-D3	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	G1/S-specific cyclin-D3	Homo sapiens (human)
centrosome	G1/S-specific cyclin-D3	Homo sapiens (human)
nucleus	G1/S-specific cyclin-D3	Homo sapiens (human)
cytoplasm	G1/S-specific cyclin-D3	Homo sapiens (human)
nucleus	Wee1-like protein kinase	Homo sapiens (human)
nucleoplasm	Wee1-like protein kinase	Homo sapiens (human)
nucleolus	Wee1-like protein kinase	Homo sapiens (human)
cytoplasm	Wee1-like protein kinase	Homo sapiens (human)
endoplasmic reticulum membrane	Heme oxygenase 2	Homo sapiens (human)
plasma membrane	Heme oxygenase 2	Homo sapiens (human)
membrane	Heme oxygenase 2	Homo sapiens (human)
specific granule membrane	Heme oxygenase 2	Homo sapiens (human)
cytosol	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
methionine adenosyltransferase complex	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
cytosol	S-adenosylmethionine synthase isoform type-2	Homo sapiens (human)
nucleus	DnaJ homolog subfamily A member 1	Homo sapiens (human)
mitochondrion	DnaJ homolog subfamily A member 1	Homo sapiens (human)
cytosol	DnaJ homolog subfamily A member 1	Homo sapiens (human)
microtubule cytoskeleton	DnaJ homolog subfamily A member 1	Homo sapiens (human)
membrane	DnaJ homolog subfamily A member 1	Homo sapiens (human)
perinuclear region of cytoplasm	DnaJ homolog subfamily A member 1	Homo sapiens (human)
extracellular exosome	DnaJ homolog subfamily A member 1	Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membrane	DnaJ homolog subfamily A member 1	Homo sapiens (human)
cytoplasm	DnaJ homolog subfamily A member 1	Homo sapiens (human)
cytosol	DnaJ homolog subfamily A member 1	Homo sapiens (human)
cytoplasm	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
mitochondrial intermembrane space	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
membrane	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
nucleus	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
nucleoplasm	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cytoplasm	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
spindle	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cytosol	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
plasma membrane	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cell-cell junction	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
cell cortex	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
microtubule cytoskeleton	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
lamellipodium	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
vesicle	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
ciliary basal body	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
postsynapse	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
glutamatergic synapse	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
protein-containing complex	RAC-alpha serine/threonine-protein kinase	Homo sapiens (human)
nucleus	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
nucleoplasm	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
early endosome	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
cytosol	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
plasma membrane	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
cell cortex	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
ruffle membrane	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
intracellular membrane-bounded organelle	RAC-beta serine/threonine-protein kinase	Homo sapiens (human)
cytoplasm	Dual specificity protein kinase TTK	Homo sapiens (human)
spindle	Dual specificity protein kinase TTK	Homo sapiens (human)
membrane	Dual specificity protein kinase TTK	Homo sapiens (human)
kinetochore	Dual specificity protein kinase TTK	Homo sapiens (human)
nucleus	Dual specificity protein kinase TTK	Homo sapiens (human)
chromosome, telomeric region	DNA replication licensing factor MCM4	Homo sapiens (human)
nucleus	DNA replication licensing factor MCM4	Homo sapiens (human)
nucleoplasm	DNA replication licensing factor MCM4	Homo sapiens (human)
membrane	DNA replication licensing factor MCM4	Homo sapiens (human)
MCM complex	DNA replication licensing factor MCM4	Homo sapiens (human)
CMG complex	DNA replication licensing factor MCM4	Homo sapiens (human)
nucleus	DNA replication licensing factor MCM4	Homo sapiens (human)
extracellular region	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
nucleus	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
mitochondrion	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
early endosome	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
late endosome	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
peroxisomal membrane	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
endoplasmic reticulum	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
Golgi apparatus	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
cytosol	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
microtubule	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
cell-cell junction	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
focal adhesion	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
cytoplasmic side of plasma membrane	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
perinuclear region of cytoplasm	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)
endoplasmic reticulum	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
endoplasmic reticulum lumen	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
plasma membrane	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
endosome membrane	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
receptor complex	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
plasma membrane	Receptor-type tyrosine-protein kinase FLT3	Homo sapiens (human)
caveola	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
plasma membrane	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
external side of plasma membrane	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
membrane	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
dendrite	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
neuronal cell body	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
HFE-transferrin receptor complex	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
plasma membrane	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
receptor complex	Bone morphogenetic protein receptor type-1A	Homo sapiens (human)
cytosol	Activin receptor type-1B	Homo sapiens (human)
plasma membrane	Activin receptor type-1B	Homo sapiens (human)
cell surface	Activin receptor type-1B	Homo sapiens (human)
receptor complex	Activin receptor type-1B	Homo sapiens (human)
activin receptor complex	Activin receptor type-1B	Homo sapiens (human)
plasma membrane	Activin receptor type-1B	Homo sapiens (human)
nucleus	TGF-beta receptor type-1	Homo sapiens (human)
endosome	TGF-beta receptor type-1	Homo sapiens (human)
plasma membrane	TGF-beta receptor type-1	Homo sapiens (human)
bicellular tight junction	TGF-beta receptor type-1	Homo sapiens (human)
cell surface	TGF-beta receptor type-1	Homo sapiens (human)
membrane raft	TGF-beta receptor type-1	Homo sapiens (human)
transforming growth factor beta ligand-receptor complex	TGF-beta receptor type-1	Homo sapiens (human)
receptor complex	TGF-beta receptor type-1	Homo sapiens (human)
plasma membrane	TGF-beta receptor type-1	Homo sapiens (human)
activin receptor complex	TGF-beta receptor type-1	Homo sapiens (human)
extracellular region	TGF-beta receptor type-2	Homo sapiens (human)
cytosol	TGF-beta receptor type-2	Homo sapiens (human)
plasma membrane	TGF-beta receptor type-2	Homo sapiens (human)
caveola	TGF-beta receptor type-2	Homo sapiens (human)
external side of plasma membrane	TGF-beta receptor type-2	Homo sapiens (human)
membrane	TGF-beta receptor type-2	Homo sapiens (human)
membrane raft	TGF-beta receptor type-2	Homo sapiens (human)
transforming growth factor beta ligand-receptor complex	TGF-beta receptor type-2	Homo sapiens (human)
receptor complex	TGF-beta receptor type-2	Homo sapiens (human)
plasma membrane	TGF-beta receptor type-2	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase CSK	Homo sapiens (human)
cytosol	Tyrosine-protein kinase CSK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase CSK	Homo sapiens (human)
cell-cell junction	Tyrosine-protein kinase CSK	Homo sapiens (human)
extracellular exosome	Tyrosine-protein kinase CSK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase CSK	Homo sapiens (human)
mitochondrial matrix	Glycine--tRNA ligase	Homo sapiens (human)
cytosol	Glycine--tRNA ligase	Homo sapiens (human)
secretory granule	Glycine--tRNA ligase	Homo sapiens (human)
axon	Glycine--tRNA ligase	Homo sapiens (human)
extracellular exosome	Glycine--tRNA ligase	Homo sapiens (human)
cytoplasm	Glycine--tRNA ligase	Homo sapiens (human)
mitochondrion	Glycine--tRNA ligase	Homo sapiens (human)
Golgi membrane	Protein kinase C iota type	Homo sapiens (human)
nucleus	Protein kinase C iota type	Homo sapiens (human)
nucleoplasm	Protein kinase C iota type	Homo sapiens (human)
endosome	Protein kinase C iota type	Homo sapiens (human)
cytosol	Protein kinase C iota type	Homo sapiens (human)
plasma membrane	Protein kinase C iota type	Homo sapiens (human)
brush border	Protein kinase C iota type	Homo sapiens (human)
bicellular tight junction	Protein kinase C iota type	Homo sapiens (human)
microtubule cytoskeleton	Protein kinase C iota type	Homo sapiens (human)
apical plasma membrane	Protein kinase C iota type	Homo sapiens (human)
cell leading edge	Protein kinase C iota type	Homo sapiens (human)
Schmidt-Lanterman incisure	Protein kinase C iota type	Homo sapiens (human)
intercellular bridge	Protein kinase C iota type	Homo sapiens (human)
extracellular exosome	Protein kinase C iota type	Homo sapiens (human)
tight junction	Protein kinase C iota type	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Protein kinase C iota type	Homo sapiens (human)
glutamatergic synapse	Protein kinase C iota type	Homo sapiens (human)
PAR polarity complex	Protein kinase C iota type	Homo sapiens (human)
nuclear exosome (RNase complex)	Exosome RNA helicase MTR4	Homo sapiens (human)
exosome (RNase complex)	Exosome RNA helicase MTR4	Homo sapiens (human)
nucleus	Exosome RNA helicase MTR4	Homo sapiens (human)
nucleoplasm	Exosome RNA helicase MTR4	Homo sapiens (human)
nucleolus	Exosome RNA helicase MTR4	Homo sapiens (human)
nuclear speck	Exosome RNA helicase MTR4	Homo sapiens (human)
TRAMP complex	Exosome RNA helicase MTR4	Homo sapiens (human)
catalytic step 2 spliceosome	Exosome RNA helicase MTR4	Homo sapiens (human)
nucleus	Exosome RNA helicase MTR4	Homo sapiens (human)
cytosol	Tyrosine-protein kinase Tec	Homo sapiens (human)
cytoskeleton	Tyrosine-protein kinase Tec	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Tec	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase Tec	Homo sapiens (human)
cytosol	Tyrosine-protein kinase ABL2	Homo sapiens (human)
actin cytoskeleton	Tyrosine-protein kinase ABL2	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase ABL2	Homo sapiens (human)
extracellular region	Tyrosine-protein kinase FRK	Homo sapiens (human)
nucleus	Tyrosine-protein kinase FRK	Homo sapiens (human)
nucleoplasm	Tyrosine-protein kinase FRK	Homo sapiens (human)
cytosol	Tyrosine-protein kinase FRK	Homo sapiens (human)
azurophil granule lumen	Tyrosine-protein kinase FRK	Homo sapiens (human)
specific granule lumen	Tyrosine-protein kinase FRK	Homo sapiens (human)
extracellular exosome	Tyrosine-protein kinase FRK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase FRK	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase SYK	Homo sapiens (human)
nucleus	Tyrosine-protein kinase SYK	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase SYK	Homo sapiens (human)
cytosol	Tyrosine-protein kinase SYK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase SYK	Homo sapiens (human)
early phagosome	Tyrosine-protein kinase SYK	Homo sapiens (human)
B cell receptor complex	Tyrosine-protein kinase SYK	Homo sapiens (human)
protein-containing complex	Tyrosine-protein kinase SYK	Homo sapiens (human)
T cell receptor complex	Tyrosine-protein kinase SYK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase SYK	Homo sapiens (human)
proteasome complex	26S proteasome regulatory subunit 6B	Homo sapiens (human)
nucleus	26S proteasome regulatory subunit 6B	Homo sapiens (human)
nucleoplasm	26S proteasome regulatory subunit 6B	Homo sapiens (human)
cytosol	26S proteasome regulatory subunit 6B	Homo sapiens (human)
membrane	26S proteasome regulatory subunit 6B	Homo sapiens (human)
inclusion body	26S proteasome regulatory subunit 6B	Homo sapiens (human)
synapse	26S proteasome regulatory subunit 6B	Homo sapiens (human)
proteasome accessory complex	26S proteasome regulatory subunit 6B	Homo sapiens (human)
cytosolic proteasome complex	26S proteasome regulatory subunit 6B	Homo sapiens (human)
proteasome regulatory particle, base subcomplex	26S proteasome regulatory subunit 6B	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 8	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 8	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 8	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 8	Homo sapiens (human)
axon	Mitogen-activated protein kinase 8	Homo sapiens (human)
synapse	Mitogen-activated protein kinase 8	Homo sapiens (human)
basal dendrite	Mitogen-activated protein kinase 8	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 8	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 9	Homo sapiens (human)
mitochondrion	Mitogen-activated protein kinase 9	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 9	Homo sapiens (human)
plasma membrane	Mitogen-activated protein kinase 9	Homo sapiens (human)
nuclear speck	Mitogen-activated protein kinase 9	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Mitogen-activated protein kinase 9	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 9	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 9	Homo sapiens (human)
cytoplasm	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
nucleoplasm	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
cytosol	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
membrane	Dual specificity mitogen-activated protein kinase kinase 3	Homo sapiens (human)
photoreceptor outer segment	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
photoreceptor inner segment	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
nucleoplasm	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
lysosome	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
autophagosome	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
cytosol	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
plasma membrane	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
plasma membrane	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	Homo sapiens (human)
mRNA cleavage and polyadenylation specificity factor complex	Casein kinase I isoform alpha	Homo sapiens (human)
keratin filament	Casein kinase I isoform alpha	Homo sapiens (human)
kinetochore	Casein kinase I isoform alpha	Homo sapiens (human)
centrosome	Casein kinase I isoform alpha	Homo sapiens (human)
spindle	Casein kinase I isoform alpha	Homo sapiens (human)
cytosol	Casein kinase I isoform alpha	Homo sapiens (human)
cilium	Casein kinase I isoform alpha	Homo sapiens (human)
membrane	Casein kinase I isoform alpha	Homo sapiens (human)
nuclear speck	Casein kinase I isoform alpha	Homo sapiens (human)
beta-catenin destruction complex	Casein kinase I isoform alpha	Homo sapiens (human)
ciliary basal body	Casein kinase I isoform alpha	Homo sapiens (human)
cytoplasm	Casein kinase I isoform alpha	Homo sapiens (human)
nucleus	Casein kinase I isoform alpha	Homo sapiens (human)
nucleus	Casein kinase I isoform delta	Homo sapiens (human)
nucleoplasm	Casein kinase I isoform delta	Homo sapiens (human)
Golgi apparatus	Casein kinase I isoform delta	Homo sapiens (human)
centrosome	Casein kinase I isoform delta	Homo sapiens (human)
spindle	Casein kinase I isoform delta	Homo sapiens (human)
cytosol	Casein kinase I isoform delta	Homo sapiens (human)
spindle microtubule	Casein kinase I isoform delta	Homo sapiens (human)
plasma membrane	Casein kinase I isoform delta	Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartment membrane	Casein kinase I isoform delta	Homo sapiens (human)
ciliary basal body	Casein kinase I isoform delta	Homo sapiens (human)
perinuclear region of cytoplasm	Casein kinase I isoform delta	Homo sapiens (human)
nucleus	Casein kinase I isoform delta	Homo sapiens (human)
cytoplasm	Casein kinase I isoform delta	Homo sapiens (human)
spindle microtubule	Casein kinase I isoform delta	Homo sapiens (human)
nucleus	MAP kinase-activated protein kinase 2	Homo sapiens (human)
nucleoplasm	MAP kinase-activated protein kinase 2	Homo sapiens (human)
cytoplasm	MAP kinase-activated protein kinase 2	Homo sapiens (human)
centrosome	MAP kinase-activated protein kinase 2	Homo sapiens (human)
cytosol	MAP kinase-activated protein kinase 2	Homo sapiens (human)
extracellular exosome	MAP kinase-activated protein kinase 2	Homo sapiens (human)
nucleus	MAP kinase-activated protein kinase 2	Homo sapiens (human)
cytoplasm	MAP kinase-activated protein kinase 2	Homo sapiens (human)
mitochondrion	Elongation factor Tu, mitochondrial	Homo sapiens (human)
mitochondrial outer membrane	Elongation factor Tu, mitochondrial	Homo sapiens (human)
membrane	Elongation factor Tu, mitochondrial	Homo sapiens (human)
mitochondrial nucleoid	Elongation factor Tu, mitochondrial	Homo sapiens (human)
synapse	Elongation factor Tu, mitochondrial	Homo sapiens (human)
extracellular exosome	Elongation factor Tu, mitochondrial	Homo sapiens (human)
mitochondrion	Elongation factor Tu, mitochondrial	Homo sapiens (human)
nucleus	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
nuclear envelope	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
endoplasmic reticulum	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
endoplasmic reticulum membrane	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
cytosol	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
glycogen granule	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
endoplasmic reticulum	Choline-phosphate cytidylyltransferase A	Homo sapiens (human)
nucleus	Casein kinase I isoform epsilon	Homo sapiens (human)
nucleoplasm	Casein kinase I isoform epsilon	Homo sapiens (human)
cytoplasm	Casein kinase I isoform epsilon	Homo sapiens (human)
cytosol	Casein kinase I isoform epsilon	Homo sapiens (human)
growth cone	Casein kinase I isoform epsilon	Homo sapiens (human)
neuronal cell body	Casein kinase I isoform epsilon	Homo sapiens (human)
ribonucleoprotein complex	Casein kinase I isoform epsilon	Homo sapiens (human)
cytoplasm	Casein kinase I isoform epsilon	Homo sapiens (human)
nucleus	Casein kinase I isoform epsilon	Homo sapiens (human)
nucleoplasm	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
nucleolus	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
mitochondrion	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
mitochondrial inner membrane	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
mitochondrial matrix	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
mitochondrial membrane	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
mitochondrial nucleoid	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	Homo sapiens (human)
nucleus	Dual specificity protein kinase CLK1	Homo sapiens (human)
acrosomal vesicle	Dual specificity protein kinase CLK3	Homo sapiens (human)
nucleus	Dual specificity protein kinase CLK3	Homo sapiens (human)
nucleoplasm	Dual specificity protein kinase CLK3	Homo sapiens (human)
membrane	Dual specificity protein kinase CLK3	Homo sapiens (human)
nuclear speck	Dual specificity protein kinase CLK3	Homo sapiens (human)
intermediate filament cytoskeleton	Dual specificity protein kinase CLK3	Homo sapiens (human)
mitochondrion	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cytosol	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
beta-catenin destruction complex	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
neuronal cell body	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
apical dendrite	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
postsynapse	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
proximal dendrite	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cytoplasm	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
nucleus	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
axon	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
cytosol	Glycogen synthase kinase-3 alpha	Homo sapiens (human)
glutamatergic synapse	Glycogen synthase kinase-3 beta	Homo sapiens (human)
nucleus	Glycogen synthase kinase-3 beta	Homo sapiens (human)
nucleoplasm	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cytoplasm	Glycogen synthase kinase-3 beta	Homo sapiens (human)
mitochondrion	Glycogen synthase kinase-3 beta	Homo sapiens (human)
centrosome	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cytosol	Glycogen synthase kinase-3 beta	Homo sapiens (human)
plasma membrane	Glycogen synthase kinase-3 beta	Homo sapiens (human)
axon	Glycogen synthase kinase-3 beta	Homo sapiens (human)
dendrite	Glycogen synthase kinase-3 beta	Homo sapiens (human)
beta-catenin destruction complex	Glycogen synthase kinase-3 beta	Homo sapiens (human)
presynapse	Glycogen synthase kinase-3 beta	Homo sapiens (human)
postsynapse	Glycogen synthase kinase-3 beta	Homo sapiens (human)
Wnt signalosome	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cytosol	Glycogen synthase kinase-3 beta	Homo sapiens (human)
axon	Glycogen synthase kinase-3 beta	Homo sapiens (human)
nucleus	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cytoplasm	Glycogen synthase kinase-3 beta	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 7	Homo sapiens (human)
fibrillar center	Cyclin-dependent kinase 7	Homo sapiens (human)
male germ cell nucleus	Cyclin-dependent kinase 7	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 7	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 7	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 7	Homo sapiens (human)
plasma membrane	Cyclin-dependent kinase 7	Homo sapiens (human)
perinuclear region of cytoplasm	Cyclin-dependent kinase 7	Homo sapiens (human)
transcription factor TFIIH core complex	Cyclin-dependent kinase 7	Homo sapiens (human)
transcription factor TFIIH holo complex	Cyclin-dependent kinase 7	Homo sapiens (human)
CAK-ERCC2 complex	Cyclin-dependent kinase 7	Homo sapiens (human)
transcription factor TFIIK complex	Cyclin-dependent kinase 7	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 7	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 7	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 9	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 9	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 9	Homo sapiens (human)
cyclin/CDK positive transcription elongation factor complex	Cyclin-dependent kinase 9	Homo sapiens (human)
membrane	Cyclin-dependent kinase 9	Homo sapiens (human)
PML body	Cyclin-dependent kinase 9	Homo sapiens (human)
cytoplasmic ribonucleoprotein granule	Cyclin-dependent kinase 9	Homo sapiens (human)
transcription elongation factor complex	Cyclin-dependent kinase 9	Homo sapiens (human)
P-TEFb complex	Cyclin-dependent kinase 9	Homo sapiens (human)
photoreceptor outer segment	Ras-related protein Rab-27A	Homo sapiens (human)
extracellular region	Ras-related protein Rab-27A	Homo sapiens (human)
lysosome	Ras-related protein Rab-27A	Homo sapiens (human)
late endosome	Ras-related protein Rab-27A	Homo sapiens (human)
cytosol	Ras-related protein Rab-27A	Homo sapiens (human)
dendrite	Ras-related protein Rab-27A	Homo sapiens (human)
multivesicular body membrane	Ras-related protein Rab-27A	Homo sapiens (human)
Weibel-Palade body	Ras-related protein Rab-27A	Homo sapiens (human)
melanosome membrane	Ras-related protein Rab-27A	Homo sapiens (human)
specific granule lumen	Ras-related protein Rab-27A	Homo sapiens (human)
melanosome	Ras-related protein Rab-27A	Homo sapiens (human)
extracellular exosome	Ras-related protein Rab-27A	Homo sapiens (human)
exocytic vesicle	Ras-related protein Rab-27A	Homo sapiens (human)
exocytic vesicle	Ras-related protein Rab-27A	Homo sapiens (human)
apical plasma membrane	Ras-related protein Rab-27A	Homo sapiens (human)
Golgi apparatus	Ras-related protein Rab-27A	Homo sapiens (human)
secretory granule	Ras-related protein Rab-27A	Homo sapiens (human)
melanosome	Ras-related protein Rab-27A	Homo sapiens (human)
cytoplasm	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
cell surface	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
nucleoplasm	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
lipid droplet	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
cytosol	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
plasma membrane	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
endosome membrane	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
protein-containing complex	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
nucleus	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
plasma membrane	Interleukin-1 receptor-associated kinase 1	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
nucleolus	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
cytosol	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
synapse	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-3	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-H	Homo sapiens (human)
nucleoplasm	Cyclin-H	Homo sapiens (human)
transcription factor TFIIH core complex	Cyclin-H	Homo sapiens (human)
transcription factor TFIIH holo complex	Cyclin-H	Homo sapiens (human)
CAK-ERCC2 complex	Cyclin-H	Homo sapiens (human)
transcription factor TFIIK complex	Cyclin-H	Homo sapiens (human)
nucleus	Cyclin-H	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
nucleoplasm	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
transcription factor TFIIH core complex	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
transcription factor TFIIH holo complex	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
CAK-ERCC2 complex	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
transcription factor TFIIK complex	CDK-activating kinase assembly factor MAT1	Homo sapiens (human)
kinetochore	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
kinetochore	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
condensed nuclear chromosome	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
spindle pole	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
nucleolus	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
microtubule	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
midbody	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
protein-containing complex	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase Nek2	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
axon	Serine/threonine-protein kinase Nek3	Homo sapiens (human)
cytoplasm	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
cytosol	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
nucleoplasm	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
cytosol	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
cytoskeleton	Dual specificity mitogen-activated protein kinase kinase 6	Homo sapiens (human)
postsynapse	LIM domain kinase 1	Homo sapiens (human)
glutamatergic synapse	LIM domain kinase 1	Homo sapiens (human)
male germ cell nucleus	LIM domain kinase 1	Homo sapiens (human)
cytoplasm	LIM domain kinase 1	Homo sapiens (human)
cytosol	LIM domain kinase 1	Homo sapiens (human)
cytoskeleton	LIM domain kinase 1	Homo sapiens (human)
focal adhesion	LIM domain kinase 1	Homo sapiens (human)
membrane	LIM domain kinase 1	Homo sapiens (human)
nuclear speck	LIM domain kinase 1	Homo sapiens (human)
lamellipodium	LIM domain kinase 1	Homo sapiens (human)
neuron projection	LIM domain kinase 1	Homo sapiens (human)
nucleus	LIM domain kinase 1	Homo sapiens (human)
neuron projection	LIM domain kinase 1	Homo sapiens (human)
cytoplasm	LIM domain kinase 1	Homo sapiens (human)
nucleus	LIM domain kinase 2	Homo sapiens (human)
cytoplasm	LIM domain kinase 2	Homo sapiens (human)
cis-Golgi network	LIM domain kinase 2	Homo sapiens (human)
centrosome	LIM domain kinase 2	Homo sapiens (human)
perinuclear region of cytoplasm	LIM domain kinase 2	Homo sapiens (human)
mitotic spindle	LIM domain kinase 2	Homo sapiens (human)
nucleus	LIM domain kinase 2	Homo sapiens (human)
cytoplasm	LIM domain kinase 2	Homo sapiens (human)
nucleus	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
cytoplasm	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
cytosol	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
extracellular space	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
cytosol	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
nuclear body	Tyrosine--tRNA ligase, cytoplasmic	Homo sapiens (human)
nucleus	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
nucleoplasm	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
cytosol	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
membrane	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
nucleotide-activated protein kinase complex	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
nucleus	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
cytoplasm	5'-AMP-activated protein kinase subunit gamma-1	Homo sapiens (human)
extracellular region	Ephrin type-B receptor 3	Homo sapiens (human)
cytosol	Ephrin type-B receptor 3	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 3	Homo sapiens (human)
dendrite	Ephrin type-B receptor 3	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 3	Homo sapiens (human)
rough endoplasmic reticulum	Ephrin type-A receptor 5	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 5	Homo sapiens (human)
external side of plasma membrane	Ephrin type-A receptor 5	Homo sapiens (human)
axon	Ephrin type-A receptor 5	Homo sapiens (human)
dendrite	Ephrin type-A receptor 5	Homo sapiens (human)
neuronal cell body	Ephrin type-A receptor 5	Homo sapiens (human)
perinuclear region of cytoplasm	Ephrin type-A receptor 5	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 5	Homo sapiens (human)
dendrite	Ephrin type-A receptor 5	Homo sapiens (human)
extracellular region	Ephrin type-B receptor 4	Homo sapiens (human)
cytosol	Ephrin type-B receptor 4	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 4	Homo sapiens (human)
extracellular exosome	Ephrin type-B receptor 4	Homo sapiens (human)
receptor complex	Ephrin type-B receptor 4	Homo sapiens (human)
plasma membrane	Ephrin type-B receptor 4	Homo sapiens (human)
cytoplasm	Ephrin type-A receptor 4	Homo sapiens (human)
mitochondrial outer membrane	Ephrin type-A receptor 4	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 4	Homo sapiens (human)
adherens junction	Ephrin type-A receptor 4	Homo sapiens (human)
cell surface	Ephrin type-A receptor 4	Homo sapiens (human)
filopodium	Ephrin type-A receptor 4	Homo sapiens (human)
axon	Ephrin type-A receptor 4	Homo sapiens (human)
dendrite	Ephrin type-A receptor 4	Homo sapiens (human)
neuromuscular junction	Ephrin type-A receptor 4	Homo sapiens (human)
early endosome membrane	Ephrin type-A receptor 4	Homo sapiens (human)
presynaptic membrane	Ephrin type-A receptor 4	Homo sapiens (human)
dendritic spine	Ephrin type-A receptor 4	Homo sapiens (human)
dendritic shaft	Ephrin type-A receptor 4	Homo sapiens (human)
perikaryon	Ephrin type-A receptor 4	Homo sapiens (human)
axon terminus	Ephrin type-A receptor 4	Homo sapiens (human)
axonal growth cone	Ephrin type-A receptor 4	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Ephrin type-A receptor 4	Homo sapiens (human)
postsynaptic density membrane	Ephrin type-A receptor 4	Homo sapiens (human)
glutamatergic synapse	Ephrin type-A receptor 4	Homo sapiens (human)
plasma membrane	Ephrin type-A receptor 4	Homo sapiens (human)
dendrite	Ephrin type-A receptor 4	Homo sapiens (human)
mitochondrial intermembrane space	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
extracellular exosome	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
sperm mitochondrial sheath	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
cytoplasm	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
mitochondrion	Adenylate kinase 2, mitochondrial	Homo sapiens (human)
nucleoplasm	Adenosine kinase	Homo sapiens (human)
cytosol	Adenosine kinase	Homo sapiens (human)
plasma membrane	Adenosine kinase	Homo sapiens (human)
nucleus	Adenosine kinase	Homo sapiens (human)
cytosol	Adenosine kinase	Homo sapiens (human)
virion membrane	Spike glycoprotein	Severe acute respiratory syndrome-related coronavirus
exocyst	Ras-related protein Rab-10	Homo sapiens (human)
plasma membrane	Ras-related protein Rab-10	Homo sapiens (human)
Golgi membrane	Ras-related protein Rab-10	Homo sapiens (human)
endosome	Ras-related protein Rab-10	Homo sapiens (human)
endoplasmic reticulum membrane	Ras-related protein Rab-10	Homo sapiens (human)
Golgi apparatus	Ras-related protein Rab-10	Homo sapiens (human)
trans-Golgi network	Ras-related protein Rab-10	Homo sapiens (human)
cytosol	Ras-related protein Rab-10	Homo sapiens (human)
cytoskeleton	Ras-related protein Rab-10	Homo sapiens (human)
plasma membrane	Ras-related protein Rab-10	Homo sapiens (human)
adherens junction	Ras-related protein Rab-10	Homo sapiens (human)
focal adhesion	Ras-related protein Rab-10	Homo sapiens (human)
cilium	Ras-related protein Rab-10	Homo sapiens (human)
endosome membrane	Ras-related protein Rab-10	Homo sapiens (human)
cytoplasmic vesicle membrane	Ras-related protein Rab-10	Homo sapiens (human)
secretory granule membrane	Ras-related protein Rab-10	Homo sapiens (human)
phagocytic vesicle membrane	Ras-related protein Rab-10	Homo sapiens (human)
insulin-responsive compartment	Ras-related protein Rab-10	Homo sapiens (human)
perinuclear region of cytoplasm	Ras-related protein Rab-10	Homo sapiens (human)
recycling endosome	Ras-related protein Rab-10	Homo sapiens (human)
recycling endosome membrane	Ras-related protein Rab-10	Homo sapiens (human)
extracellular exosome	Ras-related protein Rab-10	Homo sapiens (human)
exocytic vesicle	Ras-related protein Rab-10	Homo sapiens (human)
endoplasmic reticulum tubular network	Ras-related protein Rab-10	Homo sapiens (human)
recycling endosome	Ras-related protein Rab-10	Homo sapiens (human)
secretory vesicle	Ras-related protein Rab-10	Homo sapiens (human)
membrane	Ras-related protein Rab-10	Homo sapiens (human)
Golgi apparatus	Ras-related protein Rab-10	Homo sapiens (human)
nucleus	Actin-related protein 3	Homo sapiens (human)
cytoplasm	Actin-related protein 3	Homo sapiens (human)
cytosol	Actin-related protein 3	Homo sapiens (human)
brush border	Actin-related protein 3	Homo sapiens (human)
cell-cell junction	Actin-related protein 3	Homo sapiens (human)
focal adhesion	Actin-related protein 3	Homo sapiens (human)
actin cytoskeleton	Actin-related protein 3	Homo sapiens (human)
membrane	Actin-related protein 3	Homo sapiens (human)
lamellipodium	Actin-related protein 3	Homo sapiens (human)
site of double-strand break	Actin-related protein 3	Homo sapiens (human)
extracellular exosome	Actin-related protein 3	Homo sapiens (human)
Arp2/3 protein complex	Actin-related protein 3	Homo sapiens (human)
extracellular region	Actin-related protein 2	Homo sapiens (human)
nucleus	Actin-related protein 2	Homo sapiens (human)
cytoplasm	Actin-related protein 2	Homo sapiens (human)
cytosol	Actin-related protein 2	Homo sapiens (human)
focal adhesion	Actin-related protein 2	Homo sapiens (human)
actin cytoskeleton	Actin-related protein 2	Homo sapiens (human)
membrane	Actin-related protein 2	Homo sapiens (human)
actin cap	Actin-related protein 2	Homo sapiens (human)
azurophil granule lumen	Actin-related protein 2	Homo sapiens (human)
site of double-strand break	Actin-related protein 2	Homo sapiens (human)
cell projection	Actin-related protein 2	Homo sapiens (human)
extracellular exosome	Actin-related protein 2	Homo sapiens (human)
ficolin-1-rich granule lumen	Actin-related protein 2	Homo sapiens (human)
Arp2/3 protein complex	Actin-related protein 2	Homo sapiens (human)
cell cortex	Actin-related protein 2	Homo sapiens (human)
Flemming body	GTP-binding nuclear protein Ran	Homo sapiens (human)
male germ cell nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
manchette	GTP-binding nuclear protein Ran	Homo sapiens (human)
nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
nuclear envelope	GTP-binding nuclear protein Ran	Homo sapiens (human)
nucleoplasm	GTP-binding nuclear protein Ran	Homo sapiens (human)
nucleolus	GTP-binding nuclear protein Ran	Homo sapiens (human)
cytoplasm	GTP-binding nuclear protein Ran	Homo sapiens (human)
centriole	GTP-binding nuclear protein Ran	Homo sapiens (human)
cytosol	GTP-binding nuclear protein Ran	Homo sapiens (human)
membrane	GTP-binding nuclear protein Ran	Homo sapiens (human)
midbody	GTP-binding nuclear protein Ran	Homo sapiens (human)
sperm flagellum	GTP-binding nuclear protein Ran	Homo sapiens (human)
melanosome	GTP-binding nuclear protein Ran	Homo sapiens (human)
recycling endosome	GTP-binding nuclear protein Ran	Homo sapiens (human)
extracellular exosome	GTP-binding nuclear protein Ran	Homo sapiens (human)
chromatin	GTP-binding nuclear protein Ran	Homo sapiens (human)
nuclear pore	GTP-binding nuclear protein Ran	Homo sapiens (human)
protein-containing complex	GTP-binding nuclear protein Ran	Homo sapiens (human)
RNA nuclear export complex	GTP-binding nuclear protein Ran	Homo sapiens (human)
nucleus	GTP-binding nuclear protein Ran	Homo sapiens (human)
cytoplasm	GTP-binding nuclear protein Ran	Homo sapiens (human)
cytosol	Casein kinase I isoform gamma-2	Homo sapiens (human)
cell cortex	Casein kinase I isoform gamma-2	Homo sapiens (human)
membrane	Casein kinase I isoform gamma-2	Homo sapiens (human)
cytoplasm	Casein kinase I isoform gamma-2	Homo sapiens (human)
plasma membrane	Casein kinase I isoform gamma-2	Homo sapiens (human)
nucleus	Casein kinase I isoform gamma-2	Homo sapiens (human)
ruffle	Cyclin-dependent kinase 6	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 6	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 6	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 6	Homo sapiens (human)
centrosome	Cyclin-dependent kinase 6	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 6	Homo sapiens (human)
cyclin D1-CDK6 complex	Cyclin-dependent kinase 6	Homo sapiens (human)
cyclin D3-CDK6 complex	Cyclin-dependent kinase 6	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 6	Homo sapiens (human)
cyclin D2-CDK6 complex	Cyclin-dependent kinase 6	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 6	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 6	Homo sapiens (human)
microtubule	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent-like kinase 5	Homo sapiens (human)
nucleus	Cyclin-dependent-like kinase 5	Homo sapiens (human)
nucleoplasm	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cytoplasm	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cytosol	Cyclin-dependent-like kinase 5	Homo sapiens (human)
plasma membrane	Cyclin-dependent-like kinase 5	Homo sapiens (human)
postsynaptic density	Cyclin-dependent-like kinase 5	Homo sapiens (human)
membrane	Cyclin-dependent-like kinase 5	Homo sapiens (human)
protein kinase 5 complex	Cyclin-dependent-like kinase 5	Homo sapiens (human)
lamellipodium	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cell junction	Cyclin-dependent-like kinase 5	Homo sapiens (human)
filopodium	Cyclin-dependent-like kinase 5	Homo sapiens (human)
axon	Cyclin-dependent-like kinase 5	Homo sapiens (human)
dendrite	Cyclin-dependent-like kinase 5	Homo sapiens (human)
growth cone	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuromuscular junction	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuron projection	Cyclin-dependent-like kinase 5	Homo sapiens (human)
neuronal cell body	Cyclin-dependent-like kinase 5	Homo sapiens (human)
perikaryon	Cyclin-dependent-like kinase 5	Homo sapiens (human)
presynapse	Cyclin-dependent-like kinase 5	Homo sapiens (human)
nucleus	Cyclin-dependent-like kinase 5	Homo sapiens (human)
cytoplasm	Cyclin-dependent-like kinase 5	Homo sapiens (human)
synaptic vesicle	Cyclin-dependent kinase 16	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 16	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 16	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 16	Homo sapiens (human)
plasma membrane	Cyclin-dependent kinase 16	Homo sapiens (human)
cytoplasmic side of plasma membrane	Cyclin-dependent kinase 16	Homo sapiens (human)
microtubule cytoskeleton	Cyclin-dependent kinase 16	Homo sapiens (human)
neuron projection	Cyclin-dependent kinase 16	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 16	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 16	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 17	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 17	Homo sapiens (human)
nucleus	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
cytoplasm	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
cytosol	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
membrane	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
extracellular exosome	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
membrane	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
6-phosphofructokinase complex	ATP-dependent 6-phosphofructokinase, platelet type	Homo sapiens (human)
nucleus	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
mitochondrion	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
early endosome	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
late endosome	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
endoplasmic reticulum	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
Golgi apparatus	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
centrosome	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
cytosol	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
plasma membrane	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
focal adhesion	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)
nucleolus	DNA topoisomerase 2-beta	Homo sapiens (human)
heterochromatin	DNA topoisomerase 2-beta	Homo sapiens (human)
nucleus	DNA topoisomerase 2-beta	Homo sapiens (human)
nucleoplasm	DNA topoisomerase 2-beta	Homo sapiens (human)
nucleolus	DNA topoisomerase 2-beta	Homo sapiens (human)
cytosol	DNA topoisomerase 2-beta	Homo sapiens (human)
ribonucleoprotein complex	DNA topoisomerase 2-beta	Homo sapiens (human)
nucleus	DNA topoisomerase 2-beta	Homo sapiens (human)
immunological synapse	Protein kinase C theta type	Homo sapiens (human)
cytosol	Protein kinase C theta type	Homo sapiens (human)
plasma membrane	Protein kinase C theta type	Homo sapiens (human)
aggresome	Protein kinase C theta type	Homo sapiens (human)
centriolar satellite	Protein kinase C theta type	Homo sapiens (human)
plasma membrane	Activin receptor type-1	Homo sapiens (human)
apical part of cell	Activin receptor type-1	Homo sapiens (human)
activin receptor complex	Activin receptor type-1	Homo sapiens (human)
BMP receptor complex	Activin receptor type-1	Homo sapiens (human)
plasma membrane	Activin receptor type-1	Homo sapiens (human)
stress fiber	Macrophage-stimulating protein receptor	Homo sapiens (human)
vacuole	Macrophage-stimulating protein receptor	Homo sapiens (human)
plasma membrane	Macrophage-stimulating protein receptor	Homo sapiens (human)
cell surface	Macrophage-stimulating protein receptor	Homo sapiens (human)
receptor complex	Macrophage-stimulating protein receptor	Homo sapiens (human)
plasma membrane	Macrophage-stimulating protein receptor	Homo sapiens (human)
stress fiber	Focal adhesion kinase 1	Homo sapiens (human)
nucleus	Focal adhesion kinase 1	Homo sapiens (human)
cytoplasm	Focal adhesion kinase 1	Homo sapiens (human)
centrosome	Focal adhesion kinase 1	Homo sapiens (human)
cytosol	Focal adhesion kinase 1	Homo sapiens (human)
cytoskeleton	Focal adhesion kinase 1	Homo sapiens (human)
plasma membrane	Focal adhesion kinase 1	Homo sapiens (human)
focal adhesion	Focal adhesion kinase 1	Homo sapiens (human)
cell cortex	Focal adhesion kinase 1	Homo sapiens (human)
ciliary basal body	Focal adhesion kinase 1	Homo sapiens (human)
intracellular membrane-bounded organelle	Focal adhesion kinase 1	Homo sapiens (human)
perinuclear region of cytoplasm	Focal adhesion kinase 1	Homo sapiens (human)
plasma membrane	Focal adhesion kinase 1	Homo sapiens (human)
focal adhesion	Focal adhesion kinase 1	Homo sapiens (human)
dendritic spine	Focal adhesion kinase 1	Homo sapiens (human)
stress fiber	Protein kinase C zeta type	Homo sapiens (human)
nuclear envelope	Protein kinase C zeta type	Homo sapiens (human)
cytoplasm	Protein kinase C zeta type	Homo sapiens (human)
endosome	Protein kinase C zeta type	Homo sapiens (human)
microtubule organizing center	Protein kinase C zeta type	Homo sapiens (human)
cytosol	Protein kinase C zeta type	Homo sapiens (human)
plasma membrane	Protein kinase C zeta type	Homo sapiens (human)
cell-cell junction	Protein kinase C zeta type	Homo sapiens (human)
bicellular tight junction	Protein kinase C zeta type	Homo sapiens (human)
postsynaptic density	Protein kinase C zeta type	Homo sapiens (human)
membrane	Protein kinase C zeta type	Homo sapiens (human)
apical plasma membrane	Protein kinase C zeta type	Homo sapiens (human)
nuclear matrix	Protein kinase C zeta type	Homo sapiens (human)
cell junction	Protein kinase C zeta type	Homo sapiens (human)
cell leading edge	Protein kinase C zeta type	Homo sapiens (human)
vesicle	Protein kinase C zeta type	Homo sapiens (human)
myelin sheath abaxonal region	Protein kinase C zeta type	Homo sapiens (human)
axon hillock	Protein kinase C zeta type	Homo sapiens (human)
apical cortex	Protein kinase C zeta type	Homo sapiens (human)
perinuclear region of cytoplasm	Protein kinase C zeta type	Homo sapiens (human)
extracellular exosome	Protein kinase C zeta type	Homo sapiens (human)
tight junction	Protein kinase C zeta type	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Protein kinase C zeta type	Homo sapiens (human)
glutamatergic synapse	Protein kinase C zeta type	Homo sapiens (human)
PAR polarity complex	Protein kinase C zeta type	Homo sapiens (human)
extracellular region	Protein kinase C delta type	Homo sapiens (human)
nucleus	Protein kinase C delta type	Homo sapiens (human)
nucleoplasm	Protein kinase C delta type	Homo sapiens (human)
cytoplasm	Protein kinase C delta type	Homo sapiens (human)
mitochondrion	Protein kinase C delta type	Homo sapiens (human)
endoplasmic reticulum	Protein kinase C delta type	Homo sapiens (human)
cytosol	Protein kinase C delta type	Homo sapiens (human)
plasma membrane	Protein kinase C delta type	Homo sapiens (human)
cell-cell junction	Protein kinase C delta type	Homo sapiens (human)
nuclear matrix	Protein kinase C delta type	Homo sapiens (human)
azurophil granule lumen	Protein kinase C delta type	Homo sapiens (human)
endolysosome	Protein kinase C delta type	Homo sapiens (human)
perinuclear region of cytoplasm	Protein kinase C delta type	Homo sapiens (human)
extracellular exosome	Protein kinase C delta type	Homo sapiens (human)
nucleus	Tyrosine-protein kinase BTK	Homo sapiens (human)
cytoplasm	Tyrosine-protein kinase BTK	Homo sapiens (human)
cytosol	Tyrosine-protein kinase BTK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase BTK	Homo sapiens (human)
cytoplasmic vesicle	Tyrosine-protein kinase BTK	Homo sapiens (human)
membrane raft	Tyrosine-protein kinase BTK	Homo sapiens (human)
perinuclear region of cytoplasm	Tyrosine-protein kinase BTK	Homo sapiens (human)
plasma membrane	Tyrosine-protein kinase BTK	Homo sapiens (human)
nucleus	Activated CDC42 kinase 1	Homo sapiens (human)
cytoplasm	Activated CDC42 kinase 1	Homo sapiens (human)
endosome	Activated CDC42 kinase 1	Homo sapiens (human)
cytosol	Activated CDC42 kinase 1	Homo sapiens (human)
plasma membrane	Activated CDC42 kinase 1	Homo sapiens (human)
clathrin-coated pit	Activated CDC42 kinase 1	Homo sapiens (human)
adherens junction	Activated CDC42 kinase 1	Homo sapiens (human)
membrane	Activated CDC42 kinase 1	Homo sapiens (human)
clathrin-coated vesicle	Activated CDC42 kinase 1	Homo sapiens (human)
cytoplasmic vesicle membrane	Activated CDC42 kinase 1	Homo sapiens (human)
intracellular membrane-bounded organelle	Activated CDC42 kinase 1	Homo sapiens (human)
perinuclear region of cytoplasm	Activated CDC42 kinase 1	Homo sapiens (human)
cytoophidium	Activated CDC42 kinase 1	Homo sapiens (human)
Grb2-EGFR complex	Activated CDC42 kinase 1	Homo sapiens (human)
plasma membrane	Activated CDC42 kinase 1	Homo sapiens (human)
extracellular space	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
plasma membrane	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
extracellular exosome	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
receptor complex	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
plasma membrane	Epithelial discoidin domain-containing receptor 1	Homo sapiens (human)
plasma membrane	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
cell surface	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
perinuclear region of cytoplasm	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
voltage-gated potassium channel complex	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
inward rectifier potassium channel complex	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
plasma membrane	Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)
Golgi membrane	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
basolateral plasma membrane	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 4	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase 4	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase 4	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 4	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase 4	Homo sapiens (human)
nuclear body	Serine/threonine-protein kinase 4	Homo sapiens (human)
protein-containing complex	Serine/threonine-protein kinase 4	Homo sapiens (human)
cytoplasm	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
nucleus	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
nucleoplasm	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cytoplasm	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
cytosol	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
apical plasma membrane	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
nuclear speck	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
axon	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
dendrite	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
nucleotide-activated protein kinase complex	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
neuronal cell body	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
chromatin	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
nucleus	5'-AMP-activated protein kinase catalytic subunit alpha-1	Homo sapiens (human)
spindle	Dual specificity mitogen-activated protein kinase kinase 5	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 7	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 7	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 7	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 7	Homo sapiens (human)
PML body	Mitogen-activated protein kinase 7	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 7	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 7	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cell-cell junction	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
postsynaptic density	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
secretory granule	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
perinuclear region of cytoplasm	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
glutamatergic synapse	Serine/threonine-protein kinase PAK 2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 3	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase 3	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase 3	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase 3	Homo sapiens (human)
protein-containing complex	Serine/threonine-protein kinase 3	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens (human)
Golgi membrane	Rho-associated protein kinase 1	Homo sapiens (human)
ruffle	Rho-associated protein kinase 1	Homo sapiens (human)
extracellular region	Rho-associated protein kinase 1	Homo sapiens (human)
centriole	Rho-associated protein kinase 1	Homo sapiens (human)
cytosol	Rho-associated protein kinase 1	Homo sapiens (human)
cytoskeleton	Rho-associated protein kinase 1	Homo sapiens (human)
plasma membrane	Rho-associated protein kinase 1	Homo sapiens (human)
cytoplasmic stress granule	Rho-associated protein kinase 1	Homo sapiens (human)
lamellipodium	Rho-associated protein kinase 1	Homo sapiens (human)
bleb	Rho-associated protein kinase 1	Homo sapiens (human)
secretory granule lumen	Rho-associated protein kinase 1	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Rho-associated protein kinase 1	Homo sapiens (human)
cytoskeleton	Rho-associated protein kinase 1	Homo sapiens (human)
cytoplasm	Rho-associated protein kinase 1	Homo sapiens (human)
cytoplasmic stress granule	Rho-associated protein kinase 1	Homo sapiens (human)
cytoplasm	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
membrane	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
plasma membrane	Non-receptor tyrosine-protein kinase TNK1	Homo sapiens (human)
chromosome, telomeric region	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nuclear envelope	Serine/threonine-protein kinase ATR	Homo sapiens (human)
site of DNA damage	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase ATR	Homo sapiens (human)
chromosome	Serine/threonine-protein kinase ATR	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase ATR	Homo sapiens (human)
PML body	Serine/threonine-protein kinase ATR	Homo sapiens (human)
ATR-ATRIP complex	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase ATR	Homo sapiens (human)
chromosome	Serine/threonine-protein kinase ATR	Homo sapiens (human)
nucleoplasm	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
cytosol	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
membrane	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
endocytic vesicle membrane	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
sarcoplasmic reticulum membrane	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
calcium- and calmodulin-dependent protein kinase complex	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
neuron projection	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
cytoplasm	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Homo sapiens (human)
nucleus	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
nucleoplasm	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
cytoplasm	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
cytosol	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
membrane	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
endocytic vesicle membrane	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
sarcoplasmic reticulum membrane	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
sarcolemma	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
calcium- and calmodulin-dependent protein kinase complex	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
cytoplasm	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
neuron projection	Calcium/calmodulin-dependent protein kinase type II subunit delta	Homo sapiens (human)
cytoskeleton	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
nucleus	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
nucleus	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
nucleoplasm	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
cytoplasm	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
nuclear speck	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
axon	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
dendrite	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
ribonucleoprotein complex	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)
cytoplasm	Activin receptor type-2B	Homo sapiens (human)
plasma membrane	Activin receptor type-2B	Homo sapiens (human)
protein-containing complex	Activin receptor type-2B	Homo sapiens (human)
receptor complex	Activin receptor type-2B	Homo sapiens (human)
activin receptor complex	Activin receptor type-2B	Homo sapiens (human)
plasma membrane	Activin receptor type-2B	Homo sapiens (human)
caveola	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
extracellular space	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
nucleoplasm	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
plasma membrane	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
clathrin-coated pit	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
adherens junction	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
basal plasma membrane	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
cell surface	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
postsynaptic density	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
apical plasma membrane	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
axon	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
dendrite	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
neuronal cell body	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
plasma membrane	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
receptor complex	Bone morphogenetic protein receptor type-2	Homo sapiens (human)
ruffle	Protein-tyrosine kinase 6	Homo sapiens (human)
nucleus	Protein-tyrosine kinase 6	Homo sapiens (human)
nucleoplasm	Protein-tyrosine kinase 6	Homo sapiens (human)
cytoplasm	Protein-tyrosine kinase 6	Homo sapiens (human)
cytosol	Protein-tyrosine kinase 6	Homo sapiens (human)
plasma membrane	Protein-tyrosine kinase 6	Homo sapiens (human)
nuclear body	Protein-tyrosine kinase 6	Homo sapiens (human)
plasma membrane	Protein-tyrosine kinase 6	Homo sapiens (human)
acrosomal vesicle	cGMP-dependent protein kinase 1	Homo sapiens (human)
nucleoplasm	cGMP-dependent protein kinase 1	Homo sapiens (human)
cytoplasm	cGMP-dependent protein kinase 1	Homo sapiens (human)
Golgi apparatus	cGMP-dependent protein kinase 1	Homo sapiens (human)
cytosol	cGMP-dependent protein kinase 1	Homo sapiens (human)
plasma membrane	cGMP-dependent protein kinase 1	Homo sapiens (human)
sarcolemma	cGMP-dependent protein kinase 1	Homo sapiens (human)
cyclin K-CDK13 complex	Cyclin-dependent kinase 13	Homo sapiens (human)
extracellular region	Cyclin-dependent kinase 13	Homo sapiens (human)
extracellular space	Cyclin-dependent kinase 13	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 13	Homo sapiens (human)
Golgi apparatus	Cyclin-dependent kinase 13	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 13	Homo sapiens (human)
nuclear speck	Cyclin-dependent kinase 13	Homo sapiens (human)
ficolin-1-rich granule lumen	Cyclin-dependent kinase 13	Homo sapiens (human)
nuclear cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 13	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 13	Homo sapiens (human)
cyclin/CDK positive transcription elongation factor complex	Cyclin-dependent kinase 13	Homo sapiens (human)
nucleus	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
cytosol	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
intracellular anatomical structure	Calcium/calmodulin-dependent protein kinase type 1	Homo sapiens (human)
cytoplasm	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
nucleus	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
nucleoplasm	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
cytoplasm	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
cytosol	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
PML body	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
mitochondrial membrane	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
serine/threonine protein kinase complex	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Homo sapiens (human)
NMDA selective glutamate receptor complex	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
nucleus	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cytoplasm	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cytosol	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cytoskeleton	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
focal adhesion	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cell cortex	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
postsynaptic density	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
lamellipodium	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
dendrite	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
growth cone	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
neuronal cell body	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
cell body	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
perinuclear region of cytoplasm	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
apical dendrite	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
presynapse	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
glutamatergic synapse	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
postsynaptic density, intracellular component	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
dendritic spine	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
focal adhesion	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
plasma membrane	Protein-tyrosine kinase 2-beta	Homo sapiens (human)
plasma membrane	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
cell cortex	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
membrane	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
cytoplasm	Maternal embryonic leucine zipper kinase	Homo sapiens (human)
chromosome, centromeric region	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
kinetochore	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
condensed nuclear chromosome	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
nucleus	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
nucleoplasm	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
chromosome	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
cytosol	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
nuclear matrix	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
mitotic cohesin complex	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
meiotic cohesin complex	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
mitotic spindle pole	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
cohesin complex	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
nucleus	Structural maintenance of chromosomes protein 1A	Homo sapiens (human)
chromosome, telomeric region	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
nucleus	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
nucleoplasm	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
cytoplasm	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
centrosome	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
membrane	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
NuRD complex	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
site of DNA damage	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
cerebellar granule cell to Purkinje cell synapse	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
chromatin	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
protein-containing complex	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
RNA polymerase II transcription regulator complex	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
nucleus	Chromodomain-helicase-DNA-binding protein 4	Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cytosol	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
plasma membrane	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
postsynaptic density	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
membrane	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
protein kinase 5 complex	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
axon	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
dendrite	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
growth cone	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuromuscular junction	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuron projection	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
neuronal cell body	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
dendritic spine	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
perikaryon	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
intracellular membrane-bounded organelle	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
contractile muscle fiber	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
perinuclear region of cytoplasm	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
presynapse	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
cytoplasm	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
growth cone	Cyclin-dependent kinase 5 activator 1	Homo sapiens (human)
Golgi membrane	Delta(24)-sterol reductase	Homo sapiens (human)
nucleus	Delta(24)-sterol reductase	Homo sapiens (human)
endoplasmic reticulum	Delta(24)-sterol reductase	Homo sapiens (human)
endoplasmic reticulum membrane	Delta(24)-sterol reductase	Homo sapiens (human)
membrane	Delta(24)-sterol reductase	Homo sapiens (human)
cytoplasm	Delta(24)-sterol reductase	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
cytosol	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
synapse	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase alpha-1	Homo sapiens (human)
cytoplasmic vesicle	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
cytoplasm	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
centrosome	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
cytosol	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
lamellipodium	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
perinuclear region of cytoplasm	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
cytoplasm	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
nucleus	Dual specificity testis-specific protein kinase 1	Homo sapiens (human)
stress fiber	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
cytoplasm	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
cytosol	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
plasma membrane	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
actin cytoskeleton	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
lamellipodium	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
cleavage furrow	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
cleavage furrow	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
stress fiber	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
lamellipodium	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
cytoplasm	Myosin light chain kinase, smooth muscle	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 11	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 11	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 11	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 11	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase STK11	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase STK11	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase STK11	Homo sapiens (human)
mitochondrion	Serine/threonine-protein kinase STK11	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase STK11	Homo sapiens (human)
membrane	Serine/threonine-protein kinase STK11	Homo sapiens (human)
Z disc	Serine/threonine-protein kinase STK11	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase STK11	Homo sapiens (human)
serine/threonine protein kinase complex	Serine/threonine-protein kinase STK11	Homo sapiens (human)
intracellular protein-containing complex	Serine/threonine-protein kinase STK11	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase STK11	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase STK11	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase N1	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase N1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase N1	Homo sapiens (human)
endosome	Serine/threonine-protein kinase N1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase N1	Homo sapiens (human)
midbody	Serine/threonine-protein kinase N1	Homo sapiens (human)
cleavage furrow	Serine/threonine-protein kinase N1	Homo sapiens (human)
protein-containing complex	Serine/threonine-protein kinase N1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase N2	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase N2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase N2	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase N2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase N2	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase N2	Homo sapiens (human)
nuclear body	Serine/threonine-protein kinase N2	Homo sapiens (human)
lamellipodium	Serine/threonine-protein kinase N2	Homo sapiens (human)
midbody	Serine/threonine-protein kinase N2	Homo sapiens (human)
cleavage furrow	Serine/threonine-protein kinase N2	Homo sapiens (human)
apical junction complex	Serine/threonine-protein kinase N2	Homo sapiens (human)
intermediate filament cytoskeleton	Serine/threonine-protein kinase N2	Homo sapiens (human)
perinuclear region of cytoplasm	Serine/threonine-protein kinase N2	Homo sapiens (human)
protein-containing complex	Serine/threonine-protein kinase N2	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 14	Homo sapiens (human)
spindle pole	Mitogen-activated protein kinase 14	Homo sapiens (human)
extracellular region	Mitogen-activated protein kinase 14	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 14	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase 14	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 14	Homo sapiens (human)
mitochondrion	Mitogen-activated protein kinase 14	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase 14	Homo sapiens (human)
nuclear speck	Mitogen-activated protein kinase 14	Homo sapiens (human)
secretory granule lumen	Mitogen-activated protein kinase 14	Homo sapiens (human)
glutamatergic synapse	Mitogen-activated protein kinase 14	Homo sapiens (human)
ficolin-1-rich granule lumen	Mitogen-activated protein kinase 14	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 14	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 14	Homo sapiens (human)
fibrillar center	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
nucleoplasm	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
extracellular exosome	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
cytoplasm	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
nucleus	Calcium/calmodulin-dependent protein kinase type IV	Homo sapiens (human)
centrosome	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
microtubule	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
membrane	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
centrosome	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens (human)
nucleoplasm	MAP kinase-activated protein kinase 3	Homo sapiens (human)
cytosol	MAP kinase-activated protein kinase 3	Homo sapiens (human)
cytoplasm	MAP kinase-activated protein kinase 3	Homo sapiens (human)
nucleus	MAP kinase-activated protein kinase 3	Homo sapiens (human)
plasma membrane	Discoidin domain-containing receptor 2	Homo sapiens (human)
focal adhesion	Discoidin domain-containing receptor 2	Homo sapiens (human)
actin cytoskeleton	Discoidin domain-containing receptor 2	Homo sapiens (human)
apical plasma membrane	Discoidin domain-containing receptor 2	Homo sapiens (human)
receptor complex	Discoidin domain-containing receptor 2	Homo sapiens (human)
plasma membrane	Discoidin domain-containing receptor 2	Homo sapiens (human)
cytosol	AP2-associated protein kinase 1	Homo sapiens (human)
plasma membrane	AP2-associated protein kinase 1	Homo sapiens (human)
clathrin-coated pit	AP2-associated protein kinase 1	Homo sapiens (human)
clathrin-coated vesicle	AP2-associated protein kinase 1	Homo sapiens (human)
cell leading edge	AP2-associated protein kinase 1	Homo sapiens (human)
terminal bouton	AP2-associated protein kinase 1	Homo sapiens (human)
intracellular membrane-bounded organelle	AP2-associated protein kinase 1	Homo sapiens (human)
presynapse	AP2-associated protein kinase 1	Homo sapiens (human)
cytoplasm	Myosin light chain kinase 3	Homo sapiens (human)
cytosol	Myosin light chain kinase 3	Homo sapiens (human)
cytoplasm	Myosin light chain kinase 3	Homo sapiens (human)
actin cytoskeleton	Myosin light chain kinase 3	Homo sapiens (human)
membrane	Uncharacterized aarF domain-containing protein kinase 5	Homo sapiens (human)
extracellular exosome	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
perinuclear region of cytoplasm	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
protein-containing complex	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
plasma membrane	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
cytosol	Putative heat shock protein HSP 90-beta 2	Homo sapiens (human)
endomembrane system	Rab-like protein 3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
cell-cell junction	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
lamellipodium	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
cell leading edge	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
actomyosin	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
actomyosin	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
cytoskeleton	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase MRCK alpha	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
cell leading edge	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
centriolar satellite	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
cytoskeleton	Serine/threonine-protein kinase MRCK gamma	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase N3	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase N3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase N3	Homo sapiens (human)
perinuclear region of cytoplasm	Serine/threonine-protein kinase N3	Homo sapiens (human)
phagophore assembly site	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
ciliary tip	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
phagophore assembly site membrane	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
autophagosome	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
phagophore assembly site	Serine/threonine-protein kinase ULK3	Homo sapiens (human)
nucleus	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
mitochondrial inner membrane	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
peroxisome	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
mitochondrial membrane	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
mitochondrion	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
cytoplasm	Acyl-CoA dehydrogenase family member 11	Homo sapiens (human)
endoplasmic reticulum	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
endoplasmic reticulum quality control compartment	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
IRE1-TRAF2-ASK1 complex	Serine/threonine-protein kinase/endoribonuclease IRE2	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
mitochondrion	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
actin filament	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
membrane	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
lateral plasma membrane	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
dendrite	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
microtubule bundle	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase MARK2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
microtubule cytoskeleton	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
perinuclear region of cytoplasm	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase TAO1	Homo sapiens (human)
nucleus	STE20-related kinase adapter protein alpha	Homo sapiens (human)
nucleoplasm	STE20-related kinase adapter protein alpha	Homo sapiens (human)
cytoplasm	STE20-related kinase adapter protein alpha	Homo sapiens (human)
cytosol	STE20-related kinase adapter protein alpha	Homo sapiens (human)
serine/threonine protein kinase complex	STE20-related kinase adapter protein alpha	Homo sapiens (human)
intracellular protein-containing complex	STE20-related kinase adapter protein alpha	Homo sapiens (human)
stress fiber	Myosin-14	Homo sapiens (human)
cytosol	Myosin-14	Homo sapiens (human)
brush border	Myosin-14	Homo sapiens (human)
membrane	Myosin-14	Homo sapiens (human)
growth cone	Myosin-14	Homo sapiens (human)
actomyosin	Myosin-14	Homo sapiens (human)
extracellular exosome	Myosin-14	Homo sapiens (human)
myosin II filament	Myosin-14	Homo sapiens (human)
myosin II complex	Myosin-14	Homo sapiens (human)
cytoplasm	Myosin-14	Homo sapiens (human)
myosin filament	Myosin-14	Homo sapiens (human)
mitochondrion	AarF domain-containing protein kinase 1	Homo sapiens (human)
mitochondrial inner membrane	AarF domain-containing protein kinase 1	Homo sapiens (human)
nucleus	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
nucleoplasm	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
cytoplasm	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
cytosol	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
Cajal body	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
membrane	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
nuclear speck	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
U2-type prespliceosome	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
nucleus	ATP-dependent RNA helicase DDX42	Homo sapiens (human)
nucleus	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
nucleoplasm	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
cytoplasm	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
centrosome	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
cytosol	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
nuclear speck	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
cytoplasm	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
PML body	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
nucleus	Homeodomain-interacting protein kinase 1	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 3	Homo sapiens (human)
nucleoplasm	MAP kinase-activated protein kinase 5	Homo sapiens (human)
cytosol	MAP kinase-activated protein kinase 5	Homo sapiens (human)
septin cytoskeleton	MAP kinase-activated protein kinase 5	Homo sapiens (human)
protein-containing complex	MAP kinase-activated protein kinase 5	Homo sapiens (human)
cytoplasm	MAP kinase-activated protein kinase 5	Homo sapiens (human)
nucleus	MAP kinase-activated protein kinase 5	Homo sapiens (human)
mitochondrion	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
membrane	Atypical kinase COQ8A, mitochondrial	Homo sapiens (human)
nucleoplasm	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
autophagosome	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
endoplasmic reticulum	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
cytosol	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
plasma membrane	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
intracellular organelle	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
extracellular exosome	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
plasma membrane	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Homo sapiens (human)
axoneme	Mitogen-activated protein kinase 15	Homo sapiens (human)
extracellular region	Mitogen-activated protein kinase 15	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 15	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 15	Homo sapiens (human)
autophagosome	Mitogen-activated protein kinase 15	Homo sapiens (human)
Golgi apparatus	Mitogen-activated protein kinase 15	Homo sapiens (human)
centriole	Mitogen-activated protein kinase 15	Homo sapiens (human)
cell-cell junction	Mitogen-activated protein kinase 15	Homo sapiens (human)
bicellular tight junction	Mitogen-activated protein kinase 15	Homo sapiens (human)
cytoplasmic vesicle	Mitogen-activated protein kinase 15	Homo sapiens (human)
ciliary basal body	Mitogen-activated protein kinase 15	Homo sapiens (human)
meiotic spindle	Mitogen-activated protein kinase 15	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase 15	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase 15	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase Nek9	Homo sapiens (human)
nucleus	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
nucleoplasm	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
cytoplasm	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
mitochondrion	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
cytosol	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
cytoplasmic stress granule	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
membrane	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
cleavage body	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
tRNA-splicing ligase complex	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
ribonucleoprotein complex	ATP-dependent RNA helicase DDX1	Homo sapiens (human)
membrane	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 1	Homo sapiens (human)
kinetochore	Aurora kinase B	Homo sapiens (human)
condensed chromosome, centromeric region	Aurora kinase B	Homo sapiens (human)
nucleus	Aurora kinase B	Homo sapiens (human)
nucleoplasm	Aurora kinase B	Homo sapiens (human)
spindle	Aurora kinase B	Homo sapiens (human)
cytosol	Aurora kinase B	Homo sapiens (human)
chromocenter	Aurora kinase B	Homo sapiens (human)
microtubule cytoskeleton	Aurora kinase B	Homo sapiens (human)
midbody	Aurora kinase B	Homo sapiens (human)
chromosome passenger complex	Aurora kinase B	Homo sapiens (human)
mitotic spindle pole	Aurora kinase B	Homo sapiens (human)
mitotic spindle midzone	Aurora kinase B	Homo sapiens (human)
kinetochore	Aurora kinase B	Homo sapiens (human)
spindle pole centrosome	Aurora kinase B	Homo sapiens (human)
spindle microtubule	Aurora kinase B	Homo sapiens (human)
spindle midzone	Aurora kinase B	Homo sapiens (human)
microtubule organizing center	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
cytoplasm	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
centrosome	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
microtubule organizing center	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
cytosol	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
microtubule cytoskeleton	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
dendrite	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
midbody	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
neuron projection	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
gamma-tubulin complex	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
ciliary basal body	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
cytoplasm	MAP/microtubule affinity-regulating kinase 4	Homo sapiens (human)
pericentriolar material	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
centrosome	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
centriolar satellite	Serine/threonine-protein kinase Nek1	Homo sapiens (human)
nucleoplasm	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
cytosol	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
neuron projection	Calcium/calmodulin-dependent protein kinase kinase 2	Homo sapiens (human)
nucleus	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
nucleoplasm	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
cytoplasm	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
EKC/KEOPS complex	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
cytosol	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
nucleus	EKC/KEOPS complex subunit TP53RK	Homo sapiens (human)
Golgi membrane	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
nucleoplasm	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
nucleolus	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
endoplasmic reticulum	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
endoplasmic reticulum membrane	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
Golgi apparatus	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
cytosol	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
membrane	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
cytoplasm	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
nucleus	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
external side of plasma membrane	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein-containing complex	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
protein kinase complex	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
IRE1-TRAF2-ASK1 complex	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase 3	Homo sapiens (human)
cytosol	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
cytosol	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
nucleus	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
cytoplasm	Eukaryotic translation initiation factor 2-alpha kinase 1	Homo sapiens (human)
nucleus	Nucleolar GTP-binding protein 1	Homo sapiens (human)
nucleoplasm	Nucleolar GTP-binding protein 1	Homo sapiens (human)
nucleolus	Nucleolar GTP-binding protein 1	Homo sapiens (human)
cytoplasm	Nucleolar GTP-binding protein 1	Homo sapiens (human)
cytosol	Nucleolar GTP-binding protein 1	Homo sapiens (human)
membrane	Nucleolar GTP-binding protein 1	Homo sapiens (human)
nuclear membrane	Nucleolar GTP-binding protein 1	Homo sapiens (human)
perinuclear region of cytoplasm	Nucleolar GTP-binding protein 1	Homo sapiens (human)
nucleolus	Nucleolar GTP-binding protein 1	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase D2	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase D2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase D2	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase D2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase D2	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase D2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase D2	Homo sapiens (human)
chromosome, telomeric region	RNA cytidine acetyltransferase	Homo sapiens (human)
nucleus	RNA cytidine acetyltransferase	Homo sapiens (human)
nucleoplasm	RNA cytidine acetyltransferase	Homo sapiens (human)
nucleolus	RNA cytidine acetyltransferase	Homo sapiens (human)
membrane	RNA cytidine acetyltransferase	Homo sapiens (human)
midbody	RNA cytidine acetyltransferase	Homo sapiens (human)
telomerase holoenzyme complex	RNA cytidine acetyltransferase	Homo sapiens (human)
small-subunit processome	RNA cytidine acetyltransferase	Homo sapiens (human)
nucleolus	RNA cytidine acetyltransferase	Homo sapiens (human)
endoplasmic reticulum membrane	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase SIK2	Homo sapiens (human)
cytoplasm	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
cytosol	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
cell leading edge	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
perinuclear region of cytoplasm	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
extracellular exosome	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
cytoplasm	STE20-like serine/threonine-protein kinase	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase TAO3	Homo sapiens (human)
nucleus	dCTP pyrophosphatase 1	Homo sapiens (human)
nucleoplasm	dCTP pyrophosphatase 1	Homo sapiens (human)
mitochondrion	dCTP pyrophosphatase 1	Homo sapiens (human)
cytosol	dCTP pyrophosphatase 1	Homo sapiens (human)
cytosol	dCTP pyrophosphatase 1	Homo sapiens (human)
nucleus	Dual specificity protein kinase CLK4	Homo sapiens (human)
cytosol	Casein kinase I isoform gamma-1	Homo sapiens (human)
nucleus	Casein kinase I isoform gamma-1	Homo sapiens (human)
plasma membrane	Casein kinase I isoform gamma-1	Homo sapiens (human)
cytoplasm	Casein kinase I isoform gamma-1	Homo sapiens (human)
cytoplasm	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
cytosol	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
phenylalanine-tRNA ligase complex	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
membrane	Phenylalanine--tRNA ligase beta subunit	Homo sapiens (human)
mitochondrial matrix	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
mitochondrion	Isoleucine--tRNA ligase, mitochondrial	Homo sapiens (human)
nuclear speck	BMP-2-inducible protein kinase	Homo sapiens (human)
cytoplasm	BMP-2-inducible protein kinase	Homo sapiens (human)
nucleus	BMP-2-inducible protein kinase	Homo sapiens (human)
nucleus	Midasin	Homo sapiens (human)
nucleoplasm	Midasin	Homo sapiens (human)
nucleolus	Midasin	Homo sapiens (human)
cytosol	Midasin	Homo sapiens (human)
membrane	Midasin	Homo sapiens (human)
intermediate filament cytoskeleton	Midasin	Homo sapiens (human)
nucleus	Midasin	Homo sapiens (human)
preribosome, large subunit precursor	Midasin	Homo sapiens (human)
cytoplasm	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
cell surface	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
extrinsic component of plasma membrane	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
extracellular space	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
cytosol	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
plasma membrane	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
endosome membrane	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
nucleus	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
plasma membrane	Interleukin-1 receptor-associated kinase 4	Homo sapiens (human)
nucleus	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 20	Homo sapiens (human)
cyclin K-CDK12 complex	Cyclin-dependent kinase 12	Homo sapiens (human)
nucleoplasm	Cyclin-dependent kinase 12	Homo sapiens (human)
nuclear speck	Cyclin-dependent kinase 12	Homo sapiens (human)
nuclear cyclin-dependent protein kinase holoenzyme complex	Cyclin-dependent kinase 12	Homo sapiens (human)
nucleus	Cyclin-dependent kinase 12	Homo sapiens (human)
cyclin/CDK positive transcription elongation factor complex	Cyclin-dependent kinase 12	Homo sapiens (human)
nucleoplasm	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
cytoplasm	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
mitochondrion	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
mitochondrial inner membrane	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
mitochondrial respirasome	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
mitochondrial respiratory chain complex I	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
mitochondrial membrane	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 26	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase 26	Homo sapiens (human)
Golgi-associated vesicle	Serine/threonine-protein kinase 26	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase 26	Homo sapiens (human)
vesicle membrane	Serine/threonine-protein kinase 26	Homo sapiens (human)
membrane	Serine/threonine-protein kinase 26	Homo sapiens (human)
apical plasma membrane	Serine/threonine-protein kinase 26	Homo sapiens (human)
perinuclear region of cytoplasm	Serine/threonine-protein kinase 26	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase 26	Homo sapiens (human)
cell periphery	Serine/threonine-protein kinase 26	Homo sapiens (human)
FAR/SIN/STRIPAK complex	Serine/threonine-protein kinase 26	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase 26	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 26	Homo sapiens (human)
mitochondrion	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
mitochondrial matrix	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinate-CoA ligase complex (ADP-forming)	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
extracellular exosome	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
mitochondrion	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
succinate-CoA ligase complex	Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase NLK	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase NLK	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase NLK	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase NLK	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase NLK	Homo sapiens (human)
extracellular space	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
nucleoplasm	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
cytosol	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
nucleotide-activated protein kinase complex	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
cytoplasm	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
nucleus	5'-AMP-activated protein kinase subunit gamma-2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
intracellular membrane-bounded organelle	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
serine/threonine protein kinase complex	Serine/threonine-protein kinase TBK1	Homo sapiens (human)
stress fiber	Septin-9	Homo sapiens (human)
cytoplasm	Septin-9	Homo sapiens (human)
microtubule	Septin-9	Homo sapiens (human)
axoneme	Septin-9	Homo sapiens (human)
actin cytoskeleton	Septin-9	Homo sapiens (human)
perinuclear region of cytoplasm	Septin-9	Homo sapiens (human)
non-motile cilium	Septin-9	Homo sapiens (human)
septin complex	Septin-9	Homo sapiens (human)
septin ring	Septin-9	Homo sapiens (human)
microtubule cytoskeleton	Septin-9	Homo sapiens (human)
cell division site	Septin-9	Homo sapiens (human)
fibrillar center	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
nucleolus	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
mitochondrion	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
cytosol	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
cytoplasm	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
nucleoplasm	Ribosomal protein S6 kinase alpha-6	Homo sapiens (human)
nucleus	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
nucleoplasm	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
cytoplasm	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
cytosol	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
cytoskeleton	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
apical plasma membrane	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
recycling endosome	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
extracellular exosome	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
presynapse	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
glutamatergic synapse	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
postsynaptic density, intracellular component	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
cytoplasm	TRAF2 and NCK-interacting protein kinase	Homo sapiens (human)
actin cytoskeleton	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
nucleolus	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
axon	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
cytoplasmic vesicle membrane	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
cytoplasmic vesicle	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
neuron projection	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
dendritic growth cone	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
axonal growth cone	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
receptor complex	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase TAO2	Homo sapiens (human)
fibrillar center	Serine/threonine-protein kinase ICK	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase ICK	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase ICK	Homo sapiens (human)
cilium	Serine/threonine-protein kinase ICK	Homo sapiens (human)
ciliary basal body	Serine/threonine-protein kinase ICK	Homo sapiens (human)
ciliary tip	Serine/threonine-protein kinase ICK	Homo sapiens (human)
ciliary base	Serine/threonine-protein kinase ICK	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase ICK	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase ICK	Homo sapiens (human)
cilium	Serine/threonine-protein kinase ICK	Homo sapiens (human)
nucleus	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
cytoplasm	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
membrane	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
nucleoplasm	RAC-gamma serine/threonine-protein kinase	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase SIK3	Homo sapiens (human)
nucleoplasm	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase 2	Homo sapiens (human)
exon-exon junction complex	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nucleus	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nucleoplasm	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
nuclear speck	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
extracellular exosome	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
mediator complex	Thyroid hormone receptor-associated protein 3	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
cytosol	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
plasma membrane	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase kinase 5	Homo sapiens (human)
nucleus	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
nucleus	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
cytosol	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
protein-containing complex	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
cytoplasm	Receptor-interacting serine/threonine-protein kinase 3	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
plasma membrane	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
cell-cell junction	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
lamellipodium	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
cell leading edge	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
actomyosin	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
cytoskeleton	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
actomyosin	Serine/threonine-protein kinase MRCK beta	Homo sapiens (human)
nucleus	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
cytoplasm	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
nucleus	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
plasma membrane	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
cytoplasm	Interleukin-1 receptor-associated kinase 3	Homo sapiens (human)
Golgi membrane	Serine/threonine-protein kinase 24	Homo sapiens (human)
nucleus	Serine/threonine-protein kinase 24	Homo sapiens (human)
nucleoplasm	Serine/threonine-protein kinase 24	Homo sapiens (human)
nucleolus	Serine/threonine-protein kinase 24	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 24	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase 24	Homo sapiens (human)
cytosol	Serine/threonine-protein kinase 24	Homo sapiens (human)
extracellular exosome	Serine/threonine-protein kinase 24	Homo sapiens (human)
FAR/SIN/STRIPAK complex	Serine/threonine-protein kinase 24	Homo sapiens (human)
Golgi apparatus	Serine/threonine-protein kinase 24	Homo sapiens (human)
cytoplasm	Serine/threonine-protein kinase 24	Homo sapiens (human)
cytoplasm	Casein kinase I isoform gamma-3	Homo sapiens (human)
plasma membrane	Casein kinase I isoform gamma-3	Homo sapiens (human)
cytoplasm	Casein kinase I isoform gamma-3	Homo sapiens (human)
nucleus	Casein kinase I isoform gamma-3	Homo sapiens (human)
cytoplasm	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
perinuclear region of cytoplasm	Mitogen-activated protein kinase kinase kinase 4	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (790)

Assay ID	Title	Year	Journal	Article
AID1608889	Induction of apoptosis in human MDA-MB-231 cells at 40 nM incubated for 48 hrs by annexin V FITC and propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1424920	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588682	Inhibition of recombinant full length human GST-tagged DYRK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588728	Inhibition of recombinant full length human His-tagged JNK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588841	Inhibition of recombinant full length human GST-tagged p38alpha expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-15 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1909276	Induction of apoptosis in human MDA-MB-231 cells assessed as late apoptotic cells at 3 uM measured after 48 hrs by Annexin V-FITC/PI staining based flow cytometric analysis (Rvb = 1.06%)
AID1277161	Inhibition of CDK9/Cyclin T1 (unknown origin) using (YSPTSPS)2KK peptide as substrate in presence of [gamma-33P]ATP	2016	European journal of medicinal chemistry, Jan-27, Volume: 108	Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
AID1425198	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425038	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424962	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588765	Inhibition of recombinant full length human GST-tagged NEK4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425122	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425169	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588671	Inhibition of recombinant full length human His-tagged CAMK2beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424900	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425066	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424929	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424923	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1648274	Inhibition of recombinant human full-length N-terminal GST-tagged CDK2/cyclinA2 expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate measured after 10 mins by ADP-glo assay
AID1424924	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425199	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425194	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608876	Antiproliferative activity against HUVEC cells assessed as reduction in cell viability at 40 nM measured upto 72 hrs by CCK8 assay	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588708	Inhibition of recombinant full length human GST-tagged GRK6 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588836	Inhibition of recombinant full length human GST-tagged YES expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588661	Inhibition of recombinant full length human GST-tagged CK1 gamma 1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424951	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588777	Inhibition of recombinant human GST-tagged PI3Kgamma catalytic domain (468 to 1203 residues) expressed in insect expression system at 0.1 uM using PI Lipid Kinase as substrate incubated for 60 mins by Adapta assay relative to control
AID1425132	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551251	Half life in human	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1513692	Induction of cell cycle arrest in human HCT116 cells assessed as accumulation at G1 phase at 0.03 to 0.8 uM after 24 hrs by propidium iodide-staining based flow cytometry	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1425182	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425027	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425162	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588743	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588787	Inhibition of recombinant full length human GST-tagged PKD1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424911	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551239	Inhibition of wild-type human partial length HIPK1 (M146 to I555 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588644	Inhibition of recombinant full length human GST-tagged CDK17/Cyclin Y (2 to end amino acids) expressed in insect expression system at 0.1 uM using serine/threonine-12 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588770	Inhibition of recombinant full length human His-tagged PAK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-20 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425003	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1849057	Induction of cell cycle arrest in human MCF7 cells assessed as accumulation of cells at G1 phase at 1.5 uM incubated for 24 hrs by propidium iodide staining based flow cytometry analysis (Rvb = 57.38%)
AID1424980	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424977	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588668	Inhibition of recombinant human His-tagged CSF1R catalytic domain (538 to 910 residues) expressed in Baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1239760	Inhibition of human CDK1/cyclin B1 (unknown origin)	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
AID1425029	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425039	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425211	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425153	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588674	Inhibition of recombinant full length human full length GST-tagged CAMK4 expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-13 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425155	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1374357	Inhibition of human ERG	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1737180	Selectivity ratio of IC50 for inhibition of CDK9/cyclin T1 (unknown origin) to IC50 for inhibition of recombinant human full-length N-terminal GST-fused CDK4 (1 to 303 residues)/GST-tagged CyclinD3 (1 to 292 residues) expressed in baculovirus expression s	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1909295	Antitumor activity against mouse EMT6 cells implanted in BALB/c mouse syngenic model assessed as tumor growth inhibition at 40 mg/kg, po qd and measured after 18 days relative to control
AID1868058	Inhibition of CDK6/Cyclin D (unknown origin)	2022	Journal of medicinal chemistry, 05-12, Volume: 65, Issue:9	From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
AID1425010	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425059	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608517	Antiproliferative activity against HUVEC cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1509690	Half life in BALB/c mouse at 10 mg/kg, po measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425078	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424984	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1653035	Inhibition of CDK6 (unknown origin)	2019	European journal of medicinal chemistry, Feb-15, Volume: 164	Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
AID1509705	Antitumor activity against human MCF7 cells xenografted in BALB/c mouse assessed as reduction in tumor volume at 50 mg/kg, po administered once daily for 19 days measured on 19th day	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1424509	Inhibition of CDK6 (unknown origin)	2017	European journal of medicinal chemistry, Dec-15, Volume: 142	Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.
AID1424993	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425160	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424942	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551228	Protein binding in human plasma	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1737187	Antiproliferative activity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1424902	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1653004	Inhibition of CDK2 (unknown origin)	2019	European journal of medicinal chemistry, Feb-15, Volume: 164	Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
AID1424933	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424940	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588731	Inhibition of recombinant full length human GST-tagged KHS1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588721	Inhibition of recombinant human GST-tagged IRR (944 to 1297 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425205	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425118	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425146	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1648277	Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
AID1424965	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588764	Inhibition of recombinant full length human GST-tagged NEK1 catalytic domain (1 to 505 amino acids) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to contr
AID1588827	Inhibition of recombinant human GST-tagged TXK catalytic domain (260 to 527 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588811	Inhibition of tracer 236 binding to recombinant full length human GST-tagged SLK expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1425099	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608515	Antiproliferative activity against human SiHa cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1382372	Half life in rat liver microsomes at 1.11 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588749	Inhibition of tracer 236 binding to full length human GST-tagged MKNK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1424990	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588694	Inhibition of recombinant human GST-tagged ERBB4 catalytic domain (708 to 993 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588646	Inhibition of recombinant full length human His-tagged CDK2/Cyclin A expressed in baculovirus expression system at 0.1 uM using serine/threonine-12 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509673	Metabolic stability in mouse liver microsomes assessed as intrinsic clearance rate per mg protein incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425212	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424989	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588726	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588711	Inhibition of recombinant human GST-tagged HIPK1 catalytic domain (158 to 555 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509669	Metabolic stability in rat liver microsomes assessed as half life incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425061	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588715	Inhibition of recombinant human His-tagged IGF1R catalytic domain (960 to 1397 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425190	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1317305	Inhibition of CDK1/cyclin B (unknown origin)	2016	Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19	Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
AID1588660	Inhibition of recombinant full length human His-tagged CK1 epsilon1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424905	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588796	Inhibition of recombinant human GST-tagged RAF1 Y340D Y341D mutant catalytic domain (306 to 648 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to
AID1425137	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588662	Inhibition of recombinant full length human His-tagged CK1 gamma 2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425023	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425209	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424957	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588747	Inhibition of recombinant full length human His-tagged MKK6 expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425073	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588627	Inhibition of recombinant full length human His-tagged Aurora A expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1513679	Inhibition of His-tagged CDK2/cyclin E (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1424915	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424953	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425070	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425017	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588831	Inhibition of recombinant human His-tagged TRKA catalytic domain (441 to 796 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425159	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588638	Inhibition of tracer 236 binding to recombinant full length human GST-tagged CAMKK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1648272	Inhibition of recombinant human full-length N-terminal His-tagged CDK6/cyclinD3 expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate measured after 60 mins by ADP-glo assay
AID1588663	Inhibition of recombinant full length human His-tagged CK2 alpha 1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1915588	Inhibition of Cdk6 (unknown origin)	2021	European journal of medicinal chemistry, Jan-01, Volume: 209	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
AID1509686	Volume of distribution at steady state in BALB/c mouse at 3 mg/kg, iv measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588586	Efflux ratio in MDCK2 expressing mouse bcrp1
AID1277160	Inhibition of CDK7/Cyclin H/MAT1 (unknown origin) using (YSPTSPS)2KK peptide as substrate in presence of [gamma-33P]ATP	2016	European journal of medicinal chemistry, Jan-27, Volume: 108	Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
AID1425176	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424904	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424997	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588695	Inhibition of recombinant full length human GST-tagged FAK expressed in baculovirus expression system at 0.1 uM using tyrosine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551253	Clearance in human	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588782	Inhibition of recombinant full length human GST-tagged PKCdelta expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588775	Inhibition of recombinant human His-tagged PDK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588849	Inhibition of recombinant full length human GST-tagged PKG1 alpha expressed in baculovirus expression system at 0.1 uM using CREBtide as substrate 60 mins by Lanthascreen assay relative to control
AID1588751	Inhibition of tracer 236 binding to recombinant full length human GST-tagged MLK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1509666	Antiproliferative activity against human PC3 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1909254	Inhibition of recombinant N-terminal GST/His6-fusion tagged human CDK4/Cyclin D3 expressed in Sf9 insect cells using 5-FAM-IPTSPITTTYFFFKKK as substrate preincubated for 10 mins followed by substrate addition and incubated for 3 hrs in presence of ATP by
AID1425065	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425050	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1648278	Cytotoxicity against human L02 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
AID1425013	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425086	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382385	AUClast in ICR mouse at 0.5 mg/kg, iv by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1425052	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588651	Inhibition of recombinant full length human GST/His-tagged CDK5/p25 expressed in baculovirus expression system at 0.1 uM using serine/threonine-12 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588814	Inhibition of tracer 236 binding to recombinant full length human His-tagged STK16 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1425208	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588679	Inhibition of recombinant human DNA-PK expressed in baculovirus expression system at 0.1 uM using serine/threonine-26 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509653	Antiproliferative activity against human THP1 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588655	Inhibition of recombinant full length human His-tagged CDK9/CyclinT1 expressed in baculovirus expression system at 0.1 uM using CDK7/9tide peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1513683	Inhibition of GST-tagged CDK7/cyclinH/MAT1 (unknown origin) expressed in Baculovirus infected Sf9 cells using YSPTSPS-2 KK peptide as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1588771	Inhibition of recombinant human GST-tagged PAK4 catalytic domain (295 to 591 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-20 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425128	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424969	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1824398	Antiproliferative activity against human RPMI-8226 cells assessed as growth inhibition measured after 72 hrs by CCK8 assay
AID1588732	Inhibition of recombinant human His-tagged KIT (544 to 976 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588798	Inhibition of recombinant human GST-tagged ROCK1 catalytic domain (1 to 535 amino acids) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509621	Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 4 to 6 days by cell titer-glo luminescent cell viability assay	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588800	Inhibition of recombinant full length human His-tagged RSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382356	Cell cycle arrest in human COLO205 cells assessed as accumulation at G0/G1 phase at 1 uM after 24 hrs by propidium iodide staining based FACS analysis (Rvb = 64.4%)	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1425193	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1648275	Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
AID1824403	Antiproliferative activity against human HEK293 cells assessed as growth inhibition measured after 72 hrs by CCK8 assay
AID1648353	Antitumor activity against human MDA-MB-231 cells xenografted in BALB/c nu/nu mouse assessed as tumor growth inhibition at 45 mg/kg, po administered once daily for 3 weeks and measured at 3 days interval during compound dosing
AID1425165	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425191	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608566	Antitumor activity against human SiHa cells xenografted in NOD/SCID BALB/c mouse assessed as reduction in Ki67 expression at 40 mg/kg, po measured after 21 days by hematoxylin and eosin staining based immunohistochemistry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588703	Inhibition of recombinant human GST-tagged FLT4 catalytic domain (800 to 1297 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588850	Inhibition of recombinant full length human PRKAA1 expressed in baculovirus expression system at 0.1 uM using CREBtide as substrate 60 mins by Lanthascreen assay relative to control
AID1382390	Cmax in ICR mouse at 1 mg/kg, po via gavage by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1424893	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424974	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1653003	Inhibition of CDK1 (unknown origin)	2019	European journal of medicinal chemistry, Feb-15, Volume: 164	Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
AID1551211	Inhibition of CDK1 (unknown origin)	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1737228	Inhibition of CDK1/cyclin B (unknown origin)	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1239763	Competitive inhibition of human CDK4/cyclin D1 expressed in insect cells assessed as phosphorylation of CTRF after 50 mins by Michaelis-Menten plot analysis in presence of ATP	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
AID1824412	Induction of cell cycle arrest in human RPMI-8226 cells assessed as accumulation at G1 phase at 1 uM measured after 24 hrs by propidium iodide staining based flow cytometric analysis (Rvb = 41.96%)
AID1588707	Inhibition of recombinant full length human GST-tagged GRK5 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425156	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425207	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588701	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425002	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425110	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588838	Inhibition of recombinant full length human GST-tagged ZIPK expressed in baculovirus expression system at 0.1 uM using serine/threonine-13 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588753	Inhibition of recombinant full length human GST-tagged MSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425178	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382342	Inhibition of human CDK4/cyclin D1 using ULight-substrate after 1 hr by LANCE assay	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1425009	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588696	Inhibition of recombinant human His-tagged FGFR1 catalytic domain (308 to 731 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588851	Inhibition of recombinant full length human GST-tagged ZAK expressed in baculovirus expression system at 0.1 uM using CREBtide as substrate 60 mins by Lanthascreen assay relative to control
AID1588640	Inhibition of tracer 236 binding to recombinant human GST/His-tagged CDK11/Cyclin C catalytic domain (CDK11: 1 to 502, Cyclin C: 1 to 283) expressed in insect cells expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to contr
AID1588803	Inhibition of recombinant human GST-tagged RET (658 to 1114 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588637	Inhibition of tracer 236 binding to recombinant human GST-tagged CAMKK1 expressed in Escherichia coli expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588832	Inhibition of recombinant human His-tagged TRKB catalytic domain (526 to 838 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1909278	Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 3 uM measured after 48 hrs by Annexin V-FITC/PI staining based flow cytometric analysis (Rvb = 98.04%)
AID1588790	Inhibition of recombinant human GST-tagged PLK3 catalytic domain (58 to 340 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1513680	Inhibition of GST-tagged CDK4/cyclin D1 (unknown origin) expressed in Baculovirus infected Sf9 cells using RPPTLSPIPHIPR peptide as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1425206	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588619	Inhibition of recombinant human GST-tagged ACVR1B catalytic domain (150 to 505 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588634	Inhibition of recombinant full length human His-tagged BMX expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588783	Inhibition of recombinant full length human GST-tagged PKCepsilon expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424986	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425135	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588705	Inhibition of recombinant full length human His-tagged GRK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588801	Inhibition of recombinant full length human His-tagged RSK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425072	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425166	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382353	Cell cycle arrest in human COLO205 cells assessed as accumulation at G2/M phase up to 10 uM after 24 hrs by propidium iodide staining based FACS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588647	Inhibition of tracer 236 binding to recombinant human GST-tagged CDK2/CyclinA1 expressed by baculovirus in Sf9 insect cells expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1425149	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425064	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1648273	Inhibition of recombinant human full-length N-terminal GST-tagged CDK9/cyclinK expressed in baculovirus infected Sf9 insect cells using PDKtide as substrate measured after 120 mins by ADP-glo assay
AID1588735	Inhibition of recombinant human GST-tagged LTK (450 to 864 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509617	Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 4 to 6 days by cell titer-glo luminescent cell viability assay	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588840	Inhibition of recombinant human GST-tagged mTOR catalytic domain (1360 to 2549 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551254	Clearance in rat	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588795	Inhibition of recombinant full length human GST-tagged PRKX expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509655	Antiproliferative activity against human SKHEP1 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425140	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425163	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424941	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588672	Inhibition of recombinant full length human His-tagged CAMK1delta expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425011	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425106	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425028	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509619	Antiproliferative activity against human ZR-75-1 cells assessed as reduction in cell growth incubated for 4 to 6 days by cell titer-glo luminescent cell viability assay	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588736	Inhibition of recombinant full length human His-tagged LCK expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588805	Inhibition of recombinant human GST-tagged ROS1 catalytic domain (1883 to 2347 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1824428	Induction of apoptosis in human RPMI-8226 cells assessed as late apoptic cells at 0.5 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 2.85%)
AID1425046	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588706	Inhibition of recombinant full length human GST-tagged GRK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588813	Inhibition of recombinant full length human His-tagged SRPK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425119	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588665	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in Baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551245	Metabolic stability in human microsomes assessed as parent compound remaining after 15 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1425185	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425175	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425043	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588820	Inhibition of recombinant human GST-tagged TAO2 catalytic domain (1 to 314 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588742	Inhibition of recombinant full length human GST-tagged MARK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588673	Inhibition of recombinant full length human His-tagged CAMK2alpha expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374359	AUC in rat at 5 mg/kg	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1513684	Inhibition of GST-tagged CDK9/CyclinT1 (unknown origin) expressed in Baculovirus infected Sf9 cells using YSPTSPS-2 KK peptide as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1588845	Inhibition of recombinant human GST-tagged p70S6K catalytic domain (1 to 421 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425141	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509676	Metabolic stability in monkey liver microsomes assessed as intrinsic clearance rate per mg protein incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588807	Inhibition of recombinant human GST-tagged SGK1 catalytic domain (60 to 431 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374363	Apparent volume of distribution in rat at 5 mg/kg	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1588752	Inhibition of recombinant human His-tagged MRCKalpha catalytic domain (1 to 473 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-13 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509667	Metabolic stability in human liver microsomes assessed as half life incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425068	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551252	Half life in rat	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1915550	Inhibition of MSK1 (unknown origin) at 1 uM relative to control	2021	European journal of medicinal chemistry, Jan-01, Volume: 209	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
AID1509672	Metabolic stability in human liver microsomes assessed as intrinsic clearance rate per mg protein incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1909275	Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 3 uM measured after 48 hrs by Annexin V-FITC/PI staining based flow cytometric analysis (Rvb = 0.58%)
AID1588789	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425203	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1915552	Antiproliferative activity against breast cancer cell line (unknown origin)	2021	European journal of medicinal chemistry, Jan-01, Volume: 209	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
AID1509664	Antiproliferative activity against human BxPC3 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588810	Inhibition of recombinant full length human GST-tagged SIK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425037	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1737182	Inhibition of CDK9/cyclin T1 (unknown origin)	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1588624	Inhibition of recombinant full length human His-tagged ARK5 expressed in baculovirus expression system at 0.1 uM using CHKtide peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1588718	Inhibition of recombinant full length human GST-tagged IKKepsilon expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382345	Selectivity ratio of IC50 for CDK1 (unknown origin) to IC50 for CDK4 (unknown origin)	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1425103	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382389	Bioavailability in ICR mouse at 0.5 mg/kg, iv by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1424931	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588778	Inhibition of recombinant full length human His-tagged PIM1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608535	Induction of cell cycle arrest in human MDA-MB-231 cells assessed as accumulation in G0/G1 phase at 40 nM incubated for 36 hrs by propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588809	Inhibition of recombinant human GST-tagged SGK3 catalytic domain (87 to 496 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382346	Antiproliferative activity against human MDA-MB-468 cells after 96 hrs by CCK8 assay	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588755	Inhibition of recombinant full length human GST-tagged MST1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608891	Induction of apoptosis in human SiHa cells at 40 nM incubated for 48 hrs by annexin V FITC and propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425136	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424988	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424966	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551250	Metabolic stability in rat microsomes assessed as parent compound remaining after 45 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1551243	Metabolic stability in human microsomes assessed as parent compound remaining after 5 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588733	Inhibition of tracer 236 binding to recombinant human His-tagged LIMK1 catalytic domain (285 to 638 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588768	Inhibition of tracer 178 binding to recombinant full length human GST-tagged NLK expressed by baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1509654	Antiproliferative activity against human HepG2 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1824399	Antiproliferative activity against human U-266 cells assessed as growth inhibition measured after 72 hrs by CCK8 assay
AID1424950	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425116	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424899	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425051	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588639	Inhibition of recombinant full length human His-tagged CDK1/CyclinB expressed in baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588652	Inhibition of recombinant full length human GST-tagged CDK6/CyclinD1 expressed in baculovirus expression system at 0.1 uM using Rb peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1588734	Inhibition of recombinant human GST-tagged LRRK2 catalytic domain (970 to 2527 amino acids) expressed in baculovirus expression system at 0.1 uM using ERM (LRRKtide) peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1588628	Inhibition of recombinant full length human His-tagged Aurora B expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374364	Inhibition of recombinant human N-terminal GST-tagged CDK4 (S4 to E303 residues)/Cyclin D1 (Q4 to I295 residues) expressed in sf9 cells using Rb protein (773 to 928 residues) as substrate in presence of [33P]-ATP by scintillation counting method	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1402379	Inhibition of CDK6/Cyclin-D3 (unknown origin) using histoneH1 as substrate after 90 mins by ADP-Glo assay
AID1588750	Inhibition of recombinant human GST-tagged MLK1 catalytic domain (1 to 500 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425083	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509674	Metabolic stability in rat liver microsomes assessed as intrinsic clearance rate per mg protein incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588766	Inhibition of recombinant full length human GST-tagged NEK6 expressed in insect expression system at 0.1 uM using serine/threonine-22 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425127	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425113	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588666	Inhibition of recombinant full length human GST-tagged CLK3 expressed in Baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425150	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588804	Inhibition of recombinant human GST-tagged RON catalytic domain (983 to 1400 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382358	Inhibition of CDK4 in human COLO205 cells assessed as reduction in Rb protein phosphorylation at Ser780 residue after 24 hrs by immunoblotting method	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1509675	Metabolic stability in dog liver microsomes assessed as intrinsic clearance rate per mg protein incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1551242	Metabolic stability in rat microsomes assessed as parent compound remaining after 0 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588780	Inhibition of recombinant human GST-tagged PKCalpha expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551237	Inhibition of wild-type human partial length DYRK1A (H129 to S509 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1424907	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588821	Inhibition of recombinant full length human GST-tagged TBK1 expressed in insect expression system at 0.1 uM using serine/threonine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509657	Antiproliferative activity against human NCI-N87 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425157	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382364	Inhibition of human CDK6/Cyclin-D3	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1424906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608884	Antiproliferative activity against human MDA-MB-231 cells at 40 nM assessed as reduction in cell viability incubated for 48 hrs by EdU staining based laser scanning confocal microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1824416	Induction of apoptosis in human RPMI-8226 cells assessed as late apoptic cells at 1 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 2.85%)
AID1425004	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1915551	Antiproliferative activity against non-small cell lung cancer cell line (unknown origin)	2021	European journal of medicinal chemistry, Jan-01, Volume: 209	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
AID1588830	Inhibition of recombinant human GST-tagged TPL2 catalytic domain (30 to 397 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588737	Inhibition of recombinant full length human LYN at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588779	Inhibition of recombinant human His-tagged PKA catalytic domain (1 to 351 residues) expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424508	Inhibition of CDK4 (unknown origin)	2017	European journal of medicinal chemistry, Dec-15, Volume: 142	Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.
AID1588740	Inhibition of recombinant full length human His-tagged MAPKAPK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588700	Inhibition of recombinant full length human His-tagged FGR expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425197	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1239761	Inhibition of CDK4/6 in human COLO205 cells assessed as inhibition of Rb phosphorylation after 24 hrs by propidium iodide staining-based laser-scanning fluorescence microplate cytometric analysis	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
AID1509616	Inhibition of recombinant human full length N-terminal GST-tagged CDK2 (1 to 298 residues)/cyclin A2 (1 to 432 residues) expressed in baculovirus expression system using eIF4E-binding protein 1 peptide and ATP as substrate incubated for 30 mins by LANCE u	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1824411	Induction of cell cycle arrest in human RPMI-8226 cells assessed as accumulation at G2 phase at 0.5 uM measured after 24 hrs by propidium iodide staining based flow cytometric analysis (Rvb = 27.79%)
AID1588631	Inhibition of recombinant full length human GST-tagged BRAF expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382344	Antiproliferative activity against human COLO205 cells after 96 hrs by CCK8 assay	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1425133	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509665	Antiproliferative activity against human LNCAP cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425189	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425021	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588767	Inhibition of recombinant human GST-tagged NEK9 catalytic domain (347 to 732 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588692	Inhibition of recombinant human GST-tagged EPHB3 catalytic domain (623 to 907 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588621	Inhibition of recombinant full length human His-tagged AKT1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-06 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424894	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588741	Inhibition of recombinant full length human GST-tagged MARK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-21 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382376	Intrinsic clearance in human liver microsomes at 1.11 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1424917	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425007	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608892	Induction of apoptosis in human HeLa cells at 40 nM incubated for 48 hrs by annexin V FITC and propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425213	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509651	Antiproliferative activity against human U251 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588815	Inhibition of tracer 236 binding to recombinant full length human His-tagged STK33 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1509709	Antitumor activity against human COLO205 cells xenografted in BALB/c mouse assessed as reduction in tumor volume at 25 mg/kg, po administered once daily for 13 days relative to control	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425179	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425131	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425148	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425067	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425047	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425204	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588709	Inhibition of recombinant full length human GST-tagged GSK3alpha expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425147	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608900	Antitumor activity against human SiHa cells xenografted in NOD/SCID BALB/c mouse assessed as tumor growth inhibition at 40 mg/kg, po administered for 21 days	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1608922	Antiangiogenic activity against human SiHa cells xenografted in NOD/SCID BALB/c mouse assessed as reduction in CD31 expression at 40 mg/kg, po measured after 21 days by hematoxylin and eosin staining based immunohistochemistry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1551212	Inhibition of CDK2 (unknown origin)	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588659	Inhibition of recombinant full length human GST-tagged CK1delta expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382354	Cell cycle arrest in human COLO205 cells assessed as accumulation at G0/G1 phase at 0.01 uM after 24 hrs by propidium iodide staining based FACS analysis (Rvb = 64.4%)	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588699	Inhibition of recombinant full length human His-tagged FES (FPS) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608514	Antiproliferative activity against human T47D cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588643	Inhibition of tracer 236 binding to recombinant human GST-tagged CDK16/cyclin Y catalytic domain (CDK16: 108 to end, Cyclin Y: 2 to end) expressed by baculovirus in Sf9 insect cells expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1509658	Antiproliferative activity against human NCI-H1975 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588825	Inhibition of recombinant full length human His-tagged TSSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588625	Inhibition of tracer 236 binding to recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1608541	Induction of cell cycle arrest in human SiHa cells assessed as accumulation in G0/G1 phase at 80 nM incubated for 36 hrs by propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425196	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382359	Inhibition of CDK4 in human COLO205 cells assessed as reduction in total Rb protein level at 0.1 to 10 uM after 24 hrs by immunoblotting method	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1425130	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425020	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1824414	Induction of apoptosis in human RPMI-8226 cells assessed as viable cells at 1 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 91.6%)
AID1424947	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424949	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588781	Inhibition of recombinant full length human GST-tagged PKCbeta1 expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424901	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425090	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424948	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1374355	Inhibition of recombinant human full length CDK6 expressed in baculovirus infected Sf9 insect cells using histone H1 substrate after 90 mins by ADP-Glo assay	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1588636	Inhibition of recombinant full length human His-tagged BRK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551247	Metabolic stability in human microsomes assessed as parent compound remaining after 30 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1366693	Antiproliferative activity against human COLO205 cells after 96 hrs by CCK-8 assay	2017	Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23	Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors.
AID1424994	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425089	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1239762	Inhibition of CDK4/6 in human COLO205 cells assessed as maximum cell cycle arrest at G1 phase after 24 hrs by propidium iodide staining-based flow cytometric analysis	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
AID1425014	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588758	Inhibition of recombinant full length human GST-tagged MST4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425054	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1849048	Antiproliferative activity against human T47D cells assessed as cell growth inhibition incubated for 72 hrs by CCK-8 assay
AID1425098	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588784	Inhibition of recombinant full length human His-tagged PKCeta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424985	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424939	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588788	Inhibition of recombinant full length human His-tagged PLK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608881	Inhibition of colony formation in human HeLa cells at 80 nM incubated for 5 days by crystal violet staining based light microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425177	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424930	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1374354	Inhibition of CDK4 (unknown origin) after 90 mins by ADP-Glo assay	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1509659	Antiproliferative activity against human NCI-H1993 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588629	Inhibition of recombinant full length human GST-tagged AXL expressed in insect expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425105	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1374361	MRT in rat at 5 mg/kg	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1424981	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588802	Inhibition of recombinant full length human GST-tagged RSK3 expressed in insect expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424928	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588717	Inhibition of recombinant full length human GST-tagged IKKbeta expressed in baculovirus expression system at 0.1 uM using serine/threonine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425192	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588698	Inhibition of recombinant human His-tagged FGFR4 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424896	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588676	Inhibition of recombinant full length human GST-tagged DCAMKL2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588729	Inhibition of recombinant full length human GST-tagged JNK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608893	Induction of apoptosis in human SiHa cells assessed as decrease in Bcl2 expression at 80 nM incubated for 48 hrs by Western blot analysis	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1608879	Inhibition of colony formation in human T47D cells at 40 nM incubated for 5 days by crystal violet staining based light microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588774	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425001	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509684	AUC (0 to t) in BALB/c mouse at 3 mg/kg, iv measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588797	Inhibition of tracer 178 binding to recombinant human His-tagged RIPK2 catalytic domain (1 to 299 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1824413	Induction of cell cycle arrest in human RPMI-8226 cells assessed as accumulation at G2 phase at 1 uM measured after 24 hrs by propidium iodide staining based flow cytometric analysis (Rvb = 27.79%)
AID1425124	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509656	Antiproliferative activity against human SNU5 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1737230	Inhibition of CDK7/cyclin H (unknown origin)	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1382384	Cmax in ICR mouse at 0.5 mg/kg, iv by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1382355	Cell cycle arrest in human COLO205 cells assessed as accumulation at G0/G1 phase at 0.1 uM after 24 hrs by propidium iodide staining based FACS analysis (Rvb = 64.4%)	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588746	Inhibition of recombinant human GST-tagged MELK catalytic domain (1 to 340 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509671	Metabolic stability in monkey liver microsomes assessed as half life incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1737181	Selectivity ratio of IC50 for inhibition of CDK2/cyclin A2 (unknown origin) to IC50 for inhibition of recombinant human full-length N-terminal GST-fused CDK4 (1 to 303 residues)/GST-tagged CyclinD3 (1 to 292 residues) expressed in baculovirus expression s	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1425108	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425036	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425172	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425167	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1915549	Inhibition of IKKa (unknown origin) at 1 uM relative to control	2021	European journal of medicinal chemistry, Jan-01, Volume: 209	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
AID1317331	Inhibition of recombinant full length human N-terminal GST-tagged CDK6 (1 to 326 residues)/cyclin D1 (4 to 295 residues) expressed in sf9 cells using C-terminal retinoblastoma fragment as substrate after 90 mins by [gamma-33P]ATP based microbeta scintilla	2016	Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19	Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
AID1425080	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424891	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588756	Inhibition of recombinant full length human GST-tagged MST2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1317353	Inhibition of recombinant human full length C-terminal His6-tagged CDK7/cyclin H/N-terminal GST-tagged MAT1 expressed in baculovirus infected Sf21 insect cells using cdk7 substrate peptide	2016	Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19	Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
AID1513682	Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1424958	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588587	Efflux ratio in gMDCKI cells expressing human MDR1
AID1425019	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425049	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425022	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424934	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1513681	Inhibition of GST-tagged CDK2/cyclin A2 (unknown origin) expressed in Escherichia coli using histone H1 as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1425097	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425008	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551215	Inhibition of CDK6 (unknown origin)	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588664	Inhibition of recombinant human GST-tagged CLK1 catalytic domain (129 to 484 residues) expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425000	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1915587	Inhibition of Cdk4 (unknown origin)	2021	European journal of medicinal chemistry, Jan-01, Volume: 209	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
AID1588829	Inhibition of recombinant human GST-tagged TIE2 (817 to 1101 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509689	AUC (0 to t) in BALB/c mouse at 10 mg/kg, po measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425084	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588846	Unbound brain to plasma ratio in Sprague-Dawley rat at 30 mg/kg, po after 48 hrs by LC-MS/MS analysis
AID1551249	Metabolic stability in human microsomes assessed as parent compound remaining after 45 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1425200	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509683	Cmax in BALB/c mouse at 3 mg/kg, iv measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1509620	Antiproliferative activity against human COLO205 cells assessed as reduction in cell growth incubated for 4 to 6 days by cell titer-glo luminescent cell viability assay	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588722	Inhibition of recombinant full length human GST-tagged ITK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424952	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588713	Inhibition of recombinant full length human GST-tagged HIPK4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1239759	Inhibition of human CDK4/cyclin D1 expressed in insect cells assessed as phosphorylation of CTRF after 50 mins by microplate scintillation counter	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
AID1909277	Induction of apoptosis in human MDA-MB-231 cells assessed as early apoptotic cells at 3 uM measured after 48 hrs by Annexin V-FITC/PI staining based flow cytometric analysis (Rvb = 0.32%)
AID1588693	Inhibition of recombinant human His-tagged ERBB2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588826	Inhibition of tracer 236 binding to recombinant full length human GST-tagged TTK expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1425081	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1366701	Antitumor activity against human COLO205 cells xenografted in nude BALB/c mouse assessed as tumor volume at 100 mg/kg, po administered once daily for 3 weeks measured twice per week relative to control	2017	Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23	Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors.
AID1737185	Antiproliferative activity against human COLO 205 cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1277156	Inhibition of CDK1/Cyclin B (unknown origin) expressed in baculoviral infected insect Sf9 cells using histone H1 as substrate in presence of [gamma-33P]ATP	2016	European journal of medicinal chemistry, Jan-27, Volume: 108	Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
AID1425134	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425158	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588702	Inhibition of recombinant human His-tagged FLT3 catalytic domain (564 to 958 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424898	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509687	Clearance in BALB/c mouse at 3 mg/kg, iv measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588754	Inhibition of recombinant full length human GST-tagged MSSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1513743	Induction of cell cycle arrest in human HCT116 cells assessed as accumulation at G2/M phase at 0.03 to 0.8 uM after 24 hrs by propidium iodide-staining based flow cytometry	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1425095	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424972	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1732687	Inhibition of CDK1/cyclin B1 (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay	2021	European journal of medicinal chemistry, Apr-05, Volume: 215	Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors.
AID1588670	Inhibition of recombinant full length human His-tagged CAMK1 expressed in baculovirus expression system at 0.1 uM using ZIPtide peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1424978	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588632	Inhibition of recombinant full length human His-tagged BTK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425186	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382398	Antitumor activity against human COLO205 cells xenografted in Balb/c nude mouse assessed as tumor growth inhibition at 25 mg/kg, po administered once daily for 21 days relative to control	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1551238	Inhibition of wild-type human partial length PIM1 (A15 to K313 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1425100	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382374	Half life in mouse liver microsomes at 1.11 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1424918	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1824426	Induction of apoptosis in human RPMI-8226 cells assessed as viable cells at 0.5 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 91.6%)
AID1588748	Inhibition of recombinant full length human GST-tagged MKNK1 expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588739	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1317332	Inhibition of human CDK2/cyclin E	2016	Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19	Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
AID1588653	Inhibition of recombinant full length human His-tagged CDK7/CyclinH/MAT1 expressed in baculovirus expression system at 0.1 uM using CDK7/9tide peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1424944	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588710	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509615	Inhibition of recombinant human full length N-terminal GST-tagged CDK6 (1 to 326 residues)/cyclin D3 (1 to 292 residues) expressed in baculovirus expression system using eIF4E-binding protein 1 peptide and ATP as substrate incubated for 30 mins by LANCE u	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1424996	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588667	Inhibition of tracer 236 binding to recombinant full length human GST-tagged CLK4 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588681	Inhibition of recombinant full length human GST-tagged DYRK1A expressed in baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588611	Antiproliferative activity against human DBTRG-05MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay
AID1588626	Inhibition of recombinant full length human His-tagged ABL1 expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425025	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424935	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424946	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424995	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588843	Inhibition of recombinant full length human His-tagged p38delta expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424970	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509668	Metabolic stability in mouse liver microsomes assessed as half life incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1909315	Inhibition of SHP2 (unknown origin) using DiFMUP as substrate at 10 uM incubated for 60 mins followed by substrate addition for 30 mins by microplate reader method
AID1588635	Inhibition of recombinant full length human GST-tagged BRSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-21 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588712	Inhibition of recombinant full length human GST-tagged HIPK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425142	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425121	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588822	Inhibition of tracer 178 binding to recombinant full length human His-tagged TEC expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1588786	Inhibition of recombinant full length human PKCzeta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425123	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424971	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588686	Inhibition of recombinant full length human GST-tagged ERK2 expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382387	Apparent volume of distribution in ICR mouse at 0.5 mg/kg, iv by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588687	Inhibition of recombinant human GST-tagged EPHA1 (568 to 976 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608882	Antiproliferative activity against human T47D cells assessed as reduction in cell viability at 40 nM incubated for 48 hrs by EdU staining based laser scanning confocal microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1509685	Half life in BALB/c mouse at 3 mg/kg, iv measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425055	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425143	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425034	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608569	Toxicity in NOD/SCID BALB/c mouse xenografted with human SiHa cells assessed as body weight at 40 mg/kg, po administered for 21 days	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425076	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425035	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382365	Inhibition of human CDK9/Cyclin-T1	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588725	Inhibition of recombinant human GST-tagged JAK2 catalytic domain (809 to 1153+9 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425125	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588793	Inhibition of recombinant full length human GST-tagged PHKG1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1909273	Induction of cell cycle arrest in human MDA-MB-231 cells assessed as accumulation of cells in S phase at 3 uM incubated for 48 hrs by RNase/propidium iodide staining based flow cytometry analysis (Rvb = 71.1%)
AID1588791	Inhibition of recombinant full length human His-tagged PRAK expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588612	Antiproliferative activity against human A172 assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay
AID1588824	Inhibition of tracer 236 binding to recombinant human GST-tagged TNK2 catalytic domain (110 to 476 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1425138	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382377	Intrinsic clearance in mouse liver microsomes at 1.11 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588842	Inhibition of recombinant full length human His-tagged p38beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-15 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425161	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588812	Inhibition of recombinant full length human GST-tagged SPHK1 expressed in baculovirus expression system at 0.1 uM using Sphingosine Lipid as substrate incubated for 60 mins by Adapta assay relative to control
AID1425053	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425093	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425045	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425069	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425048	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509670	Metabolic stability in dog liver microsomes assessed as half life incubated for 10 mins followed by NADPH addition and further incubated for 1 hr by LC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588828	Inhibition of recombinant human GST-tagged TYK2 catalytic domain (833 to 1187 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425071	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608564	Induction of apoptosis in human T47D cells assessed as decrease in Bcl2 expression at 40 nM incubated for 48 hrs by Western blot analysis	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588724	Inhibition of recombinant human GST-tagged JAK1 catalytic domain (866 to 1154 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588669	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424964	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588776	Inhibition of recombinant full length human GST-tagged PI3Kalpha expressed in baculovirus expression system at 0.1 uM using PI Lipid Kinase as substrate incubated for 60 mins by Adapta assay relative to control
AID1425026	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1684534	Antiproliferative activity against human MIA PaCa-2 cells assessed as inhibition of cell growth by MTT assay	2021	Bioorganic & medicinal chemistry letters, 02-01, Volume: 33	Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells.
AID1608563	Induction of apoptosis in human MDA-MB-231 cells assessed as decrease in Bcl2 expression at 40 nM incubated for 48 hrs by Western blot analysis	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1402372	Unbound brain to plasma concentration ratio in mouse at 30 mg/kg, po
AID1317308	Inhibition of CDK9/cyclin T (unknown origin)	2016	Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19	Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
AID1588689	Inhibition of tracer 236 binding to recombinant human His-tagged EPHA7 (579 to 998 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1424987	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608513	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425082	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1509662	Antiproliferative activity against human CFPAC-1 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588763	Inhibition of recombinant human GST-tagged MUSK (519 to 869 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1424975	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382386	Elimination half life in ICR mouse at 0.5 mg/kg, iv by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588760	Inhibition of recombinant human GST-tagged MER (578 to 872 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588613	Antiproliferative activity against human T98G assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay
AID1588839	Inhibition of recombinant full length human GST-tagged EEF2K expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-24 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1277158	Inhibition of CDK4/Cyclin D1 (unknown origin) using RPPTLSPIPHIPR peptide as substrate in presence of [gamma-33P]ATP	2016	European journal of medicinal chemistry, Jan-27, Volume: 108	Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
AID1588714	Inhibition of recombinant full length human His-tagged HYL expressed in Escherichia coli expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425030	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588794	Inhibition of recombinant full length human GST-tagged PHKG2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374353	Inhibition of recombinant human full length CDK1/Cyclin D3 expressed in baculovirus infected Sf9 insect cells using histone H1 substrate after 90 mins by ADP-Glo assay	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1366691	Inhibition of CDK4 (unknown origin) using U-light as substrate preincubated for 1 hr followed by EDTA addition measured after 1 hr by LANCE Ultra kinase assay	2017	Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23	Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors.
AID1588675	Inhibition of recombinant human GST-tagged DAPK1 catalytic domain (1 to 363 residues) expressed in baculovirus expression system at 0.1 uM using ZIPtide peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1551240	Inhibition of wild-type human full length CAMK1A (M1 to L370 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588723	Inhibition of recombinant human GST-tagged INSR (1011 to 1382 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374356	Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by DAPI staining based assay	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1588808	Inhibition of recombinant human GST-tagged SGK2 catalytic domain (54 to 427 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509618	Antiproliferative activity against human T47D cells assessed as reduction in cell growth incubated for 4 to 6 days by cell titer-glo luminescent cell viability assay	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588642	Inhibition of tracer 236 binding to recombinant human GST-tagged CDK14/cyclin Y catalytic domain (CDK14: full length, Cyclin Y: 2 to end) expressed by baculovirus in Sf9 insect cells expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1425174	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588792	Inhibition of recombinant full length human GST-tagged PRK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1732739	Inhibition of human CDK4/cyclin D (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay	2021	European journal of medicinal chemistry, Apr-05, Volume: 215	Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors.
AID1588799	Inhibition of recombinant human GST-tagged ROCK2 catalytic domain (1 to 552 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-13 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374360	Half life in rat at 5 mg/kg	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1588657	Inhibition of recombinant full length human His-tagged CHK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-07 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588704	Inhibition of recombinant full length human GST-tagged FRK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1909274	Induction of cell cycle arrest in human MDA-MB-231 cells assessed as accumulation of cells in G2/M phase at 3 uM incubated for 48 hrs by RNase/propidium iodide staining based flow cytometry analysis (Rvb = 2.7%)
AID1588759	Inhibition of tracer 236 binding to recombinant full length human GST-tagged MYLK expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588745	Inhibition of tracer 236 binding to recombinant full length human GST-tagged MEKK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1425087	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424908	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425188	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588614	Antiproliferative activity against human SF539 assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay
AID1424960	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588648	Inhibition of tracer 236 binding to recombinant human GST-tagged CDK3/CyclinE1 expressed by baculovirus in Sf9 insect cells expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588762	Inhibition of recombinant human GST-tagged MINK1 catalytic domain (1 to 320 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588720	Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425164	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1909255	Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
AID1425181	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1909258	Antiproliferative activity against mouse EMT6 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
AID1424889	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425044	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425058	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424963	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425104	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425018	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1737179	Cell cycle arrest in human COLO 205 cells assessed as accumulation at G0/G1 phase at 200 nM measured after 24 hrs by propidium iodide staining based flow cytometry relative to control	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1551241	Metabolic stability in human microsomes assessed as parent compound remaining after 0 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1551227	Tmax in human	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588819	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1-TAB1 catalytic domain (437 to 504 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1653034	Inhibition of CDK4 (unknown origin)	2019	European journal of medicinal chemistry, Feb-15, Volume: 164	Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
AID1588645	Inhibition of recombinant full length human GST-tagged CDK18/Cyclin Y (2 to end amino acids) expressed in insect expression system at 0.1 uM using serine/threonine-12 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588622	Inhibition of recombinant full length human His-tagged AKT2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-06 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608883	Antiproliferative activity against human SiHa cells assessed as reduction in cell viability at 80 nM incubated for 48 hrs by EdU staining based laser scanning confocal microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1402563	Antiproliferative activity against human U87MG cells after 72 hrs by DAPI staining based assay
AID1424992	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1849071	Induction of cell cycle arrest in human T47D cells assessed as accumulation of cells at G2 phase at 1.5 uM incubated for 24 hrs by propidium iodide staining based flow cytometry analysis (Rvb = 16.57%)
AID1425115	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424961	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588658	Inhibition of recombinant full length human GST-tagged CK1alpha1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425202	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1824402	Antiproliferative activity against human 22Rv1 cells assessed as growth inhibition measured after 72 hrs by CCK8 assay
AID1382388	Clearance in ICR mouse at 0.5 mg/kg, iv by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1509663	Antiproliferative activity against human PANC1 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1608878	Inhibition of colony formation in human MDA-MB-231 cells at 40 nM incubated for 5 days by crystal violet staining based light microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1824427	Induction of apoptosis in human RPMI-8226 cells assessed as early apoptic cells at 0.5 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 3.38%)
AID1425056	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608877	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability at 80 nM incubated for 48 hrs by EdU staining based laser scanning confocal microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588656	Inhibition of recombinant full length human His-tagged CHK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-19 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509708	Antitumor activity against human MCF7 cells xenografted in BALB/c mouse assessed as reduction in tumor volume at 50 mg/kg, po administered once daily for 19 days relative to control	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1824429	Induction of apoptosis in human RPMI-8226 cells assessed as necrotic cells at 0.5 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 2.21%)
AID1588730	Inhibition of recombinant human His-tagged KDR (789 to 1356 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425173	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424976	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588744	Inhibition of recombinant full length human GST-tagged MEK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425171	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424936	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424919	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425033	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425074	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551213	Inhibition of CDK4 (unknown origin)	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588818	Inhibition of recombinant full length human GST-tagged SYK expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551244	Metabolic stability in rat microsomes assessed as parent compound remaining after 5 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1737184	Inhibition of human full-length N-terminal GST tagged CDK6 (1 to 326 residues)/GST-tagged cyclinD3 (1 to 292 residues) expressed in baculovirus expression system using ULight-elF4E-binding protein 1 peptide as substrate measured after 30 mins by LANCE ass	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1509652	Antiproliferative activity against human K562 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588685	Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant (668 to 1210: T790M/L858R residues)expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588837	Inhibition of recombinant full length human His-tagged ZAP70 expressed in baculovirus expression system at 0.1 uM using tyrosine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588610	Antiproliferative activity against human U87MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay
AID1824401	Antiproliferative activity against human HL-60 cells assessed as growth inhibition measured after 72 hrs by CCK8 assay
AID1425154	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1366692	Inhibition of CDK1 (unknown origin) using U-light as substrate preincubated for 1 hr followed by EDTA addition measured after 1 hr by LANCE Ultra kinase assay	2017	Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23	Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors.
AID1588633	Inhibition of recombinant full length human His-tagged BLK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1382373	Half life in human liver microsomes at 1.11 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1737183	Inhibition of recombinant human full-length N-terminal GST-fused CDK4 (1 to 303 residues)/GST-tagged CyclinD3 (1 to 292 residues) expressed in baculovirus expression system using ULight-elF4E-binding protein 1 peptide as substrate measured after 30 mins b	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1425170	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1909256	Antiproliferative activity against human MDA-MB-468 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
AID1648276	Antiproliferative activity against human Jurkat cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
AID1608538	Induction of cell cycle arrest in human T47D cells assessed as accumulation in G0/G1 phase at 40 nM incubated for 36 hrs by propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588772	Inhibition of recombinant full length human His-tagged PAK6 expressed in baculovirus expression system at 0.1 uM using serine/threonine-20 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588848	Inhibition of tracer 236 binding to recombinant full length human GST-tagged MYLK3 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1608894	Induction of apoptosis in human HeLa cells assessed as decrease in Bcl2 expression at 80 nM incubated for 48 hrs by Western blot analysis	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588691	Inhibition of recombinant human GST-tagged EPHB1 catalytic domain (613 to 881 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1876328	Antiviral activity against SARS-CoV-2 inoculated in african green monkey Vero E6 cells expressing ACE2 assessed as reduction of cytopathic effect measured after 72 hrs by CellTitre-Glo based plate reader method	2022	Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2	Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
AID1588727	Inhibition of recombinant full length human His-tagged JNK1alpha1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1876254	Cytotoxicity against african green monkey Vero cells	2022	Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2	Kinase Inhibitors as Underexplored Antiviral Agents.
AID1425210	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588816	Inhibition of recombinant full length human His-tagged SRC expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1551217	Inhibition of CDK9 (unknown origin)	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1425006	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424998	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1374362	Apparent clearance in rat at 5 mg/kg	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1588683	Inhibition of recombinant full length human GST-tagged DYRK4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425063	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424954	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1909272	Induction of cell cycle arrest in human MDA-MB-231 cells assessed as accumulation of cells in G0/G1 phase at 3 uM incubated for 48 hrs by RNase/propidium iodide staining based flow cytometry analysis (Rvb = 26.2%)
AID1424909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588680	Inhibition of tracer 236 binding to recombinant full length human GST-tagged DRAK1 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1513678	Inhibition of His-tagged CDK1/cyclin B1 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay	2018	Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20	How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
AID1588678	Inhibition of tracer 236 binding to recombinant full length human GST-tagged DMPK expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588833	Inhibition of tracer 178 binding to recombinant full length human GST-tagged WEE1 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1509706	Antitumor activity against human COLO205 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 25 mg/kg, po administered once daily for 13 days relative to control	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588769	Inhibition of recombinant full length human GST-tagged PAK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-19 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1608880	Inhibition of colony formation in human SiHa cells at 80 nM incubated for 5 days by crystal violet staining based light microscopy	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425168	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1876253	Antiviral activity against SARS-CoV-2 infected in african green monkey Vero cells incubated for 72 hrs by celltitre-glo luminescent assay	2022	Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2	Kinase Inhibitors as Underexplored Antiviral Agents.
AID1849050	Antiproliferative activity against human MCF-10A cells assessed as cell growth inhibition incubated for 72 hrs by CCK-8 assay
AID1732740	Inhibition of human CDK2/cyclin E (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay	2021	European journal of medicinal chemistry, Apr-05, Volume: 215	Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors.
AID1509660	Antiproliferative activity against human NCI-H358 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425042	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424967	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588761	Inhibition of recombinant human His-tagged MET (956 to 1390 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1824415	Induction of apoptosis in human RPMI-8226 cells assessed as early apoptic cells at 1 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 3.38%)
AID1849061	Induction of cell cycle arrest in human MCF7 cells assessed as accumulation of cells at G2 phase at 1.5 uM incubated for 24 hrs by propidium iodide staining based flow cytometry analysis (Rvb = 29.66%)
AID1425060	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1737186	Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1424955	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425111	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588697	Inhibition of recombinant human His-tagged FGFR3 catalytic domain (399 to 806 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1824400	Antiproliferative activity against human K562 cells assessed as growth inhibition measured after 72 hrs by CCK8 assay
AID1509650	Antiproliferative activity against human U87MG cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1737229	Inhibition of CDK2/cyclin A2 (unknown origin)	2020	European journal of medicinal chemistry, May-01, Volume: 193	Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors.
AID1509614	Inhibition of recombinant human full length N-terminal GST-tagged CDK4 (1 to 303 residues)/cyclin D3 (1 to 292 residues) expressed in baculovirus expression system using eIF4E-binding protein 1 peptide and ATP as substrate incubated for 30 mins by LANCE u	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1425085	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424983	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608511	Inhibition of recombinant full length human CDK4/Cyclin D3 using Rb-fragmen as substrate at 1 uM incubated for 40 mins by [gamma-33P]-ATP based radiometric assay relative to control	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588834	Inhibition of tracer 1710 binding to recombinant human His-tagged WNK2 catalytic domain (166 to 489 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1424890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588785	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588688	Inhibition of tracer 236 binding to recombinant human His-tagged EPHA3 (569 to 976 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588684	Inhibition of recombinant human GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588623	Inhibition of tracer 236 binding to recombinant human GST-tagged ALK2 catalytic domain (145 to 509 residues) expressed in baculovirus at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588844	Inhibition of recombinant full length human His-tagged p38gamma expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425016	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588823	Inhibition of tracer 178 binding to recombinant human GST-tagged TGFBR1 catalytic domain (200 to 503 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1424937	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588690	Inhibition of recombinant human GST-tagged EPHA8 catalytic domain (565 to 1005 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588738	Inhibition of recombinant human GST-tagged MAP4K4 catalytic domain (1 to 328 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509688	Cmax in BALB/c mouse at 10 mg/kg, po measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588630	Inhibition of tracer 178 binding to recombinant human GST-tagged BMPR1A catalytic domain (187 to 532 amino acids) expressed insect cell expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1424925	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1876332	Antiviral activity against SARS-CoV-2 inoculated in african green monkey Vero E6 cells expressing ACE2 assessed as reduction of cytopathic effect measured after 72 hrs by CellTitre-Glo based plate reader method relative to control	2022	Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2	Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
AID1588806	Inhibition of recombinant human GST-tagged RSE catalytic domain (451 to 890 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1509661	Antiproliferative activity against human H441 cells	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1588649	Inhibition of recombinant full length human GST-tagged CDK4/Cyclin D1 expressed in baculovirus expression system at 0.1 uM using Rb peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1277159	Inhibition of CDK5/p35NCK (unknown origin) using histone H1 as substrate in presence of [gamma-33P]ATP	2016	European journal of medicinal chemistry, Jan-27, Volume: 108	Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
AID1509691	Oral bioavailability in BALB/c mouse at 10 mg/kg measured upto 1440 mins by UPLC-MS/MS analysis	2019	European journal of medicinal chemistry, Sep-15, Volume: 178	Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer.
AID1551216	Inhibition of CDK7 (unknown origin)	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1382343	Inhibition of human CDK1/Cyclin-B using ULight-substrate after 1 hr by LANCE assay	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1824417	Induction of apoptosis in human RPMI-8226 cells assessed as necrotic cells at 1 uM measured after 24 hrs by Annexin-V-FITC/PI staining based flow cytometric analysis (Rvb = 2.21%)
AID1849068	Induction of cell cycle arrest in human T47D cells assessed as accumulation of cells at G1 phase at 1.5 uM incubated for 24 hrs by propidium iodide staining based flow cytometry analysis (Rvb = 69.55 %)
AID1588641	Inhibition of tracer 236 binding to human GST/His-tagged CDK13/Cyclin K at 0.1 uM
AID1608516	Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1425040	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425126	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424921	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551246	Metabolic stability in rat microsomes assessed as parent compound remaining after 15 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588773	Inhibition of recombinant human GST-tagged PASK catalytic domain (879 to 1323 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1374365	Inhibition of recombinant human N-terminal GST-tagged CDK4 (M1 to A326 residues)/Cyclin D1 (Q4 to I295 residues) expressed in sf9 cells using Rb protein (773 to 928 residues) as substrate in presence of [33P]-ATP by scintillation counting method	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1849047	Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by CCK-8 assay
AID1824410	Induction of cell cycle arrest in human RPMI-8226 cells assessed as accumulation at G1 phase at 0.5 uM measured after 24 hrs by propidium iodide staining based flow cytometric analysis (Rvb = 41.96%)
AID1424922	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1551248	Metabolic stability in rat microsomes assessed as parent compound remaining after 30 mins	2019	European journal of medicinal chemistry, Jun-15, Volume: 172	Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
AID1588654	Inhibition of tracer 236 binding to recombinant full length human His-tagged CDK8/cyclin C expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1366690	Inhibition of CDK6 (unknown origin) using U-light as substrate preincubated for 1 hr followed by EDTA addition measured after 1 hr by LANCE Ultra kinase assay	2017	Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23	Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors.
AID1382375	Intrinsic clearance in rat liver microsomes at 1.11 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588835	Inhibition of recombinant full length human GST-tagged YSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1317329	Inhibition of recombinant human N-terminal GST-tagged CDK4 (4 to 303 residues)/cyclin D1 (4 to 295 residues) expressed in sf9 cells using C-terminal retinoblastoma fragment as substrate after 90 mins by [gamma-33P]ATP based microbeta scintillation countin	2016	Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19	Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
AID1424973	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425151	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425144	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425201	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425094	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425129	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1608890	Induction of apoptosis in human T47D cells at 40 nM incubated for 48 hrs by annexin V FITC and propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1239764	Competitive inhibition of CDK6/cyclin D3 (unknown origin) assessed as phosphorylation of CTRF after 50 mins by Michaelis-Menten plot analysis in presence of ATP	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.
AID1425187	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1382391	AUClast in ICR mouse at 1 mg/kg, po via gavage by HPLC analysis	2018	European journal of medicinal chemistry, Mar-25, Volume: 148	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy.
AID1588716	Inhibition of recombinant full length human His-tagged IKKalpha expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Adapta assay relative to control
AID1425117	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1374358	Cmax in rat at 5 mg/kg	2018	Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5	Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity
AID1608544	Induction of cell cycle arrest in human HeLa cells assessed as accumulation in G0/G1 phase at 80 nM incubated for 36 hrs by propidium iodide staining based flow cytometry	2019	European journal of medicinal chemistry, Nov-01, Volume: 181	Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
AID1588817	Inhibition of recombinant full length human GST-tagged SRM expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1425145	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588677	Inhibition of tracer 178 binding to recombinant human GST-tagged DDR1 catalytic domain (440 to 876 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control
AID1588719	Inhibition of recombinant human GST-tagged IRAK1 catalytic domain (194 to 712 residues) expressed in baculovirus expression system at 0.1 uM using Histone H3 (1-20) peptide as substrate incubated for 60 mins by Adapta assay relative to control
AID1588620	Inhibition of tracer 178 binding to recombinant human GST-tagged ACVR2B catalytic domain (185 to 488 residues) expressed in baculovirus at 0.1 uM measured after 60 mins by Lanthascreen assay
AID1425180	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1425062	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424968	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1588757	Inhibition of recombinant full length human GST-tagged MST3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control
AID1588615	Antiproliferative activity against human M059J assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay
AID1424916	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1424926	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry	2017	Science (New York, N.Y.), 12-01, Volume: 358, Issue:6367	The target landscape of clinical kinase drugs.
AID1868085	Inhibition of CDK4/cyclin D (unknown origin)	2022	Journal of medicinal chemistry, 05-12, Volume: 65, Issue:9	From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
AID1296008	Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening	2020	SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1	Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159	Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347160	Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987	P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986	P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1345601	Human cyclin dependent kinase 4 (CDK4 subfamily)	2014	Investigational new drugs, Oct, Volume: 32, Issue:5	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.
AID1345613	Human cyclin dependent kinase 6 (CDK4 subfamily)	2014	Investigational new drugs, Oct, Volume: 32, Issue:5	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.
AID1347412	qHTS assay to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Counter screen cell viability and HiBit confirmation	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347411	qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1804171	DRC analysis by immunofluorescence from Article 10.1128/AAC.00819-20: \\Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.\\	2020	Antimicrobial agents and chemotherapy, 06-23, Volume: 64, Issue:7	Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	117 (33.52)	24.3611
2020's	232 (66.48)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	43 (12.22%)	5.53%
Reviews	77 (21.88%)	6.00%
Case Studies	20 (5.68%)	4.05%
Observational	8 (2.27%)	0.25%
Other	204 (57.95%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
quinacrine Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.. quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.	3.17	1	0	acridines; aromatic ether; organochlorine compound; tertiary amino compound	antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
creatine [no description available]	2.6	1	0	glycine derivative; guanidines; zwitterion	geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical
dalteparin Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)	2.31	1	0
niacinamide nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.	4.62	1	1	pyridine alkaloid; pyridinecarboxamide; vitamin B3	anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor
1-anilino-8-naphthalenesulfonate 1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd. 8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.	3.31	1	0	aminonaphthalene; naphthalenesulfonic acid	fluorescent probe
4,5,6,7-tetrabromo-2-azabenzimidazole 4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor	3.41	1	0
rtki cpd [no description available]	3.51	1	0	aromatic ether; monochlorobenzenes; quinazolines	antineoplastic agent; antiviral agent; epidermal growth factor receptor antagonist; geroprotector
amitriptyline Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.. amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.	2.17	1	0	carbotricyclic compound; tertiary amine	adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic
amodiaquine Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.. amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.	3.17	1	0	aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug
anastrozole [no description available]	15.69	11	6	nitrile; triazoles	antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor
verapamil Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.. verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.. 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.	2.25	1	0	aromatic ether; nitrile; polyether; tertiary amino compound
camostat camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.	3.17	1	0	benzoate ester; carboxylic ester; diester; guanidines; tertiary carboxamide	anti-inflammatory agent; anticoronaviral agent; antifibrinolytic drug; antihypertensive agent; antineoplastic agent; antiviral agent; serine protease inhibitor
chloroquine Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.. chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.	3.55	2	0	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
clotrimazole [no description available]	2.31	1	0	conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes	antiinfective agent; environmental contaminant; xenobiotic
dihydrocytochalasin b dihydrocytochalasin B: inhibits cell motility in many eucaryotic cells	2.15	1	0
ebastine [no description available]	3.17	1	0	organic molecular entity
fluorouracil Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.. 5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.	2.31	1	0	nucleobase analogue; organofluorine compound	antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic
gw8510 GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source	2.17	1	0
fasudil fasudil: intracellular calcium antagonist; structure in first source. fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.	2.15	1	0	isoquinolines; N-sulfonyldiazepane	antihypertensive agent; calcium channel blocker; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; geroprotector; neuroprotective agent; nootropic agent; vasodilator agent
hexachlorophene Hexachlorophene: A chlorinated bisphenol antiseptic with a bacteriostatic action against Gram-positive organisms, but much less effective against Gram-negative organisms. It is mainly used in soaps and creams and is an ingredient of various preparations used for skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p797). hexachlorophene : An organochlorine compound that is diphenylmethane in which each of the phenyl groups is substituted by chlorines at positions 2, 3, and 5, and by a hydroxy group at position 6. An antiseptic that is effective against Gram-positive organisms, it is used in soaps and creams for the treatment of various skin disorders. It is also used in agriculture as an acaricide and fungicide, but is not approved for such use within the European Union.	3.17	1	0	bridged diphenyl fungicide; polyphenol; trichlorobenzene	acaricide; antibacterial agent; antifungal agrochemical; antiseptic drug
miltefosine miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin. miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.	3.51	1	0	phosphocholines; phospholipid	anti-inflammatory agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antiprotozoal drug; apoptosis inducer; immunomodulator; protein kinase inhibitor
hydroxychloroquine Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970). hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.	2.41	1	0	aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug
indirubin-5-sulfonate [no description available]	3.51	1	0
4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration	2.15	1	0
nsc 664704 kenpaullone: inhibits CDK1/cyclin B; structure in first source. kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).	3.51	1	0	indolobenzazepine; lactam; organobromine compound	cardioprotective agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; geroprotector
ketoconazole 1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.	2.25	1	0	dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine
letrozole [no description available]	12.52	20	8	nitrile; triazoles	antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor
loperamide Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.. loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.	5.93	3	2	monocarboxylic acid amide; monochlorobenzenes; piperidines; tertiary alcohol	anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source	3.51	1	0	chromones; morpholines; organochlorine compound	autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector
mefloquine hydrochloride [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol : An organofluorine compound that consists of quinoline bearing trifluoromethyl substituents at positions 2 and 8 as well as a (2-piperidinyl)hydroxymethyl substituent at position 4.	3.17	1	0	organofluorine compound; piperidines; quinolines; secondary alcohol
mequitazine mequitazine: RN given refers to parent cpd without isomeric designation; structure	3.17	1	0	phenothiazines
metformin Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289). metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.	2.21	1	0	guanidines	environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic
modafinil Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.. modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.. 2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.	2.25	1	0	monocarboxylic acid amide; sulfoxide
entinostat [no description available]	3.41	1	0	benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline	antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor
niclosamide Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48). niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.	3.17	1	0	benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide	anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor
nu6102 NU6102: structure in first source	3.69	2	0
o(6)-benzylguanine O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity	2.31	1	0
olomoucine olomoucine: inhibits protein P34CDC2. olomoucine : A 9H-purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor.	2.13	1	0	2,6-diaminopurines; ethanolamines	EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
papaverine Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.. papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.	3.51	1	0	benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines	antispasmodic drug; vasodilator agent
perhexiline Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.	3.17	1	0	piperidines	cardiovascular drug
phenazopyridine Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.. phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.	3.17	1	0	diaminopyridine; monoazo compound	anticoronaviral agent; carcinogenic agent; local anaesthetic; non-narcotic analgesic
imatinib [no description available]	5.28	5	0	aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines	antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor
vorinostat Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.. vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).	3.41	1	0	dicarboxylic acid diamide; hydroxamic acid	antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor
temozolomide [no description available]	2.89	3	0	imidazotetrazine; monocarboxylic acid amide; triazene derivative	alkylating agent; antineoplastic agent; prodrug
thioridazine Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.. thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.	3.17	1	0	phenothiazines; piperidines	alpha-adrenergic antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist
tilorone Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.. tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.	3.17	1	0	aromatic ether; diether; fluoren-9-ones; tertiary amino compound	anti-inflammatory agent; antineoplastic agent; antiviral agent; interferon inducer; nicotinic acetylcholine receptor agonist
trimebutine Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.	8.99	1	1	trihydroxybenzoic acid
tyrphostin a9 [no description available]	3.51	1	0	alkylbenzene	geroprotector
carbostyril Quinolones: A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.. quinolin-2(1H)-one : A quinolone that is 1,2-dihydroquinoline substituted by an oxo group at position 2.	5.68	2	2	monohydroxyquinoline; quinolone	bacterial xenobiotic metabolite
colchicine (S)-colchicine : A colchicine that has (S)-configuration. It is a secondary metabolite, has anti-inflammatory properties and is used to treat gout, crystal-induced joint inflammation, familial Mediterranean fever, and many other conditions.	3.41	1	0	alkaloid; colchicine	anti-inflammatory agent; gout suppressant; mutagen
17-alpha-hydroxyprogesterone 17alpha-hydroxyprogesterone : A 17alpha-hydroxy steroid that is the 17alpha-hydroxy derivative of progesterone.	3.17	1	0	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone	human metabolite; metabolite; mouse metabolite; progestin
tryptophan Tryptophan: An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals.. tryptophan : An alpha-amino acid that is alanine bearing an indol-3-yl substituent at position 3.	2.15	1	0	erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan	antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
triparanol Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.	3.17	1	0	stilbenoid	anticoronaviral agent
pyrroles 1H-pyrrole : A tautomer of pyrrole that has the double bonds at positions 2 and 4.. pyrrole : A five-membered monocyclic heteroarene comprising one NH and four CH units which forms the parent compound of the pyrrole group of compounds. Its five-membered ring structure has three tautomers. A 'closed class'.. azole : Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen. Azoles can also contain one or more other non-carbon atoms, such as nitrogen, sulfur or oxygen.	2.21	1	0	pyrrole; secondary amine
thiophenes Thiophenes: A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur.. thiophenes : Compounds containing at least one thiophene ring.	2.21	1	0	mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound	non-polar solvent
pyrazolanthrone pyrazolanthrone: JNK (c-Jun N-terminal kinase) inhibitor; structure in first source. anthra[1,9-cd]pyrazol-6(2H)-one : A member of the class of anthrapyrazoles that is anthra[1,9-cd]pyrazole substituted at position 6 by an oxo group. An inhibitor of c-Jun N-terminal kinase.	3.51	1	0	anthrapyrazole; aromatic ketone; cyclic ketone	antineoplastic agent; c-Jun N-terminal kinase inhibitor; geroprotector
indazoles Indazoles: A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES.	5.98	2	1	indazole
isoxazoles Isoxazoles: Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.. isoxazole : A monocyclic heteroarene with a structure consisting of a 5-membered ring containing three carbon atoms and an oxygen and nitrogen atom adjacent to each other. It is the parent of the class of isoxazoles.. isoxazoles : Oxazoles in which the N and O atoms are adjacent.	2.17	1	0	isoxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
pyrazines Pyrazines: A heterocyclic aromatic organic compound with the chemical formula C4H4N2.. pyrazine : A diazine that is benzene in which the carbon atoms at positions 1 and 4 have been replaced by nitrogen atoms.	2.17	1	0	diazine; pyrazines	Daphnia magna metabolite
indirubin [no description available]	8.78	2	0
alpha-aminopyridine alpha-aminopyridine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #485. aminopyridine : Compounds containing a pyridine skeleton substituted by one or more amine groups.	21.05	276	46
deoxycytidine [no description available]	5.65	6	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
oxyclozanide Oxyclozanide: Anthelmintic used in grazing animals for fasciola and cestode infestations.	3.17	1	0
trimetazidine Trimetazidine: A vasodilator used in angina of effort or ischemic heart disease.	2.6	1	0	aromatic amine
terbium Terbium: An element of the rare earth family of metals. It has the atomic symbol Tb, atomic number 65, and atomic weight 158.92.	2.15	1	0	f-block element atom; lanthanoid atom
sodium pyrophosphate sodium pyrophosphate: RN refers to diphosphoric acid, tetra-Na salt; structure. sodium diphosphate : An inorganic sodium salt comprised of a diphosphate(4-) anion and four sodium(1+) cations. More commonly known as tetrasodium pyrophosphate, it finds much use in the food industry as an emulsifier and in dental hygiene as a calcium-chelating salt.	2.31	1	0	inorganic sodium salt	chelator; food emulsifier; food thickening agent
penfluridol Penfluridol: One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.	3.17	1	0	diarylmethane
paclitaxel Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).	3.82	2	0	taxane diterpenoid; tetracyclic diterpenoid	antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent
ribavirin Rebetron: Rebetron is tradename	2.6	1	0	1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide	anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
diltiazem Diltiazem: A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.. diltiazem : A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension.	2.25	1	0	5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate	antihypertensive agent; calcium channel blocker; vasodilator agent
triciribine phosphate [no description available]	2.15	1	0
fenticonazole fenticonazole: structure given in first source; RN given refers to parent cpd. fenticonazole : A racemate comprising equimolar amounts of (R)- and (S)-fenticonazole. Used (as its nitrate salt) for the treatment of vaginal candidiasis.. 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole : A member of the class of imidazoles that carries a 2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl group at position 1.	2.31	1	0	aryl sulfide; dichlorobenzene; ether; imidazoles
itraconazole Itraconazole: A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.. itraconazole : An N-arylpiperazine that is cis-ketoconazole in which the imidazol-1-yl group is replaced by a 1,2,4-triazol-1-yl group and in which the actyl group attached to the piperazine moiety is replaced by a p-[(+-)1-sec-butyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]phenyl group. A potent P-glycoprotein and CYP3A4 inhibitor, it is used as an antifungal drug for the treatment of various fungal infections, including aspergillosis, blastomycosis, candidiasis, chromoblastomycosis, coccidioidomycosis, cryptococcosis, histoplasmosis, and sporotrichosis.	2.25	1	0	aromatic ether; conazole antifungal drug; cyclic ketal; dichlorobenzene; dioxolane; N-arylpiperazine; triazole antifungal drug; triazoles	EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; Hedgehog signaling pathway inhibitor; P450 inhibitor
aromasil [no description available]	4.22	2	0	17-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid	antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor; environmental contaminant; xenobiotic
gemcitabine gemcitabine : A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.	5.65	6	0	organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic
acridine orange Acridine Orange: A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.. acridine orange : Fluorescent dye useful for cell cycle determination. It is cell-permeable, and interacts with DNA and RNA by intercalation or electrostatic attractions respectively.. acridine orange free base : A member of the class of aminoacridines that is acridine carrying two dimethylamino substituents at positions 3 and 6. The hydrochloride salt is the fluorescent dye 'acridine orange', used for cell cycle determination.	2.21	1	0	aminoacridines; aromatic amine; tertiary amino compound	fluorochrome; histological dye
efavirenz efavirenz: HIV-1 reverse transcriptase inhibitor. efavirenz : 1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.	2.25	1	0	acetylenic compound; benzoxazine; cyclopropanes; organochlorine compound; organofluorine compound	antiviral drug; HIV-1 reverse transcriptase inhibitor
bendamustine [no description available]	3.41	1	0	benzimidazoles
triazoles Triazoles: Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.. triazoles : An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.	9.65	7	4	1,2,3-triazole
picropodophyllin picropodophyllin: isolated from American May apple (Podophyllum); inhibits IGF-I autophosphorylation without interfering with tyrosine kinase activity. picropodophyllotoxin : An organic heterotetracyclic compound that has a furonaphthodioxole skeleton bearing 3,4,5-trimethoxyphenyl and hydroxy substituents.	2.15	1	0	furonaphthodioxole; lignan; organic heterotetracyclic compound	antineoplastic agent; insulin-like growth factor receptor 1 antagonist; plant metabolite; tyrosine kinase inhibitor
tetrandrine tetrandrine: a bisbenzylisoquinoline that exhibits antifibrogenic activity	3.17	1	0	bisbenzylisoquinoline alkaloid; isoquinolines
fascaplysine fascaplysine: from tropic sea sponges	2.13	1	0
clarithromycin Clarithromycin: A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.. clarithromycin : The 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis.	2.25	1	0	macrolide antibiotic	antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic
lopinavir [no description available]	3.17	1	0	amphetamines; dicarboxylic acid diamide	anticoronaviral agent; antiviral drug; HIV protease inhibitor
osajin osajin: from Maclura pomifera	3.17	1	0	isoflavanones
fulvestrant Fulvestrant: An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.. fulvestrant : A 3-hydroxy steroid that is 17beta-estradiol in which the 7alpha hydrogen has been replaced by a nonyl group in which one of the hydrogens of the terminal methyl has been replaced by a (4,4,5,5,5-pentafluoropentyl)sulfinyl group. An estrogen receptor antagonist, it is used in the treatment of breast cancer.	15.68	53	16	17beta-hydroxy steroid; 3-hydroxy steroid; organofluorine compound; sulfoxide	antineoplastic agent; estrogen antagonist; estrogen receptor antagonist
bosentan anhydrous Bosentan: A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.	2.25	1	0	primary alcohol; pyrimidines; sulfonamide	antihypertensive agent; endothelin receptor antagonist
n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide [no description available]	3.41	1	0
fingolimod hydrochloride Fingolimod Hydrochloride: A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.. fingolimod hydrochloride : The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod).	2.41	1	0	hydrochloride	immunosuppressive agent; prodrug; sphingosine-1-phosphate receptor agonist
gefitinib [no description available]	3.73	2	0	aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
lestaurtinib [no description available]	2.15	1	0	indolocarbazole
perifosine [no description available]	2.15	1	0	ammonium betaine; phospholipid	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
lonafarnib lonafarnib: inhibitor of farnesyl protein transferase. lonafarnib : A 4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamide that has R configuration. It is used as oral farnesyltransferase inhibitor.	3.51	1	0	4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamide	antineoplastic agent; EC 2.5.1.58 (protein farnesyltransferase) inhibitor
levofloxacin Levofloxacin: The L-isomer of Ofloxacin.. levofloxacin : An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase.	3.41	1	0	9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; fluoroquinolone antibiotic; quinolone antibiotic	antibacterial drug; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor
vatalanib [no description available]	2.15	1	0	monochlorobenzenes; phthalazines; pyridines; secondary amino compound	angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; vascular endothelial growth factor receptor antagonist
moxifloxacin Moxifloxacin: A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.. moxifloxacin : A quinolone that consists of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.	3.99	1	1	aromatic ether; cyclopropanes; fluoroquinolone antibiotic; pyrrolidinopiperidine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone	antibacterial drug
ruboxistaurin ruboxistaurin: inhibits protein kinase C beta; structure in first source	2.15	1	0
bazedoxifene [no description available]	3.17	1	0	phenylindole
canertinib [no description available]	2.15	1	0	monochlorobenzenes; morpholines; organofluorine compound; quinazolines	antineoplastic agent; tyrosine kinase inhibitor
cyc 202 seliciclib : 2,6-Diaminopurine carrying benzylamino, (2R)-1-hydroxybutan-2-yl and isopropyl substituents at C-6, C-2-N and N-9 respectively. It is an experimental drug candidate in the family of pharmacological cyclin-dependent kinase (CDK) inhibitors.	6.21	9	0	2,6-diaminopurines	antiviral drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
anidulafungin Anidulafungin: Echinocandin antifungal agent that is used in the treatment of CANDIDEMIA and CANDIDIASIS.. anidulafungin : A semisynthetic echinocandin anti-fungal drug. It is active against Aspergillus and Candida species and is used for the treatment of invasive candidiasis.	3.17	1	0	antibiotic antifungal drug; azamacrocycle; echinocandin; heterodetic cyclic peptide; semisynthetic derivative
sb 203580 [no description available]	4.43	2	0	imidazoles; monofluorobenzenes; pyridines; sulfoxide	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector; Hsp90 inhibitor; neuroprotective agent
enzastaurin [no description available]	2.15	1	0	indoles; maleimides
erlotinib [no description available]	4.55	3	0	aromatic ether; quinazolines; secondary amino compound; terminal acetylenic compound	antineoplastic agent; epidermal growth factor receptor antagonist; protein kinase inhibitor
erlotinib hydrochloride [no description available]	4.43	1	1	hydrochloride; terminal acetylenic compound	antineoplastic agent; protein kinase inhibitor
dronedarone Dronedarone: A non-iodinated derivative of amiodarone that is used for the treatment of ARRHYTHMIA.. dronedarone : A member of the class of 1-benzofurans used for the treatment of cardiac arrhythmias.	3.17	1	0	1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound	anti-arrhythmia drug; environmental contaminant; xenobiotic
lapatinib [no description available]	4.28	4	0	furans; organochlorine compound; organofluorine compound; quinazolines	antineoplastic agent; tyrosine kinase inhibitor
sorafenib [no description available]	5.56	5	0	(trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; phenylureas; pyridinecarboxamide	angiogenesis inhibitor; anticoronaviral agent; antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; ferroptosis inducer; tyrosine kinase inhibitor
benzofurans Benzofurans: Compounds that contain a BENZENE ring fused to a furan ring.	2.17	1	0
berbamine [no description available]	3.17	1	0	bisbenzylisoquinoline alkaloid; isoquinolines
wortmannin [no description available]	3.51	1	0	acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound	anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent
2H-pyrazolo[4,3-b]quinoxalin-3-amine [no description available]	2.17	1	0	quinoxaline derivative
ouabain Ouabain: A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.. cardiac glycoside : Steroid lactones containing sugar residues that act on the contractile force of the cardiac muscles.. ouabain : A steroid hormone that is a multi-hydroxylated alpha-L-rhamnosyl cardenoloide. It binds to and inhibits the plasma membrane Na(+)/K(+)-ATPase (sodium pump). It has been isolated naturally from Strophanthus gratus.	3.17	1	0	11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone	anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite
digitoxin Digitoxin: A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665). digitoxin : A cardenolide glycoside in which the 3beta-hydroxy group of digitoxigenin carries a 2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl trisaccharide chain.	3.17	1	0	cardenolide glycoside	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
ginsenoside rf ginsenoside Rf: from ginseng. ginsenoside Rf : A ginsenoside found in Panax ginseng and Panax japonicus var. major that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy group at position 6 has been converted to the corresponding beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position.	3.51	1	0	12beta-hydroxy steroid; 20-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid	antineoplastic agent; apoptosis inducer; plant metabolite
trichostatin a trichostatin A: chelates zinc ion in the active site of histone deacetylases, resulting in preventing histone unpacking so DNA is less available for transcription; do not confuse with TRICHOSANTHIN which is a protein; found in STREPTOMYCES	3.41	1	0	antibiotic antifungal agent; hydroxamic acid; trichostatin	bacterial metabolite; EC 3.5.1.98 (histone deacetylase) inhibitor; geroprotector
7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine [no description available]	3.31	1	0
6-bromoindirubin-3'-oxime 6-bromoindirubin-3'-oxime: structure in first source. 6-bromoindirubin-3'-oxime : A member of the class of biindoles that is indirubin substituted at position 6 by a bromo group and in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.	2.17	1	0
gw 257406x maribavir: has antiviral activity against human cytomegalovirus	2.31	1	0
2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione [no description available]	2.17	1	0	aminotoluene
stilbenes Stilbenes: Organic compounds that contain 1,2-diphenylethylene as a functional group.. trans-stilbene : The trans-isomer of stilbene.	2.31	1	0	stilbene
pyrophosphate Diphosphates: Inorganic salts of phosphoric acid that contain two phosphate groups.	2.31	1	0	diphosphate ion
cgp 60474 [no description available]	2.17	1	0	substituted aniline
s 1033 [no description available]	3.73	2	0	(trifluoromethyl)benzenes; imidazoles; pyridines; pyrimidines; secondary amino compound; secondary carboxamide	anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor
lanatoside c lanatoside C: RN given refers to (3beta,5beta,12beta)-isomer	3.17	1	0
curcumin Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.. curcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa.	3.01	2	0	aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol	anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger
zuclomiphene Zuclomiphene: The cis or (Z)-isomer of clomiphene.	3.17	1	0	stilbenoid
xl147 [no description available]	2.15	1	0	aromatic amine; benzothiadiazole; quinoxaline derivative; sulfonamide	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
digoxin Digoxin: A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666). digoxin : A cardenolide glycoside that is digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.	3.17	1	0	cardenolide glycoside; steroid saponin	anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope
tamoxifen [no description available]	7.7	4	2	stilbenoid; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator
cgp 74514a [no description available]	2.17	1	0
1,4-dimethoxy-10H-acridine-9-thione [no description available]	2.17	1	0	acridines
toremifene Toremifene: A first generation selective estrogen receptor modulator (SERM). Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.	3.17	1	0	aromatic ether; organochlorine compound; tertiary amine	antineoplastic agent; bone density conservation agent; estrogen antagonist; estrogen receptor modulator
u 0126 U 0126: protein kinase kinase inhibitor; structure in first source	3.51	1	0	aryl sulfide; dinitrile; enamine; substituted aniline	antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent
bms 387032 N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide: a CDK2 inhibitor with antineoplastic activity; structure in first source. N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of piperidine-4-carboxylic acid with the amino group of 5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-amine. It is an ATP-competitive inhibitor of CDK2, CDK7 and CDK9 kinases and exhibits anti-cancer properties.	4.7	4	0	1,3-oxazoles; 1,3-thiazoles; organic sulfide; piperidinecarboxamide; secondary carboxamide	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
droloxifene [no description available]	3.17	1	0	stilbenoid
sf 2370 SF 2370: indolocarbazole isolated from Actinomadura sp. SF-2370; structure given in first source. K-252a : A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a	2.15	1	0	bridged compound; gamma-lactam; methyl ester; organic heterooctacyclic compound	antimicrobial agent; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; tropomyosin-related kinase B receptor antagonist
tandutinib [no description available]	2.15	1	0	aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; piperidines; quinazolines; tertiary amino compound	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
dasatinib N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide: a dasatinib prodrug; structure in first source. dasatinib (anhydrous) : An aminopyrimidine that is 2-methylpyrimidine which is substituted at position 4 by the primary amino group of 2-amino-1,3-thiazole-5-carboxylic acid and at position 6 by a 4-(2-hydroxyethyl)piperazin-1-yl group, and in which the carboxylic acid group has been formally condensed with 2-chloro-6-methylaniline to afford the corresponding amide. A multi-targeted kinase inhibitor, it is used, particularly as the monohydrate, for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. Note that the name 'dasatinib' is used to refer to the monohydrate (USAN) as well as to anhydrous dasatinib (INN).	5.14	4	0	1,3-thiazoles; aminopyrimidine; monocarboxylic acid amide; N-(2-hydroxyethyl)piperazine; N-arylpiperazine; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor
ha 1100 HA 1100: intracellular calcium antagonist	2.15	1	0
7-epi-hydroxystaurosporine [no description available]	2.15	1	0
zd 6474 CH 331: structure in first source	4.55	3	0	aromatic ether; organobromine compound; organofluorine compound; piperidines; quinazolines; secondary amine	antineoplastic agent; tyrosine kinase inhibitor
salinomycin salinomycin: from Streptomyces albus; RN given refers to parent cpd; structure	3.17	1	0	polyketide; spiroketal	animal growth promotant; potassium ionophore
naphthoquinones Naphthoquinones: Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.	2.17	1	0
rhodamine 123 Rhodamine 123: A fluorescent probe with low toxicity which is a potent substrate for ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 and the bacterial multidrug efflux transporter. It is used to assess mitochondrial bioenergetics in living cells and to measure the efflux activity of ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 in both normal and malignant cells. (Leukemia 1997;11(7):1124-30). rhodamine 123(1+) : A cationic fluorescent dye derived from 9-phenylxanthene.	2.15	1	0	organic cation; xanthene dye	fluorochrome
alsterpaullone alsterpaullone: structure in first source. alsterpaullone : An organic heterotetracyclic compound that is 1,3-dihydro-2H-1-benzazepin-2-one which shares its 4-5 bond with the 3-2 bond of 5-nitro-1H-indole.	4.55	3	0	C-nitro compound; caprolactams; organic heterotetracyclic compound	anti-HIV-1 agent; antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor
imd 0354 N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide: a cardioprotective agent that inhibits IkappaB kinase beta (IKKbeta); structure in first source	2.15	1	0	benzamides
cholecalciferol Cholecalciferol: Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.. calciol : A hydroxy seco-steroid that is (5Z,7E)-9,10-secocholesta-5,7,10(19)-triene in which the pro-S hydrogen at position 3 has been replaced by a hydroxy group. It is the inactive form of vitamin D3, being hydroxylated in the liver to calcidiol (25-hydroxyvitamin D3), which is then further hydroxylated in the kidney to give calcitriol (1,25-dihydroxyvitamin D3), the active hormone.	3.41	1	0	D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol; steroid hormone	geroprotector; human metabolite
genistein [no description available]	3.51	1	0	7-hydroxyisoflavones	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor
cyclosporine ramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MF	3.17	1	0	homodetic cyclic peptide	anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite
proscillaridin Proscillaridin: A cardiotonic glycoside isolated from Scilla maritima var. alba (Squill).	3.17	1	0	organic molecular entity
sirolimus Sirolimus: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.. sirolimus : A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent.	3.73	2	0	antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol	antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor
alvocidib alvocidib: structure given in first source. alvocidib : A synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is substituted by a 3-hydroxy-1-methylpiperidin-4-yl group at position 8 and by a chlorine at the 2' position (the (-)-3S,4R stereoisomer). A cyclin-dependent kinase 9 (CDK9) inhibitor, it has been studied for the treatment of acute myeloid leukaemia, arthritis and atherosclerotic plaque formation.	5.8	7	0	dihydroxyflavone; hydroxypiperidine; monochlorobenzenes; tertiary amino compound	antineoplastic agent; antirheumatic drug; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
su 9516 [no description available]	2.17	1	0
cytochalasin b Cytochalasin B: A cytotoxic member of the CYTOCHALASINS.. cytochalasin B : An organic heterotricyclic compound, that is a mycotoxin which is cell permeable an an inhibitor of cytoplasmic division by blocking the formation of contractile microfilaments.	2.15	1	0	cytochalasin; lactam; lactone; organic heterotricyclic compound	actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor
casein kinase ii Casein Kinase II: A ubiquitous casein kinase that is comprised of two distinct catalytic subunits and dimeric regulatory subunit. Casein kinase II has been shown to phosphorylate a large number of substrates, many of which are proteins involved in the regulation of gene expression.	3.41	1	0
arcyriaflavin a arcyriaflavin A: from marine ascidian, Eudistoma sp.; structure given in first source	2.17	1	0	indolocarbazole
bosutinib 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile: a Src kinase inhibitor; structure in first source	3.73	2	0	aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound	antineoplastic agent; tyrosine kinase inhibitor
orantinib orantinib: an antiangiogenic agent. orantinib : An oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is substituted by a 2-(2-carboxyethyl)-3,5-dimethylpyrrol-3-yl group. It is an ATP-competitive inhibitor of the tyrosine kinase activity of fibroblast growth factor receptor 1.	2.15	1	0
su 11248 [no description available]	3.73	2	0	monocarboxylic acid amide; pyrroles	angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; immunomodulator; neuroprotective agent; vascular endothelial growth factor receptor antagonist
pd 0183812 PD 0183812: inhibits CDK4 and CDK6; structure in first source	3.51	1	0
palbociclib [no description available]	13.04	101	1	aminopyridine; aromatic ketone; cyclopentanes; piperidines; pyridopyrimidine; secondary amino compound; tertiary amino compound	antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
lead Lead: A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.	2.6	1	0	carbon group element atom; elemental lead; metal atom	neurotoxin
vx680 [no description available]	2.57	2	0	N-arylpiperazine
22,23-dihydroavermectin b(1)a 22,23-dihydroavermectin B(1)a: C48H74O14; major component of IVERMECTIN; MW 875.093; structure given in first source. 22,23-dihydroavermectin B1a : A macrocyclic lactone that is avermectin B1a in which the double bond present in the spirocyclic ring system has been reduced to a single bond. It is the major component of ivermectin.	3.51	1	0	macrocyclic lactone; spiroketal
cyc 116 4-methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine: an aurora kinase inhibitor; structure in first source	2.15	1	0
everolimus [no description available]	11.14	8	0	cyclic acetal; cyclic ketone; ether; macrolide lactam; primary alcohol; secondary alcohol	anticoronaviral agent; antineoplastic agent; geroprotector; immunosuppressive agent; mTOR inhibitor
ekb 569 EKB 569: an EGF receptor kinase inhibitor	2.15	1	0	aminoquinoline; monocarboxylic acid amide; monochlorobenzenes; nitrile	protein kinase inhibitor
axitinib [no description available]	2.15	1	0	aryl sulfide; benzamides; indazoles; pyridines	antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist
ciclesonide ciclesonide: nasal spray approved for seasonal and perennial allergic rhinitis	3.17	1	0	organic molecular entity
temsirolimus [no description available]	2.15	1	0	macrolide lactam
cvt 313 CVT 313: a potent inhibitor of CDK2 that prevents neointimal proliferation; structure given in first source	2.17	1	0
pd 184352 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide: inhibits MAP kinase kinase; structure in first source	3.51	1	0	aminobenzoic acid
on 01910 ON 01910: a Plk1 inhibitor with antineoplastic activity; structure in first source. N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine : A glycine derivative that is glycine in which one of the hydrogens of the amino group is substituted by a 2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl group.. rigosertib : An N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine in which the double bond has E-configuration. It is a non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM and exhibits anti-cancer properties.	2.15	1	0	N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine	antineoplastic agent; apoptosis inducer; EC 2.7.11.21 (polo kinase) inhibitor; microtubule-destabilising agent
vacuolin-1 vacuolin-1: inhibits Ca2-dependent lysosomal exocytosis	8.92	2	0
av 412 [no description available]	2.15	1	0
telatinib [no description available]	2.15	1	0
y-39983 Y-39983: SNJ-1656 is an ophthalmic solution of Y-39983; ROCK (rho kinase) inhibitor, promotes regeneration of crushed axons of retinal ganglion cells; structure in first source	2.15	1	0	pyrrolopyridine
cp 547632 3-(4-bromo-2,6-difluorobenzyloxy)-5-(3-(4-pyrrolidin-1-ylbutyl)ureido)isothiazole-4-carboxylic acid amide: inhibits vascular endothelial growth factor receptor-2 tyrosine kinase; structure in first source	2.15	1	0
lenvatinib lenvatinib : A member of the class of quinolines that is the carboxamide of 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxylic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine.	2.15	1	0	aromatic amide; aromatic ether; cyclopropanes; monocarboxylic acid amide; monochlorobenzenes; phenylureas; quinolines	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist; orphan drug; vascular endothelial growth factor receptor antagonist
pd 0325901 mirdametinib: has antineoplastic activity; appears to be a MEK inhibitor. PD 0325901 : A hydroxamic acid ester that is benzhydroxamic acid (N-hydroxybenzamide) in which the hydroxamic acid group has been converted to the corresponding 2,3-dihydroxypropyl ester and in which the benzene ring has been substituted at position 2 by a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 by fluorines (the R enantiomer).	2.15	1	0	difluorobenzene; hydroxamic acid ester; monofluorobenzenes; organoiodine compound; propane-1,2-diols; secondary amino compound	antineoplastic agent; EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
midostaurin midostaurin : An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.	2.15	1	0	benzamides; gamma-lactam; indolocarbazole; organic heterooctacyclic compound	antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor
sincalide Sincalide: An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas.	2.6	1	0	oligopeptide
px-866 PX-866: inhibitor of phosphoinositide-3-kinase signaling with antitumor activity; structure in first source. PX-866 : An organic heterotetracyclic compound that is obtained from wortmanin via aminolysis of its furan ring by diallyl amine.	2.15	1	0	acetate ester; delta-lactone; organic heterotetracyclic compound; tertiary amino compound	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
ripasudil [no description available]	2.15	1	0	isoquinolines
fr 148083 5Z-7-oxozeaenol : A macrolide that is the 7-oxo derivative of zeaenol (the 5Z stereoisomer). Isolated from Fungi, it exhibits cytotoxic, antibacterial and inhibitory activity against NF-kappaB.	3.51	1	0	aromatic ether; macrolide; phenols; secondary alcohol; secondary alpha-hydroxy ketone	antibacterial agent; antineoplastic agent; metabolite; NF-kappaB inhibitor
osi 930 OSI 930: inhibits both receptor tyrosine kinase Kit and kinase insert domain receptor; structure in first source	2.15	1	0	aromatic amide
scio-469 SCIO-469: a small-molecule p38 mitogen-activated protein (MAP) kinase inhibitor for potential oral therapy for inflammatory disorders; in phase lib clinical trials for rheumatoid arthritis 4/2004. talmapimod : An indolecarboxamide obtained by formal condensation of the carboxy group of 6-chloro-3-[(dimethylamino)(oxo)acetyl]-1-methylindole-5-carboxylic acid with the secondary amino group of (2S,5R)-1-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine. It is a potent inhibitor of MAPK and exhibits anti-cancer properties.	2.15	1	0	aromatic amide; aromatic ketone; chloroindole; dicarboxylic acid diamide; indolecarboxamide; monofluorobenzenes; N-acylpiperazine; N-alkylpiperazine	antineoplastic agent; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
ticagrelor Ticagrelor: An adenosine triphosphate analogue and reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION.. ticagrelor : A triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome.	2.31	1	0	aryl sulfide; hydroxyether; organofluorine compound; secondary amino compound; triazolopyrimidines	P2Y12 receptor antagonist; platelet aggregation inhibitor
cp 724714 2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide: CP-724714 is the ((2E)-isomer, 1:1.5 succinate); structure in first source	2.15	1	0	2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide	antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; hepatotoxic agent
hmn-214 (E)-4-(2-(2-(N-acetyl-N-(4-methoxybenzenesulfonyl)amino)stilbazole)) 1-oxide: an antineoplastic agent; structure in first source	2.15	1	0
tivozanib N-(2-chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea: KNR-951 is the HCl, monohydrate salt; an antineoplastic agent; structure in first source	2.15	1	0	aromatic ether
hki 272 [no description available]	2.15	1	0	nitrile; quinolines	antineoplastic agent; tyrosine kinase inhibitor
tofacitinib tofacitinib : A pyrrolopyrimidine that is pyrrolo[2,3-d]pyrimidine substituted at position 4 by an N-methyl,N-(1-cyanoacetyl-4-methylpiperidin-3-yl)amino moiety. Used as its citrate salt to treat moderately to severely active rheumatoid arthritis.	3.73	2	0	N-acylpiperidine; nitrile; pyrrolopyrimidine; tertiary amino compound	antirheumatic drug; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
cediranib [no description available]	2.15	1	0	aromatic ether
ym 201636 6-amino-N-(3-(4-(4-morpholinyl)pyrido(3',2'-4,5)furo(3,2-d)pyrimidin-2-yl)phenyl)-3-pyridinecarboxamide: an antiviral agent; structure in first source	3.51	1	0	aromatic amide
masitinib [no description available]	2.15	1	0	1,3-thiazoles; benzamides; N-alkylpiperazine; pyridines	antineoplastic agent; antirheumatic drug; tyrosine kinase inhibitor
ly-2157299 LY-2157299: an orally active transforming growth factor beta receptor (TGF-beraR) kinase inhibitor. LY-2157299 : A pyrrolopyrazole that is 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole which is substituted at positions 2 and 3 by 6-methylpyridin-2-yl and 6-(aminocarbonyl)quinolin-4-yl groups, respectively. A Transforming growth factor-betaRI (TGF-betaRI) kinase inhibitor, it blocks TGF-beta-mediated tumor growth in glioblastoma.	4.35	3	1	aromatic amide; methylpyridines; monocarboxylic acid amide; pyrrolopyrazole; quinolines	antineoplastic agent; TGFbeta receptor antagonist
pazopanib pazopanib: a protein kinase inhibitor. pazopanib : A pyrimidine that is 5-(pyrimidin-2-yl}amino-2-methylbenzenesulfonamide substituted at position 4 by a (2,3-dimethylindazol-6-yl)(methyl)amino group. Used as its hydrochloride salt for treatment of kidney cancer.	2.15	1	0	aminopyrimidine; indazoles; sulfonamide	angiogenesis modulating agent; antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist
azd 6244 AZD 6244: a MEK inhibitor	3.73	2	0	benzimidazoles; bromobenzenes; hydroxamic acid ester; monochlorobenzenes; organofluorine compound; secondary amino compound	anticoronaviral agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
su 14813 5-((5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-N-(2-hydroxy-3-morpholin-4-ylpropyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide: has both antineoplastic and antiangiogenic activities; structure in first source	2.15	1	0
apilimod [no description available]	4.43	2	0
bibw 2992 [no description available]	2.15	1	0	aromatic ether; enamide; furans; monochlorobenzenes; organofluorine compound; quinazolines; secondary carboxamide; tertiary amino compound	antineoplastic agent; tyrosine kinase inhibitor
nu 6140 4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide: a cyclin-dependent kinase inhibitor; structure in first source	2.17	1	0
pik 75 PIK 75: structure in first source	2.13	1	0
binimetinib binimetinib : A member of the class of benzimidazoles that is 1-methyl-1H-benzimidazole which is substituted at positions 4, 5, and 6 by fluorine, (4-bromo-2-fluorophenyl)nitrilo, and N-(2-hydroxyethoxy)aminocarbonyl groups, respectively. It is a MEK1 and MEK2 inhibitor (IC50= 12 nM). Approved by the FDA for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation in combination with encorafenib.	2.15	1	0	benzimidazoles; bromobenzenes; hydroxamic acid ester; monofluorobenzenes; secondary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
sotrastaurin sotrastaurin: a potent protein kinase C-selective inhibitor; structure in first source. sotrastaurin : A member of the class of maleimides that is maleimide which is substituted at position 3 by an indol-3-yl group and at position 4 by a quinazolin-4-yl group, which in turn is substituted at position 2 by a 4-methylpiperazin-1-yl group. It is a potent and selective inhibitor of protein kinase C and has been investigated as an immunosuppresant in renal transplant patients.	2.15	1	0	indoles; maleimides; N-alkylpiperazine; N-arylpiperazine; quinazolines	anticoronaviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunosuppressive agent
aee 788 AEE 788: structure in first source	2.15	1	0	6-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist; trypanocidal drug
saracatinib [no description available]	4.57	3	0	aromatic ether; benzodioxoles; diether; N-methylpiperazine; organochlorine compound; oxanes; quinazolines; secondary amino compound	anticoronaviral agent; antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; radiosensitizing agent
2-acetylfuranonaphthoquinone 2-acetylfuranonaphthoquinone: has antineoplastic activity; structure in first source	2.17	1	0
vx 702 VX 702: a p38 MAP kinase inhibitor	2.15	1	0	phenylpyridine
crenolanib [no description available]	2.15	1	0	aminopiperidine; aromatic ether; benzimidazoles; oxetanes; quinolines; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
tg100-115 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol: for treatment of ischemia reperfusion injury; structure in first source	2.15	1	0	pteridines
cc 401 CC 401: an anthrapyrazolone	2.15	1	0	pyrazoles; ring assembly
bms 599626 [no description available]	2.15	1	0
exel-7647 tesevatinib : A member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties.	2.15	1	0
volasertib BI 6727: a polo-like kinase inhibitor with broad antitumor activity; structure in first source	2.15	1	0
azd 7762 [no description available]	2.15	1	0	aromatic amide; thiophenes
regorafenib [no description available]	2.15	1	0	(trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; monofluorobenzenes; phenylureas; pyridinecarboxamide	antineoplastic agent; hepatotoxic agent; tyrosine kinase inhibitor
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one [no description available]	2.15	1	0	methoxybenzenes; substituted aniline
brivanib [no description available]	2.15	1	0	aromatic ether; diether; fluoroindole; pyrrolotriazine; secondary alcohol	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; drug metabolite; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist
mp470 [no description available]	2.15	1	0	N-arylpiperazine
rgb 286638 [no description available]	2.54	2	0
np 031112 tideglusib: an NSAID and neuroprotective agent. tideglusib : A member of the class of thiadiazolidines that is 1,2,4-thiadiazolidine-3,5-dione which is substituted by a naphthalen-1-yl group at position 2 and by a benzyl group at position 4. It is a non-ATP competitive inhibitor of glycogen synthase kinase 3beta (GSK3beta) and has neuroprotective effects. Currently under clinical investigation for the treatment of Alzheimer's disease and progressive supranuclear palsy.	3.73	2	0	benzenes; naphthalenes; thiadiazolidine	anti-inflammatory agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent
at 7519 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide : A member of the class of pryrazoles that is 4-amino-1H-pyrazole-3-carboxylic acid in which the primary amino group has been acylated by a 2,6-dichlorobenzoyl group and in which the carboxylic acid has been converted into a carboxamide by formal condensation with the primary amino group of 4-aminopiperidine.	5.37	6	0	dichlorobenzene; piperidines; pyrazoles; secondary carboxamide	antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
bms-690514 [no description available]	2.15	1	0
bi 2536 [no description available]	2.15	1	0
inno-406 [no description available]	2.15	1	0	biaryl
kw 2449 KW 2449: has both multikinase inhibitory activity and antineoplastic activity; structure in first source	2.15	1	0
danusertib [no description available]	2.15	1	0	piperazines
abt 869 [no description available]	2.15	1	0	aromatic amine; indazoles; phenylureas	angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
azd 8931 sapitinib : A member of the class of quinazolines that is 4-amino-7-methoxyquinazoline in which the amino group has been substituted by a 3-chloro-2-fluorophenyl group and in which position 6 of the quinoline ring has been substituted by a {1-[2-(methylamino)-2-oxoethyl]piperidin-4-yl}oxy group. Sapitinib is a dual tyrosine kinase inhibitor (TKI) of epithelial growth factor receptors (EGFR) HER2 and HER3.	2.15	1	0	aromatic ether; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; tertiary amino compound	EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist
arq 197 [no description available]	2.15	1	0	indoles
azd 1152 AZD-1152 : A member of the of quinazolines that is 4-aminoquinazolin-7-ol in which the amino group at position 4 has been substituted by a 5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl group, while the hydroxy group at position 7 has been converted into the corresponding 3-[ethyl(2-hydroxyethyl)aminopropyl ether.	2.15	1	0	anilide; monoalkyl phosphate; monofluorobenzenes; pyrazoles; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound	antineoplastic agent; Aurora kinase inhibitor; prodrug
pf 00299804 dacomitinib: a pan-ERBB inhibitor. dacomitinib : A member of the class of quinazolines that is 7-methoxyquinazoline-4,6-diamine in which the amino group at position 4 is substituted by a 3-chloro-4-fluorophenyl group and the amino group at position 6 is substituted by an (E)-4-(piperidin-1-yl)but-2-enoyl group.	2.15	1	0	enamide; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
ridaforolimus [no description available]	2.15	1	0	macrolide lactam
dorsomorphin dorsomorphin: an AMPK inhibitor. dorsomorphin : A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling.	3.51	1	0	aromatic ether; piperidines; pyrazolopyrimidine; pyridines	bone morphogenetic protein receptor antagonist; EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
ch 4987655 [no description available]	2.15	1	0
6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-n-(2,2-dimethylprpyl)-3-pyridinecarboxamide [no description available]	2.15	1	0	phenylpyridine
cc-930 [no description available]	2.15	1	0
tak 285 N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide: also inhibits HER2; structure in first source	2.15	1	0
idelalisib idelalisib: an antineoplastic agent and p110delta inhibitor; structure in first source. idelalisib : A member of the class of quinazolines that is 5-fluoro-3-phenylquinazolin-4-one in which the hydrogen at position 2 is replaced by a (1S)-1-(3H-purin-6-ylamino)propyl group. used for for the treatment of refractory indolent non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukemia.	2.15	1	0	aromatic amine; organofluorine compound; purines; quinazolines; secondary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
crizotinib Crizotinib: A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.. crizotinib : A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)	2.15	1	0	3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine	antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
osi 906 [no description available]	2.15	1	0	cyclobutanes; quinolines
chir-265 [no description available]	2.15	1	0	aromatic ether
motesanib [no description available]	2.15	1	0	pyridinecarboxamide
fostamatinib fostamatinib: a spleen tyrosine kinase (Syk) inhibitor, metabolized to R406	2.15	1	0
trametinib [no description available]	4	3	0	acetamides; aromatic amine; cyclopropanes; organofluorine compound; organoiodine compound; pyridopyrimidine; ring assembly	anticoronaviral agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector
mln8054 [no description available]	2.15	1	0	benzazepine
pf-562,271 [no description available]	2.15	1	0	indoles
jnj-26483327 JNJ-26483327: an orally active macrocyclic tyrosine kinase inhibitor for treatment of patients with advanced solid tumours; in Phase I trial, 9/2010	2.15	1	0
ly2603618 [no description available]	2.15	1	0	ureas
tg100801 [no description available]	2.15	1	0
dactolisib dactolisib: antineoplastic agent that inhibits both phosphatidylinositol 3-kinase and mTOR. dactolisib : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment.	2.15	1	0	imidazoquinoline; nitrile; quinolines; ring assembly; ureas	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor
bgt226 BGT226 free base : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 3-trifluoromethyl-4-(piperazin-1-yl)phenyl group and at position 8 by a 6-methoxypyridin-3-yl group. A dual PI3K/mTOR inhibitor.. BGT226 : The maleate salt of 8-(6-methoxypyridin-3-yl)-3-methyl-1-[4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl]-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one. A dual PI3K/mTOR inhibitor.	2.15	1	0	aromatic ether; imidazoquinoline; N-arylpiperazine; organofluorine compound; pyridines	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor
chidamide [no description available]	3.41	1	0	benzamides
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide [no description available]	3.51	1	0	organochlorine compound
gsk 461364 GSK 461364: an antineoplastic agent that inhibits polo-like kinase 1	2.15	1	0	(trifluoromethyl)benzenes
azd 1152-hqpa AZD2811: has antineoplastic activity; structure in first source	2.15	1	0	anilide; monofluorobenzenes; primary alcohol; pyrazoles; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound	antineoplastic agent; Aurora kinase inhibitor
enmd 2076 ENMD 2076: an antiangiogenic agent with aurora kinase inhibitory and antineoplastic activities	2.15	1	0
e 7050 [no description available]	2.15	1	0	aromatic ether
2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7-pyrido[2,3-d]pyrimidinone [no description available]	2.15	1	0	pyrazolopyridine
tak-901 [no description available]	2.15	1	0
vx-770 ivacaftor: a CFTR potentiator; structure in first source. ivacaftor : An aromatic amide obtained by formal condensation of the carboxy group of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid with the amino group of 5-amino-2,4-di-tert-butylphenol. Used for the treatment of cystic fibrosis.	3.17	1	0	aromatic amide; monocarboxylic acid amide; phenols; quinolone	CFTR potentiator; orphan drug
gdc-0973 cobimetinib: has antineoplastic activity; structure in first source. cobimetinib : A member of the class of N-acylazetidines obtained by selective formal condensation of the carboxy group of 3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid with the secondary amino group from the azetidine ring of 3-[(2S)-piperidin-2-yl]azetidin-3-ol. An inhibitor of mitogen-activated protein kinase that is used (as its fumarate salt) in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma.	2.15	1	0	aromatic amine; difluorobenzene; N-acylazetidine; organoiodine compound; piperidines; secondary amino compound; tertiary alcohol	antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
buparlisib NVP-BKM120: a pan class I PI3 kinase inhibitor with antineoplastic activity; structure in first source	2.15	1	0	aminopyridine; aminopyrimidine; morpholines; organofluorine compound	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
azd 1480 [no description available]	2.15	1	0
azd8330 [no description available]	2.15	1	0	pyridinecarboxamide
pha 848125 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide: a cyclin dependent kinase inhibitor	3.95	3	0
ro5126766 RO5126766: a dual MEK/RAF kinase inhibitor. CH5126766 : A member of the class of coumarins that is 4-methyl-7-[(pyrimidin-2-yl)oxy]coumarin carrying an additional [2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl substituent at position 3.	3.73	2	0	aryloxypyrimidine; coumarins; organofluorine compound; pyridines; sulfamides	antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
fedratinib fedratinib: a selective small-molecule inhibitor of JAK2	2.15	1	0	sulfonamide
gsk690693 [no description available]	2.15	1	0	1,2,5-oxadiazole; acetylenic compound; aromatic amine; aromatic ether; imidazopyridine; piperidines; primary amino compound; tertiary alcohol	antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene: has antineoplastic activity; also inhibits Fms-like tyrosine kinase-3; structure in first source	3.98	3	0
azd5438 [no description available]	2.15	1	0	sulfonamide
pf 04217903 [no description available]	2.15	1	0	quinolines
gdc 0941 pictrelisib : A sulfonamide composed of indazole, morpholine, and methylsulfonyl-substituted piperazine rings bound to a thienopyrimidine ring.	4.55	3	0	indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
chitosan [no description available]	7.41	1	0
icotinib [no description available]	2.15	1	0
ph 797804 PH 797804: an NSAID; structure in first source. PH 797804 : A member of the class of benzamides obtained by formal condensation of the carboxy group of 3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1-yl}-4-methylbenzoic acid with the amino group of methylamine.	2.15	1	0	aromatic ether; benzamides; organobromine compound; organofluorine compound; pyridone	anti-inflammatory agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
kx-01 [no description available]	2.15	1	0
p276-00 P276-00: antineoplastic, cyclin-dependent kinase inhibitor; structure in first source	2.13	1	0
meriolin 3 meriolin 3: a cell death-inducing kinase inhibitor; structure in first source	2.13	1	0
mk 5108 [no description available]	2.15	1	0	aromatic ether
cx 4945 [no description available]	3.73	2	0
cudc 101 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide: a histone deacetylase inhibitor; structure in first source	3.71	2	0
arry-614 pexmetinib: inhibits both p38 mitogen-activated protein kinase and Tie2 protein	2.15	1	0
tak 593 TAK 593: structure in first source	2.15	1	0
mln 8237 MLN 8237: an aurora kinase A inhibitor	2.15	1	0	benzazepine
sgx 523 [no description available]	2.15	1	0	aryl sulfide; biaryl; pyrazoles; quinolines; triazolopyridazine	c-Met tyrosine kinase inhibitor; nephrotoxic agent
bms 754807 BMS 754807: an IGR-1R kinase inhibitor; structure in first source	2.15	1	0	pyrazoles; pyridines; pyrrolidines; pyrrolotriazine	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
bms 777607 N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide: a Met kinase inhibitor; structure in first source	2.15	1	0	aromatic amide
sgi 1776 SGI 1776: a Pim kinase inhibitor; structure in first source	2.15	1	0	imidazoles
pci 32765 ibrutinib: a Btk protein inhibitor. ibrutinib : A member of the class of acrylamides that is (3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine in which the piperidine nitrogen is replaced by an acryloyl group. A selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase, it is used for treatment of B-cell malignancies.	2.15	1	0	acrylamides; aromatic amine; aromatic ether; N-acylpiperidine; pyrazolopyrimidine; tertiary carboxamide	antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
cink4 CINK4: cyclin-dependent kinase 4 inhibitor; may have tumor suppression activity; structure in first source	2.17	1	0	indoles
ponatinib [no description available]	3.73	2	0	(trifluoromethyl)benzenes; acetylenic compound; benzamides; imidazopyridazine; N-methylpiperazine	antineoplastic agent; tyrosine kinase inhibitor
amg 900 N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine: a pan-aurora kinase inhibitor; structure in first source	2.15	1	0
mk-1775 adavosertib: a Wee1 kinase inhibitor; structure in first source	2.15	1	0	piperazines
AMG-208 [no description available]	2.15	1	0	aromatic ether; quinolines; triazolopyridazine	antineoplastic agent; c-Met tyrosine kinase inhibitor
quizartinib [no description available]	2.15	1	0	benzoimidazothiazole; isoxazoles; morpholines; phenylureas	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; necroptosis inhibitor
at13148 [no description available]	2.15	1	0
tak 733 [no description available]	2.15	1	0
mk 2206 MK 2206: a protein kinase inhibitor and antineoplastic agent	2.15	1	0	organic heterotricyclic compound	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
sns 314 SNS 314: an aurora kinase inhibitor; structure in first source	2.15	1	0	ureas
lucitanib E-3810: a multi-kinase inhibitor with antineoplastic activity; structure in first source. E-3810 : A hydrochloride salt obtained by reaction of 6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-N-methyl-1-naphthamide with one equivalent of hydrochloric acid. E-3810 is a dual VEGFR and FGFR inhibitor. E-3810 free base : A naphthalenecarboxamide obtained from formal condensation of the carboxy group of aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-1-naphthoic acid with methylamine.	2.15	1	0	aromatic ether; cyclopropanes; naphthalenecarboxamide; primary amino compound; quinolines	antineoplastic agent; fibroblast growth factor receptor antagonist; vascular endothelial growth factor receptor antagonist
pf-04691502 [no description available]	2.15	1	0
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide: a Janus kinase 1 and Janus kinase 2 inhibitor; structure in first source. momelotinib : A benzamide obtained by formal condensation of the carboxy group of 4-{2-[4-(morpholin-4-yl)anilino]pyrimidin-4-yl}benzoic acid with the primary amino group of aminoacetonitrile. It is an ATP-competitive JAK1/JAK2 inhibitor with IC50 of 11 nM and 18 nM, respectively. Used for the treatment of patients with intermediate- or high-risk myelofibrosis.	2.15	1	0	aminopyrimidine; benzamides; morpholines; nitrile; secondary amino compound; tertiary amino compound	anti-anaemic agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
dcc-2036 rebastinib: an inhibitor of Tie2 tyrosine kinase receptor and antineoplastic agent	2.15	1	0	organofluorine compound; phenylureas; pyrazoles; pyridinecarboxamide; quinolines	tyrosine kinase inhibitor
cabozantinib cabozantinib: a multikinase inhibitor. cabozantinib : A dicarboxylic acid diamide that is N-phenyl-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide in which the hydrogen at position 4 on the phenyl ring is substituted by a (6,7-dimethoxyquinolin-4-yl)oxy group. A multi-tyrosine kinase inhibitor, used (as its malate salt) for the treatment of progressive, metastatic, medullary thyroid cancer.	2.58	2	0	aromatic ether; dicarboxylic acid diamide; organofluorine compound; quinolines	antineoplastic agent; tyrosine kinase inhibitor
ldc067 [no description available]	2.53	2	0
defactinib [no description available]	2.15	1	0
ly2584702 [no description available]	2.15	1	0
incb-018424 [no description available]	2.15	1	0	nitrile; pyrazoles; pyrrolopyrimidine	antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
poziotinib HM781-36B: antitumor irreversible Pan-HER inhibitor for treatment of gastric cancer	2.15	1	0	acrylamides; aromatic ether; dichlorobenzene; diether; monofluorobenzenes; N-acylpiperidine; quinazolines; secondary amino compound; substituted aniline	antineoplastic agent; apoptosis inducer; epidermal growth factor receptor antagonist
asp3026 ASP3026: an anaplastic lymphoma receptor tyrosine kinase inhibitor; structure in first source. ASP-3026 : A member of the class of diamino-1,3,5-triazines that is 1,3,5-triazine-2,4-diamine in which the amino groups at positions 2 and 4 are respectively carrying 2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl and 2-(propan-2-ylsulfonyl)phenyl substituents. It is a potent inhibitor of anaplastic lymphoma kinase (ALK), Ack and ROS1 activity (IC50 values are 3.5, 5.8 and 8.9 nM respectively) and exhibits anti-cancer properties.	2.15	1	0	aromatic amine; diamino-1,3,5-triazine; monomethoxybenzene; N-methylpiperazine; piperidines; secondary amino compound; sulfone	antimalarial; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
entrectinib entrectinib: inhibits TRK, ROS1, and ALK receptor tyrosine kinases; structure in first source. entrectinib : A member of the class of indazoles that is 1H-indazole substituted by [4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzoyl]amino and 3,5-difluorobenzyl groups at positions 3 and 5, respectively. It is a potent inhibitor of TRKA, TRKB, TRKC, ROS1, and ALK (IC50 values of 0.1 to 1.7 nM), and used for the treatment of NTRK, ROS1 and ALK gene fusion-positive solid tumours.	2.15	1	0	benzamides; difluorobenzene; indazoles; N-methylpiperazine; oxanes; secondary amino compound; secondary carboxamide	antibacterial agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
pexidartinib pexidartinib: inhibits both CSF1R and c-kit receptor tyrosine kinase; structure in first source. pexidartinib : A pyrrolopyridine that is 5-chloro-1H-pyrrolo[2,3-b]pyridine which is substituted by a [6-({[6-(trifluoromethyl)pyridin-3-yl]methyl}amino)pyridin-3-yl]methyl group at position 3. It is a potent multi-targeted receptor tyrosine kinase inhibitor of CSF-1R, KIT, and FLT3 (IC50 of 20 nM, 10 nM and 160 nM, respectively). Approved by the FDA for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT).	2.15	1	0	aminopyridine; organochlorine compound; organofluorine compound; pyrrolopyridine; secondary amino compound	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
TAK-580 MLN 2480: brain-penetrant RAF dimer antagonist. TAK-580 : A 1,3-thiazolecarboxamide that is 2-[(1R)-1-aminoethyl]-1,3-thiazole-5-carboxylic acid in which the carboxy group undergoes formal condensation with the amino group of 5-chloro-4-(trifluoromethyl)pyridin-2-amine and in which the amino group undergoes formal condensation with the carboxy group of 6-amino-5-chloropyrimidine-4-carboxylic acid. It is a pan-RAF kinase inhibitor which is currently in clinical development for the treatment of radiographically recurrent or progressive low-grade glioma in children and young adults.	2.15	1	0	1,3-thiazolecarboxamide; aminopyrimidine; chloropyridine; organofluorine compound; pyrimidinecarboxamide; secondary carboxamide	antineoplastic agent; apoptosis inducer; B-Raf inhibitor
gsk 2126458 omipalisib: inhibitor of mTOR protein. omipalisib : A member of the class of quinolines that is quinoline which is substituted by pyridazin-4-yl and 5-[(2,4-difluorobenzene-1-sulfonyl)amino]-6-methoxypyridin-3-yl groups at positions 4 and 6, respectively. It is a highly potent inhibitor of PI3K and mTOR developed by GlaxoSmithKline and was previously in human phase 1 clinical trials for the treatment of idiopathic pulmonary fibrosis and solid tumors.	3.73	2	0	aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide	anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent
(R)-DRF053 (R)-DRF053 : A member of the class of 2,6-diaminopurines that is 2,6-diamiopurine which is substituted by an isopropyl group at position 9 and in which the amino groups at positions 2 and 6 are substituted by a 1-hydroxybutan-2-yl and 3-(pyridin-2-yl)phenyl groups, respectively (the R enantiomer). A cyclin dependent kinase inhibitor, widely used as its hydrochloride hydrate.	2.17	1	0	2,6-diaminopurines; phenylpyridine; primary alcohol; secondary amino compound	EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
emd1214063 tepotinib: MET inhibitor	2.15	1	0
fit-039 FIT-039: CDK9 inhibitor; structure in first source	3.51	1	0
pf 3758309 PF 3758309: a PAK4 p21-activated kinase inhibitor; structure in first source	2.15	1	0	organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound
gdc 0980 [no description available]	2.15	1	0
azd2014 vistusertib: potent and selective dual mTORC1 and mTORC2 inhibitor; structure in first source	2.15	1	0
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol (5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol: a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity; structure in first source	2.15	1	0	benzyl alcohols; morpholines; pyridopyrimidine; tertiary amino compound	antineoplastic agent; apoptosis inducer; mTOR inhibitor
plx4032 [no description available]	3.08	4	0	aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide	antineoplastic agent; B-Raf inhibitor
gsk 1363089 GSK 1363089: a multikinase inhibitor that acts on Met, RON, Axl, and VEGFR; structure in first source	2.15	1	0	aromatic ether
arry-334543 ARRY-334543: an antagonist of ATP-binding cassette subfamily G member 2 (ABCG2); structure in first source	2.15	1	0
kin-193 [no description available]	2.15	1	0	pyridopyrimidine
mk 2461 [no description available]	2.15	1	0
bay 869766 [no description available]	2.15	1	0
as 703026 [no description available]	2.15	1	0	pyridinecarboxamide
baricitinib [no description available]	4.57	3	0	azetidines; nitrile; pyrazoles; pyrrolopyrimidine; sulfonamide	anti-inflammatory agent; antirheumatic drug; antiviral agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; immunosuppressive agent
dabrafenib [no description available]	2.61	2	0	1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide	anticoronaviral agent; antineoplastic agent; B-Raf inhibitor
pki 587 gedatolisib: inhibits both phosphatidylinositol 3-kinase and mTOR; structure in first source	2.15	1	0
n-(3-fluoro-4-((1-methyl-6-(1h-pyrazol-4-yl)-1h-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide merestinib: in phase I clinical trials (2013); structure in first source	4.92	2	1
ribociclib ribociclib: inhibits both CDK4 and CDK6	12.99	88	1
mk-8033 1-(3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo(4,5)cyclohepta(1,2-b)pyridin-7-yl)-N-(pyridin-2-ylmethyl)methanesulfonamide: inhibits both Ron and c-Met kinases; structure in first source	2.15	1	0
bay 1000394 roniciclib: an antineoplastic agent that inhibits cyclin-dependent kinases; structure in first source	5.04	4	0
pha 793887 [no description available]	2.15	1	0	piperidinecarboxamide
sb 1518 [no description available]	2.15	1	0
mk-8776 [no description available]	2.15	1	0
afuresertib [no description available]	2.15	1	0	amphetamines
arry-371797 ARRY-371797: a p38 MAP kinase inhibitor	3.51	1	0
gsk 1070916 GSK 1070916: an antineoplastic agent with aurora B/C kinase inhibitory activity	2.15	1	0	pyrazoles; ring assembly
jnj38877605 [no description available]	2.15	1	0	quinolines
dinaciclib [no description available]	5.92	8	0	pyrazolopyrimidine
gilteritinib gilteritinib: an FLT3/AXL protein tyrosine kinase inhibitor. gilteritinib : A member of the class of pyrazines that is pyrazine-2-carboxamide which is substituted by {3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}nitrilo, (oxan-4-yl)nitrilo and ethyl groups at positions 3,5 and 6, respectively. It is a potent inhibitor of FLT3 and AXL tyrosine kinase receptors (IC50 = 0.29 nM and 0.73 nM, respectively). Approved by the FDA for the treatment of acute myeloid leukemia in patients who have a FLT3 gene mutation.	4.94	3	0	aromatic amine; monomethoxybenzene; N-methylpiperazine; oxanes; piperidines; primary carboxamide; pyrazines; secondary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
alectinib [no description available]	2.15	1	0	aromatic ketone; morpholines; nitrile; organic heterotetracyclic compound; piperidines	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
glpg0634 [no description available]	2.15	1	0
lusutrombopag lusutrombopag: a thrombopoietin receptor agonist; structure in first source	3.17	1	0	cinnamic acids
abt-199 venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source.. venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion.	2.41	1	0	aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine	antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor
ly2940680 [no description available]	4.62	1	1
bs-181 BS-181: a CDK7 inhibitor with antineoplastic activity	2.13	1	0	pyrazolopyrimidine
encorafenib encorafenib: a BRAF inhibitor	2.15	1	0
bms-911543 N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide: has antineoplastic activity; structure in first source	2.15	1	0
gsk2141795 GSK2141795: an Akt inhibitor with antineoplastic activity; structure in first source	2.15	1	0
azd8186 [no description available]	2.15	1	0
acy-1215 ricolinostat: an HDAC6 inhibitor; structure in first source	3.41	1	0	pyrimidinecarboxylic acid
on123300 ON123300: a protein kinase inhibitor; structure in first source	2.17	1	0
byl719 [no description available]	2.15	1	0	proline derivative
cep-32496 agerafenib: inhibitor of RAF family kinases; structure in first source	2.15	1	0
rociletinib rociletinib: inhibits epidermal growth factor receptor tyrosine kinase activity; structure in first source	2.15	1	0
ceritinib ceritinib: an anaplastic lymphoma kinase inhibitor. ceritinib : A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonyl)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer.	3.51	2	0	aminopyrimidine; aromatic ether; organochlorine compound; piperidines; secondary amino compound; sulfone	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
azd1208 [no description available]	2.15	1	0
vx-509 [no description available]	2.15	1	0
vx-970 berzosertib: an ATR kinase inhibitor	3.76	2	0	sulfonamide
amg 925 AMG-925 : An organic heterotricyclic compound that is 9H-pyrido[4',3':4,5]pyrrolo[2,3-d]pyrimidine which is substituted by a [6-(hydroxyacetyl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-yl]nitrilo group at position 2 and by a trans-4-methylcyclohexyl group at position 9. It is a FLT3 and CDK4 dual kinase inhibitor that has antineoplastic activity. Currently under clinical investigation in patients with relapsed or refractory acute myeloid leukemia (AML).	3.51	1	0
debio 1347 CH5183284: a fibroblast growth factor receptor antagonist; structure in first source	2.15	1	0
volitinib [no description available]	2.15	1	0
osimertinib osimertinib: an EGFR tyrosine kinase inhibitor. osimertinib : A member of the class of aminopyrimidines that is 4-(1-methylindol-3-yl)pyrimidin-2-amine in which one of the amino hydrogens is replaced by a 2-methoxy-4-[2-(dimethylamino)ethyl](methyl)amino-5-acrylamidophenyl group. Used (as the mesylate salt) for treatment of EGFR T790M mutation positive non-small cell lung cancer.	5.91	5	0	acrylamides; aminopyrimidine; biaryl; indoles; monomethoxybenzene; secondary amino compound; secondary carboxamide; substituted aniline; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
cyclin d1 Cyclin D1: Protein encoded by the bcl-1 gene which plays a critical role in regulating the cell cycle. Overexpression of cyclin D1 is the result of bcl-1 rearrangement, a t(11;14) translocation, and is implicated in various neoplasms.	5.42	6	0
ldc4297 LDC4297: a CDK7 inhibitor with antineoplastic activity; structure in first source. LDC4297 : A pyrazolotriazine that is pyrazolo[1,5-a][1,3,5]triazine substituted by a piperidin-3-yloxy group, [2-(1H-pyrazol-1-yl)benzyl]nitrilo group and an isopropyl group at positions 2, 4 and 8 respectively. It is a potent and selective CDK7 inhibitor and exhibits antiviral activity.	2.31	1	0	aromatic ether; piperidines; pyrazoles; pyrazolotriazine; secondary amino compound	antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
ly2857785 [no description available]	2.13	1	0
s 8932 [no description available]	3.17	1	0	aromatic amine; C-nucleoside; carboxylic ester; nitrile; phosphoramidate ester; pyrrolotriazine	anticoronaviral agent; antiviral drug; prodrug
at 9283 [no description available]	2.15	1	0
otssp167 OTS167: inhibitor of maternal embryonic leucine zipper kinase (MELK) with potential antineoplastic activity	2.15	1	0
chir 258 [no description available]	2.15	1	0
osi 027 OSI 027: inhibits both mTORC1 and mTORC2; structure in first source	2.15	1	0
guanine [no description available]	2.31	1	0	2-aminopurines; oxopurine; purine nucleobase	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
rifampin Rifampin: A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)	2.25	1	0	cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion	angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor
dacarbazine (E)-dacarbazine : A dacarbazine in which the N=N double bond adopts a trans-configuration.	2.11	1	0	dacarbazine
ganciclovir [no description available]	2.31	1	0	2-aminopurines; oxopurine	antiinfective agent; antiviral drug
ro 3306 RO 3306: structure in first source	2.17	1	0
hymenialdisine [no description available]	7.21	1	0
ag-879 AG-879: structure given in first source	3.51	1	0
nintedanib nintedanib : A member of the class of oxindoles that is a kinase inhibitor used (in the form of its ethylsulfonate salt) for the treatment of idiopathic pulmonary fibrosis and cancer.	3.73	2	0
amg531 [no description available]	3.17	1	0
bay 80-6946 copanlisib: an antineoplastic agent with PI3K inhibitory activity; structure in first source. copanlisib : An imidazoquinazoline that is 2,3-dihydroimidazo[1,2-c]quinazoline substituted by (2-aminopyrimidine-5-carbonyl)amino, methoxy, and 3-(morpholin-4-yl)propoxy groups at positions 5, 7 and 8, respectively. It is a intravenous pan-class I PI3K inhibitor used for the treatment of relapsed follicular lymphoma in patients who have received at least 2 prior systemic therapies.	2.15	1	0
pyrimidinones Pyrimidinones: Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O.	2.17	1	0

Condition	Indicated	Relationship Strength	Studies	Trials
Benign Neoplasms [description not available]	0	14.46	52	5
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	1	19.13	104	10
Cancer of Lung [description not available]	0	7.61	21	2
Acute Myelogenous Leukemia [description not available]	0	2.98	3	0
Lung Neoplasms Tumors or cancer of the LUNG.	1	9.61	21	2
Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.	0	2.98	3	0
Experimental Neoplasms [description not available]	0	2.91	3	0
Angiogenesis, Pathologic [description not available]	0	2.21	1	0
Infections, Coronavirus [description not available]	0	3.17	1	0
2019 Novel Coronavirus Disease [description not available]	0	5.31	3	0
Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection.	0	3.17	1	0
Coronavirus Infections Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).	0	3.17	1	0
Congenital Zika Syndrome [description not available]	0	2.25	1	0
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	0	3.75	8	0
Zika Virus Infection A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.	0	2.25	1	0
Cancer of Pancreas [description not available]	0	6.31	6	4
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).	1	8.31	6	4
Viral Diseases [description not available]	0	3.33	1	0
Virus Diseases A general term for diseases caused by viruses.	0	3.33	1	0
Breast Cancer [description not available]	0	21.57	263	68
Breast Neoplasms Tumors or cancer of the human BREAST.	1	27.94	789	204
Fatty Liver, Nonalcoholic [description not available]	0	2.41	1	0
Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION.	0	2.41	1	0
Malignant Mesothelioma [description not available]	0	5.6	4	1
Bone Cancer [description not available]	0	2.41	1	0
Osteogenic Sarcoma [description not available]	0	2.41	1	0
Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES.	0	2.41	1	0
Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)	1	9.41	1	0
Local Neoplasm Recurrence [description not available]	0	12.6	29	13
Metastase [description not available]	0	9.51	13	3
Peritoneal Carcinomatosis [description not available]	0	2.31	1	0
Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	1	11.51	13	3
Peritoneal Neoplasms Tumors or cancer of the PERITONEUM.	0	2.31	1	0
Carcinoma, Ductal, Pancreatic [description not available]	0	2.41	1	0
Carcinoma, Pancreatic Ductal Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.	1	4.41	1	0
Diffuse Parenchymal Lung Disease [description not available]	0	3.07	3	0
Abscess, Hepatic [description not available]	0	2.41	1	0
Liver Abscess Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.	0	7.41	1	0
Lung Diseases, Interstitial A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.	0	3.07	3	0
Disease Exacerbation [description not available]	0	9.91	10	4
Blood Poisoning [description not available]	0	4.72	1	1
Neoplasms, Pleural [description not available]	0	5.12	2	1
Embolism, Pulmonary [description not available]	0	4.72	1	1
Infections, Respiratory [description not available]	0	4.72	1	1
Thrombopenia [description not available]	0	4.72	1	1
Emesis [description not available]	0	4.72	1	1
Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.	0	9.03	14	8
Hemoptysis Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.	0	4.72	1	1
Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)	1	11.72	1	1
Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.	0	4.72	1	1
Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.	0	4.72	1	1
Thrombocytopenia A subnormal level of BLOOD PLATELETS.	0	4.72	1	1
Vomiting The forcible expulsion of the contents of the STOMACH through the MOUTH.	0	4.72	1	1
Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.	0	4.72	1	1
Thromboembolism, Venous [description not available]	0	2.41	1	0
Blood Clot [description not available]	0	2.41	1	0
Thrombosis Formation and development of a thrombus or blood clot in the blood vessel.	0	7.41	1	0
Venous Thromboembolism Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.	0	2.41	1	0
Cirrhosis [description not available]	0	3.01	2	0
Cardiomyopathies, Primary [description not available]	0	2.6	1	0
Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.	0	3.01	2	0
Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).	0	2.6	1	0
Cancer of Endometrium [description not available]	0	4.91	1	1
Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.	1	6.91	1	1
Liver Dysfunction [description not available]	0	2.6	1	0
Liver Diseases Pathological processes of the LIVER.	0	2.6	1	0
Colorectal Cancer [description not available]	0	4.18	10	0
Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.	1	6.18	10	0
Cancer of the Retina [description not available]	0	4.21	9	0
Carcinoma, Small Cell Lung [description not available]	0	4.31	10	0
Eye Cancer, Retinoblastoma [description not available]	0	4.21	9	0
Retinoblastoma A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)	0	4.21	9	0
Small Cell Lung Carcinoma A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).	1	6.31	10	0
Canine Diseases [description not available]	0	3.52	4	0
Germinoblastoma [description not available]	0	3.52	4	0
Lymphoma A general term for various neoplastic diseases of the lymphoid tissue.	1	5.52	4	0
Chemical and Drug Induced Liver Injury, Chronic Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.	0	3.33	4	0
ER-Negative PR-Negative HER2-Negative Breast Cancer [description not available]	0	9.77	9	5
Triple Negative Breast Neoplasms Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.	1	11.77	9	5
Carcinoma, Anaplastic [description not available]	0	2.6	1	0
Cancer of Stomach [description not available]	0	3.25	4	0
Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.	1	9.6	1	0
Stomach Neoplasms Tumors or cancer of the STOMACH.	0	3.25	4	0
Carcinoma, Non-Small Cell Lung [description not available]	0	6.18	5	2
Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.	1	8.18	5	2
Carcinoma, Epidermoid [description not available]	0	4.3	3	1
Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)	1	6.3	3	1
Thyroid Cancer, Anaplastic [description not available]	0	2.6	1	0
Cancer of the Thyroid [description not available]	0	2.6	1	0
Thyroid Neoplasms Tumors or cancer of the THYROID GLAND.	1	4.6	1	0
Thyroid Carcinoma, Anaplastic An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.	0	2.6	1	0
Acute Confusional Senile Dementia [description not available]	0	2.6	1	0
Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)	0	2.6	1	0
Innate Inflammatory Response [description not available]	0	2.6	1	0
Weight Reduction [description not available]	0	4.21	2	1
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	0	2.6	1	0
Weight Loss Decrease in existing BODY WEIGHT.	0	4.21	2	1
Pleurisy INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.	0	2.6	1	0
Chronic Illness [description not available]	0	2.6	1	0
Experimental Lung Inflammation Inflammation of any part, segment or lobe, of the lung parenchyma.	0	2.6	1	0
Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).	0	2.6	1	0
Pneumonia Infection of the lung often accompanied by inflammation.	0	2.6	1	0
HPV Infection [description not available]	0	2.6	1	0
Carcinoma, Squamous Cell of Head and Neck [description not available]	0	2.69	2	0
Cancer of Head [description not available]	0	2.63	2	0
Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.	0	2.69	2	0
Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)	1	4.63	2	0
Papillomavirus Infections Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.	0	2.6	1	0
Atypical Lipomatous Tumor [description not available]	0	2.6	1	0
Liposarcoma A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)	1	9.6	1	0
Neutropenia A decrease in the number of NEUTROPHILS found in the blood.	0	12.43	8	2
Cafe-au-Lait Spots with Pulmonic Stenosis [description not available]	0	2.6	1	0
Neoplasms, Nerve Sheath [description not available]	0	2.6	1	0
Elephantiasis Neuromatosis [description not available]	0	2.6	1	0
Neurofibroma A moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. (From Adams et al., Principles of Neurology, 6th ed, p1016)	0	2.6	1	0
Neurofibromatosis 1 An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).	1	4.6	1	0
Nerve Sheath Neoplasms Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.	0	2.6	1	0
Neurofibroma, Plexiform A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. (From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131(5):678-82)	0	2.6	1	0
Adverse Drug Event [description not available]	0	2.6	1	0
Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.	0	2.6	1	0
Lymph Node Metastasis [description not available]	0	7.9	5	4
Lupus Erythematosus, Cutaneous, Subacute [description not available]	0	2.6	1	0
Lupus Erythematosus, Cutaneous A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).	0	2.6	1	0
Colonic Inertia Symptom characterized by the passage of stool once a week or less.	0	3.99	1	1
Constipation Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.	0	3.99	1	1
Fibrosis, Radiation [description not available]	0	2.6	1	0
Radiation Pneumonitis Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.	0	2.6	1	0
Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.	0	2.82	2	0
Glial Cell Tumors [description not available]	0	4.15	2	1
Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)	1	7.22	4	2
Ewing Sarcoma [description not available]	0	7.69	2	0
Sarcoma, Ewing A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.	1	4.69	2	0
Adenocarcinoma, Basal Cell [description not available]	0	4.33	3	1
Adenocarcinoma A malignant epithelial tumor with a glandular organization.	0	9.33	3	1
Benign Neoplasms, Brain [description not available]	0	6.82	7	1
Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.	1	8.82	7	1
Disease, Pulmonary [description not available]	0	2.21	1	0
Lung Diseases Pathological processes involving any part of the LUNG.	0	2.21	1	0
Lung Adenocarcinoma [description not available]	0	3.59	1	1
Adenocarcinoma of Lung A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.	0	3.59	1	1
B-Cell Lymphoma [description not available]	0	7.25	1	0
Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.	0	2.25	1	0
Alopecia Cicatrisata [description not available]	0	3.17	1	0
Alopecia Absence of hair from areas where it is normally present.	0	3.17	1	0
Recrudescence [description not available]	0	3.7	1	1
Diffuse Lymphocytic Lymphoma, Poorly-Differentiated [description not available]	0	3.7	1	1
Lymphoma, Mantle-Cell A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).	1	5.7	1	1
Cancer of Cervix [description not available]	0	2.31	1	0
Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX.	0	2.31	1	0
IgA Vasculitis A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.	0	2.25	1	0
Cancer-Associated Pain [description not available]	0	2.25	1	0
Cancer Pain Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.	0	2.25	1	0
Cancer of Colon [description not available]	0	2.61	2	0
Colonic Neoplasms Tumors or cancer of the COLON.	0	2.61	2	0
Astrocytoma, Grade IV [description not available]	0	2.58	2	0
Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.	1	4.58	2	0
Overweight A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.	0	3.7	1	1
Leanness [description not available]	0	3.7	1	1
Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).	0	4.02	2	1
Blood Diseases [description not available]	0	2.31	1	0
Hematologic Diseases Disorders of the blood and blood forming tissues.	0	2.31	1	0
Acute Liver Injury, Drug-Induced [description not available]	0	2.25	1	0
Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.	0	2.25	1	0
Hormone-Dependent Neoplasms [description not available]	0	2.61	2	0
Cardiovascular Stroke [description not available]	0	2.31	1	0
Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).	0	2.31	1	0
Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.	0	2.31	1	0
Carcinomatous Meningitis [description not available]	0	2.25	1	0
Meningeal Carcinomatosis Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.	0	2.25	1	0
Cytomegalic Inclusion Disease [description not available]	0	2.31	1	0
Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.	0	2.31	1	0
Hepatocellular Carcinoma [description not available]	0	2.72	2	0
Cancer of Liver [description not available]	0	2.72	2	0
Experimental Hepatoma [description not available]	0	2.31	1	0
Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.	1	4.72	2	0
Liver Neoplasms Tumors or cancer of the LIVER.	0	2.72	2	0
Acute Hepatic Failure [description not available]	0	7.31	1	0
Liver Failure, Acute A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.	0	2.31	1	0
Iris Neoplasms Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.	0	2.6	1	0
Response Evaluation Criteria in Solid Tumors An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.	0	4.62	1	1
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.	0	4.48	1	1
Kahler Disease [description not available]	0	2.17	1	0
Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.	1	9.17	1	0
Injuries, Radiation [description not available]	0	2.17	1	0
Dermatosclerosis [description not available]	0	2.17	1	0
Scleroderma, Localized A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.	0	2.17	1	0
Chemotherapy-Induced Febrile Neutropenia FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.	0	3.12	1	0
Sarcoma, Epithelioid [description not available]	0	2.17	1	0
Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.	0	2.17	1	0
Carcinoma, Lobular A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.	0	2.17	1	0
Carcinoma, Oat Cell [description not available]	0	2.21	1	0
Milk-Alkali Syndrome [description not available]	0	2.21	1	0
Cancer of Ovary [description not available]	0	2.21	1	0
Hypercalcemia Abnormally high level of calcium in the blood.	0	2.21	1	0
Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.	1	4.61	2	0
Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)	0	2.21	1	0
Lassitude [description not available]	0	3.12	1	0
Cholera Infantum [description not available]	0	3.12	1	0
Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.	0	3.12	1	0
Chordoma A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed)	0	2.11	1	0
Spinal Neoplasms New abnormal growth of tissue in the SPINE.	0	2.11	1	0
Malignant Melanoma [description not available]	0	2.13	1	0
Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)	1	4.53	2	0
Tetraploid [description not available]	0	2.15	1	0

abemaciclib

Cross-References

Synonyms (76)

Research Excerpts

Overview

Effects

Actions

Treatment

Toxicity

Pharmacokinetics

Compound-Compound Interactions

Bioavailability

Dosage Studied

Protein Targets (295)

Potency Measurements

Inhibition Measurements

Activation Measurements

Other Measurements

Biological Processes (2441)

Molecular Functions (482)

Ceullar Components (396)

Bioassays (790)

Research

Studies (349)

Market Indicators

Research Demand Index: 87.49

Study Types

abemaciclib

Cross-References

Synonyms (76)

Research Excerpts

Overview

Effects

Actions

Treatment

Toxicity

Pharmacokinetics

Compound-Compound Interactions

Bioavailability

Dosage Studied

Protein Targets (295)

Potency Measurements

Inhibition Measurements

Activation Measurements

Other Measurements

Biological Processes (2441)

Molecular Functions (482)

Ceullar Components (396)

Bioassays (790)

Research

Studies (349)

Market Indicators

Research Demand Index: 87.49

Study Types

Related Drugs (390)

Related Conditions (204)